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Abstract
An in vivo evaluation of pulmonary immune response and toxicity following combined
respiratory exposure to crystalline silica and diesel particulate matter
Breanne Yingling Farris

Crystalline silica (SIL) and diesel particulate matter (DPM) are each well-recognized for
their potential to cause pulmonary toxicity following inhalation. However, these particulates have
also been identified as coexisting in mixtures of respirable aerosols at a variety of industrial
settings: mining, oil and gas extraction, construction, road construction, tunneling, excavation,
foundry, and sandblasting. In order to characterize the potential for increased pulmonary health
effects when these particulates are inhaled in a mixture, a battery of acute and subacute in vivo
exposure studies were conducted. The current studies examined co-exposure to SIL and DPM
at doses that were derived from field measures collected during industrial activities. The project
had three major aims: (1a) Characterize the pulmonary response to an acute co-exposure to
DPM and SIL at varying doses; (1b) characterize the pulmonary response to a repeated coexposure to DPM and SIL in order to determine if subacute exposure vs. acute exposure altered
the effects observed for 1a; (2) establish if susceptibility to an acute respiratory infection was
altered following a co-exposure of DPM and SIL; and (3) determine whether clearance of
particulate in a co-exposure to DPM and SIL was altered compared with the clearance rate of
either particle individually to assess the effect of particle load in toxicity. Co-exposure of rats to
SIL and DPM had the capability to enhance indicators of inflammation, injury, oxidant production
by phagocytes, onset of the initiation of fibrosis, and differentially alter immunological responses
when administered in combination, compared to either particle individually. In acute infection
models examining respiratory susceptibility following exposure to particles, the highest dose of
DPM was shown to suppress bacterial clearance in the innate phase of the immune response
as compared to SIL. It was determined that although some macrophage functions were reduced
by the presence of DPM early in the time course (1 to 3 days following infection), all groups
cleared the infection at a similar rate in the adaptive phase of the immune response. Further, it
was determined that some effects in the co-exposure group were associated with the presence
of SIL and the overall particle load over time, particularly tissue remodeling and the
development of fibrosis; whereas other effects were due to specific characteristics of DPM
including inflammation, injury, and oxidant production. Overall, the studies indicate that silicaexposed workers may be at an increased risk for adverse health effects when concomitantly
exposed to diesel particulate, even doses that cause low toxicity in individual exposures.
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Chapter 1
Introduction and Literature Review

1

Literature Review
Introduction
Exposure to airborne particulate occurs in a variety of occupations. Recorded
observation of respiratory diseases resulting from such exposures date back to prehistoric eras,
including mining with origins as far back as the Paleolithic and Neolithic eras [1]. It is speculated
that silicosis, once referred to as “dust phthisis” and “knapper’s rot,” a pneumoconiosis caused
by the inhalation of crystalline silica dust, may be the oldest known occupationally acquired
disease, dating back to the flint mining and knapping origins of industry [2]. Silicosis is still
prevalent to date, associated with a number of different occupations including mining, and data
from the Coal Worker’s Health Surveillance Program (CWHSP) suggests it is again on the rise
in coal miners, after a period of decline in the 1980’s [3]. Silica exposure has been shown to
lead to several health complications, most notably progressive fibrosis and cancer [4]. In
addition to silica, workers in the oil and gas industry are also at risk for exposure to diesel
exhaust. The diesel engine, invented in the 1890s, was used mostly for industrial or publicsector transportation applications until its transformation for private use in the 1980s.
Combustion exhaust was not recognized as a health hazard until the latter part of the 20th
century. Pulmonary exposure to diesel exhaust (DE) is now associated with several adverse
health effects including but not limited to inflammation, decrements in lung function, chronic
obstructive pulmonary disorder (COPD), bronchitis, asthma, cancer, respiratory infection,
cardiovascular disease, and stroke [5, 6]. Components of diesel exhaust are complex and
variable dependent upon many factors including the type of fuel combusted, the age and
maintenance of the engine, and the temperature and pressure at which the engine is operated
[5]. Due to the complex nature of diesel exhaust the approach to regulating occupational
exposure has varied globally.
Co-exposure to respirable crystalline silica and diesel particulate matter (DPM) may
occur in occupations in which diesel-powered equipment is primarily utilized for the purposes of
disturbing the earth’s crust, crushing, grinding, or polishing rock, as well as occupations in which
the use of sand as a material is prevalent. These occupations include surface and underground
mining, road paving and construction, tunneling, as well as masonry, ceramics, and
sandblasting [7]. While the health hazards associated with each of these particles individually
have been investigated, very few studies have systematically examined the possible risks posed
by silica and DPM combined. Additionally, many of the in vivo studies examining these particles
were conducted using doses that exceed real-time measures of particles in the personal
2

breathing zones of workers collected during industrial activities. Because mixing particles may
result in chemical interactions that alter their toxicological properties compared to the individual
particles that constitute the mixture, and dose comparison to actual exposure measurements
are of utmost importance in order to determine the combined risk of silica and DPM exposure in
the workplace, it is necessary to investigate these two aspects for a better understanding of the
possible adverse health outcomes that may result due to co-exposure to these materials in
occupational settings.

Human Health Effects of Respiratory Exposure to Crystalline Silica
Currently, the Occupational Safety and Health Administration (OSHA) report that
approximately 2 million workers in the United States are potentially exposed to crystalline silica
and for many of those workers air levels may exceed recommended exposure limits (RELs)
depending upon the industry [7, 8]. Millions more are affected in middle-low income countries
such as India, China, Brazil, and South Africa. In addition to silicosis, exposure to silica is
related to other respiratory illnesses, which have been extensively reviewed, including COPD,
emphysema, chronic bronchitis, development of respiratory infection, the overall declination of
lung function and cancer [9-12].
Moreover, non-pulmonary effects of silica exposure have also been identified including
the development of autoimmune diseases, malignancies outside of the respiratory tract [13-16],
cardiovascular diseases [17, 18] such as cor pulmonale [19] and ischemia [20], and renal
disease. For the purposes of the current studies, the review will focus on the development of
respiratory conditions as they relate to silica exposure and particularly to prolonged
inflammation and alterations in immune function.
Pulmonary Disease and Lung Cancer
Pulmonary effects following silica exposure in workers are well-established. Respiratory
exposure to silica causes pneumoconiosis, more specifically, silicosis, which is a restrictive,
fibrotic lung disease. Etiology depends upon dose/exposure and duration. The four types are:
acute, accelerated, chronic, and complicated or conglomerate silicosis, where the latter may
advance to progressive massive fibrosis (PMF) [4, 21, 22]. Silicotic fibrosis has been wellstudied in humans across several decades by medical survey, retrospective, and case study
(Table 1), and though it has been recognized in the literature since it was described by Georgius
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Agricola in the mid-1500s as an occupationally relevant disease [23], it has only been clinically
recognized in the past century.
Silicosis was a grossly neglected occupational outcome of dusty trades until what is
considered one of the worst industrial disasters in the history of the United States, “The Hawk’s
Nest Incident.” In an effort to redirect the New River for hydroelectric utilization, a 3-mile-long
tunnel through a mountain face in West Virginia, and still one of the greatest engineering feats
of modern civilization, was commissioned by the Union Carbide and Carbon Corporation in
1930. The rock face was comprised heavily of crystalline silica. Nearly 5,000 workers
contributed to the project, 2500 of whom worked underground at some point during that year. Of
the 2,500 men who worked underground, 1,500 would eventually die due to complications
associated with silicosis. Within 5 years of the project completion, 764 men lost their lives to
acute silicosis. Due to underreporting of this disease, it is suspected that these numbers are
actually an underestimation of mortality. Prior to this tragedy, silicosis remained fairly
undiagnosed as it was difficult to distinguish from other respiratory diseases with similar
symptomology and presentation such as pneumonia and tuberculosis [24].
Following this and other occupational exposure incidents, efforts have been made to
improve the detection and prevention of silicosis, particularly by the International Labour
Organization that set the standard for Chest Radiograph determination of silicosis in 1930,
which has undergone several revisions to its current form in 2011 [25]. Silicosis is characterized
based on criteria including clinical presentation, exposure history, exclusion of other diagnoses,
and finally of radiographic evidence of rounded opacities. Earlier and improved detection has
also been enhanced by the use of Digital Thoracic Radiography and Thoracic Computed
Tomography with High Resolution [26].
Pneumoconioses such as silicosis develop in the lung due to unconstrained
inflammation that eventually results in the fibrosis. Specific mechanisms that relate to this
process are still actively investigated; however, it is understood that phagocytosis of silica
causes the production of reactive oxygen species (ROS). ROS initiates inflammatory processes,
which lead to the death of silica-containing phagocytes resulting in reuptake of silica particles by
new cells and the cycle is perpetuated [4, 21, 27, 28]. In an effort to control local inflammation,
fibrotic mediators are secreted to sequester damage within the formation of a granuloma. These
granulomas, also referred to as silicotic nodules, become areas that are no longer capable of air
exchange and therefore cause restrictive fibrosis or areas where lung expansion by air is no
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longer possible. Furthermore, prolonged inflammation may also lead to the upregulation of
pathways that result in carcinogenesis [21].
Silica is listed as a Group 1 carcinogen by the International Agency for Research on
Cancer (IARC) [29]. In a retrospective study conducted by Dong et al. silica exposure in
refractory workers was linked with a higher incidence in mortality from lung cancer [19]. These
studies showed a correlation in the outcomes of silicosis and lung cancer that were dependent
upon severity of silicosis and the latency since exposure. However, these findings were
determined to be independent of smoking tenure. Attfield and Costello reported that increased
incidence of lung cancer in granite workers was associated with duration and extent of silica
exposure and suggested that the exposure regulations from OSHA of 1.0 mg/m3 over 8 hours
as a time-weighted average (TWA) and the National Institute for Occupational Health (NIOSH),
0.05 mg/m3 as a TWA for respirable crystalline SiO2 [30, 31] at that time, were not sufficient for
protection of workers with a lifetime tenure for occupational exposure to silica [32]. Data
published by Preller et al. indicated similarly that silica was a lung carcinogen and that
confounding factors including smoking and exposure to asbestos, while associated with
increased risk of cancer, did not singularly result in increased risks observed for silica-exposed
workers, which were dependent on duration of exposure and overall cumulative exposure [33].
Liu et al. corroborated former findings in their extensive lung cancer risk assessment cohort
examining over 34,000 workers in which they concluded that silica was a carcinogen, that
exposure limits in many countries may be insufficient, and that smoking tenure increases risk for
lung cancer when combined with silica exposure [34]. These findings were reaffirmed by
Kachuri et al. in a population study of Canadian men where investigators found that exposure to
silica regardless of silica source or smoking history was associated with an increase incidence
of lung cancer. These findings were exposure duration dependent and additionally coincidence
with smoking tenure increased risk beyond that of silica exposure alone [35]. While lung cancer
dominates the carcinogenic findings associated with silica exposure, it does not stand alone as
the only malignancy related effect.
Beyond the growing data implicating silica exposure in the incidence of lung cancer is
the support for other malignancies such as upper airway neoplasms. In a case study conducted
by Elci et al. data suggested that patients who had been exposed to silica dust had a higher
incidence of laryngeal cancers specifically of the supraglottic region, and that this relationship
was dose- dependent [36]. The same group reported consistently that silica exposure increased
the incidence of laryngeal cancers in a group of non-smoking and non-drinking men, with the
5

majority of cases occurring in the supraglottic region [37]. Laryngeal cancer was reported as
occurring more frequently in those exposed to free respirable crystalline silica by Sartor et al. in
a case study conducted in Brazil [38].
Autoimmune Disease
Silica exposure has been shown to have an increased association with disease resulting
from autoimmune etiologies, as reviewed by Maeda et al. [39], although the American Thoracic
Society recognizes that some of these associations may need further examination including:
scleroderma (SC), systemic lupus erythematosus (SLE), and rheumatoid arthritis (RA) [40]. In
1995, during a prospective cross-sectional medical study of 764 patients admitted to a
rheumatology clinic performed by Koeger et al., it was found that work-related exposure to silica
coincided with autoimmune connective disorders in 24 patients who had been exposed to silica
for at least three years including: progressive systemic sclerosis (PSS), RA, and SLE [41].
Similarly, Makol et al. reported that silicotic patients were at a significantly increased risk for
connective tissue disorders such as SC and anti-neutrophil cytoplasmic autoantibody-related
(ANCA) vasculitis but also an increased risk for RA and SLE in a retrospective medical survey
covering patient data reported from 1985-2006 [42]. A retrospective study investigating data
collected from past medical examinations in a large cohort conducted by Blanc et al. also
showed increased risk for rheumatological diseases like RA, SLE, and SC in silica-exposed
construction industry workers and that this risk was increased for ever-smokers. The authors
used an exposure matrix to determine occupational exposure based on exposure estimations
from the 1970s. The study included over 200,000 patients after exclusions were applied and
over 35,000 non-exposed controls who performed office duties at similar job sites [43].
Beaudreuil et al. studied the hypothesis that silica exposure may result in increases in ANCA in
the plasma resulting in diseases like vasculitis or nephritis. This group concluded that silica
exposure was the only investigated hazard that resulted in a significant difference in the
presence of ANCA compared to controls suggesting silica played a role in the development of
ANCA-related autoimmunity [44]. Results from the studies of Shtraichman et al. suggest that
those exposed to silica may even be at risk for mixed connective tissue disorder reporting that
many patients have overlapping symptoms consistent with multiple autoimmunological
diagnoses [45]. In a population-based case-control study, Parks et al. found an association
between work-related silica exposure and incidence of SLE in a cohort of people from the
Southeastern United States, n = 265 SLE and n = 355 control. Further, job histories were
determined by blind assessments, and most dusty trades for this study pertained to agricultural
6

work performed in sandy soil [46]. Bovenzi et al. conducted a case-referent population study of
scleroderma patients from 1976-1991. The authors examined 21 patients with scleroderma
compared to 42 matched controls, which suggested that among other occupational exposures,
silica increased the risk for SC and systemic sclerosis (SSc). A minimum of six months of
relevant exposure was required for inclusion [47].
Association of silica exposure with development of autoimmune disease has led
investigators to examine how silica initiates this pathological process. One group has reported
that soluble Fas, an alternatively spliced variant of the important autoimmune regulator Fas, is
over-expressed in the serum of silicotics when compared with healthy donors. The increase in
soluble Fas may lead to reduced apoptosis in aberrant immune cells resulting in a loss of selftolerance and production of autoantibodies [48, 49]. Furthermore, Wu et al. reported that T-cell
activation occurring continuously by silica from consistent exposure, or buildup in the host, may
cause activity of T regulatory cells in peripheral blood to be reduced by replacement by
activated T-cells that express CD4 and CD25. It was also noted that this data was collected
prior to clinical autoimmune presentation suggesting that pools of regulatory T cells may serve
as a way to monitor autoimmune development and that silicosis may be a predetermining factor
[50]. These findings led Otsuki et al. to hypothesize that there are two subpopulations of
surviving silicosis lymphocytes: one, which is long surviving that recognizes self-antigen, and
one, which undergoes apoptosis in response to silica and is sensitive to anti-fas autoantibody
[51].
Studies conducted by Rocha-Parise et al. examined markers of immune activation in
silica-exposed workers belonging to various industries: ceramics, mining, stonecutting,
quarrying, and foundry among others. Peripheral blood was collected from 103 patients as well
as 103 matched controls. Authors focused on the interleukin (IL)-2 axis where they report that
patients exposed to silica had higher serum levels of IL-2 receptors and inflammatory cytokines
such as IL-1α, IL-6, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ. The authors also
examined immune cells and demonstrated that those from silica-exposed patients were much
more proliferative than controls [52], suggesting hyperactivation of the immune system. In an
earlier study Rocha et al. produced data that points to reduced self-tolerance due to
polymorphisms that occur in the PD-1 and reduced expression of CTLA-4 involved in signaling
that regulates apoptosis of autoreactive cells in silicosis patients [53]. Therefore, while the
relationship of silica exposure and autoreactivity is well-characterized, the role of silica in
altering immune response is not limited to autoimmune developments.
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Infectious Disease
The incidence of tuberculosis (TB) or infection with Mycobacterium tuberculosis is also
reported to increase in individuals exposed to silica [54]. It has been recognized for centuries
that exposure to dusty trade and phthisis or silicosis increases susceptibility to “consumption” or
TB infection [23, 55, 56]. When both conditions occur simultaneously, it is known as silicotuberculosis, oftentimes presenting in non-classical ways, particularly fibroid without tendency
toward cavitation, patients may present as sputum-negative despite radiological evidence of
tuberculosis [57]. More recently, it was demonstrated that workers exposed to silica were more
susceptible to TB infection even in the absence of silicosis, though susceptibility was increased
with silicotic disease [58-62]. Though TB is the most common infection associated with silica
exposure, there is evidence that chronic exposure to silica causes susceptibility to other
infections as well.
Non-tuberculous mycobacterial (NTM) infections were reported in workers exposed to
silica and most typically in those with pre-existing lung conditions such as pneumoconiosis,
silicosis, or COPD. In a case study, Bailey et al. reported on various TB and NTM infections that
occurred in silicotic sandblasters. These researchers concluded that these infections might be
opportunistic due to reduced pulmonary defenses upon the development of occupational
disease [55]. Schaefer et al. addressed NTM infections with an avian-Battey group that typically
do not infect healthy adults. Their data suggested that damage to the lungs by industrial
exposure was associated with opportunistic infection and typically poor prognosis [63]. In a
review of NTM by Wolinsky, predisposing conditions most commonly associated with NTM
infections include pneumoconiosis, previous TB infection, and COPD. Not surprisingly the
investigator outlines silicosis as being related with NTM infection as documented in several
studies [64]. Suzuki et al. more recently investigated atypical cases of M. scrofulaceum in
adults, a pathogen more typically associated with childhood lymphadenitis. They concluded that
chronic pulmonary disease was associated with this opportunistic infection and that literature
covered most-noted history of dusty occupations and silica exposure [65]. Finally, it has been
acknowledged that diagnosis with multiple and mixed pulmonary NTM is possible in patients
with underlying pulmonary disease [66]. Furthermore, it should be noted that mycobacterial
infections following silica exposure, while dominating the literature on silica-associated
infections, are not exclusively reported.
Among other infections recorded for occupational exposure to silica include bacterial
infections with nocardiosis [55] as well as infection with Acinetobacter. Cordes et al. examined
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three reported cases of non-nosocomial Acinetobacter calcoaceticus variety anitratus
pneumonia that occurred among foundry workers, one of whom had a confirmed silicotic nodule
upon post-mortem examination. It was stated that worker exposure to mixed dust, free silica,
and metallic particles were in excessive levels. Specifically, free silica exceeded NIOSH REL.
All three cases of pneumonia were of the same strain and were likely contracted by aerosol
route [67]. Though bacterial infections have been more consistently associated with silica
exposure, fungal infections are also recognized. Bailey et al. noted a few cases of sporotrichosis
and crytococcosis known among sandblasters [55]. The importance of further investigations
involving atypical tuberculosis was stressed by da Silva et al. in a report on a patient with
concomitant silicosis and crytococcosis [68]. Though complete understanding of how silica
affects the immune system remains elusive, and taking into consideration that these infections
are known to cleared by cell-mediated mechanisms, it is likely that chronic exposure to silica
impairs this response at least partially. Subra et al. showed that in individuals with pulmonary
silicosis resulting from occupational exposure, circulating numbers of total lymphocytes were
reduced when compared with controls [69]. Further, Schuyler et al. reported that lymphocytes
recovered from silicotics were less responsive to low concentrations of concanavalin A [70].
Further studies are needed in order to determine the full effects of silica exposure with regard to
cell-mediated immunity.

Effects of Respiratory Exposure to Crystalline Silica in In Vivo Models
Pulmonary Effects
Animal studies of silica exposure have been conducted over the past few decades. The
study of silica exposure in vivo has not only led to support for epidemiological/human studies
but has primarily elucidated possible mechanisms for disease progression. These studies
include, but are not limited to, mechanism related to pulmonary clearance or lack there-of,
oxidant-induced lung injury and inflammation, and the role of immune regulation in the
development of fibrosis.
It is widely accepted that the initiation of toxicity in the host is directly related to uptake of
silica particles by alveolar macrophages (AMs) and cytotoxicity on the path to progression
towards fibrosis. Schapira et al. demonstrated that instillation of silica into rat lungs caused
increased acute inflammation driven by the production of hydroxyl radicals produced in excess
when compared to instillation of a less toxic material, titanium dioxide (TiO2) [71]. In a later
study, Shapira et al. showed that phagocytic cells ex vivo produced increased levels of nitric
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oxide (NO) following exposure to silica by increased uptake and metabolism of L-arginine,
unveiling another potential mechanism for silica-induced ROS production in vivo [72]. In a
series of studies examining silica inhalation exposure in rats, Porter et al. demonstrated that NO
and ROS were increased in the lung following exposure to silica and that the production of
these molecules was associated with pathological lesions in the lung caused by silica particle
exposure [73]. Additionally, oxidative effects of silica continued after silica exposure ceased.
Their results indicated that even after exposure ends and a period of recovery occurs, and
though silica may be cleared from the lung below a specific threshold of exposure, although
slowly, damage induced by silica particles continues to increase. [74]. It was also confirmed that
these results were obtained for a level of exposure below the threshold for what would be
considered to be “overload” [75]. Moreover, it was shown that this damage was mediated by
oxidative stress resulting from increased presence of NO and ROS in the lung [76]. Sato et al.
showed that progressive inflammation caused by ROS production upon exposure led to
infiltration of cells into the lung and production of signaling molecules, but that these effects
could be reduced by treating with oligodeoxynucleotides (ODN). The authors hypothesize that
ODN suppress mitochondrial instability that contributes to the production of ROS as their data
supported that ODN helped to maintain mitochondrial stability [77].
ROS is known to upregulate the activation of transcription factor, nuclear factor-kappa B
(NF-κB) [78, 79]. Consequently, Porter et al. [80] and Castranova et al. [81] investigated the
effects of silica exposure on the activation of NF-κB. Data reported in this study concluded that
the relationship between silica exposure in vivo and the degree of NF-κB activation was directly
related to time beginning at 5 days of exposure and increasing steadily throughout the timecourse. Since fibrosis was not found to occur until a later phase of inflammation, it is reasonable
to surmise that NF-κB may be involved in the development of fibrosis in the lung following silica
exposure. Studies conducted by Zhu et al. showed imbalances of redox due to increased
production of ROS and the down regulation of the thioredoxin (TRX) system resulted in
oxidative stress, which may eventually lead to fibrosis [82]. Further, more recent investigations
have delineated mechanisms that demonstrate that TRX may have a role in inflammasome
regulation.
Peeters et al. investigated the role of TRX and inflammasome upregulation downstream
of ROS production. They concluded that rats treated with crystalline silica particles had
increased inflammasome activation indicated by increased activation of caspase-1 and IL-1β
[83]. Studies conducted by Ghio et al. focused on silica particle chemistry and the ability of silica
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to sequester iron leading to collagen deposition [84]. Supporting this mechanism, Shimizu et al.
discovered that silica particles in mouse lungs were correlated with increased iron complexes. In
addition to increased silica-iron complexes, accumulation of p62 was demonstrated in
histiocytes, primarily shown to be macrophages, of granulomas. Increased levels of p62 are
indicative of downregulation of autophagy. Decreased autophagy may allow for cell survival,
and prolonged secretion of inflammatory and fibrogenic factors by these macrophages.
Oxidative stress is initiated by iron-silica complexes, which may ultimately result in decreased
cell death by autophagic mechanisms and hence silicotic progression. It should be noted,
however, that a direct connection between increased iron-silica complexes and increased p62
have yet to be established [85]. Moreover, Jessop et al. elucidated that autophagy in vivo
following silica exposure was at least in part responsible for the regulation of the inflammasome,
and alterations in autophagy led to enhanced inflammation and cytotoxicity. Authors exposed
autophagy deficient mice to silica, which led to increased production of inflammasome products
including IL-18 in lavage fluid. These results highlight the importance of autophagy during
homeostasis of cells following particle exposure/uptake [86].
Similar to autophagy, apoptosis has been implicated in the development of silicosis and
lung cancer following exposure to silica. Upstream of the inflammasome in the proposed
pathway, Moncao-Ribeiro et al. examined the role of P2X7, a purinergic receptor that responds
to extracellular ATP, in the development of silicosis. Their data supports the conclusion that
P2X7 regulates silica-induced changes in the lung by responding to extracellular ATP produced
in response to damage created by silica, and mediating the production of ROS, which in turn
result in mitochondrial damage and eventually apoptosis and progressive inflammation [87].
Wang et al. investigated the role of the transcription factor p53 in apoptosis following silica
exposure in animals and found that when p53 was knocked out, silica-induced apoptosis was
diminished [88]. Adding to the evidence that increased apoptosis may play a role in the
development of silicosis is a study performed by Borges et al. These investigators showed the
importance of Fas ligand in the development of silicosis and the pro-inflammatory role of
apoptosis following exposure to silica. The authors demonstrated that in mice lacking Fas
ligand, macrophages failed to undergo apoptosis in response to silica exposure and neutrophil
infiltration was reduced blunting the progression to prolonged inflammation and advancement to
silicosis. These results were further supported by both the adoptive transfer of wild-type (WT)
macrophages restoring these responses in Fas ligand knock-out (KO) mice and the blockade of
silicosis induction using a Fas ligand antibody in WT mice [89].
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Inflammation is an important initiating event modulating disease following silica
exposure; therefore, research has emphasized the role of innate mechanisms following silica
particle phagocytosis in disease. However, in light of the fact that silica has such a pronounced
effect on cell-mediated immunity and disruption of proper antigen recognition, investigators have
also focused on pathways that may be involved in toxicity including, at least in part, the
development of fibrosis. Suzuki et al. report that, although T lymphocytes regulate a portion of
fibrogenesis, athymic mice still developed fibrosis in response to silica administration,
demonstrating that T cell regulation is only partly involved [90]. Langley et al. report that there is
a “biphasic” response to silica and while hyperresponsiveness of T cells occurs during the first
of two phases, this is not required for the development of granulomas and progression to
fibrosis in the second phase as adaptive immune responses were found to have returned to
normal [91]. Migliaccio et al. determined the importance of antigen presenting cell (APC)
phenotype shift and lymphocyte activation that may initiate prolonged inflammation. Treatment
of mice with silica intranasally induced increased APC activities in AMs as wells as the
expansion of a subset of interstitial macrophages with APC markers. It remains to be
determined whether these cells are recruited to the lung or if activation of existent cells occurs
due to exposures. However, it was hypothesized that these cells and the shift of their phenotype
to increase APC activity were responsible for increased activation of T-cells and therefore
initiation of inflammatory and pro-fibrotic mechanisms [92].
Due to previous findings that demonstrated the importance of T-helper Cell Type 1 (Th1)
and Type 2 (Th2) cytokines in the development of silicosis and the known role for T regulatory
lymphocytes (Tregs) for maintaining immune homeostasis, Liu et al. suggest that depleting
Tregs might help to balance the Th1 and Th2 axis and shift response back toward Th1 from Th2
to evade fibrogenesis. They showed that Treg cells modulate inflammation in early stages by
expression of CTLA-4, and IL-10 and transforming growth factor (TGF)-β expression in later
stages promote fibrosis [93]. Guo et al. examined the balance of the Th1/Th2 axis as well. Their
data suggests that suppression of IL-1β, a cytokine that is expressed following exposure to
silica, and upregulation of the Nod-like Receptor, pyrin domain-containing 3 (NLRP3)
inflammasome, may inhibit other fibrogenic mediators downstream of IL-1β, such as collagen I
and fibronectin, and offset prolonged inflammation leading to fibrosis. The authors blocked IL-1β
using an antibody in silica-exposed mice and demonstrated that inhibition of this cytokine
resulted in reductions in TNF-α and macrophage chemoattractants. Gene expression of
important fibrogenic factors was also reduced by the blockade of IL-1β [94]. Chen et al. reported
that neutralization of a different inflammatory cytokine, IL-17, known to be involved in the
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progression of autoimmune responses, resulted in reduced initial phase inflammation in
response to silica. They found that blockade of IL-17A resulted in decreased IL-6 and IL-1β
following silica exposure in mice and, therefore, a reduction in acute phase inflammation. The
authors hypothesize that IL-17A plays a role in the silica-initiated disruption of Th1/Th2
homeostasis leading to fibrosis [95]. Another group led by Li explored the possibility that 4-1BB,
a co-stimulatory molecule in T cell activation might be involved in the development of silicosis. Li
et al. reported that blockade of 4-1BB reduced fibrosis by controlling the initial Th1 driven
inflammatory response resulting in a decreased Th2 response following initial inflammation [96].
Altogether these data suggest dual phase response of the immune system following silica
exposure, which results first in hyperactivity of Th lymphocytes that may be induced by
increased and highly active macrophages and, secondly, an uncontrolled progression of
inflammation and fibrogenesis that is likely in part modulated by the inflammasome with a role
for Treg cells.
Although most in vivo studies have emphasized the development of restrictive lung
disease, fibrosis, studies also have aimed to elucidate the mechanisms that result in obstructive
lung disease following exposure to crystalline silica. Wright et al. examined quartz exposure in
rats and determined that in an animal model, quartz was capable of not only inducing silicosis
but also obstructive lung disease characteristics including morphologic alterations to small
airway tissue and functional changes consistent with emphysema [97]. Results from studies by
Li et al. demonstrated that changes observed in the former study by Wright et al. may be due to
destruction of elastic fibers that may be due to neutrophilic-derived enzymes. It was concluded
that loss of this form of connective tissue played a role in the development of silica-induced
emphysema [98, 99].
Perturbations of connective tissue by silica may also be implicated in the development of
cardiopulmonary disease. Herget et al. showed that quartz caused pulmonary hypertension and
increased heart ventricle weights [100]. Similarly, Zelko et al. showed that vascular remodeling,
endothelial dysfunction, and inflammation were responsible for pulmonary hypertension in mice
following intratracheal instillation (IT) exposure to silica [101]. Elevations in mRNA of
inflammatory mediators and matrix proteins were observed in the heart and kidney of rats
exposed to silica by Guo et al. Additionally, it was shown that neutralization of IL-1β decreased
these fibrotic markers similar to their earlier studies conducted on the pulmonary tract [102].
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Systemic Immune Effects
There have also been extensive studies in animals investigating correlations of silica
exposure with systemic disease and autoimmune diseases, as in the case of ANCA.
Autoimmune diseases, such as SLE and SSc, have been shown to occur in populations
susceptible to the production of autoantibodies when exposed to silica. Brown et al. examined
silica exposure in New Zealand mixed mice, a strain prone to lupus, to determine if a
predisposed population exposed to silica might develop autoimmune disease. This group
showed that silica significantly exacerbated the course of SLE development in these mice,
indicated by increased mortality, proteinuria, circulating immune complexes and autoantibodies
compared with saline and TiO2 control treated animals [103]. Additionally, mice had increased
inflammation collagen deposition in the lung consistent with pulmonary fibrosis. The same
investigators showed in a later study that alterations in populations of lymphocytes, primarily
increased CD4+ T cells, resulted in reduced overall numbers of Tregs, which may allow for
autoreactivity [104]. In experiments conducted by Pfau et al. it was determined that silicainduced apoptosis led to autoimmune response, by demonstrating that when apoptosis was
blocked, increased binding of autoantibodies in mice treated with silica was inhibited [105].
Brown et al. went on to investigate the hypothesis that silica-induced apoptosis in AMs
contributed to the generation of autoantibodies and showed that reduction of apoptosis by
treatment with rottlerin decreased autoimmunity related to silica-exposure [106]. Further,
Strickland et al. examined the effect of oxidants on CD4+ T cells to determine if this may be a
cause for lupus-like autoimmune developments in animals exposed to agents that cause
oxidative damage. Adoptive transfer of these oxidant-exposed T cells, which were shown to
overexpress CD40L cause anti-DNA antibodies and result in lupus flares [107]. These findings
demonstrate that silica exposure may lead to altered DNA methylation by production of oxidants
resulting in autoimmune developments in susceptible populations.
Bates et al. examined repeated, short-term silica exposure on SLE-susceptible mice and
found that silica induced pulmonary inflammation and elevated cellular infiltrates to the lung
suggestive of ectopic lymphoid tissue development. Additionally, this group showed that silica
exposure led to systemic inflammation and initiation of pathogenic mechanism in the kidney
consistent with glomerulonephritis [108]. The same investigators also showed in a later study
that the influence of diet, which alters the lipidome, may play a role in off-setting mechanisms
that promote silica-induced autoimmune development indicating that certain populations may be
at a greater risk for the initiation of autoimmune disease and recurring flares following silica
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exposure dependent upon balance of the lipidome. They found that consumption of a
polyunsaturated fatty acid, docosahexaenoic acid (DHA) may prevent onset of autoimmunity.
Treatment with DHA or consumption of DHA in susceptible populations may help to reduce or
delay the onset of autoimmune disease [109]. Ultimately, it has been demonstrated that silica
results in autoimmunity through apoptotic mechanisms, which increase production of
autoreactive antibodies, and also shifts in normal circulating T cell populations.
Susceptibility to Infectious Disease
Mechanisms elucidating susceptibility to mycobacterial infection following silica exposure
are not well investigated due to the lack of adequate animal model for investigation until
recently, because an increase in susceptibility to mycobacterial infection due to silica exposure
could not be demonstrated in vivo [110]. Interestingly, past correlations have been drawn
between human susceptibility to tuberculosis infection following exposure to silica and animal
susceptibility to infection. Badgers have always been considered to be inherently susceptible to
mycobacterial infection. Higgins et al. elucidated a possible connection with environmental
exposures to silica and propensity for disease through the discovery of silicotic fibrosis
developments in the lungs of wild badgers upon post-mortem examination [111]. While it has
been recognized for several centuries that those employed in dusty trades had a higher
incidence of infectious diseases like tuberculosis, models examining infectious disease as it
relates to occupational silica exposure have only been developed in vivo within the past few
decades. Hatch et al. investigated variable occupational exposures in mice, and their
susceptibility to infection following exposure. The authors reported that for silica, there was only
a slight increase in infectivity, though this study was conducted following acute exposure to a
low dose of silica (100 µg) and only mortality was used as an end-point for infectivity [112].
Pasula et al. describe one of the first studies conducted in mice in which they uncovered a
mechanism for silica to alter macrophage populations in a way that favors mycobacterial
persistence in the host [110] to model silicotuberculosis. Conversely, Antonini et al. showed that
short-term silica exposure resulted in enhanced microbial clearance owed to the increase in
cellular recruitment to the lung and production of oxidants likely aiding in bacterial clearance
[113]. Antonini et al. state that in a chronic study of silica exposure host defenses were impaired
requiring further examination of silica-exposure and the importance of time in relationship to
exposure and infection.
In vivo work has been critical in helping to elucidate mechanisms of disease associated
with silica exposure, but also of value are the vast number of studies that have been performed
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in vitro. Many of the limitations involving in vivo work relate to inadequate modeling of
physiological exposure of animals to silica, time-constraints, dose constraints for modeling
exposure, or insufficient techniques for examining intricate mechanisms within a host; therefore,
cellular studies have also been useful and have provided insights into the mechanisms of
disease.

In Vitro Models of Silica-Induced Toxicity
It has been shown that depending upon model of animal used, responses to silica varied
significantly. Huaux and Barbarin et al. investigated the release of cytokines by AMs following
exposure to silica and reported species-dependent expression of TNF-α [114, 115]. Dorger et
al. examined the release of NO from macrophages in response to stimulation/activation by
pulmonary irritants and found species dependent results [116]. Silica elicited fibrotic responses
varied between models also, with rats being the most sensitive to pro-inflammatory changes
induced by silica [117, 118]. These studies suggest that responses in biological systems may
vary dependent upon species. Additional studies in cellular systems including human cell lines
have been beneficial in advancing the field, particularly with regard to mechanisms of direct
particle-cell interaction.
Pulmonary Toxicology
Although most work contributing to the expansive body of silica-exposure related studies
has focused on addressing silicotic developments in the pulmonary tract, there are studies
examining other detrimental effects of silica previously mentioned including cardiovascular
disease [119]. Although, for the purposes of this review, emphasis in the in vitro section will be
focused on pulmonary related effects and mechanisms involved in immunity to respiratory
infection.
The mechanisms of action in silica toxicology and pathology have yet to be fully
elucidated, although investigators have outlined several critical events in silica toxicity, which
are widely accepted including interaction with resident alveolar macrophages [120, 121]
followed by sustained inflammatory cascades resulting from macrophage mediation [122, 123],
recruitment of additional cells [124-126], further activation of the immune system [127-129], and
cell death [130, 131]. Research on particle-cell interactions has led to 4 basic overarching
mechanisms for toxicity [27]. While an overwhelming body of literature exists addressing
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specific aspects of crystalline silica toxicity, most of this work is aimed at examining one of these
broad categories.
1) Cytotoxicity of Lung Cells Caused by Silica Particles Directly
The principle that crystalline silica causes direct cellular toxicity resulting in the creation of
cytotoxic mediators [4] is well-established. There are possible mechanisms that address the
toxicity of silica particles relating to the surface chemistry and the reactivity of SiO 2 when in
direct contact with cells. 1) Free radical groups are formed when the surface of silica contacts
aqueous solutions causing direct damage to biological membranes by lipid peroxidation. Nash
et al. concluded that the toxic effects of silica are related the ability of silica to form complexes
with structures such as phospholipids within membranes and act as a hydrogen donor [132]. Shi
et al. showed that these effects were more significant in freshly fractured silica particles
compared to those aged in aqueous solution [133]. Dalal et al. further examined this reaction
and showed that radicals were likely the initiating step in the peroxidation of lipids caused by
silica particles [134]. 2) Negative charges on the surface of silica interact with scavenger
receptors on macrophages resulting in the production of ROS. Kobzik et al. found that anionic
particles like silica were taken up by scavenger receptors (SR) on AMs. When SR were inhibited
a reduced binding occurred [120]. Research by Iyer et al. examined the potential of silica
particles to initiate apoptosis in AMs leading to the release of fibrogenic factors. Blockade of
either SR or downstream mediators of apoptosis resulted in reduced apoptosis and release of
IL-1β from silica treated AMs [131]. 3) Fracturing silica creates Si radicals on the particle surface
resulting in oxidant damage. Vallyathan et al. compared free-radical concentrations in freshly
ground silica with aged silica by using electron spin resonance (ESR). Freshly ground silica
produced silicon radicals that decreased over time in air and more rapidly in aqueous solution.
Introduction of silica particles to aqueous solution increases the biological reactivity by methods
described above. Further, freshly crushed silica induced greater lipid peroxidation as
demonstrated by Castranova [135]. Experiments that suggested surface chemistry of silica as
the initiating step in biological toxicity were further confirmed by research that showed that
coating silica particles with substances such as organosilane [136], aluminum [137],
polyvinylpyridine-N-oxide (PVNO) [132], or surfactant phospholipid [138, 139] resulted in
reduced toxicity. Though direct cytotoxicity to AMs likely initiates mechanisms of chronic
inflammation and fibrogenesis, there is a body of work that described additional mechanisms
that are crucial for the development of silicosis and silica-related pathogenesis. The reaction of
AMs and other phagocytes is also critical for the development of chronic inflammation.
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2) Activation of Phagocytes and their Release of Oxidants
Upon activation, AMs and polymorphonuclear cells (PMNs) or neutrophils release oxidants
in a ‘respiratory burst’ prior to phagocytosing particles, as reviewed by Badwey and Karnovsky,
Babior, and Fubini and Hubbard [130, 140, 141] and as demonstrated by Zhang et al. [142].
Vallyathan et al. showed that occupational particles including silica, particularly freshly fractured
crystalline silica, enhanced the respiratory burst of phagocytes [28]. Also, upon phagocytosing
silica materials, production of oxidants continued through effects on mitochondrial function
resulting in generation of mitrochondrial ROS (mtROS). Mintz determined that phagocytosis of
silica increased the mitochondrial redox state compared with the uptake of inert beads [143].
Fazzi et al. also have shown that reduction of mtROS may lead to reduced apoptosis of
macrophages due to silica exposure and overall reduction in pathogenesis [144]. Additionally, it
was suggested by Driscoll et al. that although cells have mechanisms that typically balance
these redox reactions, particles that enhance production of ROS disturb this balance and may
lead to increased cellular toxicity and mutagenesis of surrounding epithelial tissue, thereby
recruiting additional phagocytes, which further perpetuates this cycle [145]. This may in part be
due to a mechanism for chronic inflammation at the site of initial injury termed alveolitis. Lugano
et al. showed in vitro that macrophages exposed to silica released more chemotactic factors for
neutrophils and additional macrophages compared to control [126, 146]. Furthermore, it is
proposed that the release of reactive radicals by particles and ROS production by phagocytes
may interact to form additional toxic oxidant compounds contributing to cell cytotoxicity [147].
Pricop et al. have demonstrated that RO intermediates caused increased phagocytosis acting
as a mechanism for further inflammation and enhanced phagocyte effector functions [148].
Further studies have indicated a role for additional ions such as iron and calcium in the
modulation of oxidant production by phagocytes. Ghio et al. revealed that iron complexes on the
surface of silica particles may influence their potential for stimulating respiratory burst and
subsequent recruitment of cells by exposed macrophages [149]. Kim et al. investigated the
suppression of the respiratory burst of phagocytes and found that protein kinases and
intracellular calcium transport were both intimately involved in the activation and subsequent
response of AMs to silica particles [150].
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Additionally, ROS have been implicated in the initiation of several carcinogenic pathways as
well. Vallyathan et al. highlighted the importance of the increased activation of a transcription
factor for inflammatory pathways and cell adhesion, activator protein (AP)-1. AP-1 was
significantly increased in cells exposed to freshly fractured silica. This effect was attenuated by
treatment with an ROS scavenger, leading to the conclusion that ROS may be involved in the
activation of AP-1 [151]. Gwinn et al. examined the role of a transcription factor, p53, in the
regulation of gene expression as it relates to DNA repair in the context of oxidant related
damage caused by silica, both fresh and aged. Following this study, it was concluded that silica,
particularly freshly fractured and highly reactive, caused cellular damage, which if persistent
may lead to the potential to elicit carcinogenesis [152]. Based on the evidence described above,
oxidative stress response by phagocytes is a key step in the initiation of carcinogenesis and
fibrosis; however, the cascade of subsequent cell signaling events has been shown to be
equally pivotal.
3) Inflammation Caused by Immune Cell Signaling
Recent studies have shown that the respiratory burst triggered by silica particles results in
an intricate, yet not fully elucidated, series of signaling events [153, 154]. These signaling
events are part of a normal innate immune response to pathogen-associated molecular patterns
(PAMPs) and danger-associated molecular patterns (DAMPs) that trigger upregulations of
inflammation mediated by a large multi-protein complex sensor, the inflammasome [155, 156].
The studies described below focused on investigations aimed at delineating the role of
inflammasome formation as a critical part of the signaling cascade that may lead to more
chronic lung injury.
Alveolitis or chronic inflammation caused by the influx of immune cells into the lung following
exposure to particles is initiated by resident macrophages in an attempt to clear directly
cytotoxic particles from the lung [157]; nevertheless, other immune and pulmonary cells also
contribute to progression toward chronic inflammation. Beamer and Holian reported that
dendritic cells (DCs) may be important for the production of some inflammatory cytokines in this
progression [158]. Lo Re et al. have shown that T lymphocytes, including CD4+ and γδT cells,
may play an important role in early neutrophilic responses to silica exposure by IL-17A
mediation [159]. Lastly, Van Berlo et al. demonstrated that alveolar epithelial cells also may
contribute to inflammation following quartz exposure and these results were independent of NFκB driven mechanisms [160]. As previously mentioned, signaling by macrophages to different
cell types is partially mediated by the upregulation of the inflammasome [155]. However, the
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secretion of mature IL-1β by activated macrophages in response to silica, which requires the
transcription factor NF-κB [161], has been shown to be a two-step process based on reports
from Beamer and Holian, as well as Cassel et al., suggesting that induction of the
inflammasome by silica necessitates that macrophages first be primed by a stimulant, such as
bacterial lipopolysaccharide (LPS) [123, 158]. Chen et al., have shown that silica itself can
induce the activation of NF-κB, differentially from LPS [162]. Therefore, pro-IL-1β may be
produced in response to this priming signal and later be cleaved when the inflammasome is
upregulated by lysosomal damage, a DAMP resulting from the phagocytosis of silica as
investigated by Hornung et al. and Hughes et al. [129, 163]. Moncao-Ribeiro et al. as well as
Riteau et al. suggest that uptake of silica causes release of extracellular ATP succeeded by the
activation of purinergic signaling that ultimately activates the NLRP3 inflammasome [87, 164].
Additionally, Peeters et al. demonstrated that the activation of the NLRP3 inflammasome by
silica was related to particle surface reactivity, and moreover, that upregulation of this
inflammatory pathway occurred in epithelial cells of the pulmonary tract in addition to myeloidderived cells [83]. Tsugita et al. have suggested that inflammasome activation may also be
receptor signal dependent and that certain subsets of macrophages may contribute differently to
acute versus chronic inflammatory processes [165]. Cassel et al. performed studies to address
whether progression to silicosis is dependent upon inflammasome mediated IL-1β secretion, but
not all inflammatory cytokines/chemokines secreted in response to silica related to this pathway
[123], indicating the involvement of multiple pathways.
Other studies indicate that additional signaling mechanisms within the alveoli and
associated tissue, particularly in the interstitium and lymphoid tissue, may play key roles in
progression to chronic inflammation and fibrosis. Migliaccio et al. stated that alterations in APC
phenotype and presentation may contribute to the initiation of chronic inflammation [92], though
this is not necessarily independent from inflammasome activation. Other investigations led by
Migliaccio et al point to a role for Th2 mediated immunity in development of silicosis as well
[166]. While it is well-established that chronic inflammatory immune cell signaling is integral to
the development of fibrosis, this is due in part to the release of fibrogenic factors by similar cells
such as macrophages. Rom et al. demonstrated that macrophages exposed to silica signal for
the proliferation of structural cells and their release of extracellular matrix proteins [167].
4) Release of Fibrogenic Factors from Cells
While uncontrolled inflammation has been stressed as a major factor in the development of
fibrosis, it is likely not the only mechanism involved in the development of silicosis. Studies
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examining the role of immunosuppressive pathways in the development of fibrotic disease are
being investigated. In work involving eicosanoids, Koren et al. highlighted the importance of
silica modulation on the expression of eicosanoids and the opposing effects of lipoxygenase
and cyclooxygenase (COX) enzyme pathways in macrophages following silica exposure. These
experiments indicated that while the release of leukotrienes was increased, the expression of
prostaglandin (PG)E2 was reduced, suggesting the potential for increased leukocyte chemotaxis
as well as fibroblast proliferation [168]. Studies conducted by Barbarin et al. recapitulated these
findings and further elucidated that IL-10 influenced macrophages and lung fibroblasts to
increase production of fibrogenic cytokines such as TGF-β, while down regulating COX-2, an
important enzyme in the expression of an antifibrotic eicosanoid prostaglandin, PGE2 [169].
Other cell types have also been shown to be involved in the TGF-β-elicited effects during
silicotic fibrosis. For example, Th17 cell activity has been implicated in many inflammatory
diseases. Recently, Th17 cells were associated with epithelial-mesenchymal transition (EMT),
an important process in embryonic development in normal tissue and also for cancer metastasis
[170] and tissue fibrosis in pathogenesis [171]. Mi et al. demonstrated that IL-17A promoted the
expression of EMT– related biomarkers in alveolar epithelial cells and that this was dependent
upon TGF-β. Furthermore, this group established that IL-17A elicits the secretion of collagen by
lung epithelial cells and that this too is dependent upon TGF-β [172]. Therefore, the antiinflammatory cytokine TGF-β is instrumental in these processes. Lo Re et al. evaluated the role
of Tregs in expression of platelet-derived growth factor (PDGF) and found that this occurred
through a TGF-β mediated pathway and when these cells were transferred in vivo collagen
deposition occurred. This group concluded that the inflammatory effects of T effector cells may
lead to fibrosis in the absence of Tregs; however, Tregs play their own role in the fibroproliferative wound healing of the lung following silica exposure and both arms of the immune
response need to be addressed to achieve effective therapy [173].
Immune Effects
There is a clear body of evidence suggesting the involvement of silica exposure and the
development of autoimmune disorders, both from epidemiological data and in vivo study. The
mechanisms by which this occurs have also yet to be fully elucidated. Most studies investigating
this to date have been conducted ex vivo in samples from silicotic patients. Therefore, in vitro
data is limited. It is likely that several pathways are involved as a vast diversity of autoimmune
disorders are causally linked to silica exposure. Lee et al. hypothesize in their review that longterm stimulation of T effector cells and aberrant apoptotic response in contrast with increased
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apoptosis of Tregs is likely to be involved in this process [174]. In vitro evidence for this exists; it
has been shown by Rao and Frey that silica exposure may cause altered APC presentation to
lymphocytes that may result in their aberrant activation [175]. Additionally, Wu et al. examined
the early activation marker CD69 on T cells exposed to silica and found that chronic activation
of these T cells may lead to disruption of normal apoptotic mechanisms resulting in a chronically
activated population of cells [176]. In their study examining the importance of apoptosis in selfantigen recognition, Pfau et al. concluded that silica exposure results in repeated apoptosis of
cells that can increase the presentation of self-antigen and, therefore, autoantibody
development [105]. Furthermore, Holian et al. showed that silica exposure resulted in a shift of
macrophage phenotype to elicit more inflammatory conditions supporting the findings of Pfau et
al. [177].
Other studies by Beamer and Holian suggest that the inhalation of silica might predispose
individuals to infections due to alterations in APCs, disrupting their ability to adequately respond
to pathogenic stimuli by downregulation of surface molecules and production of NO in response
to bacteria [158]. Allison and Hart performed one of the earliest studies examining susceptibility
to M. tuberculosis in macrophages. They determined that bacteria could more readily replicate
and were released earlier from macrophages exposed to silica, and that this was dependent on
very low dose exposure. These findings led them to hypothesize this as an explanation, in part,
for susceptibility of silicotics to tuberculosis infections following chronic low dose exposure to
silica [178].
The body of work mentioned above is only a summary of available literature comprising the
current knowledge of silica exposure and the effects thereof. Though the field of silica exposure
is widely examined, the mechanisms by which silica elicits toxicity, fibrosis, and susceptibility to
infection are still not fully elucidated and require further investigation, especially when
considering the potential for complications and alterations to these mechanisms in models of
exposure to particle mixtures, which are prevalent in many current occupational platforms.
Therefore, the current study is necessary to explore these effects further.

Exposure to Diesel Exhaust (DE)
Following the increased dependence on the combustion engine in the industrial era and the
introduction of the diesel engine into the public-sector of transportation in the 1950s, hazardous
health effects as a result of exposure to combustion exhausts have been extensively
investigated. The association between pulmonary exposure to diesel and the development of
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diseases such as COPD, bronchitis, asthma, respiratory infection and cancer is well recognized
[5, 6]. The complex nature of diesel exhaust has resulted in variable methods of measuring and
preventing exposure. Regulations exist for several common constituents of diesel exhaust
including total particulate, total carbon (TC), elemental carbon (EC), carbon monoxide, and
nitrogen oxides [179-183]. While the United States does have RELs in place for several
constituents of diesel, the only regulations targeting diesel exhaust specifically use EC and TC,
which encompasses DPM concentrations. The State of California Department of Health
Services recommends an EC exposure limit of 20 µg/m3 [184], and the Mine Safety and Health
Administration sets an exposure limit for TC at 160 μg/m3 in below-ground settings [182].
Furthermore, in addition to the known respiratory complications associated with diesel
exposure, other systemic diseases related to these exposures have also been investigated,
including cardiovascular and ischemic disease [185-192] and malignant diseases outside the
lung including bladder cancer [193], prostate cancer [194], and ovarian cancer [195]. However,
for the purposes of the current study, the review will focus on research related to the
development of respiratory conditions as they relate to DE/DPM exposure, particularly as they
relate to prolonged inflammation and alterations in immune function.

Respiratory Effects of Work-Place Exposure to DE
The results of epidemiological studies related to lung effects caused by occupational
exposure to DE are variable and conflicting. The data available for these exposures are
confounded by other respiratory exposures including cigarette smoke and inorganic dusts,
particularly in the context of mining/tunneling. Additionally, the studies depend heavily on proxy
interviews, and predominately examined risk for lung cancer only [196, 197]. Nevertheless,
studies in the last few decades indicate DE exposure is involved in the development of not only
malignancies, but also pulmonary diseases, and is particularly highly correlated with decreased
lung function. Ulfvarson and Alexandersson conducted a study in stevedores utilizing diesel
fueled trucks to load ships. The authors determined that the DPM component contributed to a
reduction of lung function in workers exposed to total DE compared with groups exposed to
particle-filtered DE. Further, it was concluded that declination in function reflected a restrictive
pattern [198]. Chattopadhyay et al. showed DE exhaust exposure may lead to both restrictive
and/or obstructive lung symptoms in their study investigating workers in a transit diesel bus
garage. Data suggested that restrictive lung disease developments were dependent upon age,
job function, and working tenure to some extent; additionally, it was suggested that current and
previous smoking status played a role in these results [199]. Due to confounding exposures,
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there is very little epidemiological evidence to suggest that exposure to DE independently
results in fibrosis or pneumoconiosis; although, some parameters such as radiographic findings
have been examined. However, at very high levels of exposure, or in combination with other
toxic respiratory exposure, outcomes of fibrosis may be plausible. In studies performed by
Gamble et al. examining underground salt miners where diesel equipment was used, some
evidence of pneumoconiosis was evident in a small number of cases; however, due to the small
quantity of radiographic findings in these workers and the likelihood of confounding factors,
these outcomes were not further investigated [200, 201]. Similarly, Gamble et al. examined
respiratory symptoms in diesel-bus garage workers, and deemed radiographic evidence of
pneumoconiosis to be insufficient for analysis and likely a result of confounding factors.
However, it was found that a decrease in overall lung function occurred compared to other nondiesel exposed “blue-collar” workers; this result was associated with working tenure. Overall,
smoking was the most significant risk factor indicated in this study [202].
Decrements in lung function due to DE exposure are more commonly associated with
obstructive lung changes related to COPD, chronic bronchitis, and asthma. In an examination of
workers who tested diesel engines at a manufacturing plant in China, Zhang et al. showed that
exposure to DE led to lung function decrements, which were associated with long-term
exposure. It was noted that these changes were most consistent with obstructive lung disease.
Further, it was established that decreased lung function was not dependent upon smoking
status [203]. Historically, COPD has been strongly linked with tobacco smoke and cigarette
smoking in these studies. However, in addition to the Zhang et al. study, accumulating evidence
suggests that exposure to DE specifically is linked with COPD in never-smokers. One medical
surveillance study by Ulvestad et al. examined symptoms of COPD in tunnel workers (TW)
compared with other heavy construction workers and determined that DE likely enhanced the
risk for respiratory symptoms and COPD in TW [204]. An investigation of mortality in a cohort of
construction workers by Bergdahl et al. led to the conclusion that fumes including DE may
increase the risk of death by COPD particularly in never-smoking, construction workers [205].
In two retrospective cohorts examining railroad workers following the initiation of diesel
locomotive use, Hart et al. determined that workers exposed to DE were at a higher risk for
mortality caused by COPD than those who were not exposed to DE, and that this was
dependent on amount of time worked, as well as job function. Further, while smoking status was
positively associated with increased risk for COPD and tended to correlate with higher DE
exposure, after controlling for this confounder, higher risk for mortality following DE exposure
persisted, though it was slightly attenuated [206, 207]. In a population-based study examining
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cumulative lifetime occupational exposure and risk for COPD, Weinmann et al. found that those
exposed to DE were at an increased risk for diagnosis with prevalent COPD regardless of
smoking status [208].
Several studies have examined other obstructive respiratory symptoms associated with
chronic upper airway inflammation or bronchitis. Jӧrgensen and Svensson found that among
miners who worked below ground with diesel-powered vehicles, the frequency of bronchitis was
increased and that this finding was dependent upon smoking status and age; however, no
difference in lung function was noted [209]. Oliver et al. examined a cohort of Highway and
Heavy (HH) construction workers for lung function and respiratory symptoms. Authors
concluded that only TW in the cohort were at an increased risk for chronic bronchitis.
Additionally, it was found that risk for bronchitis increased with age and smoking status;
conversely, working tenure was inversely associated with incidence of bronchitis. Workers who
experience respiratory symptoms and/or are properly diagnosed by a physician may leave the
trade contributing to a phenomenon known as the “healthy worker” effect. The authors suggest
that this effect likely contributed to the finding that incidence of chronic bronchitis decreased as
working tenure increased [210]. Gluck et al. investigated the role of chronic DE exposure on the
nasal mucosa of customs officers who clear large diesel trucks. Their findings suggest that
workers exposed to DE have increased hyperplasia of the nasal mucosa resulting from
prolonged inflammation [211]. Finally, a study of toll-workers exposed to DE conducted by Safak
et al. revealed that increased work duration resulted in increased bronchus wall thickening and
decreased diameter of the large airways [212].
The incidence of asthma as a result of occupational DE exposure is now well-recognized
and dates back to an initial case study by Wade and Newman in which they concluded that
three railway workers developed asthma due to overexposure to DE, having no previous history
of airway disease or exposure resulting in asthmatic symptoms [213]. Adewole et al. reported on
three workers in diesel bus garages who developed asthma. It was concluded that the most
probable cause of the asthma was chronic low-level exposure to DE with long periods of latency
[214]. Furthermore, Oliver et al. reported an increased incidence of asthma in HH construction
workers and TW exposed to DE, specifically in women, though this may partly be due to better
reporting of symptoms to physicians by women. Additionally, it was established that incidence of
asthma resulted in reduced lung function [210].
Research investigating the effects of DE exposure in the work-place has most
historically been in an effort to determine the risk for developing lung cancer. Investigations on
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this subject vary widely in conclusion due to several confounding factors including the complex
and variable properties of DE, potential co-exposure to other chemicals, particles and irritants,
cigarette smoking, duration and magnitude of exposure, as well as age and other health
complications. The findings relating to the development of lung cancer as a result of exposure to
DE are summarized briefly (Table 2). Furthermore, based on this research and in vivo
investigations, diesel exhaust was recently identified as a Group 1 carcinogen in the 2014
Monograph of the IARC [215]. The working group states that among the most convincing
studies related to DE causality of lung cancer are the occupational cohort studies on railroad
workers, miners, and transportation industry as a result of the clearly defined exposure levels
and adjustment for confounding factors including cigarette smoking [216-219].

Respiratory Effects of Environmental Exposures to DE
In order to investigate the effects of inadvertent environmental exposure to DE,
investigators have conducted studies examining traffic-related pollutants. Air pollution, and more
specifically DE-related air pollutants, have been linked to reduced lung function, development of
respiratory diseases, and malignancies. Brunekreef et al. examined school children who lived
nearby to major roadways and measured pollutants in their schools. The authors of this study
determined that decrements in the lung function of children were more closely associated with
diesel-powered truck traffic, as compared to other motor vehicle exhaust (MVE) for which there
was less correlation. Furthermore, the data suggested that this association was strongest in
children who lived nearest to the motorways [220]. In a similar study, Northridge et al. examined
students who attended a school in Harlem to assess whether bus depots placed in
underprivileged areas of New York might contribute to the development of chronic lung disease.
The authors suggest that adolescents in this region were subjected to above normal exposure
to DE. Data gathered from this study also indicated that small airway obstruction, in the absence
of symptoms, suggestive of asthma occurred in as many as 30% of participants. Furthermore, it
was stated, since less than a third of those participants had ever been identified as having a
history of asthma, that underdiagnosing and/or underreporting of asthma was likely occurring
among Harlem adolescents [221]. Moreover, a cross-sectional study of asthmatic children living
in close proximity to heavy traffic performed by Margolis et al. explained that distance of
residence from highway was predictive of reductions in small distal airway size and risk for
greater susceptibility to lung function decrements supporting the hypothesis that DE exposure
may exacerbate existing asthma [222]. Further strengthening evidence for allergic disease
outcomes is an epidemiological study that examined proximity of children to traffic-related air
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pollutants and the development of syndromes such as asthmatic bronchitis, hayfever, eczema,
and allergic sensitization. Conclusions from this study demonstrated that children exposed to
ambient particulate matter and living less than 50 meters from busy streets were at the greatest
risk for atopic disease. Significant increased risk was found for bronchitis, hayfever, and pollen
sensitization with relation to particulate matter with a diameter smaller than 2.5 µm (PM2.5), and
eczema was more closely associated with nitrogen dioxide (NO2) exposure [223], both of which
are components of DE.
In a population-based research study of traffic-related pollution conducted by Lindgren et
al. it was found that residential traffic was associated with increased incidence of asthma and
COPD diagnosis, as well as, symptoms associated with asthma and chronic bronchitis,
suggesting that traffic-related pollution may have both short and long-term effects on human
health [224]. A study by Beatty and Shimshack analyzed the ability of filters to reduce school
bus exhaust emissions within residential communities and their impact on the health of adults
and children living nearby. Overall, it was found that incidence of asthma, bronchitis, and
pneumonia were reduced in both children and adults with chronic respiratory symptoms and
numbers of hospital cases for these complaints were reduced after retrofitting the school buses
to reduce DE [225]. Salameh et al. concluded that outdoor air pollution caused by both heavy
traffic or residing in proximity to a power plant may increase incidence of chronic bronchitis,
though home heating methods and passive smoking were also found to be factors [226]. In a
study by Shultz et al. the associations between the development of asthma, allergies, and
wheezing were investigated in relation to either annual PM2.5 exposure, industry related
exposure, or traffic exhaust exposure. The data demonstrated results similar to studies
described above; incidence of allergic asthma was associated with increasing exposure to
particulate matter, and proximity to roadways had the largest increase in asthma that suggests
traffic-related PM2.5 may be a significant risk factor for developing asthma [227].
Environmental Exposure to DE and Susceptibility to Infection
Evidence from epidemiological observations also suggest that susceptibility to infections
in the respiratory tract may be increased following environmental exposures to DE. Increases in
some components of DE, including NO2 and PM10, and ozone (O3), an allotrope of oxygen that
is created as a result of chemical interactions between combustion products (NO2 and volatile
organic compounds (VOCs)) and sunlight, were shown to be associated with increased hospital
admissions for pneumonia and influenza [228]. A population-based study by McGowan et al
suggested that increases in PM10 in the environment resulted in increased hospital admissions
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for pulmonary infections including pneumonia, influenza and other acute respiratory infections.
Furthermore, they explained that while admissions across age groups were similar, children
were at a slightly higher risk for hospitalization [229]. Neupane et al. revealed that older adults
exposed to higher levels of air-pollution including components of DE, including PM2.5 and NO2
were at an increased risk for hospitalization for pneumonia [230].

Experimental Exposures to DE in Human Volunteers
Pulmonary Effects
In an effort to determine the risk posed to humans by DE exposure by eliminating
confounders that are present in epidemiological and occupational assessments, several
researchers have conducted experiments in human volunteers in controlled environments.
Many of these studies examine a particular component of DE in order to determine which
properties have a causal relationship with the health effects that have been observed in
epidemiological studies. A study by Rudell et al. used particle trap filters to reduce DPM when
exposing healthy human subjects to DE. Additionally, they sought to determine what effects DE
had on cells recovered from bronchoalveolar lavage. Findings from this investigation resulted in
the conclusion that DE exposure caused inflammatory cell influx into the airways and that
trapping particulate did not significantly reduce these effects, suggesting that gaseous
components might be partially responsible for these effects [231]. However, in a separate study,
Rudell et al. examined additional methods of filtration in the cabins of diesel automobiles and
evaluated their effects on vehicle occupants following exposure. Particle-only filtration did not
reduce symptoms experienced, though particle filters in combination with active charcoal
filtration did significantly reduce reported symptoms. This is attributed to the reduction in the
hydrocarbon components of the gaseous fraction of DE. It should be noted that reduction of
symptoms with filtration was based on self-reporting by subjects. No measured parameters of
lung function or nasal lavage were altered between exposure filtration variations or controls
[232]. It is also important to note, with regard to self-reporting, that a separate study conducted
by Carlsten et al. demonstrated that perceived exposure to DE by study subjects in a blinded
exposure study was more important in prediction of symptom reporting than DE exposure itself,
and therefore, symptom-independent studies may be more useful in determining effects of DE
[233]. Conversely to findings relating to DPM by Rudell et al., are the conclusions of a study by
Nightingale et al. that investigated whether or not DPM caused inflammatory response in the
airways of healthy volunteers. While they did not observe any changes in lung function or
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cardiovascular parameters measured in this study, authors did observe airway inflammation at
high concentrations of DPM [234], a conclusion not based on self-reported symptoms.
In order to more fully elucidate the impact of DE on the airways, Salvi et al. exposed
healthy volunteers to dilute DE during intermittent exercise. The authors of this study reported
that acute short-term exposure to DE caused systemic and pulmonary inflammation
demonstrated by elevated neutrophils recovered in peripheral blood and lavage fluid,
respectively [235]. Behndig et al. exposed healthy volunteers to DE to determine if pulmonary
cells would elicit an antioxidant response to low doses of DE, similarly to results observed in in
vitro studies. Though they did observe inflammation and antioxidant responses in response to
DE exposure, it was in the conducting bronchial airway and not in the alveolar region suggesting
that pulmonary response to DE was compartmentalized [236]. In an investigation of DE
exposure on airway inflammation, Sehlstedt et al. aimed to clarify whether engine load or
transient speed altered effects observed with DE generated by idling engines. Authors
explained that DE produced by urban engine cycling increased the expression of adhesion
molecules in bronchial vascular endothelial cells and resulted in bronchoalveolar eosinophilia, a
finding not previously reported in relation to responses to DE generated from idling engines.
These results support the idea of variable health outcomes in response to DE produced under
differing conditions [237].
Furthermore, the composition of DE is complicated by the interaction of its components
with properties of the environment such as water vapor and sunlight. As previously mentioned,
when some combustion components chemically react with the environment, additional
hazardous inhalants such as O3 may be formed. Therefore, some experiments have been
performed to determine whether these reactions may contribute to health effects observed for
environmental exposures to DE. A non-invasive technique for the detection of airway
inflammation following controlled exposures that measures fraction of exhaled nitric oxide
(FENO) as the injury parameter has been used as a marker of adverse effects in the lung. In a
study conducted by Barath et al. DE was shown to enhance FENO and that this effect was
localized to the central airways; however, this technique was not effective for detecting the
inflammation caused by O3, possibly due to the varying mechanisms by which DE or O3 induce
inflammation [238]. An investigation carried out by Bosson et al. showed that O3 exposure
subsequent to DE had the ability to enhance DE-related airway inflammation, highlighting the
complexity of additional influences when considering health effects caused by exposure to
environmental pollutants [239]. A study by Madden et al. investigated the combinatorial effects
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of DE and O3 on lung function, both on healthy volunteers, as well as subjects with the
gluatathione S-transferase-Mu1 (GSTM1) genotype. GST enzymes have been shown to
mediate damage caused by air pollution health effects by detoxifying products of oxidative
stress and individuals with this phenotype have been shown to be more susceptible to
inflammatory diseases [240]. Madden et al. confirmed the effect of environmental mixtures
demonstrated by Bosson et al. In their study, O3 caused a decrement in lung function, and
although DE did not mirror this effect on its own, in combination with O3 it led to greater
decreased lung function. However, this effect was not observed for GSTM1 individuals
suggesting that oxidative stress may not be involved in decreased lung function [241].
Based on epidemiological findings suggesting that DE may exacerbate pre-existing
conditions of allergies and asthma [242], several studies have conducted controlled human DE
exposure in asthmatics and allergic rhinitics. Larsson et al. exposed allergic rhinitics to DE, at
doses known to cause inflammation in healthy individuals, in an effort to determine whether DE
exposure enhanced inflammation in the lower airways of individuals with pre-existing allergies.
No neutrophilic inflammation in the lower airways of participants was detected. However,
evidence of possible mast cell degranulation was found [243]. In a study carried out by Stenfors
et al., asthmatics were compared to healthy subjects in an exposure study investigating whether
DE PM10 may exacerbate existing allergic responses in asthmatics. Similar to the study by
Larsson et al., DE exposure did not enhance neutrophilic inflammation in asthmatics. This is in
contrast to the study that previously demonstrated healthy subjects did experience airway
inflammation [244]. Another study by Behndig et al. also examined DE exposure on asthmatics
comparing results to healthy controls. While they found that DE induced neutrophilic
inflammation in healthy subjects, this was not the case for asthmatics leading to the conclusion
that neutrophilic inflammation and classical cellular indicators of allergic airway response are not
necessarily accurate measure of allergic airway response to traffic-related pollutants [245].
Findings from these experiments demonstrate the complicated nature of exposure-related
health effects, particularly in the context of complex particle mixtures and the need for further
studies directly examining mechanisms for pathological development.
In order to more fully understand the response of asthmatics to environmental pollution
in an environmental setting, McCreanor et al. exposed asthmatics to real-time traffic exhaust.
The authors reported that those participants exposed to higher amounts of ultrafine particles
and EC from diesel-powered traffic developed increased sputum myeloperoxidase, an indicator
of neutrophilic inflammation, and greater reductions in lung function. These results were
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exacerbated for individuals with more severe pre-existing asthma. The data from this real-time
exposure study are more consistent with epidemiological data suggesting that laboratorycontrolled measures may not accurately represent physiological exposures in the environment
[246]. Additionally, this study highlights the importance of designing studies aimed at examining
complex exposures modelling realistic exposure scenarios to the greatest degree possible. This
was corroborated in a study by Hosseini et al. demonstrating that effects of DE exposure may
be overlooked by administering exposures in a sterile, uncomplicated environment, such as a
laboratory. Hosseini et al. sought to elucidate whether DE may be acting as an adjuvant in
combination with allergen-induced asthma and airway inflammation. These authors found minor
or nonexistent changes in eosinophilia and mast cells of the airways; however, other sensitive
measures of allergic response including CD4, IL-4, neutrophil elastase, and CD138, were
increased. Moreover, these parameters of allergic response were not elevated for either DE or
allergen exposure individually, but were synergistic in combination. This study further highlights
the important interactions of the environment with pollutants, which may affect health effects
[247].
Susceptibility to Infection
In addition to the studies of pulmonary effects following controlled exposures in human
subjects discussed above, studies investigating epidemiological findings that support the
hypothesis that DE may lead to enhanced susceptibility to infection have also been conducted.
Due to ethical ramifications of directly infecting individuals with pathogens, there are a limited
number of these controlled exposure investigations. Additionally, many of these studies use a
two-step approach with the toxicological exposure performed in vivo, while the investigations on
susceptibility are conducted ex vivo using cellular samples collected following the exposure,
which should be taken into consideration when interpreting the data. In a study conducted by
Frampton et al., it was shown that macrophages obtained from humans exposed to the DEcomponent NO2 were less effective in inactivating influenza virus ex vivo [248]. Another recent
study indicated that DPM reduced natural killer (NK) cell recruitment and activation during
influenza infection in allergic rhinitics following exposure to particles. Further, it was
demonstrated that during the context of viral infection in allergic rhinitics, allergic inflammation
may be worsened due to an inability or decreased ability for NK cells to target and clear
eosinophils [249]. Helleday et al. examined the mucociliary function of bronchial cells in human
volunteers following short-term exposures to NO2 as a measure of effects on mechanical
barriers to infection. The authors concluded that pollutant exposure caused significant reduction
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in the mucociliary activity of these cells, but that the effect was reversible [250]. Though NO2 is a
known component of DE, studies of this nature have not examined DE itself as a whole, and
therefore, results relating to whole DE may vary from these depending on the composition of DE
with relation to NO2.

Effects of Respiratory Exposure to Diesel Exhaust in in vivo Animal Models
Pulmonary Effects
While controlled studies in humans are valuable in determining physiologically relevant
health effects that may be caused by exposure to DE, ethical restraints and limited participation
significantly restricts mechanistic determinations of disease etiology. Therefore, equally
important are studies using laboratory animal models of exposure. As in epidemiological
studies, studies evaluating systemic effects of DE exposure, particularly related to
cardiovascular disease have been conducted [251-257]; however, the review below will focus
on the animal studies related to respiratory effects specifically.
Chen et al. examined species-specific responses in rats and guinea pigs to DE and
demonstrated that DE, while not necessarily cytotoxic to pulmonary macrophages studied ex
vivo following exposure, did demonstrate reductions in phagocytosis despite sufficient
adherence and motility. [258]. This study provided some of the first evidence that DE may
reduce function in AMs. Another study by Chen et al. examined the species-specific effects of
DE in a one-year, chronic, time-course study. Data indicated that biological responses were
dose and duration dependent. [259]. A study by Pepelko et al. conducted in cats suggested that
minor changes in some lung function measurements may occur after 28 days of exposure to
DE, but data was not suggestive of significant lung damage for the dose and duration examined
[260]. Abraham et al. examined lung function in sheep following exposure to DPM but did not
find significant alterations in pulmonary resistance or airway reactivity, though exposures were
acute [261]. Gross assessed the effect of chronic exposure to DE on the pulmonary function of
rats. Similarly, no significant changes were observed following approximately 9 months of DE
exposure [262]. A continued study by Gross examining function in rats after 2 years of
continuous exposure to DE suggested some significant alterations in lung function including
changes in vital capacity and forced expiratory volume (FEV) [263]. Patterns of lung function
reductions consistent with restrictive changes were found by Moorman et al. in their study,
though amounts of DE were high compared to other studies, and they used a cat model [264].
In a study of chronic DE toxicity conducted in three species, Heinrich et al. determined that
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chronic exposure to unfiltered DE caused significant changes in lung function and alveolar
clearance primarily in rats as compared with mice and hamsters. Additionally, tumors developed
in mice in response to both unfiltered and filtered DE; whereas, only unfiltered DE resulted in
lung tumor incidence in rats. This study further outlines the importance of animal model choice
in demonstrating relevant health effects of exposure to DE [265]. Moreover, in a study
comparing exposure of rats and mice to dilute DE, Henderson et al. established that despite
mice having a higher soot burden in the lung, rats exhibited more fibrogenesis. The authors
determined that this was related to the propensity of rat alveolar cells to release greater
amounts of inflammatory mediators including leukotriene B4 and PGF2 alpha than mouse cells
[266]. Finally, in a study by Ulfvarson et al. examining effect of DPM trapping on changes in
respiratory effects on rabbits it was established that the gaseous components of DE may result
in reduced compliance of the lung suggestive of fibrotic changes [267]. It is important to note
that, in addition to species-specific effects, the studies discussed above employ different doses
and durations of exposure, which may also account for differences observed in the study
outcomes. Therefore, model should be chosen based upon which health outcome is being
examined. While rats demonstrate similar inflammatory response and histological changes
observed in humans, cats may reflect more consistent functional changes, and guinea pigs
allergic developments, which are more similar to epidemiological findings.
Beyond characterizing overall pulmonary toxicity caused by DE in animal models,
investigations have aimed to determine more specific mechanisms for outcomes observed in
humans. Inflammation, specifically, has been widely investigated as the initiating event leading
to different pulmonary diseases caused by inhalation of DE through a variety of pathways. Inoue
et al. examined the role of toll-like receptor (TLR-4) in inflammation caused by DPM. By
comparing responses to IT administration of DPM, at a dose of 12 mg/kg, in TLR-4 mutant mice
to WT, the authors discovered alterations in the expression of inflammatory mediators of
chemotaxis, suggesting that DPM signals in part through the TLR-4 pathway in order to induce
inflammation [268]. Fujimaki et al. showed that IL-6 was essential for the induction of airway
inflammation mediated by cellular influx and the expression of chemotactic factors. The authors
determined this by comparing DE inhalation exposure; either 1 or 3 mg/m3 for 12 hours per day
for 4 weeks, in WT and IL-6 deficient mouse strains [269]. Ahn et al. investigated the role of
COX-2 in inflammation induced by DPM. In this study, the authors exposed mice
oropharyngeally to 1, 10, or 25 mg/kg of DPM per day for five consecutive days and showed
that DPM exposure caused inflammation that is mediated by COX-2 by ameliorating these
effects with an anti-inflammatory treatment with glucocorticoid, dexamethasone [270].
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Oxidative stress, as discussed at length with regard to inflammation caused by silica
exposure, has been indicated as a potential initiator of lung injury caused by DE as well. Sagai
et al. examined the possibility that DPM may produce biologically active ROS in the lung
following IT exposure of mice to varying doses of DPM between 0.4 mg and 1.0 mg. Data from
their experiments showed that DPM-exposed mice had increased mortality due to oxidant
radical-mediated endothelial damage resulting in pulmonary edema [271]. Lim et al.
demonstrated that either 100 or 200 μg of DPM, administered in repeated IT, 1 time per week
for 10 weeks, elicits airway hyperresponsiveness mediated by inflammation caused by
superoxide (SO) and NO. They showed that DPM increased the activity of NO synthases (NOS)
and decreased superoxide dismutase (SOD) activity. Further, treatment with inhibitors of NOS
reduced inflammatory effects of DPM treatment [272]. Ito et al. found that in rats exposed to
2mg/0.5ml/kg of DPM intratracheally, alveolar cells infiltrating the lung were nearly doubled
compared to controls, that peroxynitrite formation was increased, and that levels of inducible
NOS (iNOS) mRNA were enhanced, suggesting that DPM caused oxidative-induced
inflammation in the lung [273]. Han et al. used noninvasive spectroscopy in conjunction with a
membrane-impermeable nitroxyl probe to detect the generation of hydroxyl (OH) radicals
following exposure to DPM in mice. When scavengers of radicals were applied, the rate of
decay of the probe was decreased. The study provides further evidence that DPM causes
increased production of ROS that may contribute to lung injury following exposure [274]. Finally,
Nemmar et al. aimed to determine if Emodin, an antioxidant, may reduce DPM-induced
inflammation and oxidative stress, which contribute to decrements in lung function following DE
exposure. In their findings, it was reported that treatment with Emodin reduced airway
resistance, neutrophilic inflammation, and production of inflammatory cytokines. The authors
concluded that anti-oxidant treatments like Emodin may be useful for protection against
pollutant-derived lung toxicity [275].
An important factor in toxicity of DE is the composition of the material. DE composition
can vary based on a number of factors including fuel source and engine type as discussed
previously. Similar to studies with human volunteers, investigators have sought to determine
which component(s) of DE may be contributing to oxidative stress. Madden et al. explored the
possibility that, similar to effects observed in humans, O3 may cause exacerbation of DPMrelated toxicity. Treatment of DPM particles with O3 prior to administration in rats resulted in
enhanced inflammatory and injurious responses in the lung. These effects were not observed
with the control particle, CB (a core component of DPM), suggesting that this effect was related
to interactions of O3 with components adsorbed to DPM particles [276]. Investigations by Zhao
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et al. examined the effect of DPM or the organic extract of DPM (DPME), which lack the carbon
particulate core, on parameters of toxicity. In one study, they examined blockade of iNOS and
cytochrome p450 (CYP)-1A1 in mediating oxidative stress caused by AMs. It was highlighted
that NO played a role in inflammation caused by the organic fraction of DE and expression of
CYP1A1 by both the particulate and organic fractions of DE, but that NO regulation does not
affect inflammation induced by DPM [277]. In their subsequent study, Zhao et al. examined
oxidative stress in both WT and iNOS knockout mice. Their results demonstrated that
inflammation initiated by DPM was mediated by AM production of ROS and NO. Lack of NO
production had little effect on DPM induced oxidative stress. NO was also important for initial
induction of neutrophilic inflammation, pulmonary capillary damage, and IL-12 production.
Further, since DPM and carbon black (CB) induced inflammatory responses and injury, but the
DPME did not, these results were attributed to the particulate core and not the substances
adsorbed to it [278].
As epidemiology studies and in vivo studies indicate, obstructive lung diseases including
COPD and bronchitis are commonly associated with DE exposure. In vivo studies have been
conducted to determine the potential etiological mechanisms. A study by Fedan et al. indicated
that chronic inhalation exposure of rats to 2 mg/m3 of DE 7 hours per day, 5 days per week, for
two consecutive years, resulted in alterations of airway smooth muscle functions that may
contribute to airway obstruction [279]. A chronic exposure study, conducted by Ishihara et al.,
over a 24-month time-course evaluating rats exposed to DE, determined that moderate to high
levels of DE exposure (corresponding to between 1-3 mg/m3 particles at 18 months) resulted in
chronic inflammation, increased mucus and phospholipid production consistent with the
development of COPD. Moreover, these responses occurred in a time and concentration
dependent manner; though, some parameters plateau just after a year of exposure [280]. To
further understand which components of DE may be associated with obstructive lung disease,
Laks et al. treated DPM by different extraction processes and assessed whether exposure to
the extractions altered airway and lung mechanics following intransal exposure to 15 μg of DPM
in mice. Treatment with hexane was the most effective in removing measured polycyclic
aromatic hydrocarbons (PAHs), common components adsorbed to the carbon core of diesel
particles. Data suggested that PAHs may be important for pulmonary health effects observed
based on the findings that hexane treatment reduced alterations in lung parenchyma and lung
mechanics observed with untreated DPM [281]. Experiments examining airway inflammation in
response to repeated exposure DPM, the particulate fraction of DE, intranasally instilled in mice
were conducted by Yoshizaki et al. who demonstrated that exposure to 30 μg DPM 5 days per
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week for 60 days resulted in increased mucus production and nasal epithelium thickness,
indicating that DPM treatment resulted in respiratory tract inflammation [282]. A study by
Shaheen et al. aimed to understand the role of ceramide in airway inflammation following
exposures to DE at concentrations below those required to initiate biomarkers of oxidative
stress and inflammation. Cell stressors can induce ceramide regulated NF-κB initiation and
apoptosis. Inhibiting ceramide following exposure to DE, reduced not only ceramide but also
increased expression of enzymes involved in sequestration of ceramide-related precursors.
Overall, data suggested that even in the absence of measurable inflammation as a result of DE
exposure, biomarkers related to inflammatory initiation are up-regulated, demonstrating more
sensitive measures for low-level exposure health effects [283]. Overall, in vivo studies have
demonstrated that subacute and chronic exposures to DE resulted in enhanced airway
inflammation, increases in mucus production, and airway changes consistent with obstructive
pathologies such as COPD; moreover, this may be related to the presence of PAHs in DE since
some of these effects were attenuated when PAHs were reduced.
The development of AHR, asthma, and allergic asthma are the most well-investigated
respiratory diseases relating to DE exposure. DE has not only been shown to result in the
presence of asthma de novo, acting as an allergic adjuvant, but also to exacerbate the clinical
presentation of pre-existing disease following exposure in humans [213, 214, 227, 242, 246].
Therefore, extensive investigations have been made into discovering the biological mechanisms
that promote this pathology. Several studies have examined the role of oxidants in development
of asthma following DPM exposure. Sagai et al. examined the role of oxidant inflammation on
airway reactivity. In one study, it was shown that DPM reduced scavenging of oxygen species in
the airways resulting in increased NO2 and enhanced AHR [284]. In a subsequent study, Sagai
et al. determined that DPM caused increased inflammation, proliferation of mucus producing
cells, secretion of mucus, respiratory resistance and constriction of airways. Additionally,
eosinophilic infiltration was exacerbated. These parameters were abrogated by pre-treating with
polyethyleneglycol-conjugated SOD (PEG-SOD) to quench oxidants, suggesting that oxidants
derived from DPM exposure resulted in symptoms consistent with asthma [285]. A group led by
Aguilera-Aguirre showed that mitochondrial dysfunction resulting from oxidative stress was
responsible for exacerbating allergic inflammatory response. This finding suggests that DE
exposure leads to production of oxidants that stimulate further cellular ROS and induce
dysfunction of mitochondria in airway epithelium and in turn may be responsible for induction of
airway inflammation [286].
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Though increased oxidant burden may result in increased parameters of inflammation
resulting in asthmatic disease, it may also stimulate the release of proteins from immune cells,
which may contribute to mechanisms of pathology. Ohta et al. conducted a study to further
elucidate the role of cytokines in response to DPM exposure in the development of
bronchoconstriction and airway hyperresponsiveness. It was demonstrated that granulocyte
macrophage colony stimulating factor (GM-CSF) was intrinsic to the development of airway
hyperresponsiveness to DPM. Blockade of GM-CSF resulted in reduction of
bronchoconstriction, and hyperplasia of clara cells, both hallmarks of asthma. While IL-4 also
contributed to these effects, it was to a lesser extent [287]. A related study led by Yamashita
established that PDGF contributes to the remodeling of the airway following DPM exposure.
Although PDGF antibody treatment did not alter influx of inflammatory cells into the airways, it
reduced airway wall thickening elicited by DPM. These results suggest that PDGF, a regulator
of fibroblast growth and proliferation, played a distinct role in collagen modulation and thickening
of the asthmatic airways following exposure to particle [288]. More recently, IL-17 has been
implicated in the pathogenesis of inflammatory diseases. Brandt et al. sought to establish
whether DPM exposure exacerbates allergic asthma via an IL-17 mediated response. Results
from this study suggest that Th17 cells contribute to DPM-mediated allergic asthma. Antibody
neutralization of IL-17 resulted in abrogation of the enhanced AHR caused by DPM in this
model. Furthermore, the authors examined children with pre-existing allergic asthma in order to
determine their serum levels of circulating IL-17 based on estimated DPM exposure. They
report that children with high estimated exposures have levels nearly 6 times higher than
children exposed to low levels of DPM and that they reported more frequent and severe
symptoms [289].
Others have examined the role of DPM exposure in conjunction with allergen to elicit
airway responsiveness. A study by Suzuki et al. indicated that DPM and pyrene, a PAH
associated with DPM, act as adjuvants and stimulate greater production of immunoglobulins
when given in co-exposure with house dust mite (HDM) allergens [290]. Increased antibodies to
allergens may ultimately result in incidence of asthmatic symptoms. Investigation by Takano et
al. corroborated these results with a different allergen. The authors of this study reported that
DPM in combination with ovalbumin (OVA) resulted in increases of parameters of allergic
asthma including increased eosinophilic inflammation, goblet cells, and expression of Th2
cytokines IL-4 and IL-5. Further, they demonstrated enhanced levels of immunoglobulin (Ig) G
and IgE. Results indicated exacerbation of allergic asthma when compared with DPM or
allergen alone [291]. Miyabara et al. established that DE caused enhanced eosinophilic and
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neutrophilic infiltration, expansion of goblet cells increases in IL-5, IgG, and AHR in combination
with OVA sensitization. An increase in IgE was not observed, but authors speculate this may
have been due to the difference in route of administration. Inhalation was used in this study,
whereas, in previous studies instillation by nasal route was used. It is possible that sensitization
by direct contact with the nasal epithelium might result in increases observed in IgE observed
previously [292]. Results have been reviewed for two types of allergen models, HDM and OVA,
but another group sought to determine whether DPM would enhance allergic response to pollen
as well. Steerenberg et al. determined that, as demonstrated in previous allergen studies, DPM
enhance allergic response to pollen. This study further demonstrated the adjuvant effect of DPM
on allergy and asthma [293]. An investigation by Hao et al. sought to determine what acute
effects DPM may have on airways in the absence of their adjuvant allergic influences. The
authors established that even in the absence of allergen, DPM exposure increased airway
reactivity suggesting that not only does DPM elicit/exacerbate allergic asthma but that it may
directly induce acute asthmatic symptoms associated with AHR [294].
Many studies have been conducted to try to determine what component of DE and/or
DPM are correlated to pathogenesis. The composition of DE/DPM is widely variable as
previously discussed and this tenet appears to govern the course of pathologies associated with
exposure. Variable responses to DE/DPM reported epidemiologically and based on research
investigations appear to be directly related to the characteristics of the particles used to conduct
studies, and those conducted in vivo are briefly summarized below. An investigation by AlHumadi et al. demonstrated that the adjuvant effect of DPM on the development of allergic
airway disease may not be dependent on particle composition. By comparing DPM combined
with OVA sensitization with CB combined with OVA sensitization as a particle comparison
control, the authors showed that both co-exposures elicited similar increases in OVA specific
IgG and IgE, suggesting that both augmented allergic sensitization [295]. Inoue et al. aimed to
determine which components of DPM might be responsible for observed toxicities. This group
examined extracts of DPM organic components and washed DPM carbon nuclei. It was
explained by the authors that in response to co-exposure to OVA antigen organic components
did not elicit responses that were significantly different than the OVA control group; whereas,
washed DPM nuclei had the greatest impact on induction of airway hyperreactivity (AHR).
These results point to the carbon nuclei as being important in airway inflammation in the context
of allergic asthma [296]. As previously mentioned in a study by Laks et al. it was found that the
PAHs associated with DPM contributed to pulmonary toxicity [281]. A third study by Park et al.
investigating the components of DE and their importance in the context of inflammation found
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that how DPM are recognized by phagocytic cells, determines the inflammatory effect that they
will induce. They explain that DPM, which are engulfed by cells result in a Th2-type response;
whereas, DPM, which are not taken up by cells induce a Th1-type response. Furthermore, they
suggest that the physicochemical properties like size and charge determine how well they are
able to be taken up and how well they elicit stress responses like oxidation that has been
associated with both Th1 and Th2-types of inflammation caused by DPM [297]. A study by
Tanaka et al. determined that the gaseous components of DE may be most important for the
Th2 polarizing skew of DE, as exposure to DPM combined with OVA in the absence of gaseous
components failed to enhance eosinophilic inflammation or Th2 cytokines to the level of DE
without particles [298].
Though IgE is well-established in the importance of allergic development, IL-4 upstream
of IgE is also critical as is the polarization of the immune system to a Th2-mediated response to
stimulus that acts as a signal to initiate immunoglobulin class switching [299]. Experiments
conducted by Jang et al. aimed to elucidate whether O3 in combination with DPM might lead to
increased presence of asthmatic symptoms. These studies established that, similar to studies
conducted in human volunteers, O3 may exacerbate the induction of asthma observed following
exposure to DPM and allergen. Increases in pathological response were additive and related to
enhanced levels of IL-4 and AHR following co-exposure to DPM and O3 in an allergen sensitized
mouse [300]. More recent experiments relating to T cell differentiation following exposure to
DPM were performed by Liu et al. in a study of DPM effects on DNA methylation. These authors
demonstrated that combined exposure to DPM and fungal allergen resulted in increased
methylation of IFN-γ and decreased methylation of IL-4. Additionally, IgE production was
enhanced following exposure to both DPM and fungal allergen. These results suggest that DPM
exposure altered differentiation/function of immune cells in the presence of allergen by altering
DNA state, potentially leading to a Th2 helper polarization and allergic asthma [301]. Finally, in
a recent study of DPM, De Grove et al. investigated the role of newly discovered innate
lymphoid type 2 cells (ILC2) in allergic asthma elicited by DPM. They compared responses of
WT mice with either ILC2 deficient, lymphocyte deficient, or Gata 3 insufficient mice following
exposure to DPM in combination with HDM allergen. The co-exposure resulted in AHR and
inflammation in WT mice and this was reduced in either Gata 3 insufficient and marginally so in
ILC2 deficient animals. In lymphocyte deficient mice, it was abolished entirely suggesting that
intact adaptive responses are required for an adjuvant effect by DPM to be provoked [302].
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Extensive research has also been conducted in an effort to understand whether and by
what mechanism DE initiates tumorigenesis in the lung. These studies date back to the 1950s to
a study by Kotin et al. that determined that PAH components of exhaust resulted in tumors
when painted onto the skin of mice [303, 304]. The validity of many of the respiratory toxicity
studies in animals have created controversy due to evidence that species such as rats may
reach a burden of particle considered to be “overload” in which the mechanisms of clearance
are overwhelmed resulting in neoplasms [75], but that this bears little on the toxic properties of
the particles themselves due to composition. Further these studies were often conducted at
doses unrealistically higher than correlated to physiologically relevant levels of exposure in
humans, and due to more superior clearance mechanisms it was suggested to be unlikely for
humans to reach overload, and therefore carcinogenesis was not considered to be a valid
detriment posed by DE exposure [305, 306].
In their very thorough review of DE cancer effects, Hesterberg et al. weighed the
advantages and disadvantages of traditional (old technology emission prior to 2000) DE
exposure research to address that point. Study design, dose, route of exposure, models,
methods, and composition of the particles are all among the examined variables relating to
research findings on DE tumorigenesis. Ultimately, the authors do conclude that the only
consistent findings for carcinogenicity in laboratory animals are in rats and do not provide
sufficient or convincing evidence that these results translate to humans, as it appears to be a
species-specific phenomenon. However, they do allow that new technology (since 2000) DE
(NTDE) exposure risks be assessed separately as the chemical composition of new emissions
renders it completely different chemically from traditional DE [306], whereby the particulate
component is significantly lower, but other gaseous components may not be.
Additional investigations into both traditional and NTDE exposure and the potential for
carcinogenesis have been conducted. Moreover, research has also been conducted in animals
evaluating levels of DE exposure or exposure to specific components of DE, which are far lower
than what would be considered “overload” but that still show evidence for carcinogenesis.
Further, as of 2012, DE was reclassified by IARC as a Group 1 carcinogen, carcinogenic to
humans, ‘having sufficient evidence’ in humans for the carcinogenicity of diesel engine exhaust.
Additionally, in the 2014 Monograph it is also stated that there is ‘sufficient evidence in
experimental animals’ for the carcinogenicity of whole diesel engine exhaust and diesel engine
particulate matter, but ‘inadequate evidence’ in the gas-phase of diesel engine exhaust [215].
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Therefore, only a brief summary of studies employing whole DE or DPM will be summarized
here.
Heinrich et al. found that exposure of rats to diesel soot increased incidence of lung
tumors in rats, but no significance for lung tumors was indicated in mice [307]. In a study
conducted in rats by Mauderly et al. it was determined that DE and CB particles produced
similar carcinogenic effects. Their findings suggest that small, carbonaceous particles, in the
respirable range are responsible for lung cancer development at high concentrations, and that
constituents of DE otherwise determined to be mutagenic play a lesser role in tumor
developments in rats. Though they report the biological mechanism to be unknown as of yet, it
does correlate to impaired particle clearance and progressive particle accumulation resulting in
increased particle load [308]. An investigation by Nikula et al. examining rats also showed
increased neoplasms, both malignant and benign, following exposure to DE or CB. Additionally,
they observed increased incidence in females when compared with males, and in males the
incidences were slightly higher for DE than for CB, though this may have been due to an
enhanced mortality that occurred in male rats exposed to CB. Overall, the particulate
component of DE was determined to be the more critical portion for carcinogenic effects [309]. A
study by Iwai et al. showed more mechanistic results explaining that tumor formation in the
lungs of rats following a long latent period subsequent to exposure was due to oxidative stress
on DNA induced in early phases of exposure to DE [310]. Stinn et al. also reported that DE
particle deposition and accumulation led to tumorigenesis in rats exposed to DE; however, they
report that this happened in the absence of any significantly noted DNA adduct formation or cell
proliferation, but rather correlated to a dose related increase in sustained inflammation [311].
Ultimately, in animals, evidence of mutagenicity is limited and mostly observed in rats. However,
evidence suggests that DE results in impaired clearance mechanisms, which requires further
investigation, particularly at low levels of exposure.
Immunological Effects and Susceptibility to Infection
Human-controlled experiments in addition to epidemiological evidence suggest that
exposure to DE results in increased susceptibility to infection, particularly in the respiratory tract.
Therefore, in vivo animal studies have been conducted to examine mechanisms associated with
DE effects on the immune system and host defense. In one study, Harrod et al. observed
susceptibility to respiratory syncytial virus (RSV), a common respiratory pathogen in children.
RSV gene expression in the lungs was increased following prior DE exposure as well as
inflammatory and epithelial cell modulations consistent with reduced resistance to RSV,
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specifically a shift from normal cuboidal clara cell appearance to the presence of thickened
columnar appearing mucus cells. These findings suggest a thickening of the airway. Additionally,
reductions in clara cell-secreted, immunoregulatory proteins including clara cell secretory protein
(CCSP) and surfactant protein A (SP-A) were shown to be modulated following co-exposure to
DE and RSV. These findings indicated increased susceptibility to RSV following DE in a typicallyresistant mouse model [312]. Interestingly, in another study by Harrod et al. it is determined that
DE inhalation resulted in reduced clearance of a bacterial infection, Pseudomonas aeruginosa
(PA), in a concentration-dependent manner. Reductions in clearance were again determined to
be related to inflammation and alterations in airway epithelial cell morphology, ciliated cells in the
airway were decreased. Further, CCSP was reduced in clara cells of the distal airway following
infection. Therefore, since the protein thyroid transcription factor (TTF)-1 has been shown to be
an important transcription factor for lung host defense proteins including SPs and CCSP, the
effect on TTF-1 was investigated. TTF-1 expression during infection was reduced following DE
exposure. Altogether, these results point to DE exposure resulting in reduced respiratory
resistance to PA infection [313]. Ciencewicki et al. examined the effect of DE on subsequent
influenza infections, and showed that DE increased susceptibility to infection as determined by
increased presence of hemagglutinin mRNA, and increased staining of viral proteins in the lung.
Increased expression of IL-6 and decreased SPs occurred consistent with aforementioned
studies. The findings indicate that DE increases susceptibility to viral infection by modulating host
defense proteins [314]. Gowdy et al. demonstrated that exposure to occupational levels of DE
caused increased lung injury, inflammation, and decreases in innate immune molecules including
CCSP, and SPs consistent with Harrod et al. The authors determine that these finding point to
possible decreases in respiratory resistance to infections [315].
Other investigators have expanded their studies to examine both branches of the immune
system, examining both innate and adaptive alterations. Yin et al. studied the effect of DPM on
the functions of AMs and lymphocytes from the lymph nodes of rats. In their first study, the authors
exposed rats to DPM acutely and examined the clearance of bacteria from the lung following
Listeria monocytogenes (LM) infection. It was determined that DPM inhibited phagocytosis of
bacteria and reduced expression of cytokines from AMs. The authors also conclude that cellmediated immunity may be inhibited due to suppressed AMs effector functions [316]. In a followup study by Yin et al., the authors studied whether DPM had effects on T-cell development based
on findings that AM function was altered by DPM in the presence of infection. It was found that
DPM exposure resulted in decreased expression of IFN-γ, and that co-exposure to DPM and
bacteria resulted in increased bacterial counts in the lung on day 3 post-infection. However,
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lymphocytes from these animals increased in number and were able to clear infection, despite
alterations in innate immunity in an acute exposure to DPM [317]. Furthermore, Yin et al examined
whether DPM exposure exerts a sustained effect on lymphocytes resulting in susceptibility to LM
infection. Lymphocytes from infected animals previously exposed to DPM displayed decreased
production of cytokines compared with animals exposed to bacteria only suggesting that DPM
altered cytokine expression by lymphocytes. Further, it was found that DPM modified expression
of cytokines by AMs that initiate lymphocyte development, including IL-1β and TNF-α, as well as
cytokines that suppress macrophage function including IL-10. Overall, it was concluded that DPM
altered susceptibility to lung infection by inhibiting AM function and suppressing development of
Th1 immune-mediated responses in the lung [318]. Similarly, Hiramatsu et al. demonstrated that
long-term exposure to DE before infection with Mycobacterium tuberculosis resulted in increased
lung burden due to decreases in IL-1β, IL-12, IFN-γ expression, and iNOS mRNA [319]. An
investigation by Saito et al. showed that DE exposure resulted in modulation of cytokine mRNA
expression and their corresponding secretion. It was found that levels of important inflammatory
cytokines such as TNF-α, IL-6, and IL-1β were down-regulated by exposure to DE; whereas, antiinflammatory cytokines like IL-10 were increased by DE exposure. Further IL-4 was increased by
exposure to DE. These results indicate that DE may alter immunological defenses while
promoting allergic responses contributing to asthma [320]. Hahon et al. examined the role of DE
exposure on susceptibility to infection with influenza. Higher levels of viral growth compared to
control occurred animals exposed to DE. Additionally, depressed levels of interferon were
uncovered in DE exposed groups. Further, antibodies to hemagglutinin were reduced in DE
exposed animals compared with control. The authors concluded that results demonstrate reduced
host defense to influenza following exposure to DE [321]. Overall, DE/DPM was shown to
decrease host defenses. Both innate and adaptive immunity were hindered as decreases in
phagocytosis, the expression of inflammatory cytokines by both AMs and lymphocytes, and
decreases in antiviral antibodies were observed following DE/DPM exposure, although acute
bacterial infections are cleared effectively despite these findings.
Studies have not only examined infection concurrently or subsequent to particle exposure
but also while infection was ongoing in an effort to determine if DE exposure may result in
exacerbated or prolonged infections. Gowdy et al. conducted experiments aimed to determine if
DE would result in increased severity of and ongoing influenza infection. The authors state that
DE exposure during viral infection resulted in increased viral titer, but that this effect was not due
to reduced IFN levels, and that IL-4 expression was increased at early time points after exposure.
Blockade of oxidative stress with an antioxidant did not reduce enhanced viral titers but blocked
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alterations in cytokine profiles and inflammation. It was concluded that exposure to DE during an
active influenza infection polarizes the immune system to a Th2 response and that some of these
effects may be reversed in the absence of oxidants [322]. A study by Larcombe et al. aimed at
establishing whether DPM exposure could exacerbate existing infection reported that exposure
to DPM following influenza infection resulted in increased viral titers and inflammation but not
impairment of lung function. They concluded that although there was a presence of increased
viral titers, one dose of DPM was not able to exacerbate respiratory disease [323].
Lastly, researchers have aimed to determine which components of DE may be responsible
for the observed susceptibility to infection and alteration of immune functions described above.
Yang et al investigated the potential of DPM to impair host defense to LM compared to CB, the
core component of DE. Exposure to DPM decreased clearance of bacteria from the lungs and
oxidants produced by phagocytes. These effects were not observed following exposure to CB
and LM. Therefore, results suggest that suppression of host defenses by DPM are at least in part
a result of components adsorbed to the core of DPM [324]. Castranova et al. compared different
components of DE and CB in an effort to determine which properties of DE related to
immunological alterations. Following their investigation, authors reported that exposure to DPM
decreased bacterial clearance from the lung and that this was not observed with CB exposure.
Further DPM reduced production of interferon and suppressed lung phagocyte production of
oxidants, which was not observed with the control particle. The authors concluded that effects of
DPM on host defense are likely related to organic components adsorbed to the carbon core of
DPM [325]. Subsequently, Yin et al. explored whether DPM, specifically the organic extract or
washed core particle resulted in ROS contributing to effects observed on AMs leading to
increased intracellular infection. The authors reported that the organic extract of DPM but not the
washed DPM particle elicited heme oxygenase (HO-1) expression and production of IL-10 and
decreased expression of TNF-α and IL-12. Moreover, these effects were reversed by antioxidants
[326].

In Vitro Models of Diesel Exhaust Toxicity
Pulmonary Effects
It is understood that DE causes an array of pathologies including; pulmonary-related
disease, exacerbation of allergy, reduced immunity toward infectious insult, vascular-related
diseases, and finally, under chronic exposure conditions, cancer [327]. What is less clearly
understood, is which constituents of DE are responsible for provoking each specific response
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and the mechanisms of action of DE; however, oxidative stress, as a result of ROS production,
has been demonstrated to be one of the integral mechanisms involved in these pathological
signaling events [328]. In vitro models of toxicity have been employed to further delineated this
pathway. Furthermore, in order to maintain focus on pulmonary disease, only those studies that
pertain to respiratory pathology are summarized below.
Both carbonaceous and organic components of DPM have been implicated in the
induction of oxidative stress. Dong demonstrated in the author’s thesis work that DPM, washed
DPM, and CB induced AM production of ROS; whereas, the organic extract from washed DPM
failed to initiate a respiratory burst in AMs. Data from this study suggests that the carbonaceous
component of DPM is at least partly responsible for activating AMs to initiate oxidative stress
mechanisms leading to inflammation [327, 329]. Additionally, studies by Shukla et al. examined
increased intracellular oxidative stress following DPM exposure in murine C10 alveolar cells.
When comparing PM2.5 to both CB and glass beads, it was shown that both PM2.5 and CB
stimulated intracellular oxidant production, while glass beads did not. These results also
suggest that PM2.5 carbonaceous core components are capable of stimulating cells to produce
ROS [330]. However, there is overwhelming evidence that the organic fraction of adsorbed
chemicals, including PAHs on the surface of the carbon core, contributes to oxidant production,
particularly through the intracellular pathway. Sagai et al. examined whether DPM could induce
ROS production in an acellular system. The investigators were able to show that DPM released
SO and hydroxyl radicals until washed with organic solvents. Also, this process could be
inhibited by the addition of SOD or dimethylsulfoxide (DMSO). These results suggest that DPM
toxicity is at least in part due to the presence of radicals and ROS, and that this process is
driven by organic constituents adsorbed to particles [271]. Greenwell et al. compared the
oxidative potential of coarse and fine fractions of DPM to CB using the Plasmid Assay. The goal
was to examine the protective effects of surfactant and antioxidants against injurious inhalants.
The authors established that the coarse fraction of DPM displayed a higher oxidative potential in
this study and that soluble constituents were most directly responsible for toxicity. Moreover, it
was found that antioxidants from lung lavage with low molecular weights offered some
protection against DNA damage caused by oxidation, even when mimicked in a synthetic
surrogate lung fluid [331]. Xiao et al. examined the effects of organic extracts of DPM on the
induction of oxidative stress in mouse macrophages, examining newly formed proteins
associated with stress pathways. The authors demonstrate a dose-dependent relationship with
DPM-extract and induction of oxidative response as decrements of antioxidant ratios occured,
suggesting that organic components of DPM are responsible for the upregulation of oxidative
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responses associated with exposure to pollutants [332]. Similar studies, by Jung et al., went on
to highlight the importance of the unfolded protein response (UPR) in bronchial cells exposed to
organic extracts from DPM using proteomics approaches. The results of this study suggested
that oxidant damage caused by organic constituents of DE result in mis/unfolded proteins
leading to inflammatory damage [333]. Contrasting results obtained between studies may be
attributed to wide variations in dose, type of diesel fuel, or composition of extracts making it
difficult to clearly attribute effects to any one component of DE. Taken together, these studies
demonstrate that both the carbon core of DPM as well as the absorbed constituents are capable
of initiating oxidative stress.
Reactive oxidants have further been associated with modulating the process of
programmed cell death or apoptosis [332]. The pathways that drive this process following
exposure have been the focus of several in vitro investigations. Hiura et al. demonstrated that
DPM that had organic constituents extracted no longer caused macrophages to produce ROS
that were shown in this study to be important for initiating the process of apoptosis in these cells
following exposure [334]. Further, a subsequent study showed that ROS production by AMs
induced by DPM extracts resulted in mitochondrial toxicity and the initiation of apoptosis
mediated by mitochondrial damage [335]. The transcription factor NF-κB pathway is also known
to be involved in regulation of apoptosis following response to ROS, as previously discussed in
the context of silica exposure [79]. Therefore, Shukla et al. aimed to understand whether
pollutants such as PM2.5 could initiate NF-κB translocation. The authors demonstrated that PM2.5
does cause translocation of NF-κB subunits into the nucleus and subsequent DNA binding in
murine type-II alveolar epithelial cells. Further, they showed that this was dependent upon
oxidative stress and resulted in the expression of increased inflammatory cytokines [330].
Bonvallot et al. showed the importance of NF- κB transcription of cytokines following exposure
to DPM in human bronchial epithelial 16HBE cells. These authors added that activation of this
pathway was dependent on oxidants produced by organic components of DPM, such as PAHs.
Further, the mitogen-activated protein kinase/extracellular-signal related kinase (MAP/ERK or
MEK) pathway was implicated in this process as DPM was shown to cause phosphorylation of
ERK. However, inhibition of MEK did not always result in decreased NF-κB transcription in
response to oxidant stress. Therefore, these pathways may not be directly linked to each other
following DPM-induced oxidant stress [336]. Activation of NF-κB by DPM was increased by the
combined exposure with O3, further demonstrating a role for ambient interactions in the
environment worsening effects of air pollutants. The investigators indicated that increased NFκB activity in A549 (human airway epithelial-type II like) cells exposed to DPM and O3 resulted
46

in increased expression of downstream cytokines including IL-8. IL-8 is a robust chemotactic
factor for neutrophils, and is integral to the signaling mechanism for increased inflammation
[337]. Effects of O3 in combination with DPM altered DPM pathology, as has been suggested in
several studies [228, 239, 241, 276, 300]. Kaimul Ahsan et al. established that thioredoxin
(TRX), a redox regulation protein and antioxidant was important for mitigating the effects of
DPM-induced apoptosis. Results from this study suggest that DPM reduces phosphorylation of
an anti-apoptotic protein, Akt1. TRX prevents this effect on Akt1 allowing for A549 lung cells to
resist damage and resultant cellular death [338]. Conversely, Kafoury and Madden reported that
DPM failed to initiate apoptosis despite activated NF-κB and triggered release of TNF-α.
Further, when activation of NF-κB was blocked, apoptosis was initiated by DPM. Conversely to
others, the investigators conclude that NF-κB activation in response to DPM may actually have
a protective role against apoptosis [339]. Differences may be dose-dependent, and are also
likely specific to the type of DPM used in the studies and the relative amount of adsorbed
organic constituents that are present. From the studies above, it may be concluded that the
organic fraction may be strongly influencing the apoptotic pathway.
Trace metals associated with DPM have also been implicated in the production of ROS.
Park et al. measured ROS production comparing two types of DPM to determine importance of
transition metals in oxidative stress. The authors determined that iron was more important than
other transition metals in the production of ROS in response to hydrogen peroxide [340].
Distefano et al. examined the role of transition metals in generating ROS in response to DPM
exposure. They found that transition metals did play a role in redox activity of DPM using a
newly described assay, where ascorbic acid is used to reduce metal ions and oxygen in order to
generate SO, which is then reduced to OH radicals in the presence of transition metals [341].
Ghio et al. further showed that ROS production by BEAS-2B cells in response to the soluble
fraction of DPM does not account for total ROS production indicating that the insoluble fraction
of particulates caused the generation of quantifiable ROS as well [342].
The study by Ghio et al. also highlights a major discrepancy between studies of this
nature as described above. Studies examining the oxidative nature of components of DE
resulted in findings that were inconsistent between similarly designed studies. This is due to
several factors, the first of which being the complex nature of DE itself and the variable qualities
of DPM from different sources and collection methods. Further, these samples were produced
at different times of the year under variable conditions, resulting in environmental variability in
constituents. Methodologies used to wash particles or extract particular fractions were not
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constant nor were methods used to quantify the generated oxidants. Culture conditions, cell
types, and doses examined were also variable. Finally, the studies examined different species
of ROS, i.e. SO, hydroxyl, peroxynitrite. A review by Ghio et al. summarizes these discrepancies
[343]. All of these factors should be taken into consideration when drawing conclusions from this
body of work and when making further determinations relating to DPM-generated oxidants and
their role in the initiation of inflammation and pulmonary toxicity.
In vitro models have been employed in an effort to understand how exposure to DE
alters respiratory responses observed in obstructive pulmonary disorders such as asthma and
bronchitis, particularly in the context of pre-existing disease. In an ex vivo human study, Bayram
et al. studied the differences in airway cell responses in cells recovered from asthmatics
compared to non-atopic individuals, followed by exposure of the cells to DPM. Constitutively,
cells differed in their expression of inflammatory mediators between the experimental groups,
with asthmatic cells secreting significantly more mediators at baseline, though ciliary beat
frequencies were determined to be similar regardless of atopic status. Further, it was
determined that in response to DPM, bronchial epithelial cells of atopic individuals were more
sensitive than those of nonasthmatic individuals, with regard to cytokine secretion. Moreover,
this response was dose-dependent. The authors conclude that the altered expression of
inflammatory mediators in response to DPM in asthmatics may contribute to exacerbation of
symptoms [344].
From a mechanistic perspective, Li et al. examined the importance of matrix
metalloproteinase (MMP)-1 in the development of obstructive diseases following exposure to
DPM. MMP-1, like other MMPs, is a modulator of inflammation, tissue remodeling, wound
healing, and pathogenesis in some pulmonary diseases[345]. The authors established that
MMP-1 transcription was upregulated in primary human bronchial cells exposed to DPM, and
that this was dependent upon the MEK signaling pathway. Further, a polymorphism identified in
the MMP-1 promoter may increase susceptibility of many individuals exposed to DPM to
developing respiratory diseases associated with increased MMP-1 secretion [346]. Another
study by the group examined the involvement of calcium signaling in airway epithelial cells in
response to DPM exposure in relation to COPD pathogenesis. This set of experiments further
elucidated the link between DPM exposure and MMP-1 secretion resulting in obstructive
pulmonary disease implicating the signaling pathway upstream from the MEK pathway involved
in the influx of calcium following direct interaction between DPM and the receptor it initially
activates upon contact with cilia on epithelial cells, proteinase-activated receptor (PAR)-2. Upon
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activating PAR-2, components of DPM upregulated PI3K signaling, which in turn upregulated
influx of extracellular calcium by way of the transient receptor potential vanilloid (TRPV)-4. This
was described as being dependent upon the organic fraction of DPM. Further, a polymorphism
in TRPV4 already identified with enhanced susceptibility for COPD [347], increased the
upregulation of MMP-1 activation described in the former study further [348].
Additionally studies have also focused on the effects of DPM on the COPD
characteristics of airway mucus hypersecretion and stimulation of C-fibers in airway reactivity. In
an effort to better understand increased secretion of mucus in the airway following exposure to
pollutants, Park et al. designed studies for evaluating expression of the gene for mucin 4
(MUC4) in nasal epithelium and human lung mucoepidermoid cells (NCI-H292). The authors
determined that exposure to DPM increased the mRNA expression and protein secretion of
MUC4. Further, these results were reversed when proteins in the MAPK pathway or the cAMP
response element-binding protein pathway (CREB) were blocked. This occurred in both cell
types. These findings reveal a mechanistic understanding for hypersecretion of mucus in airway
epithelial cells following exposure to DPM [349]. More recently, the respiratory reflexes and
more specifically the innervation of the airway have been examined in response to DPM.
Robinson et al. exposed airway C-fiber afferents to DPM and observed direct activation. The
results of this study suggest that activation of the ahR causes production of ROS by
mitochondria and the downstream activation of the transient receptor potential ankyrin-1
(TRPA1) followed by depolarization of the vagal nerve c-fibers causing an action potential that is
experienced in the form of a cough or bronchospasm. Further, washing the particles of the
organic components abrogated this activation of the vagus nerve, suggesting that the organic
PAHs are primarily responsible for observed effects [350].
Due to the rise in asthma and allergic prevalence over the past few decades worldwide,
efforts have been made to advance the understanding of DE exposure in the development of
allergies and allergic asthma as discussed above for the reviewed in vivo studies. In vitro
studies have also been performed to further investigate mechanisms of DE exposure in cells
involved in allergic response. Terada et al. established that DPM organic extracts were able to
enhance the adherence of eosinophils to nasal epithelium. Further, their results demonstrated
that DPM extracts induced eosinophilic degranulation though not altering eosinophilic viability.
These findings lead the authors to conclude that DPM, more specifically PAH components of
DPM, play a role in nasal hypersensitivity and the development of allergic response [351]. The
same group further demonstrated the role of DPM in allergic responses by elucidating the
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effects of DPM on the expression of the histamine H1 receptor (H1R). Their experiments
demonstrated that extracts of DPM increased H1R mRNA expression in nasal epithelium and
mucosal endothelial cells. Further, the secretion of IL-8 and GM-CSF stimulated by histamine
was higher in cells treated with DPM than controls. The results of these investigations suggest
that organic components of DPM upregulate allergic inflammation by increasing the release of
histamine [352].
Studies have also focused on the involvement of lymphocytes in the development of
allergic disease and the skew toward a Th2-mediated response. Though these cells are
important for upregulation and induction of this response, other immune cells have been shown
to be important for polarizing lymphocytes toward allergy. Saneyoshi et al. conducted a study to
determine the role of environmental pollutants in development of allergic disease by examining
the effect of DPM on mast cells. Results from this study suggested that low levels of DPM were
capable of enhancing the expression of IL-4, which is important for the differentiation of T cells
during allergic response. However, interestingly, it was determined that this was dependent
upon time of exposure relative to activation state of the mast cells. Further, it was shown that
the enhanced expression of IL-4 may not be entirely dependent on oxidant production,
suggesting other mechanisms for allergic induction following exposure to DPM [353].
Devouassoux et al. examined the effects of DPM organic constituents on basophils, since
basophils are a major source of IL-4, and IL-4 is important for the polarization of Th2 mediated
responses. Basophils exposed to extracts of DPM displayed enhanced expression of IL-4 and
increased release of histamine compared with basophils exposed to allergen. However, no
synergy was observed when cells were co-exposed to DPM extracts and allergen. Additionally,
secretion of IL-4 by basophils exposed to DPM extract persisted for longer periods of time than
those stimulated with allergen only. Furthermore, authors demonstrated that IL-4 expression
was not altered by alternative cell types suggesting that basophils were the major contributors to
the increase observed. Finally, the study showed that antioxidant pre-treatment of basophils
reversed the expression of IL-4 observed in response to DPM extract treatment establishing that
ROS are involved in the initiation of allergic responses of basophils to pollutants [354].
Nilsen et al. investigated the importance of Th1 polarizing cytokine, IL-12, in the
involvement of allergic response. The authors determined that levels of IL-12 expressed by
activated monocytes were inversely associated with concentration of DPM exposure.
Suppression of IL-12 expression by monocytes could skew the Th1/Th2 balance in favor of a
Th2 dominated response providing further mechanisms for DPM-induced atopy [355].
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Mamessier et al. further explored the role of T cell activation involvement in allergic response to
DPM. It was determined that T cell activation and proliferation, specifically IL-4 producing T
cells, was increased in higher proportions in cells obtained from asthmatics compared with
healthy controls. These results were exacerbated for cells obtained from severely uncontrolled
asthmatics suggesting an increased susceptibility for respiratory symptoms following exposure
to DPM in these individuals [356]. A study conducted by Takenaka et al. determined that while
the organic components of DPM were able to enhance IgE production by B lymphocytes. PAHs
from DPM were not inherently able to induce IgE production or class switching of
immunoglobulin. Therefore, it was concluded that DPM exposure plays a role in upregulating
ongoing allergic responses [357]. Plé et al. more recently determined that the Th17/Th22 axis
may play a role in allergic response following exposure to air pollutants. The authors exposed
monocytes from either allergic asthmatics or non-asthmatics to DPM PAHs in order to
determine whether the organic constituents of DPM play a role in the up-regulation of allergic
response by way IL-17 and IL-22 expression. IL-17 and IL-22 were both expressed more highly
in the monocytes of asthmatics at baseline. Exposure to DPM PAHs increased expression of IL22 while decreasing IL-17 expression regardless of predisposition to disease. The increase of
IL-22 was found to be partly dependent on up-regulation of the ahR transcription factor [358].
These studies indicate a role for DPM, and specifically the organic components of DPM for upregulating the expression of cytokines important for Th2 response; further, these results were
worse in individuals predisposed to allergy/asthma suggesting that DPM may exacerbate
ongoing allergic responses.
Additionally, several ex vivo studies in addition to those of Mamessier et al. and Bayram
et al. described above, have also aimed to elucidate mechanisms leading to enhanced allergic
response caused by DPM. Similar to work previously described by Bayram et al., a study by
Devalia et al. examined the mechanisms associated with enhanced sensitivity of airways in
asthmatics. By exposing bronchial cells of asthmatics and non-atopics to DPM and comparing
the secretion of inflammatory mediators to constitutive secretion of the same mediators, it was
determined that bronchial cells of asthmatics were more sensitive to DPM at lower doses and
overall had higher constitutive secretion of inflammatory mediators than those of non-atopic
individuals [359]. Fahy et al. aimed to understand whether organic components of DPM in
concert with HDM allergen could result in hyperresponsiveness in atopics. DPM PAHs and HDM
allergen both elicited increased allergic mediators in monocytes from allergic patients.
Moreover, when co-exposed to DPM PAHs and HDM allergen, synergistic responses were
observed. Further, MEK pathway activation was implicated in the role of increased expression
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of mediators detected in response to co-exposure. The authors conclude that DPM PAHs and
allergens act jointly on the MEK signaling pathway to increase expression of inflammatory and
chemotactic proteins important in the development of hyperresponsiveness [360]. To further
investigate this, Fahy et al. exposed monocytes from HDM allergic patients to combined DPM
and allergen stimulants and observed expression of monocyte-derived chemokine (MDC), a
recruiter of Th2 cells, and IFN-γ-induced protein 10 (IP-10), a Th1 cell recruiter, to determine if
DPM might skew recruitment of T lymphocytes to allergic response. It was found that DPM
exposure alone resulted in down-regulation of IP-10 expression constitutively while exposure to
DPM in combination with HDM allergen further increased expression of MDC observed with
exposure to HDM alone. Additionally, blockade of the CD28 and CD86 pathways abrogated
increased MDC expression suggesting that this adjuvant effect is in part caused by Th2
polarizing chemokine milieu dependent upon CD28 signaling, though this effect was also
reduced by blockade of CD80, it was to a lesser extent. Further, these results were found to be
independent of IL-4, IL-13 and IFN-γ expression [361]. Chang et al. sought to examine whether
allergic responses were not only increased by contributions from DPM or whether DPM may
enhance predisposition toward allergic response even in previously non-atopic individuals. The
authors designed experiments examining the stimulation of either Th1 or Th2 chemokines in
response to DPM in peripheral blood monocytes of non-atopic individuals. Results from this
study suggest that DPM exposure induces expression of chemokines that are involved in the
recruitment of Th2 lymphocytes and down-regulation of chemokines that favor Th1 recruitment,
suggesting that even in non-atopic individuals DE exposure may result in the induction of
allergic responses [362]. These studies demonstrate that DPM, by up-regulating inflammatory
signaling may result in increased hypersensitivity and allergic response; further, this may be
related to organic components of DPM skewing response of the immune system from Th1
mediated to Th2 mediated especially in the presence of allergen.
Don Porto Carero et al. conducted studies to examine the role of pollutants in altering
expression of antigen presentation receptors as a mechanism in DPM-induced allergic
response. Human THP-1 monocytes were stimulated with environmental pollutants including
DPM simultaneously with IFN-γ in order to determine if pollutant-altered antigen presentation
might be responsible for adjuvant effects during allergic response. Although pollutants did not
stimulate expression of antigen presentation receptors on their own, they potentiated effects of
IFN-γ induced expression of these receptors. These investigators state the results suggested a
mechanism for adjuvant effect observed for environmental pollutants during allergic disease.
Additionally, the authors speculated that particle size and surface area relative to dose is critical
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for these effects to occur based on varied responses between DPM and urban particulate
matter [363]. Similar to the previous study, Takizawa et al. examined the role of antigen
presentation following exposure to DPM in the development of allergic response. The authors
specifically aimed to determine whether nasal epithelium cells (NEC) were able to act as APC
during allergic response and if DPM altered this phenotype. Experiments demonstrated that
NEC expressed APC-related receptors and that compared with pre-seasonal allergy, these
receptors were upregulated in the NEC of patients during allergy season. Further, exposure of
these NEC to DPM resulted in further increases in the expression of these receptors. These
results were dependent upon the CD86 pathway, and not the CD80 pathways, similar to the
study by Fahy et al. Co-exposure to allergen with DPM further increased the expression of APC
molecules in NEC, and initiated the proliferation of lymphocytes in response to NECs. Blockade
of APC receptors and CD86 pathway abrogated proliferation of T-cells. Overall, the results
demonstrate the role of NEC as APCs in allergic response to antigen and DPM [364].
Dendritic cells are also important for the differentiation of T cells. A study by Chan et al.
examined the effect of DPM on DCs and how this may influence the adjuvant effects of DE
exposure in the development of allergic asthma. This study demonstrated that DPM elicited
oxidant-related stress on DCs. Oxidants were shown to interfere with the TLR-mediated
expression of receptors and the production of cytokines including IL-12. These changes resulted
in altered interaction between DCs and lymphocytes, and therefore aberrant T cell differentiation
shifted toward a Th2 response. Further, the authors were able to determine that activation of
nuclear factor-erythroid 2 (NF-E2)-related factor 2 was responsible for the altered DC function.
NF-E2-related factor 2 expression suppresses IL-12. Blockade of this axis resulted in restored
DC function in the presence of DPM exposure. Therefore, altered DC function is essential in the
adjuvant effects of DPM [365]. Another study by Braun et al. examining the role of DCs in
allergic response investigated whether exposure of DCs to DPM in the presence or absence of
LPS stimulations would affect cell function or viability. Authors examined multiple types of DPM
at varying doses and concluded that only DPM with high levels of adsorbed pollutants (as from
traditional DE), were capable of altering DC phenotypes. DPM with high pollutants resulted in
altered DC expression of cytokines, as well as, inability to suppress immunoglobulin class
switching in B cells. Further they alter DC maturation. The authors conclude that aberrant DC
maturation and function contributes to the Th2 favoring environment observed following
exposure to highly polluted DPM, but that organic components may not be responsible for these
effects [366]. Taken together, these studies suggest that DE exposure up-regulated allergic
response in atopic individuals but also may play a role in induction of allergic response in
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previously non-atopic individuals. Furthermore, though many mechanisms were investigated
experimentally, the conclusions were in general agreement that allergic responses are related to
DPM constituents that alter antigen presenting cell responses and shift the inflammatory
response to one that is Th2 driven. Additionally, the components of DPM most likely responsible
are those adsorbed to the core and not carbonaceous particles themselves.
Though evidence of DE elicited carcinogenesis is conflicting in in vivo studies, in vitro
studies allow for investigations in more varied cellular systems and cultures including human
cell lines. These studies provide more mechanistic implications for the pathogenesis of DE
exposure and for the development of cancer, beginning with mutagenicity testing upon the
development of the Ames S. typhimurium assay. [367]. Therefore, after early evidence that
DPM causes mutagenicity [368-371], further analysis has been conducted to determine
carcinogenicity including more modern assays including but not limited to micronuclei assay,
cell cycle assay, and DNA damage analysis.
Bieler et al. examined a known mutagen from diesel exhaust, 3-nitrobenzathrone (NBA)
and determined that it was able to covalently bind DNA and create DNA adducts in an acellular
system. Ultimately, these adducts may result in carcinogenesis, supporting that organic
fractions of DPM may be tumorigenic [372]. Further, Shi et al. examined DPM mutagenicity
using the Ames assay following alterations to engine operating conditions and using filters for
particulate. Mutagenicity was found to be strongly correlated with engine operating condition
and although filtration reduced the concentration-normalized mutagenicity of DPM, it is likely
that mutagenicity is dependent upon the organic fraction of DPM that was allowed to pass
through the filters [373].
Arimoto et al. explained how production of oxidative stress by DPM components could
lead to carcinogenesis. DPM generated oxidative radicals in biological systems due to enzyme
activation by P450 reductase. These radicals hydroxylated guanine residues causing 8-hydroxy2’-deoxyguanosine (8-OHdG) lesions in DNA, lesions that are thought to lead to tumorigenesis
[374]. Don Porto Carero et al. also demonstrated that DPM as well as CB caused DNA damage
following exposure to non-cytotoxic doses in two human cell lines. Therefore, it is plausible that
the organic fraction of DPM is not the only genotoxic fraction of DE, though the organic extract
was shown to be genotoxic as well as whole particulate. These results suggest that
carbonaceous constituents of DPM may be partly responsible for the carcinogenesis of these
substances observed in vivo and in humans [375].
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Jardim et al. exposed human bronchial cells to DPM and examined expression of micro
RNAs (miRNAs) to determine if miRNAs might have a role in tumorigenesis of DPM. miRNAs
altered to the greatest degree were related to inflammatory pathways and tumorigenesis.
Further, DPM disruption of miRNA expression patterns was significant, leading the authors to
conclude that cellular homeostasis is generally affected by alterations in gene expression
regulated by miRNAs [376]. Zhou et al. also reported on the importance of miRNA in the
development of malignancy following exposure to DPM. The authors describe a novel pathway
for carcinogenesis caused by DPM through dysregulation of miRNA, miR-21. It was established
that upregulation of miR-21 by DPM leads to downregulation of phosphatase and tensin
homolog (PTEN) that suppresses PI3K/AKT. The PI3K/AKT pathway has anti-apoptotic activity;
therefore, upregulation of PI3K/AKT activity by miR-21 acting on target protein PTEN results in
an anti-apoptotic mechanism for cell persistence by evading programmed death [377]. A
specific amino acid transporter (LAT1/CD98hc) has been identified as upregulated in lung
cancers and is associated with poor prognosis [378, 379]. Le Vee et al. demonstrated that
exposure of bronchial epithelial cells to DPM extracts resulted in dose-dependent expression of
LAT1/CD98hc. This was found also to be dependent upon activation through the ahR pathway,
as inhibition of ahR prevented LAT1/CD98hc induction caused by DPM extracts. These results
suggest that DPM extracts initiate tumor promoting pathways through ahR pathways [380]. A
study by Yadav et al. demonstrated how a mechanism that protects cells from toxicity caused by
DPM may ultimately lead to tumorigenesis. Ubiquilin (UBQLN) proteins aid in the degradation of
ubiquitinated proteins and their gene expression has been found to be down-regulated in lung
cancers. In fact, loss of UBQLN1 may result in EMT [381]. The current study established that
exposure to DPM resulted in the upregulation of UBQLN proteins overall in two cancer cell lines
and that this was dependent on the suppression of miR-155. Conversely, over-expression of
miR-155 resulted in EMT in lung cancer cells by downregulation of UBQLN1/2. The authors
speculate that initial increases in UBQLN1 and reductions in miR-155 are part of an acute stress
response to DPM exposure leading to an eventual feedback mechanism causing the selective
deletion of UBQLN1 by increased miR-155 expression during chronic exposure [382].
Bao et al. determined that some mutagenicity by DPM is reliant on cell particle
interaction requiring the internalization of particles by the cells. The investigators exposed
human-hamster hybrid cells to DPM and examined increases in mutagenicity that were dosedependent. Further, when phagocytosis was blocked, mutations induced in the nuclei were
reduced. These results suggest that ingestion of particles and radicals produced in response to
this process may be responsible for initiation of carcinogenic processes [383]. An investigation
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led by Landvik found that nitrated PAHs (n-PAHs) commonly found in DPM have varying effects
on mutagenicity and induction of apoptosis. While all n-PAHs induced some mutagenicity, most
were pro-apoptotic due to increased phosphorylation of p53 or decreases in anti-apoptotic bclxL. However, the authors concluded that the most mutagenic n-PAH examined, 1,8dinitropyrene (1,8-DNP), resulted in the least apoptosis induction. 1,8-DNP inactivated p53 by a
pathway that was determined to be non-mutagenic. This study highlights the importance of
individual components of DPM in health outcomes as this n-PAH is only present in some DPM
based on the conditions in which the engine was run. Further, these results suggest that
increased cell survival occurs with highly damaged DNA providing a mechanism for
carcinogenesis following exposure to DPM-related substances [384]. Matsunaga et al. identified
an aldo-keto reductase (AKR) involved in the progression of tumor growth associated with
exposure to a quinone component of DE. They found that exposure of human lung cells to high
concentrations of 9,10-phenanthrenequinone (9,10-PQ) resulted in apoptosis; whereas,
exposure to lower concentrations led to proliferation and invasion. This was determined to be
related to upregulation of AKR1B10; inhibition of AKR1B10 abrogated tumorigenic processes in
9,10-PQ treated cells. Further the carcinogenic activity promoted by AKR1B10 was determined
to be dependent on the production of ROS due to disruptions in the redox balance by 9,10-PQ.
Altogether, these results from this study demonstrated a newly defined pathway for cancer
promotion by components of DE [385].
Overall, mechanisms investigated for pulmonary carcinogenesis suggest that
imbalances of redox systems result in DNA damage and initiation of pathway signaling
associated with anti-apoptotic mechanisms. Together these effects result in dysregulation of
cellular homeostasis and the persistence of aberrant cells. Further studies are needed to
elucidate the multi-phase toxicological responses to air pollutants.
Immunological Effects and Susceptibility to Infection
Due to epidemiological observations that point to air pollution and DE exposure resulting
in increased hospitalizations for pulmonary infections, many investigations have aimed to
determine more causal mechanistic relationships between DE exposure and degradation of host
defense. Thomas et al. examined peripheral monocytes and AMs exposed to either 2 or 200
μg/ml of DPM in suspended in culture medium to determine whether DPM might alter
phagocytosis mechanisms and/or secretion of TNF-α as parameters of effector functions
compared with control cells stimulated with 5 ng/ml LPS. Though no change in cell viability or
attachment was observed, reductions in phagocytosis by cells exposed to DPM occurred in a
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dose-dependent manner [386]. Castranova et al. compared the effects of either DPM or organic
extracts from DPM on the function of AMs in the context of their production of cytokines. Results
showed that macrophages exposed to DPM were less able to respond to LPS, namely in the
production of TNF-α. Further, methanol extracts of DPM were able to suppress cytokine
expression in response to LPS, whereas washed DPM was not, suggesting that these effects
were driven by the organic components adsorbed to DPM [325]. Saito et al. determined if DE
exposure altered the ability of AMs to produce cytokines in the absence and presence of
intracellular infection. The authors determined that the production of cytokines by AMs in
response to DE was altered. IL-12 and TNF-α expression was decreased, while the secretion of
IL-1β was increased. They also determined that expression of apoptotic factors was increased
in AMs following DE exposure. The effects observed in the absence of infection were more
pronounced following exposure to bacterial infection. These results suggest that DE exposure
may reduce the AMs’ effectiveness in controlling infection, thereby, increasing susceptibility to
infection [387]. Lundborg et al. established that AMs exposed to aggregates of ultrafine carbon
particles and DPM diminish phagocytosis mechanisms. Further, phagocytosis was altered for
receptors typically stimulated by four distinct ligands suggesting that phagocytosis was
universally altered, and that this effect was not specific for one receptor-type relating to this
mechanism. Since phagocytosis is crucial in the control and clearance of many pathogenic
substances in the lung these findings provide important evidence for pulmonary susceptibility
following exposure to particulate matter [388].
Yin et al exposed AMs to DPM, its organic extracts, washed DPM (wDPM), or CB
particles. Their results demonstrated that DPM and organic extracts decreased phagocytosis
and bactericidal responses to LM by AM. wDPM and CB were also able to decrease
phagocytosis. However, while CBs did not decrease bacterial killing by AMs, wDPM did affect
bactericidal activity, but also not as significantly as DPM or its extracts. DPM and its extracts
also decreased the expression of inflammatory proteins by AMs. Other particles were not
effective in altering the expression of inflammatory proteins. These collective results provide
evidence that organic components of DPM are instrumental in diminishing important
antimicrobial activities of AMs and thus enhance respiratory susceptibility to infection [389].
Sarkar et al. examined the effect of DPM on inflammatory signaling pathways during
mycobacterial infection in human monocytes. The authors demonstrate that DPM suppressed
the expression of inflammatory cytokines, IFN-γ, TNF-α, IL-1β and IL-6, in response to
mycobacterium in a dose-dependent manner. DPM treatment of cells altered the expression of
many NF-κB, TLR, and IFN constituent mRNAs as well. These results jointly suggest that
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cellular response to mycobacterial infection following DPM exposure is altered in favor of
decreased resistance [390]. Since NK cells are known to be located in nasal mucosa, Müller et
al. investigated their role in defense against viral infection and whether DPM altered these
activities. The authors conclude that DPM may reduce the ability of NK cells to kill host cells that
are infected with virus since they lose important expression of cytotoxic factors granzyme B and
perforin when exposed to DPM, results that suggest diminished host defenses [391]. Altogether,
these findings suggest that DPM reduce resistance to infection and that both the core and
adsorbed components of DPM may play a role in these effects.
Effects of DE on susceptibility to infection have also been examined in epithelial cells.
Jaspers et al. infected respiratory epithelial cells with influenza following exposure to DE and
established that exposure to DE enhanced the susceptibility to influenza infection in all cell
types tested. Moreover, this was determined to be due to enhanced attachment and entry into
cells. The effects observed were also dependent upon oxidative stress generated by DE as
antioxidant treatment reversed the infectious effects observed by DE exposure. Lastly, the
suppression of host resistance to influenza infection was shown to be independent of effects on
interferon [392]. Ito et al. also examined the effect of DPM exposure on rat lung alveolar type-II
epithelial cells. The authors observed up-regulations in mRNA expression of sites identified with
bacterial and viral invasion. They established that expression of these receptors were increased
in a concentration-and oxidative stress-dependent manner. Overall, the results of this study
demonstrate a mechanism by which pathogens may invade the site of the lung more efficiently
leading to increased host susceptibility [393]. Similarly, Ciencewicki et al. revealed that DE
exposure of lung epithelial cells resulted in enhanced TLR3 expression and function that may
provide opportunity for the increased pathogen invasion and susceptibility observed by Jaspers
et al. [394].
Taken in conjunction, the results of these studies consistently show that DPM,
specifically the organic constituents associated with DPM, causes decreases in global
phagocytosis, and reduce the ability of immune cells to secrete inflammatory mediators in
response to pathogens. Further, evidence is provided that DPM upregulates certain receptors
associated with bacterial and viral invasion of host cells. Therefore, in vitro systems provide
mechanistic support for the susceptibility to infections observed in vivo as well as in human
epidemiology associated with DE associated exposures.
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Co-Exposure to Diesel and Silica
The literature summarized here is an overview of the extensive body of investigations
that examine exposure to silica and DE as individual exposures. Co-exposure studies
investigating the health effects of DE in conjunction with other exposures, or silica in
combination with other exposures have been studied and primarily focus on ozone or asbestos
[395-398]. However to date, no studies have specifically examined a co-exposure of crystalline
silica and diesel. There are, however, a small battery of studies that examine DE in a coexposure with coal dust, which contains crystalline silica. In terms of epidemiological studies, a
few investigations have examined the role of diesel exhaust and the incidence of lung cancer in
coal miners; however, due to the lack of exposure related data, or the classification of exposure
based on job category, it is difficult to determine a causal relationship. Furthermore, coincidence
of confounding exposure including cigarette smoking needs to be considered [399, 400] . A
chronic combined inhalation exposure evaluating DE and coal dust (CD) in rats found exposure
related lesions consistent with simple coal worker’s pneumoconiosis, but this finding was not
significantly different between diesel exhaust, high concentration coal dust, or the combination
the two dusts. This finding was found to be time-dependent as longer exposures resulted in
worsened severity of lesions [401]. However, this study combined doses of particles much
higher than are permissible or consistent with underground survey measurements of particles.
Another set of studies examined DE in combined inhalation exposures with CD in rats at
exposure levels consistent with permissible exposure levels for particles (2 mg/m3) underground
at that time. Many aspects of toxicity including AM function, airway function, cardiac and arterial
pathologies, and liver and lung enzyme function were evaluated during a two-year chronic
exposure to either DE (2 mg/m3), coal dust (2 mg/m3), or a combination of DE (1mg/m3) and CD
(1mg/m3). Castranova et al. determined that DE, when in combination with coal dust was not
cytotoxic to AMs at the relatively low doses administered over the course of 2 years. However,
DE did appear to suppress the phagocytic activity of AMs while coal dust increased it.
Combining the exposures resulted in no significant enhancement in overall macrophages
recovered but may be due to the reduction in CD administered in the combined exposure
compared with the CD exposure alone [402]. From this same study, Vallyathan et al. reported
that there was no evidence that combined or separate exposure to DE or CD resulted in
detrimental effects to the heart or pulmonary arteries [251]. Lewis et al. published findings from
this same study reporting similarly to Castranova et al. that DE suppressed macrophage
function while CD enhanced these functions. Additonally DE contributed to increased
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susceptibility to influenza infection and generally caused more health effects than did CD. While
some alveolar epithelial hyperplasia and lipidosis was noted for individual exposures, these
findings were not exacerbated by the combination of DE and CD. Furthermore, no evidence of
obstructive or restrictive alterations were noted. Overall, this battery of studies suggested that
combined exposure to DE and CD does not result in additive or enhanced risk beyond that of
each component alone [403]. However, it should be noted that in this study, the co-exposure
dose was normalized to total particle equivalent to that of DE or CD alone, resulting in lower
concentrations of each in the co-exposure when compared to the individual dust exposures,
which potentially attenuate particle-specific effects in the co-exposure group.
Finally, in a separate study, Hahon et al. demonstrated that mice exposed to DE (2
mg/m3) alone caused increased severity of a subsequent influenza infection, but that exposure
to combined DE (1 mg/m3) with CD (1 mg/m3) did not significantly alter this effect. Further, these
responses were most significant following 3-6 months of previous DE exposure [321]. Overall,
these findings suggest findings similar to those previously mentioned that demonstrate that DE
may diminish immune responses. While these results do not significantly implicate co-exposure
to DE and CD as causing altered pulmonary toxicity in response beyond that observed for each
particle individually, this study examined relatively low doses that were given over a long period
of time. Furthermore, while coal dust does contain quartz, amounts are drastically variable
based upon type and location of extraction, and effects in the CD groups cannot be directly
correlated to the silica component in the studies described above. Therefore, further studies
examining acute responses, as well as studies that evaluate DE in combination with higher
concentrations of silica are necessary in order to more completely evaluate the potential
combined toxicity of co-exposure to these particles.

Summary
To this day exposures to silica in the workplace are documented to occur in a numerous
occupations in addition to mining including masonry, painting, sand blasting, construction,
demolition, and ceramics [404, 405]. Inhalation of respirable silica has been shown to cause
lung inflammation and injury, COPD, bronchitis, emphysema, fibrosis, silicotic pneumoconiosis,
cancer, heart disease, autoimmune disorders, and increased risk for infection in humans [18,
35, 404, 406-409], depending upon duration and level of exposure.
DPM exposure in occupational settings is as long-standing as the use of the combustion
engine for industrial purposes, though exposure-associated health effects have only been
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recognized in the last few decades including airway inflammation, bronchitis, altered lung and
vascular function, and the development of cancer [234, 410-415]. The complex nature of the
chemical mixture that comprises DE inherently makes it difficult to study in controlled settings.
Although the health effects of both particles individually have been reviewed at length;
there is very little information available on effects of co-exposure to silica and diesel. The
current studies were designed to address the risk for enhanced pulmonary fibrosis and
alterations in innate immunity related to susceptibility to infection following a co-exposure to
crystalline silica and DPM administered at doses related to industrial settings with three major
aims: (1a) characterize the pulmonary response to an acute co-exposure to DPM and SIL at
varying doses; (1b) characterize the pulmonary response to a repeated co-exposure to DPM
and SIL in order to determine if subacute exposure vs. acute exposure altered the effects
observed for 1a; (2) establish if susceptibility to an acute respiratory infection was altered
following a co-exposure of DPM and SIL; and (3) determine whether clearance of particulate in
a co-exposure to DPM and SIL was altered compared with the clearance rate of either particle
individually to assess the effect of particle load in toxicity.
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Table 1: Retrospective Studies of Occupational Exposure to Silica Dust with Regard to Pulmonary
Fibrosis
Study
Design

Occupation
Examined

Participant
Number (n)

Exposure Level
(Average Time)

Findings

Citation

Case
Study

Bentonite Milling

8

2-10 times the
TLV (10.5 years)

Examination of 8 workers from a
bentonite milling mine revealed
incidence of findings consistent
with silicosis; one case was
confirmed by histological analysis;
3 surveyed workers had PMF, and
4 coincidence of tuberculosis
(TB).

[416]

Case
Study

Sandblasters

4

5 times the TLV
(35 months)

Acute silicosis, fibrotic lesions in
all, co-morbidity with cor
pulmonale and autoimmune
developments

[417]

Case
Study

Stone Masonry

2

Patient 1: 0.1
mg/m3 (30 years)
followed by 2
mg/m3 (5 years)

Low quartz exposure may
contribute to hilar node fibrosis,
which may lead to PMF following
subsequent high exposure to
silica

[418]

37 year-old worker diagnosed with
silicosis advanced to PMF
following 10 year history of
polishing and laminating quartz
countertops.

[419]

Patient 2: 1.5
mg/m3 (6 years)
Case
Study

Counter Top
Fabrication

1

n/a (10 years)

62

Case
Study

Surface Coal
Mining

8

n/a (32.9 years)

High exposure to silica in surface
coal miners resulted in
pneumoconiosis with progression
to PMF

[420]

Case
Study

Stone Masonry

6

n/a (13 years)

Though cases all had low
predicted probability of
pneumoconiosis based on health
survey, all had radiological
evidence of silicosis with half
presenting with asymptomatic
PMF upon screening exhibiting
the importance of early
radiological screening

[421]

Medical
Survey

Silica Mining and
Milling

86

Above TLV (8
years for those
with silicosis)

39% of workers with a mean of
7.7 years of work had simple
silicosis and 16% of workers with
a mean of 7.1 years of work had
PMF, determined to be due to
high exposure levels of high
percentage silica dust and lack of
effective controls

[422]

Medical
Survey

Slate Pencil
Manufacturing

593

46.47 mg/m3 for
slate cutters,
24.70 mg/m3
general
environment (7.29
years for cutters,
7.62 years for
non-cutters male
and 14.69 for noncutters female)

54.6% surveyed showed
radiologic evidence of silicosis,
incidence and severity of fibrosis
correlated with degree and
duration of exposure and was
worse in females than males of
equal exposure levels

[423]

63

Medical
Survey

Iron Foundry

188

Incidence of silicosis in 9.6% of
workers surveyed with 1% PMF,
prevalence correlated to
level/duration of exposure but not
with cigarette smoking. Smoking
did increase respiratory
symptomology, however.

[424]

[425]

0.95 mg/m3 for
non silicotics
(at least one year)

Chronic simple silicosis is
correlated to loss of lung function
attributable to fibrosis, lung
function losses correlated to
exposure to respirable silica
though declination in function may
also arise from larger sized mixed
particles

Up to 30 times the
TLV for
coremakers
Up to 9 times the
TLV for fettlers
(8.6)

Medical
Survey

Granite Workers

320

2.1 mg/m3 for
silicotics

Medical
Survey

Open-cast Coal
Mining

1,249

≤1.0 mg/m3
geometric mean
for groups, some
individual
measures were
higher (n/a)

Workers performing dustiest jobs
such as rock drillers etc.
increases risk for radiological
findings consistent with
pneumoconiosis, most likely
silicosis

[426]

Medical
Survey

Stone Carving

42

1.5 mg/m3 (15.5
years)

High prevalence of silica dust
correlated with increased
incidence of silicosis and reduced
lung function, duration of
exposure also contributed to
severity of silicosis

[427]
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Medical
Survey

Sand Blasting

75

n/a (14.2 years)

Prevalence of progressive
massive fibrosis among silicotics
was 39.7%, high coincidence with
tuberculosis and calcified lymph
nodes also indicated as possible
contributors to transition from
silicosis to PMF

[428]

Medical
Survey

Denim
Sandblasting

60

n/a (18.5 months)
but, (21.4 months
for those with
silica)

73.3% of patients had silicosis, all
cases were accelerated with
11.4% having PMF, clinical score
was positively correlated with
duration of exposure, latency
since exposure, and occurrence
of PMF

[429]

Medical
Survey

Denim
Sandblasting

32

n/a (45 months)

All silicosis cases began after
acute and relatively short-term
exposure (≤ 2 years) to silica,
19% of patients died of PMF,
mean age of mortality was 35
years suggesting over-exposure
to large amounts of silica

[430]
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Medical
Survey

Surface Coal
Mining

2,328

n/a (≥ 1year –
97%)

2% of patients exhibited
pneumoconiosis, with 0.5%
exhibiting signs of PMF, many of
which had no underground mining
history, 37% of those with
pneumoconiosis were shown to
have radiological findings
consistent with silicosis, incidence
of these findings was increased
among miners from Central
Appalachian regions

[431]

Medical
Survey

Silica
Processing

250

n/a (13/14
silicotics had less
than 10 years of
tenure)

Of 250 employees surveyed 14 or
5.6% had radiologic findings
consistent with silicosis, all but 1
had tenure of less than 10 years
suggesting accelerated silicosis. 1
worker had PMF, and 5 silicotic
workers had findings consistent
with latent TB.

[432]

Cohort

Coal Mining

74

n/a (n/a)

Higher quartz content in the dust
of worker lungs resulted in more
severe lung lesions

[433]

Cohort

Granite Workers

777 granite
workers, 122
controls

n/a (n/a)

Highest prevalence of fibrosis in
dressing workers, drillers, and
sand blasters

[434]

Cohort

Tungsten Mining

1,151

0.25 mg/m3 and
2.25 mg/m3(n/a)

Cumulative exposure to silica dust
in tungsten miners was positively
correlated with probability of
silicosis development

[435]
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Cohort

Construction

1,056

n/a (20-25 years)

Chronic simple silicosis correlated
to 20+ years of exposure to silica
in the workplace, stone-splitters
and caisson workers at highest
risk, other coinciding
complications included TB

[436]

Cohort

Coal Mining

90,973

n/a (n/a)

Increases in radiological findings
associated with silica exposure,
pneumoconiosis, and PMF
occurred during 2000-2008
compared with 80s and 90s
suggesting coal miner exposure to
respirable silica is too high

[3]

Cohort

Denim
Sandblasting

145

n/a (40+ months)

Despite short exposure and
latency, incidence of silicosis and
progression of silicosis increased
in sandblaster previously
evaluated in 2007. Of those
surveyed only 1 patient of those
surviving did not have progression
of disease.

[437]
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Cohort

Coal Mining

13

n/a (32 years)

All but 1 miner in 13 surveyed for
rapid progressive pneumoconiosis
had PMF. Only 4 of 13
demonstrated classic coal
worker’s pneumoconiosis, while
11 of 13 demonstrated mixed
pneumoconiosis and lesions
consistent with silicosis. Two of 13
displayed alveolar proteinosis and
interstitial inflammation along with
silicotic nodules indicating
accelerated silicosis. Findings
suggest exposure to coal dust
containing high amounts of silica
and silicates.

[438]

PostMortem

Granite
Quarrying

15

16,082 μg/m3-y
lifetime mean
(19.4 years)

Fibrosis, evidence of
pneumoconiosis in the absence of
radiologic findings, consistent with
1955 exposure standard of 50
µg/m3

[439]

PostMortem

Coal Mining

264

n/a (21 years)

Degree of lung fibrosis was highly
correlated with silica lung content
while emphysema was positively
correlated with lung coal content

[440]

PostMortem

Gold Mining

67

n/a (25-30 years)

Lung quartz dust concentration
was associated with severity of
silicosis, though duration of
exposure did not necessarily
correlate with lung particle burden

[441]

68

PostMortem

Agricultural
Workers

112

Total dust for the
region PM10 range
43.5-122 μg/m3
(n/a)

Higher prevalence of
pneumoconiosis and small airway
disease was observed in
farmworkers compared with nonfarmworkers of the same region,
airway lesions were strongly
associated with mineral dust,
crystalline silica was significantly
associated with small airway
fibrosis

[442]

PostMortem

Platinum Mining

30

n/a (≥ 1 year)

Levels of silica that platinum
miners are exposed to are high
enough to cause silicosis, 25
workers surveyed had fibrotic
nodules in the lymph nodes, and 5
had pulmonary silicosis.

[443]
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Table 2: Retrospective Studies of Occupational Exposure to Diesel Exhaust with regard to Lung
Cancer
Study
Design

Occupation
Examined

Participant
Number (n)

Exposure Level
(Average Time)

Latency
Period

Findings

Citation

Case
Study

Varied

2,291 lung
cancer, 2,570
controls

n/a (10+ years)

n/a

An increased risk for lung
cancer mortality was
found for truck drivers a
finding that could not be
accounted for by cigarette
smoking or additional
occupational exposure.

[444]

Case
Study

Varied

996 cases,
1085 controls

n/a (~25-30
years)

n/a

Data suggest an
increased risk for lung
cancer mortality in longhaul truckers and diesel
truck drivers however
quantifiable data on DE
exposure was not
available.

[445]

Case
Study

Professional
Driving

n/a

N/a (n/a)

n/a

Excess risk for lung
cancer in chauffeurs
exposed to long-term DE
fumes was found even
after adjusting for
smoking history.

[446]

Case
Study

Varied

n/a

Estimated into
low-high
quartiles (n/a)

n/a

Men were at a higher risk
for incidence of lung
cancer, especially
squamous cell
carcinomas. This risk
increased with increasing

[447]
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estimated intensity of
exposure. Risk for other
malignancies were found
but to a lesser and in
some case non-significant
extent.
CaseControl

Railroading

54,973

Estimated into
low-high
quartiles (n/a)

0/5/10/15
years

Operating a locomotive
was associated with
increased risk of lung
cancer mortality but this
risk did not increase with
working tenure. Lung
cancer mortality was
increased on trains with
diesel-powered
locomotives.

[216]

CaseControl

Railroading

54,973

Estimated in
intensity years
(28.5 years
worked but
estimated 6.5
exposed)

5/10/15 years

Increased risk of dying
from lung cancer
compared with non-DE
exposed jobs but not with
increasing estimated
exposure.

[448]

CaseControl

Varied

1681 cancer,

Estimated as
low/medium/high
based on job
function and
years exposed
(at least 1 year)

5 years

Excess risk of lung
cancer was determined
for truck drivers, taxi
drivers, and railway
conductors especially for
squamous and large cell
carcinomas

[449]

CaseControl

Professional
Driving

n/a (n/a)

~10+ years

Professional drivers in
Korea are exposed to

[450]

2053 controls

1,280 drivers,
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33,924
general
population

increased levels of DE
and air pollution, which
increases risk for
incidence of lung cancer.

Nested
CaseControl

Non-Metal
Mining

12,315
workers w/
198 lung
cancer deaths
and 562
controls

between 0 and
29.54 divided
into quartiles of
exposure
mg/m3/year - EC
(varied)

15 years

In a study of over 12,000
miners, historical
exposure to respirable EC
was estimated. It was
reported that an
increased risk of dying
from lung cancer was
associated with exposureresponse relationship to
DE. There was in
increased trend in risk
with increasing exposure
to DE. This was
regardless of facilities,
noting that in some
facilities smoking was
prohibited.

[197]

Estimated
Risk

Mining

8,614

Surface – 14
μg/m3/12 hrs EC (45 years
est.)

n/a

Based on published risk it
was determined that
miners in Australia are
exposed to levels of DE
that would result in
excess death of lung
cancer and that additional
controls for worker
exposure are necessary.

[451]

Underground –
18-44 μg/m3/12
hrs -EC (45
years est.)
Underground
diesel loader
72

operators - 59
μg/m3/12 hrs –
EC (45 years
est.)

Pooled
Analysis

Varied

Pooled
Analysis

Varied

MetaAnalysis

MetaAnalysis

13,304 cases,

Estimated into
low-high
quartiles (1-35
years)

n/a

Occupational exposure
was consistently
associated with small
increase in risk for lung
cancer and there was a
significant exposureresponse trend.

[452]

1,593 cases,
1,427 controls

Estimated in
low-high relative
cumulative
exposure
(estimated 120+)

n/a

Both studies pooled
found an increased risk
for lung cancer
associated with exposure
to DE. Risk was higher for
squamous cell carcinoma
than for small cell or
adenocarcinomas.

[453]

Varied

Pooled 39
studies

n/a (n/a)

10+ years

Epidemiological evidence
suggests that
occupational exposure to
DE has a causal
relationship with lung
cancer.

[454]

Professional
Driving

Pooled 19
studies

n/a (~10+years)

n/a

After adjusting for
smoking, this study
reported that professional
drivers are at an 18%

[455]

16,282
controls

73

increased risk for
developing lung cancer.
Cohort

Dock Working

6,071

n/a (n/a)

(n/a)

A tendency for increased
risk of mortality due to
lung cancer was found;
however, smoking related
causalities could not be
excluded.

[456]

Cohort

Varied

62,800
exposed,
307,143
unexposed

n/a (n/a)

(n/a)

An increased risk for
mortality due to lung
cancer was found even
after adjusting for
smoking status.
Occupations that were
significantly associated
with increased risk
included miners and
heavy equipment
operators, while truckers
and railroaders had a
weaker association.

[217]

Cohort

Bus and Tram
Driving

18,174

n/a (~10 years)

Greater than
15 years
positively
correlated

Increased incidence of all
malignancies. For people
employed longer than 3
months risk of lung
cancer incidence was
significant for men and
women. Smoking cannot
be ruled out as a
confounder.

[218]

74

Cohort

Potash Mining

5,536

2.70 ymg/m3(15
years)

19 years

Relative risk of lung
cancer was doubled for
miners exposed to the
highest measure of Total
carbon after >20 years of
exposure, however, the
elevation was still not
considered to be
significant. Smoking was
not considered a
confounder in this study,
but cannot be ruled out.

[457]

Cohort

Heavy
Equipment
and Truck
Driving

20,728,

n/a (n/a)

n/a

Increased risk of lung
cancer for truck drivers
exposed to DE was
found, but not for HEO.
Increased risk for prostate
cancer was also found for
truck drivers.

[458]

n/a (~20 years)

n/a

Among the US working
population examined,
increased mortality due to
lung cancer was
observed for all drivers
and dock workers.
Relative risk for lung
cancer was found to be
consistent with other
occupational studies.
Elevated risk for lung
cancer was identified for
workers in the US
Trucking Industry

[187]

Cohort

Truck Driving

119,984
referants

54,319

75

especially for drivers;
however, smoking and
lifestyle may play a role in
these health risks.
Cohort

Truck Driving

31,135

n/a (~20 years)

76

n/a

Regular exposure to DE
and other MVE have an
elevated risk of lung
cancer, which was
associated with working
tenure.

[459]
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Abstract
The effects of acute pulmonary co-exposures to silica and diesel particulate
matter (DPM) that may occur in various mining operations were investigated in vivo.
Rats were exposed by intratracheal instillation (IT) to silica (50 or 233 µg), DPM (7.89 or
50 µg), or silica and DPM combined in phosphate-buffered saline (PBS), or to PBS
alone (control). At 1 day, 1 week, 1 month, 2 months, and 3 months post-exposure
bronchoalveolar lavage and histopathology were performed to assess lung injury,
inflammation, and immune response. While higher doses of silica caused inflammation
and injury at all time-points, DPM exposure alone did not. DPM (50 µg) combined with
silica (233 µg) increased inflammation at 1 week and 1 month post-exposure and
caused an increase in the incidence of fibrosis at 1 month compared to exposure to
silica alone. To assess susceptibility to lung infection following co-exposure, rats were
exposed by IT to 233 µg silica, 50 µg DPM, a combination of the two, or PBS control 1
week before intratracheal inoculation with 5x105 Listeria monocytogenes. At 1, 3, 5, 7,
and 14 days following infection, pulmonary immune response and bacterial clearance
from the lung were evaluated. Co-exposure to DPM and silica did not alter bacterial
clearance from the lung compared to control. Although DPM and silica co-exposure did
not alter pulmonary susceptibility to infection in this model, the study showed that noninflammatory doses of DPM had the capacity to increase silica-induced lung injury,
inflammation, and onset/incidence of fibrosis.
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Introduction
The natural gas and oil industry is one of the most rapidly growing industries in
the United States. Specifically, the industry is expanding in the area of hydraulic
fracturing, “fracking,” or horizontal drilling. This process extracts natural resources from
otherwise inaccessible deposits below the earth’s surface, provided more than 2 million
jobs in 2012, and is estimated to support approximately 4 million jobs by 2025 [460].
Two respirable particulates identified as possible exposure hazards in fracking
workplaces include diesel particulate matter (DPM) and α-quartz crystalline silica (SiO2)
[461]. These two particulates are also present in combination in other mining
operations including below ground mining operations, particularly in coal extraction.
Although toxicity of these two particulates have been studied in detail as individual
exposures, there are currently no in vivo studies, as far as we are aware, that have
examined the pulmonary effects of the particulates in combination at doses that are
relevant to various mining operations.
In addition to underground mining operations and operations in hydraulic
fracturing, where significant numbers of diesel engines are utilized (transport, drilling,
and pumping), diesel exhaust (DE) exposure is also prevalent in industries including
trucking and railroad operations [182]. DE is a highly complex mixture of chemical
substances, but is primarily composed of an elemental carbon (EC) core having
additional organic carbon constituents adsorbed to it. Other than the EC components,
compounds typically contained in DE include: polyaromatic hydrocarbons (PAHs),
sulfates, silicates, nitrates, as well as metallic particulates [182]. DPM exposure is linked
to a variety of adverse health outcomes, including enhanced sensitization to allergic
stimulus, development and aggravation of asthma, chronic bronchitis, decreased lung
function, airway inflammation, decreased vascular function, and development of
cancers, as reported in epidemiological studies [234, 410-415, 462]. Based on these
studies, DE and DPM have been identified by the International Agency for Cancer
Research (IARC) as a group 1 carcinogen [182, 463]. In addition to human cohort
studies, studies involving healthy human volunteers exposed to DE/DPM in a controlled
chamber have also shown that DE/DPM caused pulmonary inflammation in acute
exposure scenarios [234, 464]. Controlled human studies as reviewed by Ghio et al.
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[465, 466] show that inflammation occurs in the respiratory tract of humans exposed to
DPM and that this occurs in a dose-dependent manner. DPM toxicity has also been
investigated in vivo and in vitro. DPM has been shown to enhance airway reactivity,
inflammation, production of reactive oxygen species (ROS), and increased development
and severity of allergic asthma, lung fibrosis, lung injury, alveolar edema, lung cancer
and mortality in exposed animals [289, 308, 327, 467-473]. Studies conducted in vitro
suggest, similarly, that DPM contributes to airway inflammation, production of reactive
oxidants, unfolded protein response, allergic response, decreased mucociliary
clearance, and upregulation of cancer-associated proteins in lung cells [333, 377, 380,
467, 474-479]. Furthermore, DPM has been shown to alter the pulmonary immune
function and is associated with increased susceptibility to infection [316, 327, 480-485].
Regulations to control occupational exposure to DE or DPM are recognized in
several countries, and regulations vary relative to underground mining operations
versus above-ground mining and non-mining workplaces. In addition, exposure is
differentially regulated by DE constituents (total particle, elemental carbon, nitrogen)
[179-182]. In the United States, recommended exposure limits (REL) exist for many of
the components of diesel exhaust as individual emissions; however, there is currently
no Occupational Safety and Health Administration (OSHA) regulation of DPM in nonmining, occupational settings. The Mine Safety and Health Administration (MSHA) REL
for DE and DPM in underground mine operations is a time-weighted average (TWA),
based on an 8-hour work day, of 160 µg/m3 total carbon, which includes DPM as
elemental carbon. Additionally, The California Department of Health Services (CDHS)
has recommended an occupational exposure limit (OEL) of 20 µg/m3 elemental carbon
[184]. Both Switzerland and Australia have set OELs at 100 µg/m 3 elemental carbon
[179, 183].
Workplace exposure to SiO2 also occurs in a multitude of occupations and are
well documented for a variety of mining operations, as well as in masonry, painting,
sand blasting, construction, demolition, and ceramics [404, 405]. SiO2 is one of the most
common minerals occurring in the earth’s crust and is a major component of sand. Sand
that contains SiO2 is the primary proppant, or substance used to stabilize the fracture
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during hydraulic fracturing operations and subsequent resource extraction. A respirable
fraction of this sand can become airborne when transported onto/around fracking sites
or pumped at high volumes/pressure into the well-bore [486]. The respiratory toxicity of
the crystalline form of SiO2 is well-established, and therefore OSHA requires
workplaces to follow the permissible exposure limits (PEL) set at 0.05 mg/m3 as a TWA
for respirable crystalline SiO2. Inhalation of respirable SiO2 has been shown to cause
lung inflammation and injury, chronic obstructive pulmonary disorders, bronchitis,
emphysema, fibrosis, silicotic pneumoconiosis, cancer, heart disease, autoimmune
disorders, and increased risk for infection in humans [18, 35, 404, 406-409], depending
upon duration and level of exposure.
Further, in vivo studies of SiO2 exposure have investigated the mechanisms
associated with pathologies, such as fibrosis and cancer, including: chronic
inflammation and the up-regulation of acute inflammatory mediators like leukotriene B4,
up-regulation of the NF-κB pathway, increased oxidant burden attributable to both the
presence of free radicals associated with particles and oxidant production by cells in
response to SiO2 exposure, up-regulation of genes associated with mucus production
and pulmonary toxicity, and activation of the inflammasome [80, 123, 128, 487-489]. In
vitro studies have shown production of oxidants and inflammatory mediators, activation
of cell-signaling pathways associated with cancer, damage to DNA, and increased
expression of genes related to inflammation, apoptosis, cancer, and fibrosis in response
to SiO2 exposure [490-495], furthering support for mechanisms underlying the
pathologies observed in animal models of disease related to occupational exposure.
SiO2 exposure has also been implicated in the alteration to the immunological
environment in the respiratory tract [91, 496] and contributions to respiratory
susceptibility to some infections [158, 497].
While the pulmonary toxicity to constituents of diesel, and SiO2 are well-studied
as individual exposures, little is known about the effects these particles may have when
encountered as a mixed exposure. Mining operations including hydraulic fracturing for
oil and gas and above and below ground metal and non-metal mining operations, are
environments where workers may be exposed to constituents of diesel and SiO2
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simultaneously, rendering it paramount to establish whether co-exposure to these
particles will enhance or alter pulmonary toxicity. The current studies were designed to
investigate the hypothesis that combined exposures to these particles would result in
amplified injury, inflammation, and cellular recruitment to the lung in an acute exposure
scenario. Additionally, the studies addressed whether or not cell-mediated clearance of
a pathogen would be altered by the co-exposure. Existing in vivo and in vitro studies
documenting the toxicity of DPM and SiO2 in vivo often examine doses of these
materials representative of chronic exposures or doses that exceed typical workplace
exposures in single bolus doses [84, 324, 498-501]. Therefore, doses for these studies
were based on field measurements of SiO2 taken during active above-ground mining
operations [486]. Values for diesel were derived from both underground mining values
[502] for high dose values and from existing OELs for elemental carbon for the lower
dose [181, 183, 503]. A single acute bolus dose of silica, diesel particulate, or a
combination of the particles at different doses were administered to Sprague-Dawley
rats by intratracheal instillation. Lung injury, inflammation, and immune responses were
evaluated over a three-month time-course. Additionally, alteration in susceptibility to
pulmonary infection following exposure to the particles in combination was evaluated to
further assess alterations in immune response.
Methods
Particles. Particles in these studies are used as surrogates to represent work site
exposures. DPM was obtained from the National Institute of Standards and Technology
(NIST) as a commercially available NIST Standard Reference Material (SRM) 2975
(referred to as DPM in the study). SRM 2975 was originally collected from an industrial
forklift in the 1990s [504]. The surrogate particle used for SiO2 is α-quartz crystalline
silica (SIL; MIN-U-SIL® 5, US SILICA; Berkeley Springs, WV).
Dose Determination. Doses were derived from field measurements of particles and
applied to the equation below (EQ1) to quantify the amount of particle that would
deposit in the lung of an average male worker doing moderate work for 12 hours per
day for a period of 14 continuous days using a pulmonary deposition efficacy for each
particle derived using a software-based algorithm that considers particle characteristics
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including shape and density [505]. These doses were then normalized to the surface
area of both the worker’s and the rat’s lungs to obtain doses for in vivo studies (EQ2).
DPM estimated as elemental carbon was reported to be variable depending on
operations at hydraulic fracturing sites; (personal communication with JS related to
Esswein et al., 2013; unreferenced) however, it was generally below the MSHA
recommendation of 160 µg/m3 total carbon (120 µg/m3 elemental carbon equivalent),
and DPM in underground mining operations has been measured in excess of 500 µg/m 3
as elemental carbon as reviewed by Pronk et al. (2009). Therefore, in this study, two
doses of DPM were evaluated. The low dose (7.89 µg per rat) was derived from the
OELs for DPM measured as elemental carbon of 100 µg/m 3 TWA (0.100 µg/l)
(EQ3).The high dose of DPM was derived from high elemental carbon level
measurements taken during underground mining of 637 µg/m 3 (0.637 µg/l)(EQ4)
[506].The SiO2 high dose (233 µg SIL) was derived from the highest SiO2 levels
measured during hydraulic fracturing site visits [486], 2.5 mg/m3 (2.5 µg/l) (EQ5). In
addition, to assess exposure to equivalent doses of both particles at a less toxic dose of
SIL, 50 µg of SIL was also evaluated as the low dose of SIL.

EQ1 - Basic equation for standard worker lung deposition:
= (field concentration, μg/l) x (minute ventilation, l/min) x (exposure time per day,
min/d) x (total fracking days, d) x (pulmonary deposition efficacy, unitless)
EQ2 - Equation for normalization to rat lung surface area:
= (worker’s deposited dose/average male worker lung surface area) x (average
rat lung surface area)
EQ3 - Equation for low DPM dose:
Worker lung deposition = (0.10 μg/l) x (20 l/min) x (720 min/day) x (14 days) x
(0.10) = 2,016 μg
Dose calculated = (2,016 μg/102.2 m2) x (0.4 m2) ≈ 7.89 μg per rat
EQ4 - Equation for high DPM dose:
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Worker lung deposition = (0.637 μg /l) x (20 l/min) x (720 min/day) x (14 days) x
(0.10) ≈ 12,842 μg
Dose calculated = (12,842 μg/102.2 m2) x (0.4 m2) ≈ 50 μg per rat
EQ5 - Equation for high SIL Dose:
Worker lung deposition = (2.5 μg /l) x (20 l/min) x (720 min/day) x (14 days) x
(0.118) = 59,472 μg per worker
Dose calculated = (59,472 μg/102.2 m2) x (0.4 m2) ≈ 233 μg per rat
DPM and SIL Preparation and Characterization. Particles were prepared in USPgrade phosphate-buffered sterile saline (PBS) without Ca2+ or Mg2+ (AMERESCO;
Solon, OH) for intratracheal instillation. A sonication process was used to disperse
agglomerated particles. DPM was prepared as a 2 mg/ml stock solution and SIL was
prepared as a 10 mg/ml stock solution, vortex mixed for one min, followed by 1 min of
continuous sonication (GE130PB ultrasonic processor; General Electric, Boston, MA).
Aliquots of stock solution were then further diluted to: 7.89 µg DPM, 50 µg DPM, 50 µg
SIL, 233 µg SIL, 7.89 µg DPM + 233 µg SIL , 50 µg DPM + 50 µg SIL , or 50 µg DPM +
233 µg SIL in 0.3 ml PBS. Particles were then vortex mixed for an additional 30 sec,
followed by 15 sec of sonication prior to intratracheal instillation. Particle preparations
were dried onto filters and evaluated by field emission scanning electron microscopy
(FESEM) to determine particle size. The average agglomerate size of the DPM was
approximately 2 µm. SIL was evenly distributed in suspension with primary particle size
of approximately 2 µm. Energy dispersive X-ray (EDX) was performed to determine the
elemental components of the particles as a measure of particle purity. The DPM was
comprised primarily of the carbonaceous core, or EC of diesel, with very little detectable
trace elements including: Chromium, Copper, Iron, Nickel, Oxygen, Silicon, and Zinc.
Due to their volatile nature, PAHs cannot be measured using EDX, but the total
extractable mass including the certified mass fractions of PAHs contained in NIST SRM
2975 is given as 2.7% of the total sample as described in the certificate of analysis
[504]. No trace metals were detected in the SIL sample.

85

Animals. Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals
(Scottdale, PA), weighing approximately 300 g and free of viral pathogens, parasites,
mycoplasmas, Helicobacter, and CAR Bacillus, were used for all studies. Rats were
housed in the pathogen free, environmentally controlled, Association for Assessment
and Accreditation of Laboratory Animal Care International (AAALAC)-accredited facility.
The rats were housed in ventilated polycarbonate cages, two per cage, on Alpha-Dri
cellulose chips and hardwood Beta chips as bedding; they were provided HEPA-filtered
air, irradiated Teklad 2918 diet, and tap water ad libitum; and were allowed to acclimate
for one week before exposure. Rats were not restricted from enrichment activity (i.e.,
chewing/climbing). All animal procedures used during the study were reviewed and
approved by the Institutional Animal Care and Use Committee (IACUC).
Time-Course Study Design. In Vivo Lung Injury, Inflammation, and Disease. On day 0,
rats were lightly anesthetized with an intraperitoneal injection of 30-40 mg/kg sodium
methohexital (Brevital; Eli Lilly, Indianapolis, IN) and intratracheally instilled with 7.9 µg
DPM, 50 µg DPM, 50 µg SIL, 233 µg SIL, 7.89 µg DPM + 233 µg SIL, 50 µg DPM + 233
µg SIL, 50 µg DPM + 50 µg SIL, or vehicle control (PBS). All particles were delivered in
0.3 ml USP grade PBS. All animals were humanely euthanized at 1 day, 1 week, 1
month, 2 months, or 3 months following particle exposure (n = 8/group/time point) with
an intraperitoneal injection of 100-300 mg/kg sodium pentobarbital followed by
exsanguination. The trachea was cannulated, bronchoalveolar lavage (BAL) was
performed on the right lung lobes, and BAL cells (BALCs) and fluid (BALF) were
retained for analysis of parameters indicative of inflammation, injury, oxidant production,
and immune function. Lung injury and inflammation were evaluated as the presence of
lactate dehydrogenase (LDH) activity, cytokines, and chemokines in BALF. BALCs were
centrifuged onto slides, stained, and counted to determine cell phenotype differential.
BAL lymphocytes were further differentiated by phenotype by flow cytometry.
Lymphocytes from lymph nodes draining the lung were also differentiated by phenotype.
Chemiluminescence assays were used to measure oxidant/free radical production by
BAL phagocytes to evaluate the inflammatory response. The left lung was excised,
pressure-inflated with 10% neutral-buffered formalin, and weighed with waterdisplacement to determine fixed lung volume. Histopathological assessment of lung
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injury, inflammation, and disease were performed and morphometric analysis of fibrillar
collagen content was conducted.
Infection Study Design. Pulmonary Immune Response to Infection Following Particle
Exposure. In this study, rats were exposed to 50 µg DPM, 233 µg SIL, 50 µg DPM +
233 µg SIL combined in 0.3 ml PBS, or PBS alone (vehicle control) by intratracheal
instillation as described above. One week following particle exposure, rats were
intratracheally instilled with ~ 5 x 105 colony forming units (cfu) of Listeria
monocytogenes (strain 10403S, serotype 1) in 0.5 ml of sterile PBS. Animals were
euthanized at 1, 3, 5, 7, and 14 days following infection (n=8/dose/time point). BAL was
performed on the right lung lobes, and BALC and BALF were retained for analysis of
parameters indicative of inflammation, injury, and immune alteration as described for
the time course study. The left lung was clamped during lavage and subsequently
excised, homogenized, and cultured to evaluate bacterial clearance from the lung.
BAL. BAL was performed at each time point after exposure. Following euthanasia as
described above, the trachea was cannulated, the chest cavity was opened, the left lung
bronchus was clamped off, and BAL was performed on the right lung lobes. BAL was
recovered in two fractions. The first fraction of the BAL was obtained by inflating the
right lung with 4 ml of PBS, massaging for 30 sec, withdrawing, and repeating the
process a second time with the same 4 ml of PBS. The second lavage fraction
consisted of repeated 6 ml volumes of PBS instilled with massaging of the chest cavity,
withdrawal, and combination until a 30 ml volume was recovered. For each animal, both
fractions of BAL were centrifuged, the cell pellets were combined and re-suspended in
1 ml of PBS, and the acellular fluid from the first fraction was retained for further
analysis described for BALF below.
Analysis of LDH Activity. The level of LDH activity in the BALF of all treatment groups
was measured at each time point after exposure to evaluate cytotoxicity as a measure
of lung injury. Measurement of LDH activity in the acellular fluid was obtained using a
Cobas Mira chemistry analyzer (Roche Diagnostic Systems; Montclair, IN). LDH activity
was quantified by detection of the oxidation of lactate coupled to the reduction of NAD +
at a spectrophotometric setting of 340 nm.
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BALF Protein Analysis. Cytokines and chemokines involved in inflammatory and
immune responses were measured at each time point after exposure in the BALF of
rats treated with PBS, DPM, SIL, or DPM/SIL combinations, with commercially-available
enzyme-linked immunosorbent assay (ELISA) kits or by multiplex array. The following
cytokines and chemokines were quantified by ELISA: tumor necrosis factor-α (TNF-α),
transforming growth factor-β (TGF-β), interleukin (IL)-10, IL-12p70, monocyte
chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-2 (Novex, Life
Technologies; Grand Island, New York); IL-2, IL-4, IL-6, interferon (IFN)-γ (R&D
Systems; Minneapolis, Minnesota); and osteopontin (OPN, Enzo Life Sciences;
Farmingdale, New York). Additionally, two matrix metalloproteinases (MMP), MMP-2
and MMP-9, were quantified by ELISA, as well as tissue inhibitor of metalloproteinases
(TIMP)-1 (R&D Systems) as indices of tissue remodeling due to injury. IL-1α, IL-1β, IL5, IL-13, IL-17A, IL-18, granulocyte colony stimulating factor (G-CSF), granulocyte and
macrophage colony stimulating factor (GM-CSF), eotaxin, leptin, MIP-1α, epidermal
growth factor (EGF), IFN-γ inducible protein (IP)-10, growth-regulated
oncogene/keratinocyte chemoattractant (GRO/KC), vascular endothelial growth factor
(VEGF), fractalkine, lipopolysaccharide (LPS)-induced CXC chemokine (LIX) and
regulated on activation, normal T-cell expressed and secreted (RANTES) were
assessed by multiplex array (Eve Technologies; Alberta, CA).
BALC Differentials. Total BALC collected from rats intratracheally-instilled with PBS,
DPM, SIL, or DPM + SIL in combination were counted using a Coulter Multisizer II
(Coulter Electronics; Hialeah, FL). BALC differentials were performed to determine the
total number of alveolar macrophages (AMs), neutrophils, lymphocytes, and
eosinophils. Briefly, 5 × 104 cells from each rat were spun down onto slides with a
Cytospin 3 centrifuge (Shandon Life Sciences International; Cheshire, England) and
labeled with Hema 3® stain (Fisher Scientific; Kalamazoo, MI) to differentiate cell types.
Two hundred cells per slide were counted, and the percentage of AMs, neutrophils,
lymphocytes, and eosinophils was multiplied by the total number of cells to calculate the
total number of each cell type.
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Chemiluminescence (CL). To measure the production of reactive oxidant species by
BALC, CL was measured according to the method of Antonini et al. [507]. Luminol
(Sigma-Aldrich; St. Louis, MO) was used as an amplifier to enhance detection of the
light, and 0.2 mg/mL of unopsonized zymosan (Sigma-Aldrich) or 3 μM phorbol
myristate acetate (PMA; Sigma-Aldrich) was added to the assay immediately prior to the
measurement of CL to activate the cells. Because rat neutrophils do not respond to
unopsonized zymosan, the zymosan-stimulated CL produced is from AMs, whereas the
soluble stimulant, PMA, activates both neutrophils and AMs to generate reactive oxidant
species [508]. CL was quantified using an automated Berthold Autolumat LB 953
luminometer (Wallace, Inc.; Gaithersburg, MD). Each sample was measured for 15 min,
and the integral of counts per minute (cpm) versus time was calculated. The production
of CL was calculated as the cpm of stimulated cells minus the cpm of the corresponding
resting cells, then normalized to the total number of BAL AMs for zymosan-stimulated
CL and total BALC for PMA-stimulated CL.
Phenotypic Quantification of BALC and Mediastinal Lymph Node (MLN) Cells by
Flow Cytometry. Lymphocyte populations in BALC and MLN were differentially
assessed for phenotype by multicolor flow cytometry analysis. Briefly, cells were
obtained by lavage (BALC) or by homogenizing the MLN manually between frosted
glass slides followed by filtration. 106 cells were plated in a 96-well round bottom plate.
Cells were washed and blocked for non-specific staining using mouse anti-rat CD32
(FCγRII) antibody (BD Pharmingen™; San Diego, CA). Cell were then fluorescentlylabeled with one or a combination of the following mouse-anti-rat antibodies to
determine phenotype: CD3 (T cells), CD3 and CD4 (T-helper cells), CD3 and CD8a
(cytotoxic T cells), CD161a (NKR-P1A; natural killer cells), or CD45R (B220; B Cells)
(BD Pharmingen™). Cells were then washed and fixed with BD Cytofix/Cytoperm™ (BD
Pharmingen™) and stored at 4 °C until phenotyped using a BD™ LSRII flow cytometer
and BD FACSDiva™ software v6 (Becton, Dickinson and Company; San Jose, CA)
(within 24 h). Results were gated and analyzed using ©FlowJo Software v10 (FlowJo,
LLC; Ashland, OR).
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Histopathology. The left lungs of rats were fixed with 10% neutral buffered formalin by
airway pressure fixation under 30 cm-water pressure to total lung capacity for 15 min.
Lung volumes were assessed by weight of water displacement. The left lungs were
embedded in paraffin, sectioned onto slides, and stained with hematoxylin and eosin
(H&E) or trichrome. An n = 5 stained slides per treatment group per time-point per study
block were assessed; blocks were designed with paired controls resulting in n = 10 for
saline and SIL 233 µg groups from each of the blocks when combined. Stained slides
were analyzed for indications of inflammation, injury, and fibrosis by a certified
veterinary pathologist at Charles River Laboratories (Wilmington, MA) who was blinded
to the treatment groups. Indices of pathology were scored on scale of 0 – 5, where 0 =
no observed effect, 1 = minimal response, 2 = mild response, 3= moderate response, 4
= marked response, and 5 = severe response.
Morphometric Analysis of Connective Tissue Thickness. Tissue sections from left
lung were deparaffinized and stained with Sirius Red for detection of connective tissue,
particularly fibrillar collagen. Slides were immersed in 0.1% picrosirius solution (100 mg
of Sirius Red F3BA in 100 ml of saturated aqueous picric acid) for 2 h followed by
washing for 1 min in 0.01 N HCl. Slides were then counterstained with hematoxylin for 2
min, dehydrated, and mounted with a coverslip for imaging. Quantitative morphometric
methods were used to measure the average thickness of Sirius Red-positive connective
tissue in the alveolar regions. Volume (% of the alveolar wall) and thickness were
measured by standard morphometric analyses [509, 510]. This consisted of basic point
and intercept counting. An eyepiece counting overlay consisting of 11 by 11 lines (121
total points for each throw of the overlay) was used with a 40X objective. A grid pattern
for throws of the counting overlay was used in order to ensure a uniform sampling of the
section, which did not overweight interior points. The counting overlay throws of the
eyepiece were positioned over the section at 12 uniformly spaced grid points in both X
and Y coordinates. These 12 grid points were determined using the stage micrometer
scale to measure the X and Y bounds of the section. Using the bounding rectangle of
these coordinates a 3 by 4 grid was selected and the 12 intersections were used as the
center point for each of the eyepiece counting overlay throws. Volume was determined
by counting the number of points over the Sirius Red-positive connective tissues in the
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alveolar regions. Surface density of the alveolar wall was determined from intercepts
between a line overlay and the alveolar wall. To limit the measurements to alveolar
parenchyma, areas containing airways or blood vessels 25 μm in diameter was
excluded from the analysis. Average thickness of the Sirius Red-positive connective
tissue of the alveolar wall was computed from two times the ratio of volume density of
point to the surface density of the alveolar wall.
Bacterial Clearance from the Lung. To measure the clearance of bacteria from the
lung, left lungs were excised and placed in 10 ml of sterile deionized water. Lungs were
homogenized using a Polytron®PT-2100 homogenizer with PT-DA 2112/EC aggregate
attachment (Kinematica; Bohemia, NY). Homogenates were diluted and cultured on
prepared Brain Heart Infusion Agar plates (Becton, Dickinson and Company). Cultures
were incubated at 37 °C for 24 h. Cfu were counted and multiplied according to culture
dilution factors.
Statistical Analyses. Results for all BAL parameters, cellular phenotype, morphometry
and bacterial clearance were expressed as mean fold change from control ± standard
error calculated as

∆𝑥̅
𝑐𝑜𝑛𝑡𝑟𝑜𝑙𝑥̅

and a one way analysis of variance (ANOVA) was

performed between all treatments groups at each time point. Significant differences
among groups were determined using the Student-Newman-Keuls post-hoc test. Data
were analyzed using SigmaPlot for Windows Version 12.5 (Systat Software, Inc, Ekrath,
Germany). For all analyses, significance was set at p < 0.05. Because data from
histopathology studies are inherently categorical, nonparametric analysis of variance
was assessed using SAS/STAT software, Version 9.1, of the SAS System for Windows
statistical programs (SAS Institute, Inc.; Cary, NC). In this instance groups were
compared using the Wilcoxon rank sum test.
Results
Particle Characterization. One ml aliquots of 7.89 µg dose DPM, 50 µg dose DPM,
233 µg dose of SIL, as well as 7.89 µg and 50 µg DPM in combination with SIL 233 µg
(DS) in PBS solution, were dried on carbon filters and examined using FESEM in order
to characterize size of the primary particles and their degree of agglomeration. In
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solution, DPM was found to agglomerate to a size of approximately 2 µm in diameter.
The primary particle size was found to be smaller in size, ~ 200 nm. The primary
particles of SIL were approximately 2 µm in size and were evenly distributed in
suspension (Figure 1A, 1B). The association between DPM and SIL in solution was
minimal. EDX was used to evaluate the elemental components of each particle. DPM
was found to be composed of primarily carbon, reflecting the carbonaceous core of the
DPM, with very little detectable trace elements including: Chromium, Copper, Iron,
Nickel, Oxygen, Silicon, and Zinc adsorbed to it (Figure 1C). The EDX spectrum of the
SIL sample is depicted in Figure 1D.
Time-Course Study. Lung injury was evaluated by examining LDH in the BALF
collected from rats at 1 day, 1 week, 1 month, 2 months, and 3 months post-exposure to
particles. LDH activity was significantly increased in all groups that contained the high
dose of SIL (233 µg), and the high dose of SIL alone at all time points following
exposure when compared to control (Figure 2). At early time points, the increase in
groups that were co-exposed to SIL and DPM was primarily driven by SIL particles.
However, by 3 months, co-exposure to the high doses of DPM and SIL (DS 50/233)
resulted in an increase when compared to all other groups. There were no significant
increases in LDH activity in groups exposed to DPM alone at either dose, SIL 50 alone,
or DS 50/50.
Protein mediators were evaluated in BALF as a measure of inflammation and immune
response (Table 1). The low dose of DPM (DPM 7.89) and the low dose of silica (SIL
50) did not cause any significant changes in BALF protein when compared to control
with the exception of DPM 7.89, whereby IL-10 was significantly elevated (data not
shown). The high dose of SIL caused increases in several proteins associated with
inflammation; MCP-1, MIP-1α, RANTES, GRO/KC, MIP-2, IP-10, TNF-α, and IFN-γ
compared with the control and groups exposed to DPM only. SIL 233 alone and the DS
50/233 groups caused a decrease in the anti-inflammatory protein IL-10 from 1 week to
2 months post-exposure compared with control and DPM exposed groups. SIL 233
alone and the DS 50/233 groups also caused a significant increase in MMP-9, a protein
associated with tissue remodeling that has implications in the development of fibrotic
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changes in the lung, at all time-points following exposure. Additionally, SIL high dose
exposure increased MMP-2 and OPN, additional proteins associated with tissue
remodeling, wound healing, and fibrosis at one month post-exposure, and at all time
points thereafter for OPN. Finally, the SIL high dose alone or in combination with the
DPM high dose caused an increase in IL-18, a protein associated with upregulation of
the NLRP3/NALP3 inflammasome, at later time-points. DPM 50 alone did not illicit an
increase in pro-inflammatory cytokines. However, the high dose of DPM did cause a
decrease in IL-2 and IFN-γ proteins associated with the effector properties of T h1 cells,
when compared with controls. The decrease in IL-2 was also present in the high dose
co-exposure group (DS 50/233). Similarly, DPM in combination with SIL exhibited
independent action on the expression of some cytokines like, MIP-α, GRO/KC, MIP-2,
MMP-2 and MMP-9 at some time-points (Table 1), suggesting that DPM in a coexposure may have the capability to reduce the effects observed with SIL alone. These
observations may indicate altered macrophage and lymphocyte activity in response to
treatment with DPM. There were no significant changes in the following cytokines in any
group: EGF, eotaxin, fractalkine, G-CSF, GM-CSF, IL-1α, IL-1β, IL-4, IL-5, IL-6, IL12p70, IL-13, IL-17A, leptin, LIX, TGF-β, TIMP-1, and VEGF (data not shown).
Cell differentials were performed on BALC to further assess inflammation (Figure
3A&B). DPM alone at either dose did not cause an increase in the influx of AMs (Figure
3A) or neutrophils (Figure 3B). AM influx was increased in all groups that contained SIL
233 beginning at 1 week post-exposure. Neutrophil influx significantly increased as
early as 1 day post-exposure in all groups containing SIL 233 (Figure 3B), and persisted
throughout the time course. Exposure to SIL 50 µg showed a trend toward an increase
in neutrophils up to 1 month following exposure with resolution of response over time. At
1 month, exposure to DS 50/233 caused a significant increase in neutrophils when
compared to all groups. The DS50/50 group followed a similar pattern as SIL 50 alone.
BALC activation was also evaluated as oxidant production ex vivo (Figure 3 C&D). DPM
only doses used in this study did not cause an increase in oxidant production by AMs
and neutrophils as measured by CL. Oxidant production in the SIL 233 group
significantly increased for both total phagocytes at 1 day and at 3 months post-exposure
(Figure 3C), and oxidant production by macrophages followed a similar pattern
93

(Figure 3D). Interestingly, exposure to the higher dose of DPM combined with the high
dose of SIL resulted in significantly increased oxidant production over exposure to the
high dose of SIL alone at 1 week, 1 month, and 2 months post-exposure, suggesting a
higher oxidant burden in the lung of rats in the high dose co-exposure group at these
times.
BAL and MLN lymphocytes were phenotyped by flow cytometry. In addition to
phagocytic influx described in Figure 3, exposure to SIL at the high dose alone or in
combinations with DPM 50 caused significantly increased lymphocyte influx into the
lung as early as 1 day following exposure (Table 2) and proliferation in the MLN as early
as 1 week post-exposure (Table 3). This effect was attributed primarily to CD4+ and
CD8+ T cell population subsets. Exposure to DPM 50 alone did not cause a significant
increase in lymphocyte populations in BAL or MLN. Additionally, it was noted that for
the co-exposed group, DPM exhibited independent action reducing the influx of the
CD8+ subset of cells into the lung observed with the SIL only exposed group at 1 month
and total T cells, which was mostly attributed to reduced influx of the CD4 + T cell
subset, at 3 months following exposure.
H&E and trichrome-stained tissue sections were evaluated by a board certified
veterinarian pathologist (Table 4). DPM alone at either dose did not cause pathological
changes in the lung. Influx of AMs, as a measure of inflammation, was significantly
elevated in the SIL 233 group alone at all time-points following exposure and when
combined with DPM at 1 month following exposure. Alveolar epithelial hyperplasia
(AEH) was also observed at all points following exposure in DS 50/233 exposed groups.
At 1 month following exposure to particles, minimal to mild septal fibrosis was observed
in groups exposed to SIL 233. Interestingly, incidence of septal fibrosis was significantly
increased by co-exposure to the high doses of DPM and SIL at 1 month. By 3 months
after exposure, occurrence of septal fibrosis was equivalent in both SIL 233 only and
co-exposed groups. Groups exposed to SIL in combination with high dose DPM scored
significantly higher for particles in tissue versus DPM alone as indicated by the
presence of brown granules accumulated in macrophages, which corresponds to an
observation of increased coloration in lymph nodes as well. Furthermore, mild
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hyperplasia of the bronchiolar/alveolar epithelium was observed near the terminal
bronchioles at 2 months following exposure and was found to be associated with the
presence of macrophages loaded with high particle content, suggesting a correlation
between tissue damage and the presence of particles (data not shown). SIL 50 and DS
50/50 were not evaluated. Overall, most histopathological changes were attributable to
exposure to 233 µg of SIL; however, the presence of DPM often increased the severity
and/or incidence of these changes in the co-exposure groups.
To further quantify observations of fibrosis, alveolar expansion, alveolar septal wall
thickness, and thickness of fibrillar collagen were measured by morphometry to further
assess the fibrotic response to exposure. Alveolar expansion was measured as a ratio
of the total airspace volume to volume versus the surface to volume of the epithelial
surface intercepts or thickness of airspace between alveolar tissues. Alveolar septal
wall thickness was measured as a ratio of the total volume to volume of alveolar tissue
versus the surface to volume of epithelial surface intercepts. No significant differences
were observed between the treatment groups. Additionally, fibrillar collagen thickness
was measured as the ratio of total collagen volume to volume versus total epithelial
surface intercepts surface to volume. This measurement is indicative of fibrotic
development in lung tissue. Although not statistically significant, there was a trend for
increased fibrillar collagen volume in SIL 233-exposed groups and this trend was further
increased for co-exposed groups at the latest time points measured (data not shown).
Infection Study. In order to investigate the effects of particle exposure on respiratory
susceptibility to a bacterial pathogen, an infectivity study was conducted to assess the
clearance of L. monocytogenes from the lung over a 14 day time course 1 week
following exposure to particles. Despite lung inflammation and phagocytic cell activity
observed in the absence of infection in co-exposed groups (Figure 3), overall clearance
of the pathogen was not significantly altered between these treatment groups (Figure
4A). The data suggest that, for the doses of DPM used in this study, which were not
found to induce toxicity by themselves, combination with moderately toxic doses of SIL
did not alter susceptibility to an infection with Listeria monocytogenes. Influx of cells into
the lungs was significantly increased for SIL 233 exposed groups at day 1 post-infection
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(Figure 4). This influx appeared to be comprised mostly of neutrophils (Figure 4D) and
lymphocytes. By day 3 post-infection, the influx of cells in SIL 233-exposed groups was
resolved. Finally, cells from the BAL and MLN were phenotyped as in the time-course
study to evaluate lymphocyte populations. For the SIL 233-exposed group the influx of
lymphocytes into the BAL at day 1 post-infection was significantly greater when
compared with the control group, and again on day 14. DPM exposure caused no
significant alterations in lymphocyte influx into the lung, while combined exposure to
particles caused significant increases in total lymphocyte influx at day 14 compared with
control and DPM exposed groups comprised mostly of CD4+ cells (Table 5). In the
MLN, the SIL 233-exposed group had significantly increased lymphocytes, specifically
CD4+ T Cells, compared with control and overall T cell populations were significantly
increased when compared to control and DPM 50 at day 1 post-infection. SIL-233
exposure also increased total lymphocytes in the MLN compared with all other groups
at day 3 post infection. DPM exposure caused significant decreases compared with SILexposed group for total T Cells at day 3 post-infection and caused significant decreases
in the CD8+ subset of T cells compared with SIL-233 and control groups for the same
time-point. Finally, combined exposure caused increased lymphocytes at Day 1 for total
cells and total T cells compared with control group and compared with DPM and control
for the CD4+ T cell subset (Table 6).
Discussion
The current studies were conducted in order to address a knowledge gap with
relation to co-exposures representative of those that may occur in mining industry
occupations, including hydraulic fracturing. It is important to note that the DPM used in
this study was extracted from DE collected from an industrial forklift in the 1990s, which
qualifies it as “transitional” in nature (collected between 1988 and 2006). Transitional
DE samples vary from “traditional” DE or “TDE” (collected prior to 1988) and New
Technology DE or “NTDE” (collected post-2006) in chemical and physical properties.
TDE is considered to be more hazardous in nature due to having a larger amount of
particulate matter, carbon monoxide, and hydrocarbon emissions, while NTDE has
significantly lower TDE-related emissions, [511]; however, very little information is
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available on health outcomes related to NTDE exposure. Additionally, the current study
examined DPM only and not total DE, which contains higher levels of metals and
hydrocarbons, which in turn may lead to greater toxicity following exposure to DE. The
silica used in this study was also a surrogate for occupational exposures that occur in
mining operations and oil and gas extraction. It is not a freshly fractured form of
crystalline silica, which has been shown to be higher in toxicity than aged silica [487],
and although sand used at hydraulic fracturing sites contains respirable silica,
composition of the sand may vary from site to site [512, 513].
While most parameters of toxicity evaluated could be attributed to the more
reactive and toxic crystalline silica particles, DPM, at doses that represent different
durations of exposure based on field measures taken at mining sites and OELs, did
exacerbate the effects of silica in the acute exposure model examined, particularly
between 1 week and 1 month post-exposure. This effect was observed for the
parameters of pulmonary inflammation, quantified by the influx of neutrophils into the
lung (Figure 3B) as well as by the oxidant production by phagocytes (Figure 3 C, D) at
time points up to one month for inflammation and up to three months for oxidant
production. Furthermore, assessment of pathology in the lung tissue suggested that
DPM may be contributing to the mild fibrotic response induced by silica in the lung,
whereby there was an increased incidence of mild fibrosis at 1 month post-exposure in
the animals that were exposed to the combination of the high doses of particulate.
Additionally, while silica contributed to an increase in lymphocyte- and immune-related
cytokines in the lungs (Tables 1-3), DPM reduced the expression of many proteins
including: MIP-1α, GRO/KC, MIP-2, IL-2, IFN-γ, MMP-2, and MMP-9, in the BALF when
in combination with silica, especially at early time-points. DPM may exhibit independent
action on macrophage activity, as well as lymphocyte influx and proliferation thus
attenuating the effects induced on these cell types by silica alone (Table 1-3).
Immunological alterations were further examined by evaluating susceptibility to an
infection following particulate exposure. While some alterations in immune cellular influx
were observed in silica-exposed groups (Tables 6-7), the exposures did not alter the
bacterial clearance rate or resolution of infection.
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The toxicological properties of crystalline silica are well-established. Silica is
known to cause fibrotic changes in the lung following both acute exposures to bolus
doses of particles and chronic lower dose exposure to particles [514]. The mechanism
directing the toxicity of silica particles in the lung still remains ambiguous but is thought
to stem from multiple attributes relating to the crystalline structure of silica and its
reactivity based on either surface charge or silicon-containing groups present on the
surface of silica due to disruptions made to its structure during crushing, grinding, and
drilling [514]. In conjunction with this, reactive oxygen/nitrogen species (ROS/RNS)
associated with the particles themselves or as products of the respiratory burst following
activation of phagocytes have been shown to drive a prolonged state of inflammation in
the lungs [487, 490, 515, 516]. Studies investigating pulmonary toxicity of diesel
demonstrate DPM-induced inflammation and oxidative stress as well [467, 473-476];
however, unlike silica, DPM exposure does not have the same propensity to cause
fibrosis. Instead, chronic exposures to DE/DPM have been shown to cause disease
outcomes including chronic obstructive pulmonary disorder, emphysema, and cancer
[411, 415, 517, 518].
In regards to potential mechanisms in the development of fibrosis, crystalline
silica particles have been shown to either bind to scavenger receptors on alternatively
activated macrophages (M2) followed by uptake into the cell in a phagosome, or the
particles are phagocytosed by a classically activated macrophage (M1) in the
interstitium once the M2 macrophages become overloaded [128]. M2s are
phenotypically distinct from M1s, being activated primarily by IL-4 and IL-13 rather than
IFN-γ and are typically less involved in killing of microbes/clearance and more
associated with functions of wound healing and collagen development [519]. As
reviewed by Kawasaki et al. and demonstrated in original work by Joshi et al. [128, 130,
520], the uptake of these particles triggers a signaling cascade within macrophages that
leads to: the release of recruitment factors for additional inflammatory/immune cells,
stimulation of the autocrine and paracrine production of fibrogenic mediators, and, most
notably, either the successful clearance of particles from the lung to either the GI tract
or lymphatics or the eventual phagolysosomal destruction and death of the cell that
engulfed the particles. Directly following the death of a macrophage containing silica,
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the particles are engulfed by another nearby phagocyte. This repeated cycle of uptake,
release, and re-uptake continues in the lung until a point when cellular signals lead to
the formation of a granuloma to sequester particles in an effort to reduce damage to the
surrounding tissue [521-523]. It is hypothesized that M1 type macrophages may initiate
this process [128], but other cell types including lymphocytes, epitheliod monocytes and
macrophages, and giant cells are involved as well [91, 524, 525].
In relationship to the fibrotic paradigm discussed above, this study showed that
there were significant increases in neutrophil and lymphocyte recruitment in the high
dose co-exposed group when compared to the silica-exposed group, along with
significant increases in cytotoxicity in the lung measured as LDH in BALF, and this was
accompanied by the increase in incidence of mild fibrosis at 1 month post-exposure in
the high dose co-exposure group. While the interaction of silica with receptors was not
investigated in the present study, downstream mediators of these interactions were
increased in the BALF. Increases in chemotactic/recruitment proteins associated with
inflammation (MCP-1 (CCL2), MIP-1α (CCL3), RANTES (CCL5), GRO/KC (CXCL1),
MIP-2 (CXCL2), IP-10 (CXCL10), and TNF-α) were significantly increased in the groups
containing the high dose of silica, and the increases tended to progress throughout the
time-course (Table 1); whereas, the anti-inflammatory protein, IL-10, was significantly
decreased in silica-exposed groups throughout the time-course. Additionally, OPN,
MMP-2, and MMP-9, proteins involved in tissue remodeling, were also significantly
increased in silica-exposed groups, particularly later in the time-course. Though
differences between the high dose co-exposed group and high dose silica-exposed
group separately were not statistically significant for this parameter, there was
approximately a 30% increase in MMP-9 expression, at the latest time-point, suggesting
a trend for increased tissue remodeling in the co-exposed group over that of silica
alone.
In addition to the pro-inflammatory responses discussed above, a significant
increase in IL-18 at later time-points following silica exposure was measured for both
the high dose co-exposed and high dose silica only groups. The NLRP3 inflammasome
is an immune system mediator that detects danger signals produced by damaged cells.
99

The inflammasome is also activated by stimulation with foreign bioreactive particles like
multi-walled carbon nanotubes, which cause production of oxidants by phagocytic cells
leading to up-regulation of NLRP3 complex formation, resulting in the cleavage of IL-18
and IL-1β and prolonged inflammation and fibrotic development in the lung [526-530].
Crystalline silica exposure has also been shown to upregulate the activity of the
NALP3/NLRP3 inflammasome following binding to scavenger receptors on
macrophages both in vitro [123, 531, 532] and in vivo [532] leading to the cleavage of
IL-1β and IL-18 to their active forms by caspases leading to apoptosis or pyroptosis in
cells [123, 131] . While we did not observe an increase in IL-1β we did observe an
increase in IL-18 for both the SIL 233 and high dose co-exposed groups. At time-points
as early as 1 week following exposure, IL-18 was significantly increased in both groups
compared with DPM 50, but by 3 months both groups were significantly greater than
both DPM 50 and control (Table 1). Therefore, inflammasome activation may also be
occurring as an early response in the development of fibrosis.
In addition to the pro-inflammatory properties of both DPM and crystalline silica,
both particles have been shown to alter mechanisms of pulmonary immunity, although
the effects following exposure to these particles differ in this regard. Silica has been
shown to cause hyper-activation and hyper-responsiveness of both macrophages [92,
402] and T-cells [52, 91]. This was also demonstrated in the current study in the group
exposed only to the high dose of silica individually. Conversely, DPM has been shown
to suppress activation and effector functions of macrophages and T cells, and this
suppression has been associated with increased susceptibility to infection and reduced
pulmonary clearance of pathogens [316, 324, 402, 483, 485, 533-535]. Because both
DPM and silica exposure have been shown to increase lung inflammation and
phagocytic recruitment in acute exposures, but lead to decreased clearance following
chronic exposure, it was of interest to determine whether the capacity for clearance of a
pathogen in an acute model of exposure to the particles in combination would be
altered. In the present study, a difference in bacterial clearance from the lungs was not
observed following exposure to DPM, silica, or the DPM and silica co-exposure (Figure
4A); this may reflect the lower doses delivered here when compared to previous studies
[59, 62, 316, 324, 481, 497]. Other differences among studies include the degree to
100

which DPM or SIL were freshly collected, thus making them less reactive than particles
that workers in the field may be exposed to [514, 536, 537], and the engine source of
the DPM, which would determine the elemental constituents. In addition, the timing of
the infection may influence clearance of the infection following exposure. In studies that
examined a pathogenic response more acutely (within 3 days of particle exposure),
DPM exposure reduced clearance of the infection [316, 324, 481]. In response to silica
exposure, clearance of bacteria has been shown to be critically dependent upon
whether exposure is acute [538], resulting in increased clearance of infection due to
enhanced inflammatory and essentially a “primed” macrophage response for effective
uptake and clearance of the bacteria, or chronic, resulting in decreased clearance [59,
62, 497] suggesting the degree of lung injury present would alter susceptibility to
infection. Further investigation is needed to determine the effects that particles might
have on clearance and susceptibility to infections experienced more subsequently to
particle exposure. Given that we observed development of fibrosis at later time-points,
administering bacteria later in the time-course, such as at 1, 2, or 3 months may result
in more similar effects to what has been observed in chronic silica exposures previously
[59, 62, 497].
Conclusion
The data taken together show that DPM exposure at doses that do not elicit
pulmonary toxicity has the capacity to significantly alter silica-induced pulmonary
effects, primarily inflammation, oxidant production, and rate of onset of fibrotic changes
in the lung, as well as exhibit independent action, which mediates some immune cell
activity when the exposure occurs simultaneously as a mixture. The current study does
not delineate the specific interactions between the two particulates in the lung following
exposure and leading to the observed effects. One possibility is that presence of and/or
injury induced by crystalline silica alters the clearance rate of the DPM particles from the
lung, which in turn results in a longer persistence of DPM in the lung in conjunction with
silica. DPM alone may be cleared at a greater rate resulting in the lack of observed
toxicity following the individual exposures in this study. This hypothesis is supported by
the evidence from the histopathology analysis in the observance of brown granules
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(DPM) in the lungs of only the co-exposed group and by the presence of DPM particles
in the lymph nodes of only the co-exposed group at the later time points and not the
DPM-only exposure. Another possibility for the observed effects may be related to the
particle load as a result of DPM and crystalline silica delivered to the lung
simultaneously. Although the delivered doses by intratracheal instillation in these
studies are lower than many previous studies [324, 481, 497, 538], the co-exposed
group received a total particle load of 283 µg compared to the individual silica load of
233 µg and the DPM load of 50 µg, which is an increase in load of ~18 %. Studies are
underway to address the effects of load and clearance in relationship to the combined
exposure of DPM and silica.
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Table 1: Immunoregulatory Proteins Recovered from BALF of Sprague -Dawley Rats Exposed to DPM,
SIL, or Combination of DPM and SIL
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All data are shown as mean fold change over control ± standard error. *Different from control and DPM 50 µg; ^different from
DPM 50 µg and DS 50/233 µg groups; +different from all other groups; &different from DPM 50 µg;

@different

from control.

Results that were below the limit of detection (BLD) were noted; 1/2 of the lowest limit of detection was used for statistical
analysis of values BLD. Statistical significance is p ≤ 0.05.
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Table 2: Lymphocyte Phenotype Determination by Flow Cytometry in the BALF
Recovered from Sprague-Dawley Rats Exposed to DPM, SIL, or DPM and SIL
Combined

All data are expressed as mean fold change over control ± standard error. *Different from control
and DPM 50 µg; & different from DPM 50 µg; + different from all other groups. Statistical
significance is p ≤ 0.05.
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Table 3: Lymphocyte Phenotype Determination by Flow Cytometry in the
MLN Excised from Sprague-Dawley Rats Exposed to DPM, SIL, or DPM
and SIL Combined

All data are shown as mean fold change over control ± standard error. *Different from control and
DPM 50 µg. Statistical significance is p ≤ 0.05.
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Table 4: Severity and Incidence Scores for Left Lung Lobes of Sprague Dawley Rats Exposed to DPM, SIL, or DPM and SIL Combined in Varyin g
Doses

Lung tissue was analyzed and scored for accumulation of alveolar macrophages as an
index of inflammation (AM), alveolar epithelial hyperplasia (AEH), bronchus associated
lymphoid tissue hyperplasia (BH), lymphoid nodules in the interstitium (LNI), brown
granules in alveolar macrophages (BG; presence of DPM particles), fibrosis in alveolar
septae (F) (n=5 or 10 per group per time point). Severity was scored as 0 - 5: 0 =
normal, 1 = minimal/slight, 2 = mild, 3 = moderate, 4 = marked, and 5 = severe.
Incidence was noted as Focal (F), Multi-focal (M), and Diffuse (D). Data are presented
as means with incidence (number of animals with a positive score per total animals) in
parentheses. bDifferent from all other groups; ddifferent from control and DPM 50 µg
only; hdifferent from control only; idifferent from control, DPM 7.89 µg, and DPM 50 µg
group; jdifferent from control and SIL 233 µg group; kdifferent from control and DPM
7.89 µg group. Note: all notations indicate a p value <0.05 except where asterisks
indicate * p < 0.01 and ** p < 0.05 for all groups except control where p < 0.01.
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Table 5: Lymphocyte Phenotype Determination by Flow Cytometry in the
BALF Recovered from Sprague-Dawley Rats Exposed to DPM, SIL, or
DPM and SIL Combined with LM

All data are shown as mean fold change over control ± standard error. *Different from
control and DPM 50 µg; @different from control. Statistical significance is p ≤ 0.05.
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Table 6: Lymphocyte Phenotype Determination by Flow Cytometry in the
MLN Excised from Sprague-Dawley Rats Exposed to DPM, SIL, or DPM
and SIL Combined with LM

All data are shown as mean fold change over control ± standard error. *Different from
control and DPM 50 µg; @different from control; ^ different from DPM 50 µg and DS 50/233
µg groups; #different from SIL 233 µg; +different from all other groups. Statistical
significance is p ≤ 0.05.
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Figure 1

A

B

C

D

Figure 1: FESEM images of particles. (A) 233 µg SIL and 7.89 µg DPM in combination
prepared in PBS solution, diluted 1:10 in PBS, then dried onto a filter under 20,000x
magnification (scale bar = 2 µm with 10 segments of 0.2 µm each) (B) 233 µg SIL and
50 µg DPM prepared in PBS solution, diluted 1:10 in PBS, then dried onto a filter in PBS
solution under 20,000x magnification (scale bar = 2 µm with 10 segments of 0.2 µm
each). Red arrows indicate SIL and yellow arrows indicate DPM. (C) EDX of DPM
particles pictured in the FESEM above at 20 keV. Labeled spectral peaks for elements
primarily present in the samples appear in red (carbon). All other labeled peaks are
elements commonly found in DPM but present only in trace amounts in this sample
(Chromium, Copper, Iron, Nickel, Oxygen, Silicon, and Zinc). (D) EDX of SIL particles
pictured in FESEM above at 20 keV.
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Figure 2
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Figure 2: LDH activity in BALF after exposure to DPM, SIL, or a combination of DPM
and SIL (DS) at indicated doses (µg). Data are shown as mean fold change over control
(y = 0). DPM 7.89 µg was not evaluated at 2 months. aDifferent from control, DPM 7.89
µg, DPM 50 µg, SIL 50 µg, DS 50/50 µg groups; bdifferent from all other groups;
cdifferent from control, DPM 50 µg, SIL 50 µg, and DS 50/50 µg groups. Statistical
significance is p ≤ 0.05.
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Figure 3

Figure 3: Total AMs (A) and neutrophils (B) in the BALF following exposure to DPM,
SIL, or DS at doses indicated. Production of oxidants by total phagocytes stimulated
with PMA (C) or by AMs only stimulated by zymosan (D) measured by
chemiluminescence following exposure to DPM, SIL or DS at doses indicated. DPM
7.89 µg was not evaluated at 2 months. All data are shown as a mean fold change over
control (y = 0). aDifferent from control, DPM 7.89 µg, DPM 50 µg, SIL 50 µg, DS 50/50
µg groups; bdifferent from all other groups; cdifferent from control, DPM 7.89 µg, DPM
50 µg, SIL 50 µg, and DS 50/50 µg groups; ddifferent from control and DPM 50 µg only;
edifferent from control , DPM 50 µg, and SIL 50 µg groups; fdifferent from control, DPM
7.89 µg, DPM 50 µg, SIL 50 µg, and DS 50/50 µg; gdifferent from control, DPM 7.89 µg,
DPM 50 µg, and SIL 50 µg groups. Statistical significance measured as p ≤ 0.05.
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Figure 4
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Figure 4: (A) Bacterial burden in the left lung over the time-course. Data is shown on a
Log10 scale. Total cells (B), total AMs (C), and total neutrophils (D) recovered by lavage
following exposure to DPM, SIL, or DS at doses indicated. (B-D) Data are shown as a
mean fold change over control (y = 0). *Different from control and DPM 50 µg; @different
from control. Statistical significance is p≤ 0.05.
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Chapter 3 - Study 2
The following represents data that will be submitted to a peer-reviewed journal for publication.
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Abstract
The effects of acute pulmonary co-exposures to silica and diesel particulate matter
(DPM), which may occur in various occupations including the mining and construction
industries, were investigated in vivo. Rats were exposed by intratracheal instillation (IT) to silica
(SIL) 233 µg, DPM 233 µg, carbon black (CB) 233 µg, DPM and SIL (DPM/SIL) combined, CB
and SIL (CB/SIL) combined, or to PBS alone (vehicle control). At 1 day, 1 week, 1 month, 2
months, and 3 months post-exposure, bronchoalveolar lavage and histopathology were
performed to assess lung injury, inflammation, and immune response. Although SIL caused
enhanced parameters of inflammation and injury at all times-points, DPM exposure alone
caused increased lactate dehydrogenase activity only at the early time-points (1 day, 1 week)
post-exposure when compared to control. Parameters of increased injury were also observed in
the CB group compared to control and compared to DPM and control for inflammation at day 1;
however, these effects were transient and subsided by 1 week. DPM combined with SIL
increased oxidant production by phagocytes compared with all other groups at all time-points
post exposure, and increased markers of inflammation, injury, the influx of lymphocytes in the
lung, the proliferation of lymphocytes in the mediastinal lymph nodes (MLN), and the incidence
of epithelial hyperplasia in lung tissue, scored as minimal, at later time-points compared to
exposure to SIL alone. The combination of CB with SIL caused increased macrophage oxidant
production at 1 day compared with control and DPM groups, and 1 week and 1 month
compared with all individual particle dose groups, which resolved by 2 months post-exposure.
Additionally, CB combined with SIL resulted in increased markers of inflammation and injury at
all time-points following exposure; however, these effects were primarily attributed to the effects
of SIL, particularly at later time-points following exposure. To assess susceptibility to lung
infection following co-exposure, rats were exposed to particles, as described above, 1 week
before intratracheal inoculation with 5x105 Listeria monocytogenes. At 1, 3, 5, 7, and 14 days
following infection, pulmonary immune response and bacterial clearance from the lung were
evaluated. Co-exposure to CB and SIL increased bacterial clearance at day 1 compared with
control and CB only. At day 3, animals exposed to SIL alone or in combination with CB or DPM
cleared the infection to a greater degree than those exposed to DPM alone. No differences in
clearance rate occurred beyond day 3 and all groups effectively resolved the infection by day
14. The study showed that DPM had the capacity to increase SIL-induced lung injury,
inflammation and oxidant production to a greater degree than equal doses of CB and SIL,
indicating these effects are due to properties inherent to DPM rather than particle load.
Alternately, tissue remodeling at later time points, indicated by increased incidence of tissue
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remodeling proteins in the lung and fibrosis, correlated better with particle load and the
presence of SIL following co-exposures. Additionally, particle-specific effects were observed in
the susceptibility model whereby DPM alone transiently reduced innate immune response to a
pathogen, and SIL appeared to enhance the bacterial clearance at early time points postinfection; however, effects on susceptibility to infection did not occur during the adaptive phase
of the response. Overall, the study showed that in co-exposure to SIL and DPM, total particle
load and the presence of SIL contribute to toxicity in the lung, and in addition, DPM caused
particle specific effects that significantly altered the toxicological outcomes beyond that of just
particle load.

Introduction
Many workers in industrial occupations may be at risk for exposure to respirable
particles as a part of their regular duties. This is particularly true in industries that utilize heavy
machinery powered by diesel engines. Diesel exhaust releases particulates into the air, which
are respirable in size. Furthermore, occupations that involve the redistribution of earth or the
extraction of natural resources including construction, excavation, tunneling, agriculture, metal
and non-metal mining, and the oil and gas industry may not only utilize this equipment during
operations, but depending on the industry or operation, a co-exposure with quartz or crystalline
silica (SiO2) that is ubiquitous in nature may also occur. Field studies performed by researchers
at the National Institute for Occupational Safety and Health (NIOSH) identified both of these
particulates as potential concerns for occupational exposure [461]. Furthermore, since dieselpowered equipment has gained popularity as a mechanical mechanism of extracting mineral
resources underground, these types of co-exposures are common in many mining
environments, and have the potential to create particulate exposures that are greater in
concentration due to the confined working environments encountered underground [403]. While
the toxicities of these two particulates have been studied in detail as individual exposures, there
are very few in vivo studies examining the pulmonary effects of these particulates in
combination or at doses that are comparable to measurements collected during occupational
activities.
Previously we have shown that exposure to DPM at doses derived from particulate
measures collected during different mining operations were minimally toxic as an individual
exposure; however, when in combination with crystalline silica, the presence of DPM
significantly enhanced parameters of inflammation, oxidant production, and the onset of fibrotic
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tissue changes in the lung as compared to silica (SIL) alone. Furthermore, DPM in combination
with SIL was shown to alter some immunological responses observed individually due to SIL
exposure [539]. The study however, did not delineate whether specific properties of DPM
contributed to these responses or whether the presence of additional particle, or overall particle
load, influenced these effects. The goal of the current study was to evaluate whether those
effects are particle- or particle load-specific. DPM is a complex mixture of aromatic
hydrocarbons, metals, nitrates, sulfates, and other chemicals complexed to a carbon core. For
this purpose, carbon black (Printex® 90; CB) was used as a reference particle to control for load
effects versus DPM-specific effects, as it represents the core material of DPM without the
constituents of DPM frequently associated with toxicity [277, 281, 298, 326, 332, 333, 335, 467,
481].
Doses for the current study were based on field measurements of SiO2 taken during
active surface-level mining operations [486]. Equivalent doses of DPM and CB were
administered in an effort to determine the toxicological effects due specifically to a particular
particle (SIL, DPM, or CB). Further, combinations of CB or DPM with SIL were administered to
determine load versus particle specific effects that may result in a co-exposure scenario. Similar
to the previous study [539], a single acute bolus dose of SIL, DPM, CB, a combination of DPM
and SIL (DPM/SIL), or a combination of CB and SIL (CB/SIL), were administered to SpragueDawley rats by a single intratracheal instillation (IT). Parameters of lung injury, inflammation,
histopathology, and immune responses were evaluated over a three-month time-course. In
addition, susceptibility to pulmonary infection following exposure to the particles individually and
in combination was also evaluated to further assess alterations in immune response following
particle exposure.
Methods
Particles. Particles in these studies were used as surrogates to represent work site exposures.
The surrogate particle used for SiO2 was α-quartz crystalline silica (SIL; MIN-U-SIL® 5, US
SILICA; Berkeley Springs, WV). DPM was obtained from the National Institute of Standards and
Technology (NIST) as a commercially available NIST Standard Reference Material (SRM) 2975
(referred to as DPM in this study). SRM 2975 was originally collected from an industrial forklift in
the 1990s [540]. Carbon black (CB; Printex®90 from Degussa-Hüls, Parsippany, NJ) was used
as a reference material and control for effects related to particle load. The particle was selected
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based on composition, as carbon black comprises the core material of DPM, and size of primary
particles derived from field emission scanning electron micrographs.
Dose Determination. Doses were derived from field measurements of SiO2 and applied to the
equation below (EQ1) to quantify the amount of particle that would deposit in the lungs of an
average male worker doing moderate work for 12 hours per day for a period of 14 continuous
days using pulmonary deposition efficacy for each particle. Deposition efficacy was derived from
a software-based algorithm that considers particle characteristics including shape and density
[541]. This dose was then normalized to the surface area of both the worker’s and rat’s lungs to
obtain dose for in vivo studies (EQ2). The SIL dose (233 µg SIL) was derived from the highest
SiO2 levels measured during hydraulic fracturing site visits [486], 2.5 mg/m3 (2.5 µg/l) (EQ3). It
was previously demonstrated that DPM in a co-exposure with SIL induced greater inflammation,
oxidant production by phagocytes, and onset of pulmonary fibrosis in comparison to either
particle individually. The goal of this study was to determine whether particle load induced these
effects or if effects were due to DPM specifically. For this purpose, DPM or CB were
administered at a dose equivalent to that of SIL to determine which particle, if either, had a
greater toxic effect in a co-exposure.
EQ1 - Basic equation for standard worker lung deposition:
= (field concentration, μg/l) x (minute ventilation, l/min) x (exposure time per day, min/d)
x (total fracking days, d) x (pulmonary deposition efficacy, unitless)
EQ2 - Equation for normalization to rat lung surface area:
= (worker’s deposited dose/average male worker lung surface area) x (average rat lung
surface area)
EQ3 - Equation for SIL Dose:
Worker lung deposition = (2.5 μg /l) x (20 l/min) x (720 min/day) x (14 days) x (0.118) =
59,472 μg per worker
Dose calculated = (59,472 μg/102.2 m2) x (0.4 m2) ≈ 233 μg per rat
SIL, DPM, and CB Preparation and Characterization. Particles were prepared in USP-grade
phosphate-buffered sterile saline without Ca2+ or Mg2+ (PBS: AMERESCO, Solon, OH) for IT. A
sonication process was used to disperse agglomerated particles. SIL was prepared as a 10
mg/ml stock solution, DPM and CB were prepared as 2 mg/ml stock solutions. All particles were
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vortex mixed for 1 min, followed by 1 min of continuous sonication (GE130PB ultrasonic
processor; General Electric, Boston, MA). Aliquots of stock solution were then further diluted to
233 µg SIL, 233 µg DPM, 233 µg CB, 233 µg DPM + 233 µg SIL , or 233 µg CB + 233 µg SIL in
0.3 ml PBS. Particles were then administered to the rats by IT as a single dose as previously
described [539].
Animals. Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals (Scottdale,
PA), weighing approximately 300 g and free of viral pathogens, parasites, mycoplasmas,
Helicobacter, and CAR Bacillus, were used for all studies. Rats were housed in the pathogen
free, environmentally controlled, AAALAC-accredited facility. The rats were housed in ventilated
polycarbonate cages, two per cage, on Alpha-Dri cellulose chips and hardwood Beta chips as
bedding; they were provided HEPA-filtered air, irradiated Teklad 2918 diet, and tap water ad
libitum; and were allowed to acclimate for one week before exposure. Rats were not restricted
from enrichment activity
(i.e., chewing/climbing). All animal procedures used during the study were reviewed and
approved by the IACUC in the Health Effects Laboratory Division (HELD) at NIOSH.
Time-Course Study Design. In Vivo Lung Injury, Inflammation, and Disease. On day 0, rats
were lightly anesthetized with an intraperitoneal injection of 30-40 mg/kg sodium methohexital
(Brevital; Eli Lilly, Indianapolis, IN) and intratracheally instilled with 233 µg DPM, 233 µg CB,
233 µg SIL, 233 µg DPM + 233 µg SIL, 233 µg CB + 233 µg SIL, or vehicle control (PBS).
Studies were conducted in two blocks with paired PBS and SIL controls. All particles were
delivered in 0.3 ml USP grade PBS. All animals were humanely euthanized at 1 day, 1 week, 1
month, 2 months, or 3 months following particle exposure (n = 8/group/time point for DPM, CB,
DPM/SIL, and CB/SIL groups and n = 16 for PBS and SIL groups) with an intraperitoneal
injection of 100-300 mg/kg sodium pentobarbital, followed by exsanguination. The trachea was
cannulated, bronchoalveolar lavage (BAL) was performed on the right lung lobes, and BAL cells
(BALCs) and fluid (BALF) were retained for analysis of parameters indicative of inflammation,
injury, oxidant production, and immune function. Lung injury and inflammation were evaluated
as the presence of lactate dehydrogenase (LDH) activity, cytokines, and chemokines in BALF.
BALCs were differentiated and phenotyped. Lymphocytes from the mediastinal lymph nodes
(MLN) draining the lung were also differentiated by phenotype. Chemiluminescence assays
were used to measure oxidant/free radical production by BAL phagocytes to evaluate the
inflammatory response. The left lung was excised, pressure-inflated with 10% neutral-buffered
formalin, and weighed with water-displacement to determine fixed lung volume.
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Histopathological assessment of lung injury, inflammation, and disease was performed, and
morphometric analysis was performed to assess particulate lung burden.
Infection Study Design. Pulmonary Immune Response to Infection Following Particle
Exposure. In this study, rats were exposed to 233 µg DPM, 233 µg CB, 233 µg SIL, 233 µg
DPM + 233 µg SIL, or 233 µg CB + 233 µg SIL combined in 0.3 ml PBS, or PBS alone (vehicle
control) by intratracheal instillation as described above. One week following particle exposure,
rats were intratracheally instilled with ~ 5 x 105 colony forming units (cfu) of Listeria
monocytogenes (strain 10403S, serotype 1; LM) in 0.5 ml of sterile PBS. The study was
conducted with the same block design as the previous study with paired PBS and SIL controls.
Animals were euthanized at 1, 3, 5, 7, and 14 days following infection (n = 8/dose/time point for
DPM, CB, DPM/SIL, and CB/SIL groups and n = 16 for PBS and SIL groups). BAL was
performed on the right lung lobes, and BALC and BALF were retained for analysis of
parameters indicative of inflammation, injury, and immune alteration as described for the time
course study. The left lung was clamped during lavage and subsequently excised,
homogenized, and cultured to evaluate bacterial clearance from the lung.
BAL. BAL was performed at each time point after exposure as previously described [539]. The
acellular first fraction of fluid was retained for analysis of LDH, cytokines and chemokines. The
BALC were counted, differentiated, and assess for oxidative potential as described previously.
BALF Analysis: LDH activity in the BALF of all treatment groups was measured
spectrophotometrically at each time point after exposure to evaluate cytotoxicity as a measure
of lung injury as previously described [539].Cytokines and chemokines involved in inflammatory
and immune responses were measured in the BALF at each time-point after exposure using
commercially-available enzyme-linked immunosorbent assay (ELISA) kits or by multiplex array.
The following cytokines and chemokines were quantified by ELISA: monocyte chemotactic
protein (MCP)-1, macrophage inflammatory protein (MIP)-2 (Novex, Life Technologies; Grand
Island, New York); and osteopontin (OPN, Enzo Life Sciences; Farmingdale, New York).
Additionally, two matrix metalloproteinases (MMP), MMP-2 and MMP-9, and tissue inhibitor of
metalloproteinases (TIMP)-1 were quantified by ELISA (R&D Systems) as indices of tissue
remodeling due to injury. Interleukin (IL)-1α, IL-1β, IL-5, IL-13, IL-17A, IL-18, granulocyte colony
stimulating factor (G-CSF), granulocyte and macrophage colony stimulating factor (GM-CSF),
eotaxin, fractalkine, leptin, MIP-1α, epidermal growth factor (EGF), IFN-γ inducible protein (IP)10, growth-regulated oncogene/keratinocyte chemoattractant (GRO/KC), vascular endothelial
growth factor (VEGF), tumor necrosis factor-α (TNF-α), transforming growth factor-β2 (TGF-β2),
121

IL-2, IL-4, IL-6, IL-10, IL-12p70, interferon (IFN)-γ, lipopolysaccharide (LPS)-induced CXC
chemokine (LIX) and regulated on activation, normal T-cell expressed and secreted (RANTES)
were assessed by multiplex array (Eve Technologies; Alberta, CA).
BALC and Mediastinal Lymph Node (MLN) Cell Differentiation and Phenotyping. Total
BALC collected from rats were counted using a Coulter Multisizer II (Coulter Electronics;
Hialeah, FL), followed by differentiation into alveolar macrophages (AMs) and neutrophils as
previously described [539]. Flow cytometry was performed to enumerate and phenotype BALC.
The total number of lymphocytes, B cells (CD45R), and T cells (CD3+), as well as T cell subsets
(CD4+/CD8+) cells were quantified.
Chemiluminescence (CL). To measure the production of reactive oxidant species by BALC,
CL was measured according to the method of Antonini et al. [507] as previously described [539].
Briefly, extracellular oxidant production was measured as light emitted as a reaction of oxidants
with luminol following stimulation of BAL AMs by zymosan or total BAL phagocytes (AMs and
neutrophils) by phorbal myristate acetate (PMA).
Histopathology. The left lungs of rats were fixed with 10% neutral buffered formalin by airway
pressure fixation under 30 cm-water pressure to total lung capacity for 15 min. Lung volumes
were assessed by weight of water displacement. The left lungs were embedded in paraffin,
sectioned onto slides, and stained with hematoxylin and eosin (H&E) or trichrome. An n = 5
stained slides per treatment group per time-point per study block were assessed; blocks were
designed with paired controls resulting in n = 10 for saline and SIL groups from each of the
blocks when combined. Stained slides were analyzed for indications of inflammation, injury, and
fibrosis by a certified veterinary pathologist at Charles River Laboratories (Wilmington, MA) who
was blinded to the treatment groups. Indices of pathology were scored on scale of 0 – 5, where
0 = no observed effect, 1 = minimal response, 2 = mild response, 3= moderate response, 4 =
marked response, and 5 = severe response.
Determination of Particle Clearance – Clearance of particles from the lungs was evaluated
both qualitatively by examining representative images of particle loaded phagocytes from
cytospins using light field microscopy on an Olympus BX63 using CellSens Dimensions
Software version 1.15 (Olympus, Tokyo, Japan) and quantitatively by morphometrical analysis
of tissue section. Tissue sections from left lung were deparaffinized and stained lightly with
Sirius Red. Slides were immersed in 0.1% picrosirius solution (100 mg of Sirius Red F3BA in
100 ml of saturated aqueous picric acid) for 2 h followed by washing for 1 min in 0.01 N HCl.
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Slides were then counterstained with hematoxylin for 2 min, dehydrated, and mounted with a
coverslip for imaging. Quantitative morphometric methods were used to measure the volume (%
of the alveolar wall) and enumerate particles present by standard morphometric analyses
(Underwood 1970; Mercer et al. 1994). This consisted of basic point counting. An eyepiece
counting overlay consisting of 11 by 11 lines (121 total points for each throw of the overlay) was
used with a 40X objective. A grid pattern for throws of the counting overlay was used in order to
ensure a uniform sampling of the section, which did not overweigh interior points. An n = 5
slides was evaluated for each group at time-points of 1 day, 1 week, 1 month, and 3 months
following exposure. Briefly, clearance was calculated by finding the total volume of particle,
normalizing data to 1 at day 1 and deriving a natural log curve from latter time-points. Tissue
stained lightly with Sirius red was examined by dark-field microscopy on an Olympus BX41
using CellSens Dimensions Software version 1.15 (Olympus, Tokyo, Japan) at a magnification
of 20x. Representative images of total particle load were captured using darkfield microscopy at
1 day, 1 month, and 3 months to illustrate the morphometric findings.
Bacterial Clearance from the Lung. To measure the clearance of bacteria from the lung, left
lungs were excised and placed in 10 ml of sterile deionized water. Lungs were homogenized
using a Polytron®PT-2100 homogenizer with PT-DA 2112/EC aggregate attachment
(Kinematica; Bohemia, NY). Homogenates were diluted and cultured on prepared Brain Heart
Infusion Agar plates (Becton, Dickinson and Company). Cultures were incubated at 37 °C for 24
h. Cfu were counted and multiplied according to culture dilution factors.
Statistical Analyses. Results for all BAL parameters and bacterial clearance were expressed
as mean ± standard error. For BAL proteins that were below the limit of detection, 1/2 of the
lowest limit of detection was used for statistical analysis of values. Lymphocyte phenotype
derived from flow cytometry was expressed as fold change from control ± standard error
calculated as

∆𝑥̅
𝑐𝑜𝑛𝑡𝑟𝑜𝑙𝑥̅

and a one-way analysis of variance (ANOVA) was performed between all

treatments groups at each time point. Significant differences among groups were determined
using the Student-Newman-Keuls post-hoc test. Data were analyzed using SigmaPlot for
Windows Version 12.5 (Systat Software, Inc, Ekrath, Germany). For all analyses, significance
was set at p < 0.05. Because data from histopathology studies are inherently categorical,
nonparametric analysis of variance was assessed using SAS/STAT software, Version 9.1, of the
SAS System for Windows statistical programs (SAS Institute, Inc.; Cary, NC). In this instance,
groups were compared using the Wilcoxon rank sum test.
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Results
Particle Characterization. One ml aliquots of 233 µg dose DPM, 233 µg dose CB, 233 µg dose
of SIL, 233 µg DPM in combination with SIL 233 µg (DPM/SIL), and 233 µg CB in combination
with SIL 233 µg (CB/SIL) in PBS solution, were dried on carbon filters and examined using
FESEM in order to characterize size of the primary particles and their degree of agglomeration.
The primary particles of SIL were approximately 2 µm in size and were evenly distributed in
suspension (Figure 1A, 1B). DPM and CB were found to agglomerate in the vehicle to a size of
approximately 1-2 µm in diameter. The primary particle size of DPM was found to be smaller in
size than SIL, < 200 nm (Figure 1A). The form of CB selected (Printex 90) had a primary particle
size of ~20 nm (Figure 1B). This form of CB was selected over fine or coarse mode CB as their
primary particles were larger than the DPM agglomerates and the surface area and particle
number per mass did not correlate well to the DPM represented. The FESEM images show
similar agglomerates and primary particle size of the DPM and CB. Additionally, the association
between DPM and SIL or CB and SIL in solution was minimal.
Time-Course Study. Lung injury was evaluated by examining LDH in the BALF collected from
rats at 1 day, 1 week, 1 month, 2 months, and 3 months post-exposure to particles (Figure 2). A
significant increase in LDH activity resulting from exposure to DPM alone occurred at 1 day and
1 week post-exposure, and at 1 day post-exposure for CB-exposed animals. SIL caused a
significant increase beginning at 1 week post-exposure that persisted throughout the time
course. LDH activity was significantly increased in both the DPM/SIL and CB/SIL groups at all
time-points when compared to control, DPM, and CB. In the DPM/SIL group the increase was
greater than all other groups at 1, 2, and 3 months post-exposure, whereas the CB/SIL and SIL
group were comparable to each other at these time-points.
Cell differentials were performed on BALC to further assess inflammation (Figure 3A&B). DPM
alone caused an increase in AMs in the lungs at 1 day post-exposure when compared to
controls. CB alone did not increase AM number at any time point. SIL alone caused increased
AM influx into the lungs at the later time-points (1 month and following). Increased AMs
following exposure to CB/SIL did not differ greatly from that of SIL at the later time-points.
However, DPM/SIL caused a significantly greater increase in AMs when compared to all groups
at 1, 2, and 3 months post-exposure. DPM exposure alone did not cause an increase in BAL
neutrophils at any time-point. CB exposure alone caused an increase in neutrophil recruitment
at day 1 post-exposure only. SIL, DPM/SIL and CB/SIL caused a significant increase in
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neutrophils at all time-points following exposure. At the later timepoints, SIL and CB/SIL did not
differ from each other; however, exposure to DPM/SIL caused a significant increase when
compared to all groups.
Oxidant production by BALC was evaluated ex vivo (Figure 3C&D). DPM alone did not cause a
significant increase in oxidant production by total phagocytes (Figure 3C) nor AMs (Figure 3D)
as measured by CL at any of the time points. CB and SIL alone caused increased AM oxidant
production at 1 day following exposure compared to control and DPM, although there was a
trend for an increase in the SIL group at the later time points when compared to control. The
CB/SIL group caused a significant increase in AM oxidant production up to 1 month postexposure when compared to control and at 1 week and 1 month when compared to all individual
particle groups. Although not significantly different from control, the increase persisted at 2 and
3 months post-exposure and was comparable to that of SIL. Interestingly, exposure to DPM
combined with SIL resulted in significantly increased and synergistic production of oxidants
beyond that of exposure to any single particle alone at all time-points post-exposure for total
phagocytes and at all time-points post-exposure with the exception of 1 week for AM oxidant
production.
BAL and MLN lymphocytes were phenotyped by flow cytometry (Table 1&2). Exposure to DPM
alone caused only mild increases in lymphocyte populations in BAL with the exception of a trend
for increased T cells observed at 1 month becoming significant at 2 months. DPM caused
increased B cells at 1 week and 1 month post-exposure (Table 1). However, at the early time
points DPM alone did increase all MLN lymphocyte proliferation (Table 2), and though these
populations remained elevated compared to control throughout the time-course, this result was
not significant after 1 week. CB alone did not cause any increases in lymphocyte populations
when compared to control. In addition to phagocytic influx described in Figure 3, exposure to
SIL alone caused significantly increased lymphocyte influx into the lung (Table 1) and increased
proliferation in the MLN (Table 2) as early as 1 week following exposure. When SIL was
combined with DPM, proliferation of MLN lymphocytes were observed as early as 1 day postexposure (Table 2). Influx of lymphocytes was primarily attributed T cell population subsets,
specifically CD4+ cells, though all subsets were increased for the DPM/SIL co-exposure group.
CB in combination with SIL did increase the influx of lymphocytes in the BAL between 1 week
and 3 months for T lymphocytes, primarily due to increased CD4+ cells. Interestingly, there were
no significant increases in lymphocytes in the MLN following CB/SIL exposure.
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Protein mediators were evaluated in BALF as a measure of inflammation and immune response
(Table 3-5). CB caused some transient changes, particularly for inflammatory proteins including
MCP-1, MIP-1α, and TNF-α, at the earliest time-point when compared to control (Table 3).
There is a trend for increased MIP-2 by CB but this is only significant when compared with DPM
groups, which demonstrated decreased expression of this chemokine compared to control. IP10 expression was also increased by CB at 1 day following exposure (Table 4). Similar to
inflammatory proteins, CB increased expression of tissue remodeling proteins in the BALF at
the earliest time-point (Table 5). DPM alone elicited only an increase in MIP-1 α, TNF- α, IL-18,
IP-10, and TGFβ-2. However, these changes were not consistent throughout the time course
(Table 3-5). Conversely, DPM exhibited a trend for reduced expression of some proteins
including MIP-2, IL-6, IL-10, IL-12p70, and OPN, throughout the time course (Tables 3-5), and
IL-2, IL-4, and IFN-γ at the latest time-points (Table 4). SIL alone caused increases in proteins
associated with inflammation including LIX, MCP-1, MIP-1α, MIP-2, and TNF-α, at most timepoints compared with the control and/or groups exposed to DPM or CB only. SIL alone also
caused an increase in IL-18, a protein associated with upregulation of the NLRP3/NALP3
inflammasome (Table 3). Further, proteins associated with tissue remodeling, OPN and MMP-9,
which have implications in the development of fibrotic changes in the lung, were increased by
treatment with SIL particularly at time points after 1 week (Table 5). DPM, when in combination
with SIL, increased expression of MIP-1α, IL-18, and TNF- α at some time-points (Table 3), and
tissue remodeling proteins including MMP-9, TGFβ2, and TIMP-1 throughout the time course,
as well as, OPN at time points as early as 1 month (Table 5). CB in combination with SIL
showed effects very similar to SIL for most inflammatory proteins including LIX, MCP-1, MIP1-α,
MIP-2, IL-18, and TNF-α (Table 3), though at some early time-points CB/SIL increased
expression of MCP-1 and MIP-2 over that of SIL alone. Similarly to CB alone, CB combined with
SIL increased expression of IP-10, particularly at earlier time-points. This was also observed for
DPM/SIL at 1 week and 1 month. CB/SIL also enhanced the expression of tissue remodeling
proteins MMP-9, OPN, and TGFβ2 throughout the time course, similar to that of DPM/SIL
suggesting that these proteins may be most responsive to overall load of particles. Lastly, in the
co-exposure with SIL, DPM exhibited independent action, reducing the expression of LIX, MIP2, IL-2, IL-4, and IL-12p70 at some time-points compared to SIL (Table 3&4). Interestingly, this
was not the case for CB/SIL, suggesting specific properties of DPM may be responsible for this
effect. There were no significant changes in the following cytokines in any group: IL-1α, IL-1β,
IL-5, IL-13, IL-17A, EGF, eotaxin, fractalkine, GRO/KC, G-CSF, GM-CSF, leptin, IFN-γ, MMP-2,
and VEGF (data not shown).
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H&E and trichrome-stained tissue sections were evaluated by a board-certified veterinarian
pathologist (Table 6). DPM caused only mild influx of AMs, as a measure of inflammation;
however, this did not differ significantly from control. SIL alone and in combination with DPM or
CB, significantly increased influx of AMs at all time-points following exposure. Alveolar epithelial
hyperplasia (AEH) was also observed following co-exposures with both particles beginning at 1
month and persisting up to 3 months. SIL alone also increased AEH at 2 and 3 months postexposure. In general, the degree of significance was greater for the DPM/SIL group when
compared to control versus the SIL and CB/SIL group when compared to control. Beginning at 1
month following exposure to particles, minimal to mild septal fibrosis was observed in groups
that contained SIL. At 1 month, the incidence of fibrosis was greatest in the DPM/SIL coexposure group (60% of animals), whereas 20% of animals had fibrosis in the SIL and CB/SIL
groups. At 2 months post-exposure, the DPM/SIL and CB/SIL group had a similar degree of
fibrosis, which was greater than that of SIL alone. By 3 months post-exposure, the degree of
fibrosis in all groups containing SIL were similar to each other, with a trend toward the coexposures having a slightly greater incidence. Mild hyperplasia of the bronchiolar/alveolar
epithelium was observed near the terminal bronchioles as early at 1 month following exposure
to groups containing SIL and was found to be associated with the presence of macrophages
loaded with high particle content, suggesting a correlation between tissue damage and the
presence of particles. Overall, most histopathological changes were attributable to exposure to
233 µg of SIL; however, the presence of DPM or CB increased the severity and/or incidence of
some of these changes in the co-exposure groups, suggesting particle load as an additional
factor in toxicity. DPM increased the onset of fibrosis, but not the degree of fibrosis, which was
attributable primarily to particle load.
Lung particle burden and clearance were evaluated both qualitatively in tissue and
macrophages (Figures 5-10) and quantitatively in tissue by morphometric analysis (Figure 4A).
Between day 1 and week 1 approximately 2% of DPM was cleared with an increase in the rate
of clearance following the first week (Figure 4A). By 1 month, 55% of DPM had been cleared;
after 1 month there was a steady decline in particle burden with only 15% overall DPM
remaining at 3 months post-exposure. CB was cleared at a faster rate initially, with only 60% of
particle remaining at 1 week following exposure, and this is evident by the macrophage burden
of particle observed at 1 day as compared with that of DPM (Figure 5). By 1 month, the
clearance of CB had slowed to nearly that of DPM with 16% of particles remaining at 3 months
post-exposure. Initial clearance of SIL between the time-points of 1 day and 1 week was similar
to CB, and faster than DPM, with nearly 30% of particle cleared; the rate of clearance slowed
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after 1 week and by 1 month only 45% SIL particle had been cleared (Figure 4A). Following this,
there was only approximately an additional 10% clearance of particle by 3 months, suggesting
that the rate of clearance for SIL slows significantly after 1 month. Clearance in the co-exposure
groups was significantly slower than any individual particle at time-points following 1 week as
expected by increase in overall particle load as can be seen in figures 7-10. By 1 week,
between 2-3% of particle was cleared for the CB/SIL or DPM/SIL groups and the rate of
clearance remains very slow compared with individual particles up to 1 month following
exposure where only measurable clearance was observed for the CB/SIL group since 1 week
following exposure (Figure 4A). By 3 months post-exposure approximately 35% of particle
burden had been cleared.
Infection Study. Respiratory susceptibility to a bacterial pathogen was determined following
particle exposure in an infectivity study assessing the clearance of LM from the lung over a 14day time course, 1 week following exposure to particles. Despite lung inflammation and
phagocytic cell activity observed in the absence of infection in co-exposed groups (Figure 3),
overall clearance of the pathogen was not significantly altered for most time-points (Figure 11).
Clearance in the CB/SIL co-exposure was enhanced at 1 day compared with control and CB
alone. At 3 days following infection the slowest degree of bacterial clearance was associated
with the DPM group; whereas, all groups that contained SIL were comparable to control or
cleared the bacteria faster than DPM alone. However, by 5 days post-exposure there were no
differences in bacterial clearance among groups. Neutrophil influx into the lung was significantly
increased for SIL-containing groups at day 1 post-infection (Figure 12B). By day 3 postinfection, the influx of cells in SIL- exposed groups was similar to control with the exception of
neutrophils, which were enhanced beyond that of CB or DPM alone groups at day 14. Influx of
lymphocytes into the BAL at day 14 was also significantly increased in co-exposed groups
(Figure 13A). Similarly, proliferation of lymphocytes in the MLN was elevated in groups that
contained SIL as early as 1-day post-infection, and significantly elevated again by day 14 in the
co-exposed groups (Figure 13B). BAL and MLN lymphocytes were phenotyped as in the timecourse study to evaluate lymphocyte populations. Neither DPM nor CB exposure caused
notable lymphocytic influx into the lung when compared to infected controls, while combined
exposure to particles caused significant increases in total lymphocyte influx at day 14 compared
with other groups, attributed primarily to an increase in T lymphocytes (Table 7). In the MLN,
combined exposure followed by infection caused increased lymphocytes at day 1 compared
with all other non-SIL-containing groups. For co-exposure groups, proliferation of all MLN cells
was greater than SIL for all subsets (Table 8). At 14 days post-infection T cell-subsets were
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increased in both co-exposed groups, attributed mainly to an increase in CD4+ and CD8+ T
lymphocytes. Overall, the results suggest that DPM may have impaired the innate response to
infection to a degree; whereas, the presence of SIL may have enhanced the response at the
early time-points to a degree. By day 14, the infection had resolved and the observed increased
inflammation and immune cell proliferation may be largely attributable to particle effect.
Discussion
Our previous study had shown that low- to no-toxicity doses of DPM in combination with
SIL caused increased inflammation and lung injury when compared to SIL alone [539]. The goal
of the present study was to determine if those effects were particle-specific or if the effects were
due to an increased particle load as a result of the co-exposure. It is well-established that
overall particle load contributes to the development of disease in the lung. Particles with known
low cytotoxicity or particles not otherwise classified/regulated (PNOC/R) due to low toxicity have
been shown in animals to contribute to inflammation, fibrosis, and tumor development if the
number/mass of particles administered exceeds the capabilities of alveolar macrophages to
adequately clear them [542-546]. In order to address these questions, the current study was
designed examining an equivalent dose of DPM particles as SIL alone, DPM in combination
with SIL, and CB at an equivalent dose to DPM alone and in combination with SIL as a
reference particle for load control.
In the present study, DPM and CB alone produced inflammation and lung injury only at
early time-points post-exposure and resolved by 1 week to 1 month. SIL alone increased
parameters of inflammation and lung injury throughout the time course. In several instances, the
co-exposures to DPM or CB and SIL further enhanced these effects, which may be attributed to
particle-specific effect or to load effects depending on the parameter. In general, DPM/SIL had a
greater effect than CB/SIL on parameters including lung injury (cytotoxicity), cellular influx into
the lung, and ex vivo oxidant production by phagocytes in the lung, indicating a particle-specific
effect relating to a constituent other than the carbon core of DPM; whereas particle load and the
presence of SIL appeared to affect tissue remodeling and fibrosis to a greater degree, although
DPM co-exposed with SIL did increase the incidence of pathology at 1 month following
exposure when compared to SIL or CB/SIL groups .
In the case of cytotoxicity, while both combined exposures caused significant toxicity
compared with control at all time-points following exposure, DPM combined with SIL increased
cytotoxicity examined at all time-points following 1 week (Figure 2). Though CB in combination
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with SIL also increased cytotoxicity after 1 month, this effect was similar to the level caused by
SIL alone suggesting that for the DPM/SIL combo group, DPM characteristics and not simply
the carbon core of DPM enhanced cytotoxicity. Further, this suggests that it is not simply the
overall load of nearly 500 µg of particles contributing to cell injury. DPM also had particlespecific effects on the influx of phagocytes into the lung and their oxidant producing activities
(Figure 3). Though DPM alone had little effect on the influx of phagocytes into the lung, when
combined with SIL, the presence of macrophages and neutrophils were significantly increased
compared to all groups and therefore exacerbated the inflammation observed for SIL alone or
CB/SIL. These effects were observed beginning at one month following exposure for both
macrophages and neutrophils. In the case of oxidants produced by either total phagocytes or
macrophages alone, DPM when combined with SIL, synergistically enhanced this effect (Figure
3 C&D). The same effect was not observed in the CB/SIL co-exposure. Though CB/SIL
enhanced oxidant production by macrophages alone above that of SIL, the effect was
diminished after 1 month. Because the rate of particle clearance in the combined exposures is
similar after 1 month, it is unlikely that these effects are driven entirely by particle burden. Taken
together, these results suggest that DPM in combination with SIL not only enhanced the influx of
phagocytic cells into the lung but also increased their function with regard to the production of
oxidants. Moreover, these results suggest that though particle load may play a role in these
findings, DPM specific properties also contribute to the overall effect, particularly in the case of
total oxidant burden that reached as high as 100-fold change from control at some time-points
for total phagocytes (Figure 3C).
With regard to the influx of lymphocytes into the lung, CB alone had no effect (Table 1).
DPM caused slightly enhanced influx of all immune cells examined when compared to control,
particularly at the earlier time-points. SIL resulted in significantly increased influx of cells at most
time-points following exposure, attributable primarily to T lymphocytes. When DPM was
combined with SIL these results were further exacerbated. Though combination of CB with SIL
did enhance the influx of lymphocytes at some time-points this effect was significantly greater
for DPM/SIL and therefore suggests that while particle load may contribute to stimulation of
lymphocyte influx into the lung, DPM-specific properties further enhance this response. Similar
findings were observed for the proliferation of lymphocytes in the MLN (Table 2). Interestingly,
there was a trend of increased MLN proliferation for DPM in a co-exposure with SIL as
compared with control that was not observed for the CB/SIL co-exposure. This finding would
suggest that although SIL plays a significant role in many facets of pulmonary toxicity relating to
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this co-exposure, DPM is also contributing significantly, particularly in the context of immune
alteration.
Similarly, SIL exposure resulted in increases in several inflammatory, immunoregulatory,
and tissue remodeling proteins in the lungs (Tables 3-5). Although both DPM/SIL and CB/SIL
led to equal or enhanced expression of some of these proteins including: MCP-1, MIP-1α, IP-10,
and MMP-9. DPM reduced the expression of others including: LIX, MIP-2, IL-2, IL-4, and IL-6 in
the BALF when in combination with SIL. DPM appeared to be exhibiting independent action on
the expression of these proteins possibly stemming from the suppression of macrophage
function. Monocytes or macrophages secrete these proteins in order to recruit additional
phagocytes to the site of acute inflammation, as well as to cause autocrine and paracrine
activation of cells, and to differentiate lymphocytes (Table 3-5). Furthermore, these results were
not reflected in the CB/SIL co-exposure suggesting that, despite increased cellular recruitment
to the lung, potential suppression of macrophage function may be occurring and may be due to
specific properties related to DPM and not simply an effect of overall particle load. These
findings are in agreement with conclusions made by Yin et al. that organic fractions of DPM
result in the reduced expression of cytokines from AMs [316, 535]. This is effect is also evident
in the innate response to LM infection whereby pulmonary clearance of the bacteria was slowest
in the DPM only group at day 3.
Pathological tissue analysis showed that either DPM or CB alone had little influence on
the histological changes evaluated, with the exception of the incidence of AM influx into the lung
(Table 6), and the presence of dark granules noted within macrophages throughout the time
course, representative of particles that had been phagocytosed. Further, brown granules
observed by the pathologist were scored as more severe in groups exposed to combinations of
particles when compared to single particle groups, particularly at later time-points, which agrees
with the morphometrical finding of reduced clearance of particles in these groups (data not
shown). Tissue from animals exposed to SIL alone or groups containing SIL were characterized
by enhanced inflammation, alveolar (AEH) and bronchial epithelial hyperplasia (BEH), and
alveolar septal thickening or fibrosis. Though these parameters were enhanced over that of SIL
at times in the co-exposure groups, as in the case of BEH and AEH at 1 month post-exposure,
these effects were correlated better with overall particle load at the later time-points, as there
were no observed differences between the two co-exposure groups. Furthermore, these
findings are supported by the observed increases in tissue remodeling proteins expressed in the
BALF at these time-points. Increases in MMP-9 and OPN were observed throughout the time
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course with significant differences observed at 1 month post-exposure in the combined groups
compared with single dose groups. These findings correlate with the earlier incidence of
hyperplasia developing for these groups compared with SIL alone. Also at 1 month postexposure, there are particle specific effects of DPM evident in the incidence of fibrosis and AEH
that may have related to increases in the expression of tissue remodeling proteins TGFβ and
TIMP-1 in the DPM/SIL groups at this time-point. This finding was also apparent when
qualitatively assessing tissue by dark field microscopy (Figure 7). Interestingly, particle
clearance rate for the CB/SIL group was slightly increased compared with the DPM/SIL group
between the time-points of 1 week and 1 month, which may also account for the increase in
injury in the DPM/SIL group observed at this time-point (Figure 10).
Susceptibility to an infection following particulate exposure was also examined to further
assess alterations in immune function following particle exposure. Neutrophilic influx, and
proliferation of lymphocytes in the MLN (Figure 11, Table 8) were increased at 1 day following
infection for all groups exposed to SIL. Differences between SIL exposure groups were not
significant with the exception of lymphocyte proliferation in MLN at day 1 following infection in
the CB/SIL group. This result correlates to increased clearance of bacteria from the lung at 1
day following infection observed for this group, although this result was only significant when
compared with control and CB exposures. Clearance of bacteria was significantly enhanced for
all groups except CB when compared to the DPM only group at day 3 following infection,
suggesting further that DPM may lead to a degree of inhibition in the innate immune response
early after infection. This effect is similar to other studies examining diesel exposure and
infection. In a study examining inhalation exposure to total DE, Harrod et al. determined that
exposure resulted in reduced clearance of Pseudomonas aeruginosa infection [313]. Similarly,
Yin et al. demonstrated reduced clearance of bacteria from the lung of rats following DPM
exposure, citing reduced phagocytic function and reduction in cytokine expression by
macrophages as possible DPM-related effects resulting in increased susceptibility [316]. In a
follow-up study, Yin et al. demonstrated increased bacterial burden at day 3 following coexposure of rats to DPM and LM. However, similar to the present study, despite reduced
expression of cytokines by macrophages, rats were able to ultimately clear infection suggesting
that the adaptive cell-mediated response was still sufficiently initiated despite the reduction in
response of the innate immune system [317].
Our previous study examining a lower dose of DPM (50 μg) indicated that DPM
increased parameters of toxicity such as inflammation, oxidant production, and the onset of
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initiation of fibrosis in the co-exposure compared to SIL, particularly at 1 month following
exposure. Though these effects were still comparable to SIL at 3 months post-exposure, they no
longer exceeded that of SIL. Therefore, the present study examined whether the exacerbated
effects of the combined exposure were no longer apparent compared to silica at 3 months time
due to clearance of DPM or if the progression of effects due to SIL alone or particle load were
the primary factor in toxicity. This study showed that combination of DPM and SIL at equivalent
doses resulted in not only enhanced inflammation and oxidant production as previously
observed, but increases in cytotoxicity as well. DPM also increased the incidence of fibrosis at 1
month post-exposure, similar to the previous study; however severity of fibrosis was similar
between SIL and co-exposure groups. Further, by the later time-points, the incidence and
severity were more similar in the co-exposure groups. This is in combination with the slower
particle clearance rate of the co-exposure groups suggests that tissue remodeling initiated by
SIL exposure and total particle load were the primary factors in progression of fibrosis (Table 6).
Although SIL is the more toxic particle in the study as compared to DPM alone, when given at a
dose equal to SIL, effects of DPM co-exposed with SIL were still apparent at 3 months following
exposure, particularly for cytotoxicity, inflammation, and the production of oxidants. This was not
the case for the CB/SIL exposure at equivalent loads, suggesting these effects were particle
specific for both the previous study, as well as this study.
Overall, this study indicated that both load and particle type, SIL and DPM, contribute to
toxicity in a co-exposure scenario depending on the effect. The toxicological properties of
crystalline silica and DPM are well-established individually. Both acute exposures to large doses
of particles and chronic low-level exposure to silica are known to contribute to the development
of fibrotic lung diseases related to oxidant-induced lung injury [4, 487, 490, 515, 516]. DPM is
also known to induce inflammation resulting in oxidative stress [467, 473-476]. Although DPM is
not typically associated with the restrictive fibrotic disease outcomes that are associated with
silica exposure at doses below overload, these particles are known to result in obstructive lung
diseases such as chronic obstructive pulmonary disease and emphysema, as well as cancer
[411, 415, 517, 518]. While specific mechanisms governing the progression of these diseases
have been elucidated, many remain unknown. Delineating the mechanisms of action in a coexposure is further complicated by potential synergistic or antagonist actions of the materials.
This study, however does show that SIL-induced inflammation and oxidant production are
further enhanced by particle specific effects of DPM, but that particle load may also be a
significant factor particularly at the later time points where clearance is slower in the co-exposed
groups.
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It should be noted that the particles used for this study and Farris et al. (2017) were
selected as surrogates for measuring toxicity of particles encountered in the workplace, which
may be more complex in chemical nature and reactivity. Factors contributing to the workplace
exposures would include freshly fractured silica, which is more reactive than the aged silica in
this study. In addition, NIST SRM 2975 only represents the particulate component of diesel
exhaust (DE). Whole DE, depending on the engine type, contains higher fractions of
hydrocarbons, as well as metals, and these components may contribute to increased toxicity as
compared to that observed in this study. These factors are important considerations in the
interpretation of the data as it pertains to exposure in the workplace.
Conclusion
In the present study, DPM or CB alone caused a transient inflammation and lung injury,
whereas SIL alone caused an increase in inflammation characterized by cellular influx into the
lung, increased inflammatory mediator production in the lung, and alterations in lung histology.
In general, co-exposure to DPM or CB and SIL followed a similar pattern as SIL alone, and, in
some instances, the effects were increased relative to SIL alone suggesting particle-specific
effects or effects due to load. SIL and particle load appear better correlated with tissue
remodeling (fibrosis and tissue remodeling proteins in the lung) and some inflammatory proteins
in the lung, including MCP-1, MIP-1α, and MIP-2. DPM combined with SIL increased production
of oxidants by phagocytes compared with all other groups at all time-points post exposure. In
addition, DPM/SIL co-exposure enhanced AMs and neutrophil influx into the lung, lung injury
(LDH), the influx of lymphocytes in the lung, the proliferation of lymphocytes in the MLN, and the
incidence of epithelial hyperplasia in lung tissue at later time-points compared to exposure to
SIL alone. Although CB/SIL co-exposure increased lung injury and cellular influx into the lung,
as well as epithelial hyperplasia, the increase was comparable to that of SIL alone. The data
taken together show that DPM exposure at doses that elicit only minimal pulmonary toxicity has
the capacity to significantly alter SIL-induced pulmonary effects, primarily cytotoxicity,
inflammation, oxidant production, lymphocytic proliferation, as well as exhibit independent action
on the expression of immune protein mediators of inflammation. Furthermore, comparison of
these effects to a reference particle for size and particle load comparison revealed that many of
these findings relate directly to unique characteristics of DPM rather than being related only to
dose administered.
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Table 1: Lymphocyte Phenotype of BALC

All data are shown as mean fold change over control ± standard error: b different from control
only; c different from control and all single dose groups; d different from control and CB; e
different from all other groups; g different from CB only; j different from control and both CB
groups; k different from control, DPM, and both CB groups; and l different from control, SIL, and
both CB groups. Statistical significance is p ≤ 0.05.
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Table 2: Lymphocyte Phenotype in the MLN

All data are shown as mean fold change over control ± standard error: d different from control and CB;
e
different from all other groups; g different from CB only; j different from control and both CB groups;
and l different from control, SIL, and both CB groups. Statistical significance is p ≤ 0.05.
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Table 3: Inflammatory Proteins in BALF

All data are shown as mean ± standard error: a different than control and SIL groups; b different from
control only; c different from control and all single dose groups; d different from control and CB; e
different from all other groups; f different from control, DPM and CB; g different from CB only; i different
from control and DPM groups; m different from control, SIL, and both DPM groups; n different from
control both DPM groups; o different from both DPM groups only; p different from control, SIL, and
CB/SIL; and q different from control and CB/SIL groups. Statistical significance is p ≤ 0.05.
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Table 4: Immuno-regulatory Proteins in BALF

All data are shown as mean ± standard error:c different from control and all single dose groups;
d
different from control and CB; e different from all other groups; h different from control, DPM,
and SIL groups; n different from control and both DPM groups; r different from control, SIL, and
DPM/SIL groups; and sdifferent from SIL and both DPM groups. Statistical significance is p ≤
0.05.
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Table 5: Tissue Remodeling/Wound Healing Proteins in BALF

All data are shown as mean ± standard error: a different than control and SIL groups; b different
from control only; c different from control and all single dose groups; d different from control and
CB; e different from all other groups; f different from control, DPM and CB; g different from CB
only; and m different from control, SIL, and both DPM groups. Statistical significance is p ≤ 0.05.
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Table 6: Severity and Incidence Scores for Lung Pathology

Lung tissue was analyzed and scored for accumulation of alveolar macrophages as an index of
inflammation (AM), alveolar epithelial hyperplasia (AEH), bronchial epithelial hyperplasia (BEH),
and fibrosis in alveolar septae (F) (n=5 for CB, DPM, DPM/SIL, and CB/SIL groups and n=10
per PBS and SIL per time point). Severity was scored as 0 - 5: 0 = normal, 1 = minimal/slight, 2
= mild, 3 = moderate, 4 = marked, and 5 = severe. Incidence was noted as Focal (F), Multi-focal
(M), and Diffuse (D). Data are presented as means with incidence (number of animals with a
positive score per total animals) in parentheses. a different than control and SIL groups; b
different from control only; c different from control and all single dose groups; d different from
control and CB; f different from control, DPM and CB; and g different from CB only; Note: all
letter symbol notations indicate a p value <0.05 except where a single asterisk indicates p <
0.05 for all groups except control < 0.01, a double asterisk indicates p < 0.01 for all groups. A
single cross indicates p < 0.05 for all groups except control and SIL where p < 0.01, and a
double cross indicates p < 0.05 for SIL and p < 0.01 for all other groups.
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Table 7: Lymphocyte Phenotype of BALC Following LM Infection

All data are shown as mean fold change over control ± standard error: C different than control,
DPM, and CB groups; D different from control and CB groups; E different from control only; G
different from all other groups; I different from CB and SIL groups; J different from control, CB,
and SIL groups; and K different from CB only. Statistical significance is p ≤ 0.05.
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Table 8: Lymphocyte Phenotype in the MLN Following LM Infection

All data are shown as mean fold change over control ± standard error: A different from control
and DPM groups; B different from DPM only; E different from control only; F different from control
and all single dose groups; G different from all other groups; and H different from control and SIL
groups. Statistical significance is p ≤ 0.05.
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Figure 1:

Figure 1: Field emission scanning electron microscopy (FESEM) images of particles. (A) 233
µg SIL and 233 µg DPM in combination prepared in PBS solution, diluted 1:10 in PBS, then
dried onto a filter under 25,000x magnification (micron bar = 2 µm with 10 segments of 0.2 µm
each) (B) 233 µg SIL and 233 µg CB prepared in PBS solution, diluted 1:10 in PBS, then dried
onto a filter in PBS solution under 25,000x magnification (micron bar = 2 µm with 10 segments
of 0.2 µm each). White arrows indicate SIL particles and black arrows indicate DPM or CB
agglomerates, respectively.
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Figure 2:

Figure 2: Lactate dehydrogenase activity (LDH) in BALF after exposure to DPM, CB, SIL, a
combination of DPM and SIL (DPM/SIL), or a combination of CB and SIL (CB/SIL): a different
from control and SIL groups; b different from control only; c different from control and all single
dose groups; d different from control and CB; e different from all other groups; and f different from
control, DPM, and CB. Statistical significance is p ≤ 0.05.
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Figure 3:

Figure 3: Total AMs (A) and neutrophils (B) in the BALF following exposure to DPM, CB, SIL,
DPM/SIL, or CB/SIL. Production of oxidants by total phagocytes stimulated with PMA (C) or by
AMs only stimulated by zymosan (D) measured by chemiluminescence following exposure to
DPM, CB, SIL, DPM/SIL, or CB/SIL: b different from control only; c different from control and all
single dose groups; d different from control and CB; e different from all other groups; f different
from control, DPM, and CB; g different from CB only; h different from control, DPM and SIL
groups; and I different from control and DPM groups. Statistical significance measured as p ≤
0.05.
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Figure 4:

Figure 4: Particle clearance curve for each treatment group as quantitatively evaluated by
morphometric analysis of tissue For each group an n = 5 tissue sections per time-point were
morphometrically assessed: c different from all single dose groups; e different from all other
groups; and f different DPM and CB groups. p ≤ 0.05.
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Figure 5:

Figure 5: Light field microscopy images of cytospins used to qualitatively assess particulate
clearance by BAL AMs at 1 day following instillation. Images were taken at 40x magnification
and scale bar represents 20µm in length. Green arrows indicate the presence of silica
particulates within macrophages.
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Figure 6:

Figure 6: Dark field microscopy images of Sirius red stained tissue representing injury and
particulate load in cells at 1 day following instillation. Images were taken at 20x magnification
and scale bar represents 20µm in length. White arrows indicate the presence of particulate
within macrophages.
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Figure 7:

Figure 7: Light field microscopy images of cytospins used to qualitatively assess particulate
clearance by BAL AMs at 1 month following instillation. Images were taken at 40x magnification
and scale bar represents 20µm in length. Green arrows indicate the presence of silica
particulates within macrophages.
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Figure 8:

Figure 8: Dark field microscopy images of Sirius red stained tissue representing tissue injury
and particulate load in cells at 1 month following instillation. Images were taken at 20x
magnification and scale bar represents 20µm in length. White arrows indicate the presence of
particulate within macrophages.
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Figure 9:

Figure 9: Light field microscopy images of cytospins used to qualitatively assess particulate
clearance by BAL AMs at 3 months following instillation. Images were taken at 40x
magnification and scale bar represents 20µm in length. Green arrows indicate the presence of
silica particulates within macrophages.
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Figure 10:

Figure 10: Dark field microscopy images of Sirius red stained tissue representing tissue injury
and particulate load in cells at 3 months following instillation. Images were taken at 20x
magnification and scale bar represents 20µm in length. White arrows indicate the presence of
particulate within macrophages.
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Figure 11:

Figure 11: Lung clearance of bacteria from the left lung over the time-course recovered by
lavage following exposure to DPM, CB, SIL, DPM/SIL, or CB/SIL followed by LM infection.
*CB/SIL lower than control and CB only. +DPM greater than control, SIL, and both combo
groups. Statistical significance is p≤ 0.05.
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Figure 12:

Figure 12: Total AMs (A), and total neutrophils (B) recovered by lavage following exposure to
DPM, CB, SIL, DPM/SIL, or CB/SIL followed by LM infection. All data are shown as mean ±
standard error: A different from control and DPM groups; B different from DPM only; C different
than control, DPM, and CB groups; D different from control and CB groups; E different from
control only; and F different from control and all single dose groups. Statistical significance is p ≤
0.05.
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Figure 13:

Figure 13: Total Lymphocytes recovered from BALF (A), and mediastinal lymph nodes (B)
following exposure to DPM, CB, SIL, DPM/SIL, or CB/SIL followed by LM infection. All data are
shown as mean ± standard error: A different from control and DPM groups; C different than
control, DPM, and CB groups; D different from control and CB groups; E different from control
only; F different from control and all single dose groups; G different from all other groups; and H
different from control and SIL groups. Statistical significance is p≤ 0.05.
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Chapter 4 - Study 3
The following represents data that will be submitted to a peer-reviewed journal for publication.
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Abstract
The effects of repeated pulmonary co-exposures to silica and diesel particulate matter
(DPM) that may occur in various occupational settings were investigated in vivo. Previous acute
single dose co-exposures revealed that DPM increased the inflammatory effects of silica in the
lung at time-points of up to three months. The goal of this study was to investigate the effects of
subacute repeated pulmonary co-exposures to silica and DPM. Rats were exposed by
intratracheal instillation (IT) to 116 µg of silica (SIL), 25 µg of DPM, SIL and DPM combined in
phosphate-buffered saline (PBS), or to PBS alone (control) once per week for 4 weeks. At one
day, one month, and three months following the last exposure bronchoalveolar lavage (BAL)
and histopathology were performed, and lymphocytes from local lymph nodes were phenotyped
to assess lung injury, inflammation, and immune response. SIL alone caused inflammation,
oxidant production, lung injury, increased populations of immune proteins and cells in the lung,
and increased lymphocyte populations in the local lymph nodes; whereas, DPM alone caused a
lesser degree of injury primarily at one day post-exposure, enhanced proliferation of local lymph
node cells at one month, but did not increase inflammatory cells and proteins in the lung and
suppressed levels of some immunoregulatory proteins. Co-exposure to DPM and SIL resulted in
neutrophilic influx and lung injury comparable to that of SIL alone. Oxidant production by
stimulated macrophages in the co-exposure group was significantly elevated at all time points
compared to DPM and control and at 1 day and 1 month when compared to all groups. Coexposure also significantly increased lung and local lymph node lymphocytes at all times points
compared to DPM and control, but further increased T cells in the lung at one month and
proliferation of total lymphocytes in the local lymph node at 3 months over SIL alone. Overall,
while DPM co-exposure with SIL exhibited the capability to exacerbate oxidant production and
increase lymphocyte populations to a greater degree than SIL in the lung, most parameters of
toxicity were comparable to that of SIL, indicating SIL as the primary factor in toxicity. However,
alteration in immune cell populations and immune proteins secreted in the lung by the presence
of DPM in the co-exposure may alter overall immune response.

Introduction
Due to the vast number of industrial occupations that involve the disruption of terrain
including surface and below-ground mining, tunneling, construction, road construction, and
excavation, the health risks of exposure to silica have been recognized and well-characterized
[4, 23]. Furthermore, with the advent of diesel engine powered equipment in the late 1800s [5]
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and the expanding utilization in these industries for enhanced productivity, exposure of workers
to respirable particulate mixtures including silica and diesel particulate matter (DPM) is a
concern [279, 461]. Though toxicity of DPM and silica as individual exposures has been wellinvestigated, there is a possibility that health effects observed following a co-exposure to the
particulates may be exacerbated or altered following exposure to the mixture versus the
individual exposures alone.
Previously, a single acute exposure to either particle individually or as a co-exposure
were investigated at various doses derived to represent acute, short duration exposures of
varying degrees in industrial operations [547]. The findings from these studies demonstrated
that doses of DPM that were not found to be significantly toxic individually, had the potential to
exacerbate inflammation, oxidant production, alterations of innate immune response, and the
incidence of the onset of fibrotic changes in the lung in a co-exposure with silica over that of
silica alone. Alterations in inflammation, injury, oxidant production, and immunological response
were determined to be due in part to specific characteristics of DPM, rather than an increase in
overall particle load, as these changes were not observed for similar doses of carbon black, the
core material of DPM, in combination with silica (Chapter 3). However, some indications of
pathology, including alveolar or bronchiolar epithelial hyperplasia and fibrosis, were determined
to be mainly initiated by silica and enhanced by the presence of increased particle load, as
effects were similar between combinations of either DPM or CB in equal doses with silica.
Fibrotic and toxic characteristics of crystalline silica have been determined, and both
acute high doses, as well as longer exposures to reduced doses, lead to progressive fibrosis,
and in chronic exposure, cancer [4]. Mechanisms that govern the development of pathology are
not clearly delineated; however, oxidative stress and continuous lung injury due to persistence
of silica in the lung are involved. Inflammation and oxidative stress in response to exposure to
DPM are also well-studied [467, 473-476]; DPM exposure is classically associated with
obstructive changes including emphysema and COPD, rather than fibrosis [411, 415, 517, 518].
Our previous studies examined single exposures at doses of DPM and silica that represented
various concentrations in a model of a two-week industrial exposure. This study investigated a
lower but more-prolonged exposure to particles employing a sub-chronic repeated dosing
schedule. The goal of this study was to determine if sub-chronic exposure to DPM further
enhanced the effects of silica, or if this longer, lower dose exposure caused effects that differ
from the previous studies. To address this, particles were administered to rats, individually and
in a co-exposure one time per week for 4 weeks. Parameters of lung injury, inflammation,
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oxidant production, and immune response were assessed at 1 day, 1 month, and 3 months
following the last exposure. The endpoints selected were similar to studies 1 and 2 for
comparative purposes.
Methods
Particles. Particles in these studies are used as surrogates to represent work site exposures.
DPM was obtained from the National Institute of Standards and Technology (NIST) as a
commercially available NIST Standard Reference Material (SRM) 2975 (referred to as DPM in
the study). SRM 2975 was originally collected from an industrial forklift in the 1990s [540]. The
surrogate particle used for SiO2 was α-quartz crystalline silica (SIL; MIN-U-SIL® 5, US SILICA;
Berkeley Springs, WV).
Dose Determination. Doses were derived from field measurements of particles and applied to
the equation below (EQ1) to quantify the amount of particle that would deposit in the lung of an
average male worker doing moderate work for 12 hours per day for a period of 7 continuous
days using a pulmonary deposition efficacy for each particle derived from a software-based
algorithm that considers particle characteristics including shape and density [505]. These doses
were then normalized from the surface area of human lung to the rat lung to obtain doses for in
vivo studies (EQ2). There are very few studies reporting carbon levels representative of diesel
emissions at above ground mining operations such as hydraulic fracturing sites. DPM in
underground mining operations has been measured in excess of 500 µg/m3 as elemental
carbon (EC) as reviewed by Pronk et al. (2009). In this study, the dose of DPM was derived
from high EC level measurements taken during underground mining of 637 µg/m 3 (0.637
µg/l)(EQ3) [506].The SIL dose was derived from the highest SiO2 levels measured at hydraulic
fracturing site visits [486], 2.5 mg/m3 (2.5 µg/l) (EQ4). These levels are also common or
exceeded in underground mining operations as well [548, 549].
EQ1 - Basic equation for standard worker lung deposition:
= (field concentration, μg/l) x (minute ventilation, l/min) x (exposure time per day, min/d)
x (total fracking days, d) x (pulmonary deposition efficacy, unitless)
EQ2 - Equation normalizing for species specific lung surface area:
= (worker’s deposited dose/average male worker lung surface area) x (average rat lung
surface area)
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EQ3 - Equation for DPM dose:
Worker lung deposition = (0.637 μg /l) x (20 l/min) x (720 min/day) x (7 days) x (0.10) ≈
6,421 μg
Dose calculated = (6,421 μg/102.2 m2) x (0.4 m2) ≈ 25 μg per rat
EQ4 - Equation for SIL dose:
Worker lung deposition = (2.5 μg /l) x (20 l/min) x (720 min/day) x (14 days) x (0.118) =
29,736 μg per worker
Dose calculated = (29,736 μg/102.2 m2) x (0.4 m2) ≈ 116 μg per rat
DPM and SIL Preparation and Characterization. Particles were prepared in USP-grade
phosphate-buffered sterile saline (PBS) without Ca2+ or Mg2+ (AMERESCO; Solon, OH) for
intratracheal instillation. A sonication process was used to disperse agglomerated particles.
DPM was prepared as a 2 mg/ml stock solution and SIL was prepared as a 10 mg/ml stock
solution, vortex mixed for one min, followed by 1 min of continuous sonication (GE130PB
ultrasonic processor; General Electric, Boston, MA). Aliquots of stock solution were then further
diluted to 25 µg DPM, 116 µg SIL, or 25 µg DPM + 116 µg SIL in 0.3 ml PBS. Particles were
then vortex mixed for an additional 30 secs, followed by 15 secs of sonication prior to
intratracheal instillation.
Animals. Male Sprague-Dawley [Hla:(SD) CVF] (SD) rats from Hilltop Lab Animals (Scottdale,
PA), weighing approximately 300 g and free of viral pathogens, parasites, mycoplasmas,
Helicobacter, and CAR Bacillus, were used for all studies. Rats were housed in the pathogen
free, environmentally controlled, AAALAC-accredited facility. The rats were housed in ventilated
polycarbonate cages, two per cage, on Alpha-Dri cellulose chips and hardwood Beta chips as
bedding; they were provided HEPA-filtered air, irradiated Teklad 2918 diet, and tap water ad
libitum; and were allowed to acclimate for one week before exposure. Rats were not restricted
from enrichment activity (i.e., chewing/climbing). All animal procedures used during the study
were reviewed and approved by the IACUC at NIOSH.
Repeated Dose Study Design. In Vivo Lung Injury, Inflammation, and Disease. On day 0, 7,
14, and 21 rats were lightly anesthetized with an intraperitoneal injection of 30-40 mg/kg sodium
methohexital (Brevital; Eli Lilly, Indianapolis, IN) and intratracheally instilled with 25 µg DPM,
116 µg SIL, 25 µg DPM + 116 µg SIL (DS), or vehicle control (PBS). All particles were delivered
in 0.3 ml USP grade PBS. All animals were humanely euthanized at 1 day, 1 month, or 3
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months following final particle exposure (n = 8/group/time point) with an intraperitoneal injection
of 100-300 mg/kg sodium pentobarbital followed by exsanguination. The trachea was
cannulated, bronchoalveolar lavage (BAL) was performed on the right lung lobes, and BAL cells
(BALCs) and fluid (BALF) were retained for analysis of parameters indicative of inflammation,
injury, oxidant production, and immune function as described below. Lymphocytes from local
lymph nodes draining the lung were also differentiated by phenotype. The left lung was excised,
pressure-inflated with 10% neutral-buffered formalin, and weighed with water-displacement to
determine fixed lung volume. Histopathological assessment of lung injury, inflammation, and
disease were performed and morphometric analysis of particle clearance was conducted.
BAL. BAL was performed at 1 day, 1 month, and 3 months following the last exposure. The
trachea was cannulated, the chest cavity was opened, the left lung bronchus was clamped off,
and BAL was performed on the right lung lobes. BAL was recovered in two fractions As
described previously [547]. For each animal, both fractions of BAL were centrifuged, the
acellular fluid (supernatant) from the first fraction was retained for further analysis described for
BALF below, the supernatant from the second fraction was discarded, and the cell pellets
(BALC) from both fractions were combined and re-suspended in 1 ml of PBS.
BALF Analysis: LDH Activity and Proteins: The level of LDH activity in the BALF of all
treatment groups was measured at 1 day, 1 month, and 3 months following the final exposure to
evaluate cytotoxicity as a measure of lung injury. Measurement of LDH activity in the acellular
fluid was obtained using a Cobas Mira chemistry analyzer (Roche Diagnostic Systems;
Montclair, IN). LDH activity was quantified by detection of the oxidation of lactate coupled to the
reduction of NAD+ at a spectrophotometric setting of 340 nm. Cytokines and chemokines
involved in inflammatory, tissue remodeling, and immune responses were measured at each
time point after exposure in the BALF of rats treated with PBS, DPM, SIL, or DS combination,
with commercially-available enzyme-linked immunosorbent assay (ELISA) kits or by multiplex
array. The following cytokines and chemokines were quantified by ELISA: interleukin (IL)-10, IL12p70, monocyte chemotactic protein (MCP)-1, macrophage inflammatory protein (MIP)-2
(Novex, Life Technologies; Grand Island, New York); IL-2, IL-4, IL-6, interferon (IFN)-γ (R&D
Systems; Minneapolis, Minnesota); and osteopontin (OPN, Enzo Life Sciences; Farmingdale,
New York). Additionally, two matrix metalloproteinases (MMP), MMP-2 and MMP-9, were
quantified by ELISA, as well as tissue inhibitor of metalloproteinase (TIMP)-1 (R&D Systems) as
indices of tissue remodeling due to injury. IL-1α, IL-1β,
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IL-5, IL-13, IL-17A, IL-18, granulocyte colony stimulating factor (G-CSF), granulocyte and
macrophage colony stimulating factor (GM-CSF), eotaxin, MIP-1α, IFN-γ inducible protein (IP)10, growth-regulated oncogene/keratinocyte chemoattractant (GRO/KC), lipopolysaccharide
(LPS)-induced CXC chemokine (LIX), regulated on activation normal T-cell expressed and
secreted (RANTES), tumor necrosis factor-α (TNF-α), and transforming growth factor-β (TGF-β)
were assessed by multiplex array (Eve Technologies; Alberta, CA).
BALC Differentials. Total BALC collected from rats intratracheally-instilled with PBS, DPM,
SIL, or DS were counted using a Coulter Multisizer II (Coulter Electronics; Hialeah, FL). BALC
differentials were performed to determine the total number of alveolar macrophages (AMs) and
neutrophils previously described (Farris et al 2017). Briefly, 5 × 104 cells from each rat were
spun down onto slides with a Cytospin 3 centrifuge (Shandon Life Sciences International;
Cheshire, England) and labeled with Hema 3® stain (Fisher Scientific; Kalamazoo, MI) to
differentiate cell types. Two hundred cells per slide were counted, and the percentage of AMs
and neutrophils was multiplied by the total number of cells to calculate the total number of each
cell type.
Chemiluminescence (CL). To measure the production of reactive oxidant species by BALC,
CL was measured according to the method of Antonini et al. [507] as previously described [547].
Briefly, extracellular oxidant production was measured as light emitted as a reaction of oxidants
with luminol following stimulation of BAL AMs by zymosan or total BAL phagocytes (AMs and
neutrophils) by phorbal myristate acetate (PMA).
Phenotypic Quantification of BALC and Mediastinal Lymph Node (MLN) Cells by Flow
Cytometry.
Total BALC collected from rats were counted using a Coulter Multisizer II (Coulter Electronics;
Hialeah, FL), followed by differentiation into alveolar macrophages (AMs) and neutrophils as
previously described [547]. Flow cytometry was performed to enumerate and phenotype BALC.
The total number of lymphocytes, B cells (CD45R), and T cells (CD3+), as well as T cell subsets
(CD4+/CD8+) cells were quantified.
Histopathology. The left lungs of rats were fixed with 10% neutral buffered formalin by airway
pressure fixation under 30 cm-water pressure to total lung capacity for 15 min. Lung volumes for
morphometric analyses were assessed by weight of water displacement. The left lungs were
embedded in paraffin, sectioned onto slides, and stained with hematoxylin and eosin (H&E) or
trichrome. An n = 5 stained slides per treatment group per time-point were assessed; stained
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slides were analyzed for indications of inflammation, injury, and fibrosis by a certified veterinary
pathologist at Charles River Laboratories (Wilmington, MA) who was blinded to the treatment
groups. Indices of pathology were scored on scale of 0 – 5, where 0 = no observed effect, 1 =
minimal response, 2 = mild response, 3= moderate response, 4 = marked response, and 5 =
severe response. Tissue stained lightly with Sirius red was also qualitatively examined by darkfield microscopy on an Olympus BX41 using CellSens Dimensions Software version 1.15
(Olympus, Tokyo, Japan) at a magnification of 20x in order to observe particle-loaded cells
within alveolar regions and injury to alveolar septae.
Determination of Particle Clearance – Clearance was evaluated both qualitatively by
examining representative images of particle loaded phagocytes from cytospins using light field
microscopy on an Olympus BX63 using CellSens Dimensions Software version 1.15 (Olympus,
Tokyo, Japan) and quantitatively by morphometrical analysis. Tissue sections from left lung
were deparaffinized and stained lightly with Sirius Red. Slides were immersed in 0.1%
picrosirius solution (100 mg of Sirius Red F3BA in 100 ml of saturated aqueous picric acid) for 2
h followed by washing for 1 min in 0.01 N HCl. Slides were then counterstained with
hematoxylin for 2 min, dehydrated, and mounted with a coverslip for imaging. Quantitative
morphometric methods were used to measure the volume (% of the alveolar wall) and
enumerate particles present by standard morphometric analyses (Underwood 1970; Mercer et
al. 1994). This consisted of basic point counting. An eyepiece counting overlay consisting of 11
by 11 lines (121 total points for each throw of the overlay) was used with a 40X objective. A grid
pattern for throws of the counting overlay was used in order to ensure a uniform sampling of the
section, which did not overweigh interior points. An n = 5 slides was evaluated for each group at
time-points of 1 day, 1 month, and 3 months following exposure. Briefly, clearance was
calculated by finding the total volume of particle, normalizing data to 1 at day 1 and deriving a
natural log curve from latter time-points.
Statistical Analyses. Results for all BAL parameters, and cellular phenotype were expressed
as mean ± standard error and a one-way analysis of variance (ANOVA) was performed between
all treatments groups at each time point. For BAL proteins that were below the limit of detection,
1/2 of the lowest limit of detection was used for statistical analysis of values. Significant
differences among groups were determined using the Student-Newman-Keuls (SNK) post-hoc
test using SigmaPlot for Windows Version 12.5 (Systat Software, Inc, Ekrath, Germany). For
those groups failing normality or variance in the software analysis, ANOVA was run on log
transformed data followed by SNK post-hoc test. For all analyses, significance was set at p <
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0.05. Because data from histopathology studies are inherently categorical, nonparametric
analysis of variance was assessed using SAS/STAT software, Version 9.1, of the SAS System
for Windows statistical programs (SAS Institute, Inc.; Cary, NC). In this instance, groups were
compared using the Wilcoxon rank sum test.
Results
Lung injury was evaluated as LDH activity in the BALF collected from rats at 1 day, 1 month,
and 3 months post-final exposure to particles. LDH activity was significantly increased in all
groups that contained SIL when compared to control and DPM only group (Figure 1). DPM
alone also increased LDH activity compared with control at 1 day and 3 months following the
last exposure. Although LDH activity was increased in the groups co-exposed to DPM and SIL,
this effect was not different from SIL only at any time-point.
Protein mediators were evaluated in BALF as a measure of inflammation and immune response
(Tables 1-2). DPM did not cause significant increases in the majority of the inflammatory BALF
proteins that were measured when compared to control (Table 1). Only eoxtaxin was elevated
at 3 months. Exposure to SIL alone caused persistent increases in the following inflammatory
proteins: LIX, MIP-1α, MIP-2, MCP-1, IL-18, and TNF-α. For several of the cytokines, the
elevation not only persisted but increased with time. Additionally, Il-1β and RANTES were also
elevated at 3 months when compared to control. Co-exposure to DPM and SIL resulted in
increased MCP-1, MIP-1α, MIP-2, IL-18, TNF-α, and a trend for an increase in LIX at various
time-points when compared with control and DPM. Further, combined exposure did not increase
inflammatory protein expression significantly above that of SIL, and for 3 months post-exposure,
there were a number of inflammatory proteins that were significantly greater in the SIL group
compared to the DS group. SIL and DS co-exposure also caused a significant increase in MMP9, a protein associated with tissue remodeling that has implications in the development of
fibrotic changes in the lung, at all time-points following exposure (Table 2). Additionally, SIL
exposure and DS co-exposure increased OPN at 1 day with a trend for an increase at the later
time-points, and TGFβ2 at 1 and 3 months. These proteins are also integral in tissue
remodeling, wound healing, and development of fibrosis. DPM alone increased OPN only at 1
day post-exposure. SIL alone caused an increase in immunoregulatory protein IL-2 at the later
time points and IP-10 at all time-points (Table 2). IP-10 was also increased at the later time
points in the co-exposure group. DPM alone and in the co-exposure with SIL caused a
downregulation of IFN-. Interestingly, this effect in combination with an attenuation of several
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inflammatory cytokines relative to SIL alone indicated that DPM in a co-exposure with SIL may
be exerting independent action on the immune and inflammatory response. These observations
may indicate altered macrophage and lymphocyte activity in response to treatment with DPM.
There were no significant changes in the following cytokines in any group: GRO/KC, G-CSF,
GM-CSF, IL-1α, IL-4, IL-5, IL-10, IL-12p70, IL-13, IL-17A, MMP-2, and TIMP-1 (data not
shown).
Cell differentials were performed on BALC to further assess inflammation (Figure 2A&B). DPM
alone did not cause an increase in the influx of AMs (Figure 2A) or neutrophils (Figure 2B). DPM
did suppress macrophage influx at the one month time-point compared with control (Figure 2A).
Macrophage influx was increased in all groups that contained SIL beginning at one month postexposure. Neutrophil influx significantly increased as early as one-day post-exposure in all
groups containing SIL (Figure 2B), and the pattern of inflammation persisted and increased
throughout the time course. There were no significant differences when comparing influx of cells
between SIL and co-exposure group, which were also increased throughout the time course.
BALC activation was also evaluated as oxidant production ex vivo (Figure 2 C&D). DPM alone
did not cause an increase in oxidant production by AMs and neutrophils as measured by CL.
Oxidant production in the SIL group significantly increased for total phagocytes at all times postfinal exposure (Figure 2C), and oxidant production by macrophages increased at later timepoints (Figure 2D). Co-exposure to DPM and SIL caused an increase in oxidant production at all
time-points. Interestingly, exposure to DPM combined with SIL resulted in significantly increased
oxidant production over exposure to SIL alone at one-day and one-month, suggesting a
potentially higher oxidant burden in the lung of rats in the co-exposure group at these times.
Total BAL and MLN lymphocytes are shown in Figure 3 and phenotype determined by flow
cytometry is shown in Tables 3 and 4. In addition to phagocytic influx described in Figure 2,
exposure to SIL alone or in combination with DPM caused significantly increased lymphocyte
influx into the lung as early as 1 day following exposure (Figure 3A) and proliferation in the MLN
(Figure 3B) as early as one month following the last exposure. This effect was attributed
primarily to CD4+ and CD8+ T cell population subsets (Tables 3 & 4). Exposure to DPM alone
caused a decrease in CD4+ and CD8+ subsets in the lung at the one-month time-point compared
with control (Table 3). In the MLN, proliferation of total lymphocytes and all subsets measured
were increased for DPM exposure at the same time-point. Additionally, it was noted that for the
co-exposed group, DPM enhanced the influx of T cells into the lung compared with all groups,
though this was only significantly different from SIL at one-month following the final exposure.
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However, in the MLN, DS exposure resulted in increased lymphocyte proliferation, particularly at
later time-points compare with all groups. These results were significantly different from SIL only
exposure for T cells as early as one-day after final exposure, and for total lymphocytes
comprised primarily by increased T and B cell lymphocyte populations at three-months following
exposure (Table 4).
H&E and trichrome-stained tissue sections were evaluated by a board-certified
veterinarian pathologist (Table 5). Influx of AMs, as a measure of inflammation, was increased
in SIL and DS groups at later time points of one and three months following exposure when
compared to control and DPM, but there was no significant change between SIL and DS. Mixed
cell infiltration (MI) was initiated by SIL as there were no changes for DPM alone, and the DS
group was similar to SIL for later time-points. Significant alveolar epithelial hyperplasia (AEH)
and minimal to mild septal fibrosis were observed in only the combined exposure group at the
later time-points, which is reflected in the sirius red stained tissue as evaluated qualitatively by
dark field microscopy (Figure 5). The presence of brown granules was significantly apparent for
both DPM only and DS groups as compared to control and SIL groups, indicating the presence
of diesel (SIL would not appear unless examined under polarized light); interestingly, for the
DPM group, brown granules were not increased at three months compared with DS group,
which was still significantly elevated, indicating increased clearance in the DPM group.
Macrophage particle load was qualitatively observed using images of cytospins collected from
BAL that reflect particle load evaluated quantitatively by morphometry (Figure 4). This
suggests that clearance of DPM in the co-exposure group may be decreased over time
compared to DPM alone. Morphometrical analysis of particle clearance showed that clearance
for the SIL and DS group was significantly slower than that of DPM alone at 1 day following the
final exposure, and particle burden in the lung was greater for DS and SIL groups at all time
points with the greatest load in the DS group (Figure 6A). Cumulative doses for each particle
were also estimated based on morphometrical clearance data analyzed in study 2. Though a
degree of particle clearance may have occurred between each dosing week, assuming a
constant rate of clearance throughout the repeated exposure time course of 21 days, total
burden of particle at day 1 post final-exposure is still estimated to be 80% of cumulative DPM
dose; whereas, 90% of either SIL or 95% of DS total dose remained at day 1 following final
exposure. Additionally, rate of clearance slowed for the co-exposure group by 1 month
becoming significantly slower than both SIL and DPM. At 1 day post-final exposure, DPM
comprised 30% of overall remaining DS dose; however, by 3 months following exposure,
approximately 90% of DS dose remaining was comprised of silica and only 10% remaining was
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comprised of DPM (Figure 6B). By three-months only 33% of particle had been cleared in the
co-exposure as compared with SIL or DPM, where 56 % and 74 % had been cleared,
respectively (Figure 6A). Although clearance of DPM in the co-exposure is slower than DPM
alone, clearance of this particle in a co-exposure is still occurring at a steady rate.
Discussion
The toxicological and fibrotic properties of crystalline silica are well-established, and both
acute bolus doses of silica and more chronic lower dose exposure lead to fibrotic conditions and
in the latter case, cancer [4], though the overall mechanisms of action are not fully elucidated.
DPM-induced inflammation and oxidative stress are also well-investigated [467, 473-476];
though, DPM exposure is more closely associated with obstructive respiratory conditions and
cancer, rather than restrictive fibrosis [411, 415, 517, 518]. The current study was conducted in
order to investigate a model of repeated administrations of DPM and crystalline silica, which
have been previously shown to cause respiratory health effects individually, and that may be
encountered in a co-exposure during different mining operations. Previous studies in our lab
established that combinations of these particles, given in one bolus dose, exacerbated or
altered toxicological effects observed for either particle alone. These results were particularly
significant for inflammation, production of oxidants by phagocytes, initiation of fibrotic changes
in the lung, and differential alteration of immune protein secretion (Farris et al 2017). Further, it
was established that particle load and SIL particle exposure were the primary determinants for
histopathological effects related to tissue remodeling; whereas, DPM itself caused particle
specific effects related to inflammation and oxidant production when in combination with SIL in a
single dose scenario (Study 2). In both studies, irrespective of the DPM doses, SIL was the
primary particle by which toxic outcomes were determined, and DPM produced particle specific
effects that modified or enhanced the toxicity of SIL alone, even at non-toxic doses of DPM. In
this study, particles were administered in repeated lower doses in order to characterize toxicity
of SIL and DPM in combination in a sub-chronic exposure scenario.
In the present study, most of the effects observed in the co-exposure correlated closely
to effects that were initiated by the presence of SIL, as the SIL and DS groups did not differ
significantly from each other in many instances. For the parameters of cellular injury and
pulmonary inflammation, measured by the activity of LDH in the BALF and influx of
macrophages and neutrophils into the lung, respectively, there were no significant differences
between the SIL exposed group and the group exposed to the combination of DPM and SIL
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(Figure 1 and 2 A,B). However, when assessing the potential contribution of inflammation
caused by production of oxidants by phagocytes, there was an increase in the macrophage
oxidant production in the co-exposed group compared to SIL alone at one month following the
final exposure. By the three-month time-point, although still increased, there were no significant
differences between the two groups. Interestingly, at one-month following exposure, not only did
DPM alone not cause any change in production of oxidants from that of the control group, DPM
exposure alone caused a significant decrease in the influx of macrophages into the lung (Figure
2A). This effect demonstrates a distinct alteration in the toxicological responses in the lung to a
combination of particles compared to single particle exposure to either DPM or SIL.
Other studies examining longer duration or higher doses of silica and DPM have also
shown differential effects on the function of alveolar macrophages, which may play a role in
differences in effect overall on the immune system and have been reviewed in depth [5, 115,
127, 128, 511, 550-552]. While crystalline silica characteristically causes acute increases in
activity of macrophages, inducing production of oxidants and triggering a cascade of
inflammatory signaling events, it has also been shown to cause eventual cytotoxicity to
macrophages as reviewed by Fubini and Hubbard [130]. The exact biochemical mechanism(s)
that govern this event are not fully understood but apoptosis is likely triggered by the
involvement of scavenger receptors and recognition of damage signals, production of oxidants,
or some combination of the two events [553]. DPM, similarly, is associated with variable effects
on alveolar macrophages in some instances triggering inflammatory responses by increased
oxidant and cytokine production, classically associated with the development of allergic
hypersensitivity; however, DPM has also been shown by several studies to suppress the
activities of macrophages particularly associated with effective clearance of pathogens from the
lung. Dose of DPM administered, as well as, composition of DPM are suspected to be major
factors in effects upon macrophages as reviewed by Lawal [554]. With regard to effects on the
immune system, silica has been shown to have variable effects dependent upon length of
exposure. Acutely, silica increases inflammation and production of oxidants by phagocytes that
contribute to enhanced clearance of infection acutely [113]. However, when silica exposure
occurs subchronically and chronically, cytotoxicity, oxidant injury, and a possible shift in resident
AM population, contribute to reduction of clearance of infection [59, 62, 110]. DPM has been
shown to suppress activation and effector functions of macrophages and T cells, and these
alterations are associated with increased susceptibility to infection and reduced pulmonary
clearance of pathogens [316, 324, 535, 555, 556].
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In the current study, when evaluating the immunological proteins that were secreted into
the BALF, SIL increased the expression of many inflammatory chemokines and cytokines
associated with the recruitment of immune cells to the lung including LIX, MIP-1α, MIP-2, and
MCP-1 (Table 1). At day 1, expression of several of these proteins was slightly reduced in the
DPM exposed group compared to control, although not to a statistically significant degree. This
trend may contribute to the reduction of macrophage recruitment observed in the lung at one
month following the last exposure (Figure 2A). Interestingly, these same proteins in the DS
group, although increased overall, were lower when compared to SIL in some instances, and
more significantly at later time-points. This suggests that DPM may have differentially altered
the response to SIL in a co-exposure. At some time-points, SIL also enhanced the expression of
inflammatory proteins such as TNF-α and IL-18 or IL-1β involved in the activation of
inflammatory cascades including NF-κB and the inflammasome, respectively, and that are also
involved in apoptotic pathways. These effects, while often mirrored in the co-exposure, were not
altered by the presence of DPM suggesting that for the expression of these proteins, SIL
appeared to be the initiating factor, and that DPM did not alter or further enhance the response.
Proteins involved in immunoregulation and the activation/differentiation of lymphocytes and
macrophages were also increased in the SIL group: IL-2, IFN-γ, and IP-10 (Table 2). Similar to
chemotactic factors that were down-regulated by DPM, immunoregulatory proteins were also
lower than control, particularly at early time-points. These proteins were also reduced in
expression in the co-exposure group as compared with SIL alone at various time-points. IP-10
expression is dependent upon the increased levels of IFN-γ, and IFN-γ in turn activates
macrophages. Therefore, it is plausible that the reduction in IFN-γ in the DPM group at one day
following exposure may contribute to reduction in macrophage recruitment and a decrease in
expression of IP-10. Though expression of IFN-γ is reduced for the co-exposure group
throughout the time-course, IP-10 expression is only reduced at 1 day following the final
exposure, and macrophage recruitment was not altered in the co-exposure group when
compared to SIL alone.
The lack of the DPM-specific enhancement of various inflammatory responses, as
observed in the first two studies, and a decrease in differences observed between SIL and DS
groups may also be partly due to differential clearance of SIL versus DPM over time in the coexposure group. Clearance analysis in the DS group revealed that DPM accounted for only 20%
of the total particle remaining at the 1 month and only approximately 10% by the 3 month timepoint. Therefore, it is likely that the persistence of SIL in the co-exposure group is the primary
particle contributing to the response at the later time points; whereas in study 2, an acute bolus
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dose higher than that in the present study may be contributing to a greater degree of particle
specific effects by DPM in that study.
Another difference between the present study and studies 1 and 2 occurred in regard to
lymphocyte proliferation. SIL exposure caused an increased influx of lymphocytes into the lung
(Table 3). This was followed by enhanced proliferation of lymphocytes in local lymph nodes by
one month following the last exposure (Table 4). These lymphocytes were found to be
comprised primarily of T cells, and more specifically, the CD4+ subset of T lymphocytes. DPM
caused a transient decrease in the subsets of T cells present in the lungs at one month
following exposure (Table 3), which may reflect the reduction in protein expression and
macrophage activity observed at this time point as discussed above (Table 1,2 and Figure 2A).
For most lung lymphocyte parameters, there were no significant differences between the SIL
and DS groups. However, for T cells, and more specifically CD4+ and CD8+ subsets, there were
elevations in the co-exposure group as compared with SIL suggesting an increase, albeit
transient, in the immunological response for this combined exposure (Table 3). Interestingly, at
the same time-point, DPM alone reduced overall influx of these subsets into the lung. It is
possible that load of particle is a contributing factor for this effect in the DS group accounting for
the increase versus the suppressive effects of DPM alone. Similarly, Yin et al. reported that
though DPM suppressed some parameters of innate immune function, recruitment of T cells
following an LM infection, specifically in CD4+ and CD8+ subsets, was sufficient for clearing
bacteria despite hindered innate immunity [317].
Similar to the previous studies (study 1 and 2), the toxic properties of SIL and particle
load are also the primary factors in the tissue remodeling and fibrotic effects following exposure.
SIL increased the expression of tissue remodeling proteins involved in would healing and
fibrosis: MMP-9, OPN, and TGFβ2 (Table 2). Changes for OPN were more significant at the
earliest time-point. MMP-9 was significantly increased throughout the time course, and TGFβ2
levels continued to increase over time being significantly different from DPM and control at 3
months. A similar pattern was observed for the DS group with the exception of a significant
increase in TGF2 at 1 month in the DS group when compared to all groups. The data suggest
that SIL was the primary particle causing alterations in the signaling for tissue remodeling.
Interestingly, the most persistent histopathological changes related to inflammation, epithelial
hyperplasia, and fibrosis occurred in the DS group. In this group, total particle, and SIL
specifically, was cleared at a slower rate from the lung when compared to the individual
particles, resulting in a greater total particle load over time as compared to all other groups
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(Figure 6A). Therefore, a combination of these effects may account for the increase in fibrosis
observed in the DS group only.
Overall, in the previous study (Study 2), effects of the single bolus dose related to
inflammatory influx of cells, increased inflammatory proteins, altered immune regulatory
proteins, and increased oxidant production were particle specific responses to DPM, whereas
tissue remodeling correlated better to total load of particle and the presence of SIL in the
exposure. There are some differences and similarities between the acute dose and repeated
subacute dose studies. The DPM specific effect of enhanced oxidant production by
macrophages in the lung was conserved. However, exacerbation of lung injury indicated by LDH
in BALF was not observed in the co-exposure group in the current study, where SIL and DS did
not differ from each other. This could be due to a greater burden of SIL in the lungs following the
repeated exposure, whereby total SIL is the primary factor for this parameter. Additionally,
alterations in immunoregulatory proteins in the DPM group and in the co-exposure were more
pronounced than the previous study, and a decrease in T cells in the lung was also present in
the DPM group, possibly reflecting a greater effect of exposure to DPM over time versus a
higher single dose exposure to DPM. In the DS group, although SIL was the primary factor
causing an increase in all parameters, the effect of the subacute exposure to DPM may have
contributed to some trends in slight reductions in certain parameters of inflammation and
immune response in the co-exposure group relative to SIL alone.
Conclusion
The data taken together show that DPM exposure at doses in the sub-chronic exposure
do not elicit significant pulmonary toxicity; however, in combination with silica, the co-exposure
had the capability to alter some silica-induced pulmonary effects, primarily oxidant production,
and initiation of fibrotic changes in the lung. When administered in combination with SIL, DPM
had the capacity to exhibit independent action on the expression of some proteins that may alter
the inflammatory/immunological response in the lung, as demonstrated by a reduction in
macrophage recruitment at 1 month post-exposure and reductions in immune regulatory
proteins, particularly IFN-. While it was not examined in this study, these results may have
implications for adverse outcomes involving the immune system such as susceptibility to
infection or regulation of auto-immune responses following a sub-acute or even chronic
exposure to low doses of particles. Overall, the data suggest that there is an increased risk of
adverse outcomes when there is a co-exposure to SIL and DPM, even at relatively non-toxic
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doses of DPM. Since clearance of particles in the co-exposure is significantly reduced, more
chronic exposure may lead to an increase in severity of effects when compared to exposure to
either particle alone, particularly if accumulation of particles were to exceed rate of clearance.
Furthermore, the intratracheal bolus doses of particles administered in this and the previous
studies (Studies 1 and 2) are much lower than what have been previously investigated in similar
models [271, 325, 498, 557, 558], and better reflect deposition that would occur overtime in
inhalation models. This suggests that chronic lower-level exposures to a mixture of silica and
diesel exhaust in the work place may still be sufficient for the development of adverse
pulmonary health effects.
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Table 1: BALF Inflammatory Proteins

All data are shown as mean ± standard error: a different from control and DPM; b different from control; c different from all other
groups; d different from DPM; and e different from SIL; p ≤ 0.05.
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Table 2: BALF Immunoregulatory Proteins and Tissue Remodeling Proteins

All data are shown as mean ± standard error: adifferent from control and DPM; b different from control;
c
different from all other groups; and f different from control and SIL; p ≤ 0.05. ND: not detected.
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Table 3: Lymphocyte Phenotype of the BALC

All data are shown as mean ± standard error: a different from control and DPM; b different from
control; c different from all other groups; and d different from DPM; p ≤ 0.05. Red text indicates a
value significantly less than control.
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Table 4: Lymphocyte Phenotype in the MLN

All data are shown as mean ± standard error: a different from control and DPM; b different from
control; and c different from all other groups; p ≤ 0.05.
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Table 5: Lung Histopathology Severity and Incidence Scores

Lung tissue was analyzed and scored for accumulation of alveolar macrophages (AM), alveolar
epithelial hyperplasia (AEH), brown granules in alveolar macrophages (BG; presence of DPM
particles), mixed cellular infiltration (MI), and fibrosis in alveolar septae (F) (n=5 per group per
time point). Severity was scored as 0 - 5: 0 = normal, 1 = minimal/slight, 2 = mild, 3 = moderate,
4 = marked, and 5 = severe. Incidence was noted as focal (F), multi-focal (M), and diffuse (D).
Data are presented as means with incidence (number of animals with a positive score per total
animals) in parentheses. aDifferent from control and DPM groups; cdifferent from all other
groups; ddifferent from DPM only; and fdifferent from control and SIL groups; p value <0.05.
Additional symbols indicate * p <0.01; ** p <0.01 compared with control and DPM; †p <0.01
compared with DPM; and ††p <0.01 compared with control.
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Figure 1:

Figure 1: Lactate dehydrogenase activity (LDH) in BALF after exposure to PBS, DPM, SIL, or a
combination of DPM and SIL (DS). All data are shown as mean ± standard error: adifferent from
control and DPM; bdifferent from control; p ≤ 0.05.
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Figure 2:

Figure 2: Total macrophages (A) and neutrophils (B) in the BALF following exposure to PBS, DPM,
SIL, or DS. Production of oxidants by total phagocytes stimulated with PMA (C) or by macrophages
only stimulated by zymosan (D) measured by chemiluminescence following exposure to PBS, DPM,
SIL, or DS. All data are shown as mean ± standard error: adifferent from control and DPM; bdifferent
from control; and cdifferent from all groups; p ≤ 0.05.
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Figure 3:

Figure 3: Total BAL Lymphocytes (A) and MLN Lymphocytes (B) following exposure to PBS, DPM,
SIL, or DS. For individual cell phenotypes see Tables 3 and 4. aDifferent from control and DPM;
b
different from control only; and cdifferent from all groups. Statistical significance measured as p ≤
0.05.
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Figure 4:

Light field microscopy images of cytospins used to qualitatively assess particulate clearance by
BAL AMs at 1 day, 1 month, and 3 months following instillation. Images were taken at 40x
magnification and scale bar represents 20µm in length. Green arrows indicate the presence of
silica particulates within AMs.
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Figure 5:

Figure 5: Dark field microscopy images of Sirius red stained tissue used to qualitatively assess
tissue injury and particulate loaded cells at 1 day, 1 month, and 3 months following instillation.
Images were taken at 20x magnification and scale bar represents 20µm in length. White arrows
indicate the presence of particulate within macrophages.
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Figure 6:

Figure 6: Particle clearance for each dosing group as quantitatively evaluated by morphometry;
data was normalized to 1.0 for day one following the last instillation in order to compare groups
that received variable particle masses of initial dose; data shown is Ln of normalized data. For
each group an n = 5 tissue slides per time-point were morphometrically assessed (A). Relative
ratio of each particulate remaining in the co-exposure group at each time-point as assessed by
morphometry (B).
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Chapter 5
Overall Discussion
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Discussion
Industrial operations such as above and below-ground mining may result in occupational
respiratory exposure to complex mixtures of particulates including crystalline silica and diesel
exhaust. Toxicity following pulmonary exposure to either crystalline silica or diesel exhaust have
been studied in detail as individual exposures, as extensively reviewed by several investigators
[4, 5, 21, 128, 306, 465, 511, 550-552, 559-561]. Silica has been shown to cause oxidative
stress, prolonged inflammation, development of restrictive fibrotic lung disease,
hyperresponsiveness of some T cell subsets, upregulation of the inflammasome, incidence of
autoimmune developments, increased susceptibility to infections, and cancers. Diesel exposure
may result in oxidative stress, inflammation, suppression of macrophage function, reduced T
cell activity, increased susceptibility to infection, allergic sensitization, development of
obstructive lung diseases, and cancer. The hazards associated with these exposures are wellrecognized and regulatory organizations have recommended exposure limits (RELs) [30, 184],
permissible exposure limits (PELs) [7, 31, 182], or occupational exposure limits (OELs) [179181, 183] for crystalline silica and in some instances for underground levels of diesel (regulated
as total carbon). However, there are very few studies that investigate the health effects of these
two materials in a co-exposure scenario that may occur in occupational setting, such as surface
or below-ground mining operations, including hydraulic fracturing, a fast-expanding form of oil
and gas extraction that utilizes diesel-powered engines as the motive force in moving proppant
and sand containing crystalline silica.
The current series of investigations was designed to address these main knowledge
gaps in the literature. The overall goal of these studies was to characterize pulmonary toxicity
following a co-exposure to diesel particulate matter (DPM) and crystalline silica (SIL) at doses
derived from current occupational measures, and determine if these effects were variable
compared with exposure to the particles individually. The project had three major aims: (1a)
Characterize the pulmonary response to an acute co-exposure to DPM and SIL at varying
doses; (1b) characterize the pulmonary response to a repeated co-exposure to DPM and SIL in
order to determine if subacute exposure vs. acute exposure altered the effects observed for 1a;
(2) establish if susceptibility to an acute respiratory infection was altered following a coexposure of DPM and SIL; and (3) determine whether clearance of particulate in a co-exposure
to DPM and SIL was altered compared with the clearance rate of either particle individually to
assess the effect of particle load in toxicity
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In Study 1, two doses of DPM were employed, which were derived from field measures
of elemental carbon (EC) collected either above or below-ground during mining operations
[547]. Particulates were administered to rats by intratracheal instillation in one bolus dose to
model an acute exposure. The study showed that these doses of DPM, ~7 or 50 g, produced
low to no effect on pulmonary toxicity individually. The high dose of SIL (233 g), which was
greater than that of the DPM by mass, but not the lower dose (50 g), did result in acute injury,
inflammation, alterations in immune response, and the induction of pathological changes in the
lung associated with fibrosis. When the higher of the two DPM doses was combined with the
high dose of SIL, inflammation, and oxidant production by phagocytes were enhanced at early
time-points. By 3 months post-exposure, effects of the co-exposure were similar to that of SIL
alone, which persisted or progressed depending on the parameter of toxicity. This led to the
goal of determining whether the increase in toxic effects elicited by DPM at earlier time-points
were not enhanced beyond that of SIL at 3 months following exposure due to clearance of DPM,
or a masking of any additional effect of DPM due to the progression of toxicity caused by SIL.
Additionally, there was a need to address whether the effects observed were due to increased
particle load administered to the co-exposure group, or rather, due to specific properties of DPM
in the co-exposure.
This concept was addressed in Study 2, where equal doses of SIL, and DPM or CB were
administered to determine if the effects observed in Study 1 were particle-specific to DPM or if
total particle load was a factor in toxicity. CB was employed as a particle load control for
comparison to DPM as it is comprised of the primary core component of DPM, but does not
have the metal and PAH components, and it is relatively low in pulmonary toxicity at nonoverload doses [267, 277, 281]. It was determined from this investigation that DPM given at a
dose equivalent to that of silica, also enhanced inflammation, injury, oxidant production, and
induction of pathological changes observed for silica alone. Further, CB did not contribute to
enhanced inflammation, injury, and oxidant production beyond that of silica alone suggesting
that for DPM and silica combined, these responses were due to specific characteristics of DPM
and not due specifically to an increase in overall particle load. However, pathological changes
were closely correlated to SIL exposure, but were enhanced by particle load as these changes
were slightly increased beyond that of SIL for both DPM and CB co-exposed groups. Further, it
was established that overall clearance of particles was reduced in the co-exposures compared
with individual particles, which may suggest worsened outcomes for more chronic co-exposure
scenarios.
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Study 3 investigated toxicological changes that occur during a sub-chronic, repeated coexposure to lower concentrations of particles representing a longer period of working conditions
from mining sites. Rats were exposed intratracheally to DPM (25 g), SIL (116 g), or DPM (25
g) and SIL (116 g) combined once per week for four consecutive weeks. Effects observed in
the co-exposure group in this study were primarily due to silica, as this group did not differ from
SIL alone as had been observed in the acute dose study; however, relatively low doses of DPM
were sufficient to enhance the production of oxidants by phagocytes at 1 month following final
exposure, and increase the incidence of fibrotic pathological changes in the lung tissue
beginning at 1 month following exposure that increased further at 3 months following final
exposure. Additionally, it was observed that DPM both alone, and in co-exposure with SIL was
capable of eliciting independent action on the expression of some proteins in the lung
associated with chemotaxis of innate immune cells and the differentiation of lymphocytes.
Based on the findings related to immune response in the characterization studies, further
studies examining the susceptibility to infection were designed to determine if alterations of
inflammation, oxidant production, and protein expression might alter pulmonary response to a
pathogen using the acute exposure models in studies 1 and 2. Although bacterial clearance was
reduced for the highest dose of DPM at day 3 following infection when compared to all groups
that contained SIL, all exposed groups were able to clear infection in the adaptive phase of the
immune response following exposure to bacteria. The high dose DPM group showed a degree
of increased T cell response to infection at days 5 and 7 (Study 2, Table 7), although not to the
level of significance, which may have been compensatory to the initial suppression in innate
immune response and increased bacterial load at day 3. Therefore, the differential effects on
immune parameters of DPM in the co-exposure groups observed in studies 1 and 2 in the
absence of infection were not significant enough to disrupt immune function in the response to a
pathogen.
Taken together, these results suggest that acute exposure to DPM and SIL in
combination showed that relatively low toxicity doses of DPM could exacerbate the effects of
lung injury and inflammation and alter immune responses when compared to that of SIL
exposure alone, while total particle load in the presence of SIL contributed to fibrotic response
and tissue remodeling. Further, the finding that combined exposure to DPM and SIL results in
reduced clearance rate of particles when compared to individual exposures may have
implications in development of adverse pulmonary outcomes following chronic exposures,
where persistent particle load could further exacerbate lung pathology. It is well-accepted that
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particle clearance and load are critical factors in toxicity, and that particle overload can be a
mechanism of toxicity for particles that are considered relatively non-toxic or “nuisance dusts.”
Overload is described as a particle load that overwhelms the capability of natural clearance
mechanisms by way of mucociliary escalation or uptake by macrophages, and is dependent on
a number of particle properties including size, shape, and density, occurring when a
macrophage reaches a particle burden of ~ 60 % of its volume [75, 562].
Although combined exposure to DPM and SIL led to reduced rate of particle clearance,
continued particle clearance was observed throughout the time course suggesting that the
doses of particles administered did not reach overload. Also, although there were macrophages
that were in particle overload conditions at the highest doses of DPM administered in study 2,
the vast majority of macrophages recovered by BAL did not have greater than 60% volume in
particles. It is important to note that the instillation doses used in these studies better reflect
doses delivered by inhalation as calculated based on worksite measurements and pulmonary
deposition models; whereas, historically, intratracheal instillation studies of silica and diesel
individually have used much higher acute bolus doses of the materials to represent longer, more
chronic exposures or to determine maximal effect of toxicity [291, 468, 521, 563-567].
Therefore, bolus dose delivery often reflect amounts of particulate that far-exceed exposure
levels that are likely to occur routinely in the workplace, and may reflect to some degree the
state of particle overload, which may not adequately reflect workplace exposures where particle
concentrations are kept within the limitations outlined by governing agencies [31, 180-183]. The
reduced rate of particle clearance observed in the co-exposures in the present studies are not a
product of particle overload in the lung, which allows the investigators to be able to determine
effects that are correlated to particle specific toxicity or general particle load effects under nonoverload conditions.
Reduced clearance of a highly toxic material, such as silica, following exposure is of
significant concern. As silica is known to be directly cytotoxic and reactive, is it not surprising
that parameters of toxicity associated with silica, such as inflammation and cytotoxicity, are
dose and exposure duration dependent [568-570]. It has been shown that once a given
threshold of silica exposure has been reached and exposure has ceased, progression of
pathology may still occur [74, 80, 81, 570]. This was also observed in the SIL group in the
current studies; whereas, the dose-dependent effects for DPM alone resolved over time [547].
In study 1 and study 2, the total particle load increased in the co-exposure groups over the
individual exposures on a mass basis, and although several parameters measured showed a
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particle-specific effect due to DPM, other parameters were influenced more by particle load and
the presence of SIL. Tissue remodeling and fibrosis, although dependent upon the presence of
SIL, were increased due to overall particle load, as the DPM or CB co-exposures did not differ
from each other and resulted in increased tissue injury over that of SIL alone. This suggests
that particulate combined with a toxic dose of SIL may be sufficient to elicit these effects,
regardless of the specific particle.
Overall, these studies show particle specific effects of DPM as well as particle load
effects in the co-exposure; however the majority of the underlying toxicity during this
investigation was initiated by SIL. As mentioned, inflammation, cytotoxic injury, migration of
immune cells into the lung, proliferation of lymphocytes in MLN, production of oxidants by
phagocytes, and expression of inflammatory and tissue remodeling proteins in the lung were
increased in response to silica at the high dose (233 g) throughout the time course. These
results are in agreement with numerous studies examining the pulmonary toxicity of silica [80,
81, 571]. In sharp contrast to the effects of silica, the doses of DPM used in our studies (~7, 50,
or 233 g) did not elicit persistent inflammatory effects beyond 1 day or 1 week for most
parameters when administered as an individual exposure, although DPM did appear to alter
effects related to immune function differentially from that of SIL. The transient inflammatory
responses are in contrast to other investigations of DPM toxicity [268-272], and this may be due
to several factors including dose, whereby the doses used in the present study are lower than
those employed in other installation studies, as well as duration of exposure (an acute or
subacute dose versus subchronic or chronic studies), and/or composition of diesel depending
on source, engine type, whole exhaust, or particulate fraction [278, 280, 308, 572].
Immune effects related to DPM are most often associated with suppression of certain
parameters of innate immunity related to macrophage effector functions [248, 316, 318, 324,
325, 387, 573, 574]. In the current studies, we did observe decreased influx of macrophages
following subacute exposure and the expression of inflammatory cytokines associated with
macrophage effector functions for both acute and subacute exposure, specifically signaling
chemotaxis of additional immune cells and auto-activation. Furthermore, DPM exposure
resulted in the decreased influx of some sets of T cells into the lung corresponding with a
decrease in IP-10 at 1 month following final exposure in our subacute model. Interestingly,
some suppression of macrophage related proteins was also observed in the DPM and SIL
combined exposure as compared with SIL exposure alone, suggesting that DPM has the
capability to attenuate the effects observed for SIL depending on the time point and parameter
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examined, which may play a role in susceptibility to infection during a chronic model of exposure
and infection. Though an alteration in bacterial clearance following infection was not observed
for the lower dose of DPM (50 µg), the higher dose exposure group (233 µg) had significantly
decreased clearance at day 3 following infection, which was not observed for the same particle
load of CB (Study 2). Moreover, clearance of bacteria in the DPM/SIL group was not different
from that of SIL.
Overall, the suppressive effects of DPM in the present studies were transient and,
although there were clear trends in the suppression of macrophage response, not all
parameters were statistically significant from control, as has been observed in other studies of
diesel reviewed in Chapter 1 [387, 573, 574]. As mentioned above, the differences in the degree
of immune suppression observed in other investigations versus the current studies described
here may be attributable to the form of diesel used in this study. Investigators have
demonstrated that the immunoregulatory effects of DPM are more closely related to the organic
fraction of the material adsorbed to the carbon core of DPM [268, 296, 298, 324, 325, 330, 335,
337, 339], and not to the carbon core itself, which is similar to the CB control used in study 2.
Relative to other studies, the diesel exposure in this study used only the particulate form diesel
collected from a forklift (NIST SRM 2975) representing a “tranisitional” form of diesel exhaust.
This particle is relatively low in organic material relative to freshly generated diesel exhaust. The
studies did show, however, a degree of suppression in macrophage- and immune-related
responses over that of the carbon core control group (CB), suggesting that the levels of
components adsorbed to the core of the DPM in this study may contribute to the particle specific
effects related to immune parameters in the co-exposure group.
Taken together, the data indicate that toxicity in the co-exposure group was attributable
to SIL, and although there was a degree of independent action due to DPM in the co-exposure
group in regard to immune function, DPM did have particle-specific effects in the co-exposure
group related to exacerbation of inflammation and oxidant production; whereas,
histopathological changes were primarily attributable to particle load and the presence of SIL.
These studies are the first to characterize effects that are specific to the interaction of DPM with
SIL in a co-exposure and are important for the continued understanding of workplace
exposures, which are relevant to a wide number of occupations.
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Model for Overall Progression of Lung Toxicity

1) A worker is exposed to silica particles. 2) Silica particles may cause direct damage to
bronchiolar or alveolar epithelial cells in the form of reactive oxidants leading to oxidative stress
(2a), or may be phagocytosed by cells such as alveolar macrophages when deposited deeply
within the lung (2b). 3) Particles that are phagocytosed will result in cellular damage in the form
of reactive oxidants that may cause cellular damage (oxidative stress) or cell death. 4) Cells,
either bronchial or alveolar epithelial, or cells that have phagocytosed particles will express
inflammatory mediators and/or fibrogenic mediators. 5) Inflammatory mediators signal the
infiltration of additional immune cells such as monocytes, macrophages, and neutrophils. 6) Cell
damage/death leads to the re-release of silica particles into the alveolar spaces, which must be
phagocytosed by newly recruited cells. This process is reinitiated again at 2b. 7) Fibrogenic
mediators recruit fibroblasts to the site of prolonged inflammation in order to secrete
extracellular matrix proteins such as collagen in an effort to sequester silica particles to a
particular area. 8) Collagen deposition results in the development of fibrosis. This study also
showed that exposure to DPM in addition to silica resulted in more prolonged and increased
parameters of inflammation, cellular injury, and oxidative stress. Furthermore, the increase in
particle load resulted in an early progression of mild alveolar epithelial hyperplasia and mild
fibrosis.

192

Bibliography
1.
2.
3.

4.
5.
6.
7.
8.
9.
10.

11.

12.
13.
14.
15.
16.
17.
18.
19.
20.
21.

Rosen, G., The history of miners' diseases, a medical and social interpretation, by George Rosen
... With an introduction by Henry E. Sigerist. 1943, New York: Schuman's. xii, 490 p.
Collis, E.L., Industrial pneumonoconioses, with special reference to dust-phthisis. Public Health,
1915. 28(4): p. 252-264.
Laney, A.S., E.L. Petsonk, and M.D. Attfield, Pneumoconiosis among underground bituminous
coal miners in the United States: is silicosis becoming more frequent? Occup Environ Med, 2010.
67(10): p. 652-6.
Castranova, V. and V. Vallyathan, Silicosis and coal workers' pneumoconiosis. Environmental
Health Perspectives, 2000. 108(Suppl 4): p. 675-684.
Steiner, S., et al., Diesel exhaust: current knowledge of adverse effects and underlying cellular
mechanisms. Arch Toxicol, 2016. 90(7): p. 1541-53.
CATF, Occupational Exposure to Diesel Exhaust, C.A.T. Force, Editor. 2008.
OSHA, Worker's Exposure to Respirable Crystalline Silica: Final Rule Overview, in OSHA Fact
Sheet. 2016, United States Department of Labor: Online.
Yassin, A., F. Yebesi, and R. Tingle, Occupational Exposure to Crystalline Silica Dust in the United
States, 1988–2003. Environmental Health Perspectives, 2005. 113(3): p. 255-260.
Cohen, R.A.C., A. Patel, and F.H.Y. Green, Lung Disease Caused by Exposure to Coal Mine and
Silica Dust. Semin Respir Crit Care Med, 2008. 29(06): p. 651-661.
Möhner, M., N. Kersten, and J. Gellissen, Chronic obstructive pulmonary disease and longitudinal
changes in pulmonary function due to occupational exposure to respirable quartz. Occupational
and Environmental Medicine, 2012. 70(1): p. 9.
Hnizdo, E. and V. Vallyathan, Chronic obstructive pulmonary disease due to occupational
exposure to silica dust: a review of epidemiological and pathological evidence. Occupational and
Environmental Medicine, 2003. 60(4): p. 237.
Steenland, K. and E. Ward, Silica: a lung carcinogen. CA Cancer J Clin, 2014. 64(1): p. 63-9.
Ojajarvi, I.A., et al., Occupational exposures and pancreatic cancer: a meta-analysis. Occup
Environ Med, 2000. 57(5): p. 316-24.
Pan, G., et al., Nested case-control study of esophageal cancer in relation to occupational
exposure to silica and other dusts. Am J Ind Med, 1999. 35(3): p. 272-80.
Sjodahl, K., et al., Airborne exposures and risk of gastric cancer: a prospective cohort study. Int J
Cancer, 2007. 120(9): p. 2013-8.
Tsuda, T., et al., A case-control study of the relationships among silica exposure, gastric cancer,
and esophageal cancer. Am J Ind Med, 2001. 39(1): p. 52-7.
Chen, W., et al., Long-Term Exposure to Silica Dust and Risk of Total and Cause-Specific Mortality
in Chinese Workers: A Cohort Study. PLOS Medicine, 2012. 9(4): p. e1001206.
Liu, Y., et al., Long-term exposure to crystalline silica and risk of heart disease mortality.
Epidemiology, 2014. 25(5): p. 689-96.
Dong, D., et al., Lung cancer among workers exposed to silica dust in Chinese refractory plants.
Scand J Work Environ Health, 1995. 21 Suppl 2: p. 69-72.
Weiner, J., L. Barlow, and B. Sjogren, Ischemic heart disease mortality among miners and other
potentially silica-exposed workers. Am J Ind Med, 2007. 50(6): p. 403-8.
Leung, C.C., I.T. Yu, and W. Chen, Silicosis. Lancet, 2012. 379(9830): p. 2008-18.

193

22.
23.

24.
25.
26.
27.
28.
29.
30.
31.
32.
33.
34.

35.
36.
37.
38.
39.
40.

41.
42.

Middleton, E.L., THE PRESENT POSITION OF SILICOSIS IN INDUSTRY IN BRITAIN. British Medical
Journal, 1929. 2(3584): p. 485-489.
Agricola, G., De re metallica / Georgius Agricola ; translated from the first Latin edition of 1556,
with biographical introduction, annotations and appendices, ed. H. Hoover and L.H. Hoover.
1950, New York: Dover Publications.
Cherniak, M., The Hawk's Nest incident : America's worst industrial disaster. 1986, New Haven;
London: Yale University Press.
ILO, Guidelines for the use of the ILO International Classification of Radiographs of
Pneumoconioses (OSH 22). 2011, International Labour Office: Geneva :.
Delgado García, D.D., Silicosis: controversy in detection. Medicina y Seguridad del Trabajo, 2014.
60: p. 4-8.
Castranova, V., Particulates and the Airways: Basic Biological Mechanisms of Pulmonary
Pathogenicity. Applied Occupational and Environmental Hygiene, 1998. 13(8): p. 613-616.
Vallyathan, V., et al., Generation of free radicals from freshly fractured silica dust. Potential role
in acute silica-induced lung injury. Am Rev Respir Dis, 1988. 138(5): p. 1213-9.
IARC, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 2012, World Health
Organization: International Agency for Research on Cancer: Online.
NIOSH, Criteria for a Recommended Standard: Occupational Exposure to Crystalline Silica,
D.o.H.E.a. Welfare, Editor. 1974: National Institute for Occupational Safety and Health.
OSHA, Occupational Exposure to Respirable Crystalline Silica, in 29 CFR Parts 1910, 1915, and
1926, U.S.F. Government, Editor. 2016, Department of Labor: Federal Register. p. 605.
Attfield, M.D. and J. Costello, Quantitative exposure-response for silica dust and lung cancer in
Vermont granite workers. American Journal of Industrial Medicine, 2004. 45(2): p. 129-138.
Preller, L., et al., Occupational exposure to silica and lung cancer risk in the Netherlands. Occup
Environ Med, 2010. 67(10): p. 657-63.
Liu, Y., et al., Exposure-response analysis and risk assessment for lung cancer in relationship to
silica exposure: a 44-year cohort study of 34,018 workers. Am J Epidemiol, 2013. 178(9): p. 142433.
Kachuri, L., et al., Occupational exposure to crystalline silica and the risk of lung cancer in
Canadian men. Int J Cancer, 2014. 135(1): p. 138-48.
Elci, O.C., et al., Occupational dust exposure and the risk of laryngeal cancer in Turkey. Scand J
Work Environ Health, 2002. 28(4): p. 278-84.
Elci, O.C. and M. Akpinar-Elci, Occupational exposures and laryngeal cancer among non-smoking
and non-drinking men. Int J Occup Environ Health, 2009. 15(4): p. 370-3.
Sartor, S.G., et al., [Occupational risks for laryngeal cancer: a case-control study]. Cad Saude
Publica, 2007. 23(6): p. 1473-81.
Maeda, M., et al., Dysregulation of the immune system caused by silica and asbestos. J
Immunotoxicol, 2010. 7(4): p. 268-78.
ATS, Adverse effects of crystalline silica exposure. American Thoracic Society Committee of the
Scientific Assembly on Environmental and Occupational Health. Am J Respir Crit Care Med, 1997.
155(2): p. 761-8.
Koeger, A.C., et al., Silica-associated connective tissue disease. A study of 24 cases. Medicine
(Baltimore), 1995. 74(5): p. 221-37.
Makol, A., M.J. Reilly, and K.D. Rosenman, Prevalence of connective tissue disease in silicosis
(1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med,
2011. 54(4): p. 255-62.

194

43.

44.
45.
46.

47.
48.

49.
50.
51.
52.
53.

54.
55.
56.

57.
58.
59.
60.
61.
62.
63.
64.

Blanc, P.D., B. Jarvholm, and K. Toren, Prospective risk of rheumatologic disease associated with
occupational exposure in a cohort of male construction workers. Am J Med, 2015. 128(10): p.
1094-101.
Beaudreuil, S., et al., Occupational exposure in ANCA-positive patients: a case-control study.
Kidney Int, 2005. 67(5): p. 1961-6.
Shtraichman, O., et al., Outbreak of autoimmune disease in silicosis linked to artificial stone.
Occup Med (Lond), 2015. 65(6): p. 444-50.
Parks, C.G., et al., Occupational exposure to crystalline silica and risk of systemic lupus
erythematosus: a population-based, case-control study in the southeastern United States.
Arthritis Rheum, 2002. 46(7): p. 1840-50.
Bovenzi, M., et al., Scleroderma and occupational exposure. Scand J Work Environ Health, 1995.
21(4): p. 289-92.
Hayashi, H., et al., Dysregulation of autoimmunity caused by silica exposure and alteration of
Fas-mediated apoptosis in T lymphocytes derived from silicosis patients. Int J Immunopathol
Pharmacol, 2011. 24(1 Suppl): p. 11s-16s.
Otsuki, T., et al., Soluble Fas mRNA is dominantly expressed in cases with silicosis. Immunology,
1998. 94(2): p. 258-62.
Wu, P., et al., Reduced function of CD4+25+ regulatory T cell fraction in silicosis patients. Int J
Immunopathol Pharmacol, 2006. 19(2): p. 357-68.
Otsuki, T., et al., Alterations of Fas and Fas-related molecules in patients with silicosis. Exp Biol
Med (Maywood), 2006. 231(5): p. 522-33.
Rocha-Parise, M., et al., Lymphocyte activation in silica-exposed workers. Int J Hyg Environ
Health, 2014. 217(4-5): p. 586-91.
Rocha, M.C., et al., Genetic polymorphisms and surface expression of CTLA-4 and PD-1 on T cells
of silica-exposed workers. International Journal of Hygiene and Environmental Health, 2012.
215(6): p. 562-569.
Rees, D. and J. Murray, Silica, silicosis and tuberculosis. Int J Tuberc Lung Dis, 2007. 11(5): p. 47484.
Bailey, W.C., et al., Silico-mycobacterial disease in sandblasters. Am Rev Respir Dis, 1974. 110(2):
p. 115-25.
Shufflebotham, F., The Milroy Lectures on the hygienic aspect of the coal-mining industry in the
United Kingdom: Delivered before the Royal College of Physicians of London. Br Med J, 1914.
1(2779): p. 755-9.
Hale, L.W., Tin mining and silicosis in Cornwall. Thorax, 1946. 1: p. 71-92.
Hnizdo, E. and J. Murray, Risk of pulmonary tuberculosis relative to silicosis and exposure to silica
dust in South African gold miners. Occup Environ Med, 1998. 55(7): p. 496-502.
Cowie, R.L., The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care
Med, 1994. 150(5 Pt 1): p. 1460-2.
teWaternaude, J.M., et al., Tuberculosis and silica exposure in South African gold miners. Occup
Environ Med, 2006. 63(3): p. 187-92.
Barboza, C.E., et al., Tuberculosis and silicosis: epidemiology, diagnosis and chemoprophylaxis. J
Bras Pneumol, 2008. 34(11): p. 959-66.
Sherson, D. and F. Lander, Morbidity of pulmonary tuberculosis among silicotic and nonsilicotic
foundry workers in Denmark. J Occup Med, 1990. 32(2): p. 110-3.
Schaefer, W.B., et al., Infection with the avian-Battey group of mycobacteria in England and
Wales. Br Med J, 1969. 2(5654): p. 412-5.
Wolinsky, E., Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis, 1979.
119(1): p. 107-59.
195

65.
66.
67.
68.

69.
70.
71.
72.

73.
74.
75.
76.
77.
78.

79.
80.

81.
82.
83.
84.
85.

Suzuki, S., et al., Clinical characteristics of pulmonary Mycobacterium scrofulaceum disease in
2001-2011: A case series and literature review. J Infect Chemother, 2016. 22(9): p. 611-6.
Kurahara, Y., et al., Mixed Pulmonary Infection with Three Types of Nontuberculous
Mycobacteria. Internal Medicine, 2013. 52(4): p. 507-510.
Cordes, L.G., et al., A cluster of Acinetobacter Pneumonia in foundry workers. Ann Intern Med,
1981. 95(6): p. 688-93.
da Silva, G.A., et al., Cryptococcosis, silicosis, and tuberculous pseudotumor in the same
pulmonary lobe. Jornal Brasileiro de Pneumologia : Publicaça̋o Oficial da Sociedade Brasileira de
Pneumologia e Tisilogia, 2013. 39(5): p. 620-626.
Subra, J.F., et al., Lymphopenia in occupational pulmonary silicosis with or without autoimmune
disease. Clin Exp Immunol, 2001. 126(3): p. 540-4.
Schuyler, M., M. Ziskind, and J. Salvaggio, Cell-mediated immunity in silicosis. Am Rev Respir Dis,
1977. 116(1): p. 147-51.
Schapira, R.M., et al., Hydroxyl radical production and lung injury in the rat following silica or
titanium dioxide instillation in vivo. Am J Respir Cell Mol Biol, 1995. 12(2): p. 220-6.
Schapira, R.M., et al., L-arginine uptake and metabolism by lung macrophages and neutrophils
following intratracheal instillation of silica in vivo. Am J Respir Cell Mol Biol, 1998. 19(2): p. 30815.
Porter, D.W., et al., Enhanced nitric oxide and reactive oxygen species production and damage
after inhalation of silica. Am J Physiol Lung Cell Mol Physiol, 2002. 283(2): p. L485-93.
Porter, D.W., et al., Progression of lung inflammation and damage in rats after cessation of silica
inhalation. Toxicol Sci, 2004. 79(2): p. 370-80.
Oberdorster, G., Toxicokinetics and effects of fibrous and nonfibrous particles. Inhal Toxicol,
2002. 14(1): p. 29-56.
Porter, D.W., et al., Nitric oxide and reactive oxygen species production causes progressive
damage in rats after cessation of silica inhalation. Toxicol Sci, 2006. 90(1): p. 188-97.
Sato, T., et al., Suppressive Oligodeoxynucleotides Inhibit Silica-Induced Pulmonary
Inflammation. The Journal of Immunology, 2008. 180(11): p. 7648-7654.
Schreck, R., P. Rieber, and P.A. Baeuerle, Reactive oxygen intermediates as apparently widely
used messengers in the activation of the NF-kappa B transcription factor and HIV-1. The EMBO
Journal, 1991. 10(8): p. 2247-2258.
Sen, C.K. and L. Packer, Antioxidant and redox regulation of gene transcription. Faseb j, 1996.
10(7): p. 709-20.
Porter, D.W., et al., Time course of pulmonary response of rats to inhalation of crystalline silica:
NF-kappa B activation, inflammation, cytokine production, and damage. Inhal Toxicol, 2002.
14(4): p. 349-67.
Castranova, V., et al., Effect of inhaled crystalline silica in a rat model: Time course of pulmonary
reactions. Molecular and Cellular Biochemistry, 2002. 234(1): p. 177-184.
Zhu, Z., et al., Suppression of thioredoxin system contributes to silica-induced oxidative stress
and pulmonary fibrogenesis in rats. Toxicol Lett, 2013. 222(3): p. 289-94.
Peeters, P.M., et al., Silica-induced NLRP3 inflammasome activation in vitro and in rat lungs.
Particle and Fibre Toxicology, 2014. 11(1): p. 58.
Ghio, A.J., R.H. Jaskot, and G.E. Hatch, Lung injury after silica instillation is associated with an
accumulation of iron in rats. Am J Physiol, 1994. 267(6 Pt 1): p. L686-92.
Shimizu, Y., et al., Co-localization of iron binding on silica with p62/sequestosome1 (SQSTM1) in
lung granulomas of mice with acute silicosis. Journal of Clinical Biochemistry and Nutrition,
2015. 56(1): p. 74-83.

196

86.
87.
88.
89.
90.
91.
92.

93.
94.
95.
96.
97.

98.

99.
100.
101.
102.

103.
104.
105.
106.
107.

Jessop, F., et al., Autophagy deficiency in macrophages enhances NLRP3 inflammasome activity
and chronic lung disease following silica exposure. Toxicol Appl Pharmacol, 2016. 309: p. 101-10.
Moncao-Ribeiro, L.C., et al., P2X7 receptor modulates inflammatory and functional pulmonary
changes induced by silica. PLoS One, 2014. 9(10): p. e110185.
Wang, L., et al., Essential role of p53 in silica-induced apoptosis. Am J Physiol Lung Cell Mol
Physiol, 2005. 288(3): p. L488-96.
Borges, V.M., et al., FAS Ligand Triggers Pulmonary Silicosis. The Journal of Experimental
Medicine, 2001. 194(2): p. 155-164.
Suzuki, N., et al., T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice.
Thorax, 1996. 51(10): p. 1036-42.
Langley, R.J., et al., A biphasic response to silica: I. Immunostimulation is restricted to the early
stage of silicosis in lewis rats. Am J Respir Cell Mol Biol, 2004. 30(6): p. 823-9.
Migliaccio, C.T., R.F. Hamilton, Jr., and A. Holian, Increase in a distinct pulmonary macrophage
subset possessing an antigen-presenting cell phenotype and in vitro APC activity following silica
exposure. Toxicol Appl Pharmacol, 2005. 205(2): p. 168-76.
Liu, F., et al., CD4+CD25+Foxp3+ Regulatory T Cells Depletion May Attenuate the Development of
Silica-Induced Lung Fibrosis in Mice. PLOS ONE, 2010. 5(11): p. e15404.
Guo, J., et al., Neutralization of interleukin-1 beta attenuates silica-induced lung inflammation
and fibrosis in C57BL/6 mice. Arch Toxicol, 2013. 87.
Chen, Y., et al., Neutralization of interleukin-17A delays progression of silica-induced lung
inflammation and fibrosis in C57BL/6 mice. Toxicol Appl Pharmacol, 2014. 275(1): p. 62-72.
Li, C., et al., Blocking the 4-1BB Pathway Ameliorates Crystalline Silica-induced Lung
Inflammation and Fibrosis in Mice. Theranostics, 2016. 6(12): p. 2052-2067.
Wright, J.L., et al., Quartz But Not Iron Oxide Causes Air-Flow Obstruction, Emphysema, and
Small Airways Lesions in the Rat. American Review of Respiratory Disease, 1988. 138(1): p. 129135.
Li, K., B. Keeling, and A. Churg, Mineral dusts cause elastin and collagen breakdown in the rat
lung: a potential mechanism of dust-induced emphysema. Am J Respir Crit Care Med, 1996.
153(2): p. 644-9.
Churg, A., J. Hobson, and J. Wright, Functional and morphologic comparison of silica- and
elastase-induced airflow obstruction. Exp Lung Res, 1989. 15(6): p. 813-22.
Herget, J., et al., Pulmonary Hypertension in Silicotic Rats. Archives of Environmental Health: An
International Journal, 1979. 34(5): p. 320-324.
Zelko, I.N., et al., Pulmonary hypertension and vascular remodeling in mice exposed to crystalline
silica. Respir Res, 2016. 17(1): p. 160.
Guo, J., et al., Effects of silica exposure on the cardiac and renal inflammatory and fibrotic
response and the antagonistic role of interleukin-1 beta in C57BL/6 mice. Archives of Toxicology,
2016. 90(2): p. 247-258.
Brown, J.M., et al., Silica accelerated systemic autoimmune disease in lupus-prone New Zealand
mixed mice. Clin Exp Immunol, 2003. 131(3): p. 415-21.
Brown, J.M., J.C. Pfau, and A. Holian, Immunoglobulin and Lymphocyte Responses Following
Silica Exposure in New Zealand Mixed Mice. Inhalation Toxicology, 2004. 16(3): p. 133-139.
Pfau, J.C., J.M. Brown, and A. Holian, Silica-exposed mice generate autoantibodies to apoptotic
cells. Toxicology, 2004. 195(2): p. 167-176.
Brown, J.M., et al., Effects of rottlerin on silica-exacerbated systemic autoimmune disease in New
Zealand mixed mice. Am J Physiol Lung Cell Mol Physiol, 2005. 289(6): p. L990-8.
Strickland, F.M., et al., CD4(+) T cells epigenetically modified by oxidative stress cause lupus-like
autoimmunity in mice. Journal of autoimmunity, 2015. 62: p. 75-80.
197

108.

109.
110.

111.
112.
113.
114.
115.
116.
117.

118.

119.
120.
121.
122.
123.
124.

125.

126.
127.
128.

Bates, M.A., et al., Silica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in
Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the LupusProne NZBWF1 Mouse. PLOS ONE, 2015. 10(5): p. e0125481.
Bates, M.A., et al., Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by
Docosahexaenoic Acid Consumption. PLOS ONE, 2016. 11(8): p. e0160622.
Pasula, R., et al., Airway Delivery of Silica Increases Susceptibility to Mycobacterial Infection in
Mice: Potential Role of Repopulating Macrophages. The Journal of Immunology, 2009. 182(11):
p. 7102-7109.
Higgins, D.A., I.T. Kung, and R.S. Or, Environmental silica in badger lungs: a possible association
with susceptibility to Mycobacterium bovis infection. Infect Immun, 1985. 48(1): p. 252-6.
Hatch, G.E., et al., Inhalable particles and pulmonary host defense: In vivo and in vitro effects of
ambient air and combustion particles. Environmental Research, 1985. 36(1): p. 67-80.
Antonini, J.M., et al., Effect of silica inhalation on the pulmonary clearance of a bacterial
pathogen in Fischer 344 rats. Lung, 2000. 178(6): p. 341-50.
Barbarin, V., et al., The role of pro- and anti-inflammatory responses in silica-induced lung
fibrosis. Respir Res, 2005. 6: p. 112.
Huaux, F., Contribution of macrophage derived cytokines in the pathogenesis of lung fibrosis
induced by inhaled mineral particles. 1998, Universite Catholique de Louvain.
Dörger, M., et al., Species differences in NO formation by rat and hamster alveolar macrophages
in vitro. American Journal of Respiratory Cell and Molecular Biology, 1997. 16(4): p. 413-420.
Carter, J.M. and K.E. Driscoll, The role of inflammation, oxidative stress, and proliferation in
silica-induced lung disease: a species comparison. J Environ Pathol Toxicol Oncol, 2001. 20 Suppl
1: p. 33-43.
Hatch, G.E., J.A. Raub, and J.A. Graham, Functional and biochemical indicators of
pneumoconiosis in mice: comparison with rats. J Toxicol Environ Health, 1984. 13(4-6): p. 48797.
Liu, X., et al., Enhancement of proinflammatory and procoagulant responses to silica particles by
monocyte-endothelial cell interactions. Particle and Fibre Toxicology, 2012. 9: p. 36-36.
Kobzik, L., Lung macrophage uptake of unopsonized environmental particulates. Role of
scavenger-type receptors. J Immunol, 1995. 155(1): p. 367-76.
Allison, A.C., J.S. Harington, and M. Birbeck, An examination of the cytotoxic effects of silica on
macrophages. J Exp Med, 1966. 124(2): p. 141-54.
Ding, M., et al., Diseases caused by silica: mechanisms of injury and disease development. Int
Immunopharmacol, 2002. 2(2-3): p. 173-82.
Cassel, S.L., et al., The Nalp3 inflammasome is essential for the development of silicosis. Proc
Natl Acad Sci U S A, 2008. 105(26): p. 9035-40.
Rom, W.N., Relationship of inflammatory cell cytokines to disease severity in individuals with
occupational inorganic dust exposure. American Journal of Industrial Medicine, 1991. 19(1): p.
15-27.
Driscoll, K.E., et al., Macrophage Inflammatory Proteins 1 and 2: Expression by Rat Alveolar
Macrophages, Fibroblasts, and Epithelial Cells and in Rat Lung after Mineral Dust Exposure.
American Journal of Respiratory Cell and Molecular Biology, 1993. 8(3): p. 311-318.
Lugano, E.M., J.H. Dauber, and R.P. Daniele, Acute experimental silicosis. Lung morphology,
histology, and macrophage chemotaxin secretion. Am J Pathol, 1982. 109(1): p. 27-36.
Huaux, F., New developments in the understanding of immunology in silicosis. Curr Opin Allergy
Clin Immunol, 2007. 7(2): p. 168-73.
Kawasaki, H., A mechanistic review of silica-induced inhalation toxicity. Inhal Toxicol, 2015.
27(8): p. 363-77.
198

129.
130.
131.
132.
133.

134.

135.
136.

137.
138.

139.
140.
141.
142.
143.
144.
145.
146.
147.
148.
149.
150.

Hornung, V., et al., Silica crystals and aluminum salts activate the NALP3 inflammasome through
phagosomal destabilization. Nat Immunol, 2008. 9(8): p. 847-56.
Fubini, B. and A. Hubbard, Reactive oxygen species (ROS) and reactive nitrogen species (RNS)
generation by silica in inflammation and fibrosis. Free Radic Biol Med, 2003. 34(12): p. 1507-16.
Iyer, R., et al., Silica-induced apoptosis mediated via scavenger receptor in human alveolar
macrophages. Toxicol Appl Pharmacol, 1996. 141(1): p. 84-92.
Nash, T., A.C. Allison, and J.S. Harington, Physico-chemical properties of silica in relation to its
toxicity. Nature, 1966. 210(5033): p. 259-61.
Shi, X.L., N.S. Dalal, and V. Vallyathan, ESR evidence for the hydroxyl radical formation in
aqueous suspension of quartz particles and its possible significance to lipid peroxidation in
silicosis. J Toxicol Environ Health, 1988. 25(2): p. 237-45.
Dalal, N.S., X.L. Shi, and V. Vallyathan, Role of free radicals in the mechanisms of hemolysis and
lipid peroxidation by silica: comparative ESR and cytotoxicity studies. J Toxicol Environ Health,
1990. 29(3): p. 307-16.
Castranova, V., Generation of oxygen radicals and mechanisms of injury prevention.
Environmental Health Perspectives, 1994. 102(Suppl 10): p. 65-68.
Vallyathan, V., et al., Response of alveolar macrophages to in vitro exposure to freshly fractured
versus aged silica dust: the ability of Prosil 28, an organosilane material, to coat silica and reduce
its biological reactivity. J Toxicol Environ Health, 1991. 33(3): p. 303-15.
Begin, R., et al., Aluminum lactate treatment alters the lung biological activity of quartz. Exp
Lung Res, 1986. 10(4): p. 385-99.
Antonini, J.M. and M.J. Reasor, Effect of short-term exogenous pulmonary surfactant treatment
on acute lung damage associated with the intratracheal instillation of silica. J Toxicol Environ
Health, 1994. 43(1): p. 85-101.
Liu, X., et al., Phospholipid surfactant adsorption by respirable quartz and in vitro expression of
cytotoxicity and DNA damage. Toxicol Lett, 1998. 96-97: p. 77-84.
Babior, B.M., The respiratory burst of phagocytes. J Clin Invest, 1984. 73(3): p. 599-601.
Badwey, J.A. and M.L. Karnovsky, Active oxygen species and the functions of phagocytic
leukocytes. Annu Rev Biochem, 1980. 49: p. 695-726.
Zhang, Z., et al., Involvement of oxidative stress in crystalline silica-induced cytotoxicity and
genotoxicity in rat alveolar macrophages. Environ Res, 2000. 82(3): p. 245-52.
Mintz, S., The effects of silica on the free, apparent redox state (NAD+/NADH) of the alveolar
macrophage; a possible mitochondrial membrane effect. Chest, 1976. 69(2 Suppl): p. 298.
Fazzi, F., et al., TNFR1/Phox Interaction and TNFR1 Mitochondrial Translocation Thwart SilicaInduced Pulmonary Fibrosis. The Journal of Immunology, 2014. 192(8): p. 3837-3846.
Driscoll, K.E., et al., Effects of particle exposure and particle-elicited inflammatory cells on
mutation in rat alveolar epithelial cells. Carcinogenesis, 1997. 18(2): p. 423-30.
Vallyathan, V., et al., Enhanced Generation of Free Radicals from Phagocytes Induced by Mineral
Dusts. American Journal of Respiratory Cell and Molecular Biology, 1992. 6(4): p. 404-413.
Fubini, B., Surface Chemistry and Quartz Hazard. The Annals of Occupational Hygiene, 1998.
42(8): p. 521-530.
Pricop, L., et al., Reactive oxygen intermediates enhance Fc gamma receptor signaling and
amplify phagocytic capacity. J Immunol, 1999. 162(12): p. 7041-8.
Ghio, A.J., et al., Role of surface complexed iron in oxidant generation and lung inflammation
induced by silicates. Am J Physiol, 1992. 263(5 Pt 1): p. L511-8.
Kim, Y.K., et al., Depressant effect of ambroxol on stimulated functional responses and cell death
in rat alveolar macrophages exposed to silica in vitro. J Pharmacol Exp Ther, 2002. 300(2): p.
629-37.
199

151.
152.

153.
154.
155.
156.
157.
158.
159.
160.

161.

162.
163.

164.
165.
166.
167.

168.
169.
170.

Vallyathan, V., et al., Molecular Activation of Activator Protein-1 In Silica and Asbestos-Induced
Carcinogenesis. Inhalation Toxicology, 2000. 12(sup3): p. 353-357.
Gwinn, M.R., et al., The Role of p53 in Silica-Induced Cellular and Molecular Responses
Associated with Carcinogenesis. Journal of Toxicology and Environmental Health, Part A, 2009.
72(23): p. 1509-1519.
Naik, E. and V.M. Dixit, Mitochondrial reactive oxygen species drive proinflammatory cytokine
production. The Journal of Experimental Medicine, 2011. 208(3): p. 417-420.
Abais, J.M., et al., Redox Regulation of NLRP3 Inflammasomes: ROS as Trigger or Effector?
Antioxidants & Redox Signaling, 2015. 22(13): p. 1111-1129.
Dostert, C., et al., Innate immune activation through Nalp3 inflammasome sensing of asbestos
and silica. Science, 2008. 320.
Petrilli, V., et al., The inflammasome: a danger sensing complex triggering innate immunity. Curr
Opin Immunol, 2007. 19(6): p. 615-22.
Dörger, M. and F. Krombach, Response of Alveolar Macrophages to Inhaled Particulates.
European Surgical Research, 2002. 34(1-2): p. 47-52.
Beamer, C.A. and A. Holian, Silica suppresses Toll-like receptor ligand-induced dendritic cell
activation. Faseb j, 2008. 22(6): p. 2053-63.
Lo Re, S., et al., IL-17A–Producing γδ T and Th17 Lymphocytes Mediate Lung Inflammation but
Not Fibrosis in Experimental Silicosis. The Journal of Immunology, 2010. 184(11): p. 6367-6377.
van Berlo, D., et al., NF-κB dependent and independent mechanisms of quartz-induced
proinflammatory activation of lung epithelial cells. Particle and Fibre Toxicology, 2010. 7: p. 1313.
Goto, M., et al., Involvement of NF-kappaB p50/p65 heterodimer in activation of the human prointerleukin-1beta gene at two subregions of the upstream enhancer element. Cytokine, 1999.
11(1): p. 16-28.
Chen, F., et al., Essential role of NF-kappa B activation in silica-induced inflammatory mediator
production in macrophages. Biochem Biophys Res Commun, 1995. 214(3): p. 985-92.
Hughes, C.S., et al., Extracellular cathepsin S and intracellular caspase 1 activation are surrogate
biomarkers of particulate-induced lysosomal disruption in macrophages. Part Fibre Toxicol,
2016. 13: p. 19.
Riteau, N., et al., ATP release and purinergic signaling: a common pathway for particle-mediated
inflammasome activation. Cell Death & Disease, 2012. 3(10).
Tsugita, M., et al., SR-B1 Is a Silica Receptor that Mediates Canonical Inflammasome Activation.
Cell Rep, 2017. 18(5): p. 1298-1311.
Migliaccio, C.T., et al., The IL-4Ralpha pathway in macrophages and its potential role in silicainduced pulmonary fibrosis. J Leukoc Biol, 2008. 83(3): p. 630-9.
Rom, W.N., et al., Characterization of the lower respiratory tract inflammation of nonsmoking
individuals with interstitial lung disease associated with chronic inhalation of inorganic dusts. Am
Rev Respir Dis, 1987. 136(6): p. 1429-34.
Koren, H.S., et al., Modulation of eicosanoid production by human alveolar macrophages
exposed to silica in vitro. Environ Health Perspect, 1992. 97: p. 77-83.
Barbarin, V., et al., Characterization of the effect of interleukin-10 on silica-induced lung fibrosis
in mice. Am J Respir Cell Mol Biol, 2004. 31(1): p. 78-85.
Antognelli, C., et al., Glyoxalase I drives epithelial-to-mesenchymal transition via argpyrimidinemodified Hsp70, miR-21 and SMAD signalling in human bronchial cells BEAS-2B chronically
exposed to crystalline silica Min-U-Sil 5: Transformation into a neoplastic-like phenotype. Free
Radical Biology and Medicine, 2016. 92: p. 110-125.

200

171.

172.

173.
174.
175.

176.

177.
178.
179.

180.
181.
182.
183.
184.

185.
186.
187.
188.

189.
190.

Ji, X., et al., IL4 and IL-17A provide a Th2/Th17-polarized inflammatory milieu in favor of TGF-β(1)
to induce bronchial epithelial-mesenchymal transition (EMT). International Journal of Clinical and
Experimental Pathology, 2013. 6(8): p. 1481-1492.
Mi, S., et al., Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis
Via TGF-β1–Dependent and –Independent Mechanisms. The Journal of Immunology, 2011.
187(6): p. 3003-3014.
Lo Re, S., et al., Platelet-derived growth factor-producing CD4+ Foxp3+ regulatory T lymphocytes
promote lung fibrosis. Am J Respir Crit Care Med, 2011. 184(11): p. 1270-81.
Lee, S., et al., Silicosis and autoimmunity. Current Opinion in Allergy and Clinical Immunology,
2017. 17(2): p. 78-84.
Rao, T.D. and A.B. Frey, Administration of silica sensitizes lipopolysaccharide responsiveness of
murine macrophages but inhibits T and B cell priming by inhibition of antigen presenting
function. Immunol Invest, 1998. 27(3): p. 181-99.
Wu, P., et al., Induction of CD69 antigen expression in peripheral blood mononuclear cells on
exposure to silica, but not by asbestos/chrysotile-A. Immunology Letters, 2005. 98(1): p. 145152.
Holian, A., et al., Asbestos and silica-induced changes in human alveolar macrophage phenotype.
Environ Health Perspect, 1997. 105 Suppl 5: p. 1139-42.
Allison, A.C. and P.D. Hart, Potentiation by silica of the growth of Mycobacterium tuberculosis in
macrophage cultures. Br J Exp Pathol, 1968. 49(5): p. 465-76.
QDNRM, Guidance note for management of diesel engine exhuast in metalliferous mines, in QGN
21, D.o.N.R.a.M. State of Queensland, Editor. 2014, Queensland Government, Australia: Mining
and Quarrying Safety and Health Act of 1999. p. 1-26.
HSE, Control of diesel engine exhaust emissions in the workplace, in HSG187, H.a.S. Executive,
Editor. 2012, Crown Copyright: Online. p. 1-21.
SUVA, D.o.O.M., Grenzwerte am Arbeitsplatz, in 1903.d, S.N.A.I.O. (SUVA), Editor. 2013, SUVA:
online. p. 1-150.
OSHA/MSHA, Diesel Exhaust/Diesel Particulate Matter, in Hazard Alert. 2013, OSHA/MSHA:
United States Department of Labor. p. 4.
TERA, Occupational Exposure Limit Evaluation: Diesel Particulate Matter, P. Nance, Editor. 2014,
Toxicology Excellence for Risk Assessment: online. p. 1-15.
CDHS, Diesel Engine Exhaust Health Hazard Advisory, C.D.o.P. Health, Editor. 2002, Hazard
Evaluation System and Information Service Health Hazard Advisory California Department of
Public Health. p. 1-6.
Finkelstein, M.M., et al., Ischemic heart disease mortality among heavy equipment operators.
American Journal of Industrial Medicine, 2004. 46(1): p. 16-22.
Hart, J.E., et al., Ischaemic heart disease mortality and years of work in trucking industry
workers. Occup Environ Med, 2013. 70(8): p. 523-8.
Laden, F., et al., Cause-Specific Mortality in the Unionized U.S. Trucking Industry. Environmental
Health Perspectives, 2007. 115(8): p. 1192-1196.
Torén, K., et al., Occupational exposure to particulate air pollution and mortality due to
ischaemic heart disease and cerebrovascular disease. Occupational and Environmental
Medicine, 2007. 64(8): p. 515-519.
Peters, A., et al., Increased particulate air pollution and the triggering of myocardial infarction.
Circulation, 2001. 103(23): p. 2810-5.
Peng, R.D., et al., Emergency admissions for cardiovascular and respiratory diseases and the
chemical composition of fine particle air pollution. Environ Health Perspect, 2009. 117(6): p. 95763.
201

191.
192.
193.
194.
195.

196.
197.

198.
199.

200.
201.
202.

203.
204.
205.
206.
207.
208.
209.

210.

Pope, C.A., 3rd, et al., Ischemic heart disease events triggered by short-term exposure to fine
particulate air pollution. Circulation, 2006. 114(23): p. 2443-8.
Yorifuji, T., S. Kashima, and H. Doi, Fine-particulate Air Pollution from Diesel Emission Control
and Mortality Rates in Tokyo: A Quasi-experimental Study. Epidemiology, 2016. 27(6): p. 769-78.
Latifovic, L., et al., Bladder cancer and occupational exposure to diesel and gasoline engine
emissions among Canadian men. Cancer Med, 2015. 4(12): p. 1948-62.
Seidler, A., et al., Association between diesel exposure at work and prostate cancer.
Scandinavian journal of work, environment & health, 1998. 24(6): p. 486-94.
Guo, J., et al., Risk of esophageal, ovarian, testicular, kidney and bladder cancers and leukemia
among finnish workers exposed to diesel or gasoline engine exhaust. Int J Cancer, 2004. 111(2):
p. 286-92.
Bakke, B., et al., Cumulative exposure to dust and gases as determinants of lung function decline
in tunnel construction workers. Occup Environ Med, 2004. 61(3): p. 262-9.
Silverman, D.T., et al., The Diesel Exhaust in Miners Study: A Nested Case–Control Study of Lung
Cancer and Diesel Exhaust. JNCI Journal of the National Cancer Institute, 2012. 104(11): p. 855868.
Ulfvarson, U. and R. Alexandersson, Reduction in adverse effect on pulmonary function after
exposure to filtered diesel exhaust. Am J Ind Med, 1990. 17(3): p. 341-7.
Chattopadhyay, B.P., J. Alam, and A. Roychowdhury, Pulmonary Function Abnormalities
Associated with Exposure to Automobile Exhaust in a Diesel Bus Garage and Roads. Lung, 2003.
181(5): p. 291-302.
Gamble, J.F. and W.G. Jones, Respiratory Effects of Diesel Exhaust in Salt Miners. American
Review of Respiratory Disease, 1983. 128(3): p. 389-394.
Gamble, J., W. Jones, and J. Hudak, An epidemiological study of salt miners in diesel and
nondiesel mines. Am J Ind Med, 1983. 4(3): p. 435-58.
Gamble, J., W. Jones, and S. Minshall, Epidemiological-environmental study of diesel bus garage
workers: Chronic effects of diesel exhaust on the respiratory system. Environmental Research,
1987. 44(1): p. 6-17.
Zhang, L.P., et al., Long-term exposure to diesel engine exhaust induced lung function decline in a
cross sectional study. Ind Health, 2017. 55(1): p. 13-26.
Ulvestad, B., et al., Increased risk of obstructive pulmonary disease in tunnel workers. Thorax,
2000. 55(4): p. 277-282.
Bergdahl, I.A., et al., Increased mortality in COPD among construction workers exposed to
inorganic dust. European Respiratory Journal, 2004. 23(3): p. 402-406.
Hart, J.E., et al., Chronic obstructive pulmonary disease mortality in railroad workers.
Occupational and environmental medicine, 2009. 66(4): p. 221-226.
Hart, J.E., et al., Chronic obstructive pulmonary disease mortality in diesel-exposed railroad
workers. Environ Health Perspect, 2006. 114(7): p. 1013-7.
Weinmann, S., et al., COPD and Occupational Exposures: A Case-Control Study. Journal of
Occupational and Environmental Medicine, 2008. 50(5): p. 561-569.
Jrgensen, H. and A. Svensson, Studies on Pulmonary Function and Respiratory Tract Symptoms
of Workers in an Iron Ore Mine Where Diesel Trucks are Used Underground. Journal of
Occupational and Environmental Medicine, 1970. 12(9): p. 348-354.
Oliver, L.C., et al., Respiratory symptoms and lung function in workers in heavy and highway
construction: A cross-sectional study*. American Journal of Industrial Medicine, 2001. 40(1): p.
73-86.

202

211.

212.
213.
214.
215.

216.
217.

218.
219.
220.
221.
222.
223.

224.

225.
226.
227.
228.
229.
230.

231.

Gluck, U., R. Schutz, and J.O. Gebbers, Cytopathology of the nasal mucosa in chronic exposure to
diesel engine emission: a five-year survey of Swiss customs officers. Environ Health Perspect,
2003. 111(7): p. 925-9.
Safak, A.A., et al., Bronchial wall thickness in toll collectors. Ind Health, 2010. 48(3): p. 317-23.
Wade, J.F., 3rd and L.S. Newman, Diesel asthma. Reactive airways disease following
overexposure to locomotive exhaust. J Occup Med, 1993. 35(2): p. 149-54.
Adewole, F., et al., Diesel exhaust causing low-dose irritant asthma with latency? Occup Med
(Lond), 2009. 59(6): p. 424-7.
IARC, Diesel and Gasoline Engine Exhausts and Some Nitroarenes. IARC Monographs on the
Evaluation of Carcinogenic Risks to Humans. IARC Monogr Eval Carcinog Risks Hum, 2014. 105:
p. 9-699.
Garshick, E., et al., Lung Cancer in Railroad Workers Exposed to Diesel Exhaust. Environmental
Health Perspectives, 2004. 112(15): p. 1539-1543.
Boffetta, P., S.D. Stellman, and L. Garfinkel, Diesel exhaust exposure and mortality among males
in the American cancer society prospective study. American Journal of Industrial Medicine, 1988.
14(4): p. 403-415.
Soll-Johanning, H., et al., Cancer incidence in urban bus drivers and tramway employees: a
retrospective cohort study. Occup Environ Med, 1998. 55(9): p. 594-8.
Steenland, K., J. Deddens, and L. Stayner, Diesel exhaust and lung cancer in the trucking industry:
exposure-response analyses and risk assessment. Am J Ind Med, 1998. 34(3): p. 220-8.
Brunekreef, B., et al., Air Pollution from Truck Traffic and Lung Function in Children Living near
Motorways. Epidemiology, 1997. 8(3): p. 298-303.
Northridge, M.E., et al., Diesel exhaust exposure among adolescents in Harlem: a communitydriven study. Am J Public Health, 1999. 89(7): p. 998-1002.
Margolis, H.G., et al., Altered pulmonary function in children with asthma associated with
highway traffic near residence. Int J Environ Health Res, 2009. 19(2): p. 139-55.
Morgenstern, V., et al., Atopic Diseases, Allergic Sensitization, and Exposure to Traffic-related Air
Pollution in Children. American Journal of Respiratory and Critical Care Medicine, 2008. 177(12):
p. 1331-1337.
Lindgren, A., et al., Traffic-related air pollution associated with prevalence of asthma and
COPD/chronic bronchitis. A cross-sectional study in Southern Sweden. International Journal of
Health Geographics, 2009. 8(1): p. 2.
Beatty, T.K.M. and J.P. Shimshack, School buses, diesel emissions, and respiratory health. Journal
of Health Economics, 2011. 30(5): p. 987-999.
Salameh, P., et al., Exposure to outdoor air pollution and chronic bronchitis in adults: a casecontrol study. Int J Occup Environ Med, 2012. 3(4): p. 165-77.
Schultz, A.A., J.J. Schauer, and K.M. Malecki, Allergic disease associations with regional and
localized estimates of air pollution. Environmental research, 2017. 155: p. 77-85.
Wong, T.W., et al., Air pollution and hospital admissions for respiratory and cardiovascular
diseases in Hong Kong. Occupational and Environmental Medicine, 1999. 56(10): p. 679-683.
McGowan, J.A., et al., Particulate air pollution and hospital admissions in Christchurch, New
Zealand. Aust N Z J Public Health, 2002. 26(1): p. 23-9.
Neupane, B., et al., Long-term exposure to ambient air pollution and risk of hospitalization with
community-acquired pneumonia in older adults. American journal of respiratory and critical care
medicine, 2010. 181(1): p. 47-53.
Rudell, B., et al., Bronchoalveolar inflammation after exposure to diesel exhaust: comparison
between unfiltered and particle trap filtered exhaust. Occupational and Environmental Medicine,
1999. 56(8): p. 527-534.
203

232.
233.
234.
235.

236.
237.
238.

239.
240.
241.
242.
243.
244.
245.

246.
247.

248.
249.

250.
251.
252.

Rudell, B., et al., Efficiency of automotive cabin air filters to reduce acute health effects of diesel
exhaust in human subjects. Occupational and Environmental Medicine, 1999. 56(4): p. 222-231.
Carlsten, C., et al., Symptoms in Response to Controlled Diesel Exhaust More Closely Reflect
Exposure Perception Than True Exposure. PLoS ONE, 2013. 8(12): p. e83573.
Nightingale, J.A., et al., Airway inflammation after controlled exposure to diesel exhaust
particulates. Am J Respir Crit Care Med, 2000. 162(1): p. 161-6.
Salvi, S., et al., Acute inflammatory responses in the airways and peripheral blood after shortterm exposure to diesel exhaust in healthy human volunteers. American journal of respiratory
and critical care medicine, 1999. 159(3): p. 702-9.
Behndig, A.F., et al., Airway antioxidant and inflammatory responses to diesel exhaust exposure
in healthy humans. European Respiratory Journal, 2006. 27(2): p. 359-365.
Sehlstedt, M., et al. Airway inflammatory response to diesel exhaust generated at urban cycle
running conditions. Inhalation Toxicology, 2010. 22, 1144-1150.
Barath, S., et al., Diesel exhaust but not ozone increases fraction of exhaled nitric oxide in a
randomized controlled experimental exposure study of healthy human subjects. Environmental
Health, 2013. 12: p. 36-36.
Bosson, J., et al., Ozone enhances the airway inflammation initiated by diesel exhaust.
Respiratory Medicine, 2007. 101(6): p. 1140-1146.
Hayes, J.D., J.U. Flanagan, and I.R. Jowsey, Glutathione transferases. Annual review of
pharmacology and toxicology, 2005. 45: p. 51-88.
Madden, M.C., et al., Diesel exhaust modulates ozone-induced lung function decrements in
healthy human volunteers. Part Fibre Toxicol, 2014. 11: p. 37.
Miyamoto, T., Epidemiology of pollution-induced airwav disease in Japan. Allergy, 1997. 52: p.
30-34.
Larsson, N., et al., Airway inflammatory responses to diesel exhaust in allergic rhinitics.
Inhalation toxicology, 2013. 25(3): p. 160-7.
Stenfors, N., et al., Different airway inflammatory responses in asthmatic and healthy humans
exposed to diesel. European Respiratory Journal, 2004. 23(1): p. 82-86.
Behndig, A.F., et al., Proinflammatory doses of diesel exhaust in healthy subjects fail to elicit
equivalent or augmented airway inflammation in subjects with asthma. Thorax, 2011. 66(1): p.
12-19.
McCreanor , J., et al., Respiratory Effects of Exposure to Diesel Traffic in Persons with Asthma.
New England Journal of Medicine, 2007. 357(23): p. 2348-2358.
Hosseini, A., et al., Morphometric analysis of inflammation in bronchial biopsies following
exposure to inhaled diesel exhaust and allergen challenge in atopic subjects. Particle and Fibre
Toxicology, 2015. 13: p. 2.
Frampton, M.W., et al., Nitrogen dioxide exposure in vivo and human alveolar macrophage
inactivation of influenza virus in vitro. Environ Res, 1989. 48(2): p. 179-92.
Pawlak, E.A., et al., Diesel exposure suppresses natural killer cell function and resolution of
eosinophil inflammation: a randomized controlled trial of exposure in allergic rhinitics. Part Fibre
Toxicol, 2016. 13(1): p. 24.
Helleday, R., et al., Nitrogen dioxide exposure impairs the frequency of the mucociliary activity in
healthy subjects. European Respiratory Journal, 1995. 8(10): p. 1664-1668.
Vallyathan, V., et al., Effect of diesel emissions and coal dust inhalation on heart and pulmonary
arteries of rats. J Toxicol Environ Health, 1986. 19(1): p. 33-41.
Campen, M.J., et al., Nonparticulate components of diesel exhaust promote constriction in
coronary arteries from ApoE-/- mice. Toxicol Sci, 2005. 88(1): p. 95-102.

204

253.
254.
255.

256.

257.

258.
259.

260.
261.
262.
263.
264.
265.

266.
267.
268.
269.
270.
271.
272.

273.

Campen, M.J., et al., Cardiovascular effects of inhaled diesel exhaust in spontaneously
hypertensive rats. Cardiovasc Toxicol, 2003. 3(4): p. 353-61.
Hazari, M.S., et al., Dobutamine "stress" test and latent cardiac susceptibility to inhaled diesel
exhaust in normal and hypertensive rats. Environ Health Perspect, 2012. 120(8): p. 1088-93.
Carll, A.P., et al., Whole and particle-free diesel exhausts differentially affect cardiac
electrophysiology, blood pressure, and autonomic balance in heart failure-prone rats. Toxicol Sci,
2012. 128(2): p. 490-9.
Yokota, S., et al., Tracheal instillation of diesel exhaust particles component causes blood and
pulmonary neutrophilia and enhances myocardial oxidative stress in mice. J Toxicol Sci, 2008.
33(5): p. 609-20.
Robertson, S., et al., Pulmonary diesel particulate increases susceptibility to myocardial
ischemia/reperfusion injury via activation of sensory TRPV1 and beta1 adrenoreceptors. Part
Fibre Toxicol, 2014. 11: p. 12.
Chen, S., M.A. Weller, and M.I. Barnhart, Effects of Diesel engine exhaust on pulmonary alveolar
macrophages. Scan Electron Microsc, 1980(3): p. 327-38.
Chen, S., M.A. Weller, and M.I. Barnhart, Species comparisons of bronchoalveolar lavages from
guinea pigs and rats exposed in vivo to diesel exhaust for one year. Scanning electron
microscopy, 1982(Pt 4): p. 1687-98.
Pepelko, W.E., et al., Pulmonary function and pathology in cats exposed 28 days to diesel
exhaust. J Environ Pathol Toxicol, 1980. 4(2-3): p. 449-57.
Abraham, W.M., et al., Effects of a brief low-level exposure to the particulate fraction of diesel
exhaust on pulmonary function of conscious sheep. Arch Environ Health, 1980. 35(2): p. 77-80.
Gross, K.B., Pulmonary function testing of animals chronically exposed to diluted diesel exhaust
for 267 days. Environment International, 1981. 5(4): p. 331-337.
Gross, K.B., Pulmonary function testing of animals chronically exposed to diluted diesel exhaust. J
Appl Toxicol, 1981. 1(2): p. 116-23.
Moorman, W.J., et al., Pulmonary function responses in cats following long-term exposure to
diesel exhaust. J Appl Toxicol, 1985. 5(5): p. 301-5.
Heinrich, U., et al., Chronic effects on the respiratory tract of hamsters, mice and rats after longterm inhalation of high concentrations of filtered and unfiltered diesel engine emissions. J Appl
Toxicol, 1986. 6(6): p. 383-95.
Henderson, R.F., et al., Species differences in release of arachidonate metabolites in response to
inhaled diluted diesel exhaust. Toxicology Letters, 1988. 42(3): p. 325-332.
Ulfvarson, U., et al., Experimental Evaluation of the Effect of Filtration of Diesel Exhaust by
Biologic Exposure Indicators. American Journal of Industrial Medicine, 1995. 27(1): p. 91-106.
Inoue, K., et al., The role of toll-like receptor 4 in airway inflammation induced by diesel exhaust
particles. Arch Toxicol, 2006. 80(5): p. 275-9.
Fujimaki, H., et al., Distinct requirements for interleukin-6 in airway inflammation induced by
diesel exhaust in mice. Immunopharmacol Immunotoxicol, 2006. 28(4): p. 703-14.
Ahn, E.-K., et al., COX-2 expression and inflammatory effects by diesel exhaust particles in vitro
and in vivo. Toxicology Letters, 2008. 176(3): p. 178-187.
Sagai, M., et al., Biological effects of diesel exhaust particles. I. in vitro production of superoxide
and in vivo toxicity in mouse. Free Radical Biology and Medicine, 1993. 14(1): p. 37-47.
Lim, H.B., et al., Involvement of superoxide and nitric oxide on airway inflammation and
hyperresponsiveness induced by diesel exhaust particles in mice. Free Radic Biol Med, 1998.
25(6): p. 635-44.
Ito, T., et al., Peroxynitrite formation by diesel exhaust particles in alveolar cells: Links to
pulmonary inflammation. Environmental Toxicology and Pharmacology, 2000. 9(1): p. 1-8.
205

274.
275.

276.
277.

278.

279.

280.
281.
282.
283.

284.
285.

286.
287.

288.

289.
290.
291.
292.
293.

Han, J.-Y., K. Takeshita, and H. Utsumi, Noninvasive detection of hydroxyl radical generation in
lung by diesel exhaust particles. Free Radical Biology and Medicine, 2001. 30(5): p. 516-525.
Nemmar, A., et al., Emodin mitigates diesel exhaust particles-induced increase in airway
resistance, inflammation and oxidative stress in mice. Respiratory Physiology & Neurobiology,
2015. 215: p. 51-57.
Madden, M.C., et al., Effect of Ozone on Diesel Exhaust Particle Toxicity in Rat Lung. Toxicology
and Applied Pharmacology, 2000. 168(2): p. 140-148.
Zhao, H., et al., Cooperation of the inducible nitric oxide synthase and cytochrome P450 1A1 in
mediating lung inflammation and mutagenicity induced by diesel exhaust particles. Environ
Health Perspect, 2006. 114(8): p. 1253-8.
Zhao, H., et al., Reactive oxygen species- and nitric oxide-mediated lung inflammation and
mitochondrial dysfunction in wild-type and iNOS-deficient mice exposed to diesel exhaust
particles. Journal of toxicology and environmental health. Part A, 2009. 72(8): p. 560-70.
Fedan, J.S., et al., Effects of a two-year inhalation exposure of rats to coal dust and/or diesel
exhaust on tension responses of isolated airway smooth muscle. Am Rev Respir Dis, 1985.
131(4): p. 651-5.
Ishihara, Y. and J. Kagawa, Chronic diesel exhaust exposures of rats demonstrate concentration
and time-dependent effects on pulmonary inflammation. Inhal Toxicol, 2003. 15(5): p. 473-92.
Laks, D., et al., Composition of diesel particles influences acute pulmonary toxicity: an
experimental study in mice. Inhal Toxicol, 2008. 20(11): p. 1037-42.
Yoshizaki, K., et al., Subchronic effects of nasally instilled diesel exhaust particulates on the nasal
and airway epithelia in mice. Inhalation Toxicology, 2010. 22(7): p. 610-617.
Shaheen, H.M., et al., The ceramide inhibitor fumonisin B1 mitigates the pulmonary effects of
low-dose diesel exhaust inhalation in mice. Ecotoxicology and Environmental Safety, 2016. 132:
p. 390-396.
Sagai, M. and T. Ichinose, [Role of nitric oxide in asthma-like symptoms induced by diesel exhaust
particles in mice]. Nihon Kyobu Shikkan Gakkai Zasshi, 1995. 33 Suppl: p. 212-7.
Sagai, M., A. Furuyama, and T. Ichinose, Biological effects of diesel exhaust particles (DEP). III.
Pathogenesis of asthma like symptoms in mice. Free Radical Biology and Medicine, 1996. 21(2):
p. 199-209.
Aguilera-Aguirre, L., et al., Mitochondrial dysfunction increases allergic airway inflammation. J
Immunol, 2009. 183(8): p. 5379-87.
Ohta, K., et al., Diesel exhaust particulate induces airway hyperresponsiveness in a murine
model: Essential role of GM-CSF. Journal of Allergy and Clinical Immunology, 1999. 104(5): p.
1024-1030.
Yamashita, N., et al., Platelet-derived growth factor is involved in the augmentation of airway
responsiveness through remodeling of airways in diesel exhaust particulate-treated mice. J
Allergy Clin Immunol, 2001. 107(1): p. 135-42.
Brandt, E.B., et al., Diesel exhaust particle induction of IL-17A contributes to severe asthma. J
Allergy Clin Immunol, 2013. 132(5): p. 1194-1204.e2.
Suzuki, T., et al., Adjuvant activity of diesel exhaust particulates (DEP) in production of anti-IgE
and anti-IgG1 antibodies to mite allergen in mice. J Clin Lab Immunol, 1996. 48(5): p. 187-99.
Takano, H., et al., Diesel exhaust particles enhance antigen-induced airway inflammation and
local cytokine expression in mice. Am J Respir Crit Care Med, 1997. 156(1): p. 36-42.
Miyabara, Y., et al., Effects of diesel exhaust on allergic airway inflammation in mice. Journal of
Allergy and Clinical Immunology, 1998. 102(5): p. 805-812.
Steerenberg, P.A., et al., A pollen model in the rat for testing adjuvant activity of air pollution
components. Inhal Toxicol, 1999. 11(12): p. 1109-22.
206

294.
295.

296.
297.
298.
299.
300.

301.
302.
303.

304.

305.
306.

307.

308.

309.

310.
311.
312.
313.

Hao, M., et al., Diesel exhaust particles exert acute effects on airway inflammation and function
in murine allergen provocation models. J Allergy Clin Immunol, 2003. 112(5): p. 905-14.
Al-Humadi, N.H., et al., The effect of diesel exhaust particles (DEP) and carbon black (CB) on thiol
changes in pulmonary ovalbumin allergic sensitized Brown Norway rats. Exp Lung Res, 2002.
28(5): p. 333-49.
Inoue, K., et al., Effects of components derived from diesel exhaust particles on lung physiology
related to antigen. Immunopharmacol Immunotoxicol, 2007. 29(3-4): p. 403-12.
Park, E.J., et al., Biological responses to diesel exhaust particles (DEPs) depend on the
physicochemical properties of the DEPs. PLoS One, 2011. 6(10): p. e26749.
Tanaka, M., et al., Effects of exposure to nanoparticle-rich or -depleted diesel exhaust on allergic
pathophysiology in the murine lung. J Toxicol Sci, 2013. 38(1): p. 35-48.
Stone, K.D., C. Prussin, and D.D. Metcalfe, IgE, mast cells, basophils, and eosinophils. J Allergy
Clin Immunol, 2010. 125(2 Suppl 2): p. S73-80.
Jang, A.S., et al., Additive effect of diesel exhaust particulates and ozone on airway
hyperresponsiveness and inflammation in a mouse model of asthma. J Korean Med Sci, 2005.
20(5): p. 759-63.
Liu, J., et al., Combined inhaled diesel exhaust particles and allergen exposure alter methylation
of T helper genes and IgE production in vivo. Toxicol Sci, 2008. 102(1): p. 76-81.
De Grove, K.C., et al., Dysregulation of type 2 innate lymphoid cells and TH2 cells impairs
pollutant-induced allergic airway responses. J Allergy Clin Immunol, 2017. 139(1): p. 246-257.e4.
Kotin, P., H.L. Falk, and M. Thomas, Aromatic hydrocarbons. II. Presence in the particulate phase
of gasoline-engine exhausts and the carcinogenicity of exhaust extracts. AMA Arch Ind Hyg
Occup Med, 1954. 9(2): p. 164-77.
Kotin, P., H.L. Falk, and M. Thomas, Aromatic hydrocarbons. III. Presence in the particulate phase
of diesel-engine exhausts and the carcinogenicity of exhaust extracts. AMA Arch Ind Health,
1955. 11(2): p. 113-20.
Oberdorster, G., Lung particle overload: implications for occupational exposures to particles.
Regul Toxicol Pharmacol, 1995. 21(1): p. 123-35.
Hesterberg, T.W., et al., Carcinogenicity studies of diesel engine exhausts in laboratory animals:
a review of past studies and a discussion of future research needs. Crit Rev Toxicol, 2005. 35(5):
p. 379-411.
Heinrich, U., et al., Chronic Inhalation Exposure of Wistar Rats and two Different Strains of Mice
to Diesel Engine Exhaust, Carbon Black, and Titanium Dioxide. Inhalation Toxicology, 1995. 7(4):
p. 533-556.
Mauderly, J.L., et al., Pulmonary toxicity of inhaled diesel exhaust and carbon black in chronically
exposed rats. Part I: Neoplastic and nonneoplastic lung lesions. Res Rep Health Eff Inst, 1994(68
Pt 1): p. 1-75; discussion 77-97.
Nikula, K.J., et al., Comparative Pulmonary Toxicities and Carcinogenicities of Chronically Inhaled
Diesel Exhaust and Carbon Black in F344 Rats. Fundamental and Applied Toxicology, 1995. 25(1):
p. 80-94.
Iwai, K., et al., Early oxidative DNA damages and late development of lung cancer in diesel
exhaust-exposed rats. Environ Res, 2000. 84(3): p. 255-64.
Stinn, W., et al., Chronic Nose-only Inhalation Study in Rats, comparing Room-aged Sidestream
Cigarette Smoke and Diesel Engine Exhaust. Inhalation Toxicology, 2005. 17(11): p. 549-576.
Harrod, K.S., et al., Increased susceptibility to RSV infection by exposure to inhaled diesel engine
emissions. Am J Respir Cell Mol Biol, 2003. 28(4): p. 451-63.
Harrod, K.S., et al., Inhaled diesel engine emissions reduce bacterial clearance and exacerbate
lung disease to Pseudomonas aeruginosa infection in vivo. Toxicol Sci, 2005. 83(1): p. 155-65.
207

314.
315.
316.

317.

318.
319.
320.

321.
322.
323.

324.

325.
326.

327.

328.
329.
330.

331.
332.

Ciencewicki, J., et al., Diesel exhaust enhanced susceptibility to influenza infection is associated
with decreased surfactant protein expression. Inhal Toxicol, 2007. 19(14): p. 1121-33.
Gowdy, K., et al., Modulation of pulmonary inflammatory responses and antimicrobial defenses
in mice exposed to diesel exhaust. Toxicol Appl Pharmacol, 2008. 229(3): p. 310-9.
Yin, X.J., et al., Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust
particles (DEPs). I. Effects of DEPs on early pulmonary responses. Environ Health Perspect, 2002.
110(11): p. 1105-11.
Yin, X.J., et al., Alteration of pulmonary immunity to Listeria monocytogenes by diesel exhaust
particles (DEPs). II. Effects of DEPs on T-cell-mediated immune responses in rats. Environ Health
Perspect, 2003. 111(4): p. 524-30.
Yin, X.J., et al., Sustained effect of inhaled diesel exhaust particles on T-lymphocyte-mediated
immune responses against Listeria monocytogenes. Toxicol Sci, 2005. 88(1): p. 73-81.
Hiramatsu, K., et al., The effects of inhalation of diesel exhaust on murine mycobacterial
infection. Exp Lung Res, 2005. 31(4): p. 405-15.
Saito, Y., et al., Long-term inhalation of diesel exhaust affects cytokine expression in murine lung
tissues: comparison between low- and high-dose diesel exhaust exposure. Exp Lung Res, 2002.
28(6): p. 493-506.
Hahon, N., et al., Influenza virus infection in mice after exposure to coal dust and diesel engine
emissions. Environ Res, 1985. 37(1): p. 44-60.
Gowdy, K.M., et al., Role of oxidative stress on diesel-enhanced influenza infection in mice. Part
Fibre Toxicol, 2010. 7: p. 34.
Larcombe, A.N., et al., Acute diesel exhaust particle exposure increases viral titre and
inflammation associated with existing influenza infection, but does not exacerbate deficits in
lung function. Influenza Other Respir Viruses, 2013. 7(5): p. 701-9.
Yang, H.M., et al., Diesel exhaust particles suppress macrophage function and slow the
pulmonary clearance of Listeria monocytogenes in rats. Environ Health Perspect, 2001. 109(5):
p. 515-21.
Castranova, V., et al., Effect of exposure to diesel exhaust particles on the susceptibility of the
lung to infection. Environ Health Perspect, 2001. 109 Suppl 4: p. 609-12.
Yin, X.J., et al., Roles of reactive oxygen species and heme oxygenase-1 in modulation of alveolar
macrophage-mediated pulmonary immune responses to Listeria monocytogenes by diesel
exhaust particles. Toxicol Sci, 2004. 82(1): p. 143-53.
Ma, J.Y. and J.K. Ma, The dual effect of the particulate and organic components of diesel exhaust
particles on the alteration of pulmonary immune/inflammatory responses and metabolic
enzymes. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev, 2002. 20(2): p. 117-47.
Vogl, G. and E.F. Elstner, Diesel soot particles catalyze the production of oxy-radicals. Toxicol
Lett, 1989. 47(1): p. 17-23.
Dong, C., Diesel exhaust particulate-mediated oxidative response by alveolar macrophages.
1998.
Shukla, A., et al., Inhaled particulate matter causes expression of nuclear factor (NF)-kappaBrelated genes and oxidant-dependent NF-kappaB activation in vitro. Am J Respir Cell Mol Biol,
2000. 23(2): p. 182-7.
Greenwell, L.L., et al., Particle-induced oxidative damage is ameliorated by pulmonary
antioxidants. Free Radical Biology and Medicine, 2002. 32(9): p. 898-905.
Xiao, G.G., et al., Use of proteomics to demonstrate a hierarchical oxidative stress response to
diesel exhaust particle chemicals in a macrophage cell line. J Biol Chem, 2003. 278(50): p. 5078190.

208

333.

334.
335.
336.
337.

338.

339.

340.
341.
342.
343.

344.

345.
346.

347.
348.
349.
350.
351.

Jung, E.J., et al., Pro-oxidative DEP chemicals induce heat shock proteins and an unfolding
protein response in a bronchial epithelial cell line as determined by DIGE analysis. Proteomics,
2007. 7(21): p. 3906-18.
Hiura, T.S., et al., Chemicals in Diesel Exhaust Particles Generate Reactive Oxygen Radicals and
Induce Apoptosis in Macrophages. The Journal of Immunology, 1999. 163(10): p. 5582-5591.
Hiura, T.S., et al., The role of a mitochondrial pathway in the induction of apoptosis by chemicals
extracted from diesel exhaust particles. J Immunol, 2000. 165(5): p. 2703-11.
Bonvallot, V., et al., Activation of Transcription Factors by Diesel Exhaust Particles in Human
Bronchial Epithelial Cells In Vitro. Inhalation Toxicology, 2000. 12(sup3): p. 359-364.
Kafoury, R.M. and J. Kelley, Ozone enhances diesel exhaust particles (DEP)-induced interleukin-8
(IL-8) gene expression in human airway epithelial cells through activation of nuclear factorskappaB (NF-kappaB) and IL-6 (NF-IL6). Int J Environ Res Public Health, 2005. 2(3-4): p. 403-10.
Kaimul Ahsan, M., et al., Thioredoxin-1 suppresses lung injury and apoptosis induced by diesel
exhaust particles (DEP) by scavenging reactive oxygen species and by inhibiting DEP-induced
downregulation of Akt. Free Radic Biol Med, 2005. 39(12): p. 1549-59.
Kafoury, R.M. and M.C. Madden, Diesel Exhaust Particles Induce the Over expression of Tumor
Necrosis Factor-α (TNF-α) Gene in Alveolar Macrophages and Failed to Induce Apoptosis through
Activation of Nuclear Factor-κB (NF-κB). International Journal of Environmental Research and
Public Health, 2005. 2(1): p. 107-113.
Park, S., et al., The role of iron in reactive oxygen species generation from diesel exhaust
particles. Toxicology in Vitro, 2006. 20(6): p. 851-857.
DiStefano, E., et al., Determination of metal-based hydroxyl radical generating capacity of
ambient and diesel exhaust particles. Inhalation toxicology, 2009. 21(9): p. 731-8.
Ghio, A.J., et al., Metals associated with both the water-soluble and insoluble fractions of an
ambient air pollution particle catalyze an oxidative stress. Inhal Toxicol, 1999. 11(1): p. 37-49.
Ghio, A.J., M.S. Carraway, and M.C. Madden, Composition of air pollution particles and oxidative
stress in cells, tissues, and living systems. J Toxicol Environ Health B Crit Rev, 2012. 15(1): p. 121.
Bayram, H., et al., Comparison of ciliary activity and inflammatory mediator release from
bronchial epithelial cells of nonatopic nonasthmatic subjects and atopic asthmatic patients and
the effect of diesel exhaust particles in vitro. Journal of Allergy and Clinical Immunology, 1998.
102(5): p. 771-782.
Segura-Valdez, L., et al., Upregulation of gelatinases A and B, collagenases 1 and 2, and
increased parenchymal cell death in COPD. Chest, 2000. 117(3): p. 684-94.
Li, J., et al., Diesel exhaust particles activate the matrix-metalloproteinase-1 gene in human
bronchial epithelia in a beta-arrestin-dependent manner via activation of RAS. Environ Health
Perspect, 2009. 117(3): p. 400-9.
Zhu, G., et al., Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary
disease. Hum Mol Genet, 2009. 18(11): p. 2053-62.
Li, J., et al., TRPV4-mediated calcium influx into human bronchial epithelia upon exposure to
diesel exhaust particles. Environ Health Perspect, 2011. 119(6): p. 784-93.
Park, I.H., et al., Diesel Exhaust Particles Enhance MUC4 Expression in NCI-H292 Cells and Nasal
Epithelial Cells via the p38/CREB Pathway. Int Arch Allergy Immunol, 2016. 171(3-4): p. 209-216.
Robinson, R.K., et al., Mechanistic link between diesel exhaust particles and respiratory reflexes.
J Allergy Clin Immunol, 2017.
Terada, N., et al., Diesel exhaust particulates enhance eosinophil adhesion to nasal epithelial
cells and cause degranulation. Int Arch Allergy Immunol, 1997. 114(2): p. 167-74.

209

352.

353.
354.
355.
356.
357.

358.

359.

360.

361.

362.
363.
364.

365.
366.
367.

368.

369.
370.

Terada, N., et al., Diesel exhaust particulates upregulate histamine receptor mRNA and increase
histamine-induced IL-8 and GM-CSF production in nasal epithelial cells and endothelial cells. Clin
Exp Allergy, 1999. 29(1): p. 52-9.
Saneyoshi, K., et al., IL-4 and IL-6 production of bone marrow-derived mast cells is enhanced by
treatment with environmental pollutants. Int Arch Allergy Immunol, 1997. 114(3): p. 237-45.
Devouassoux, G., et al., Chemical constituents of diesel exhaust particles induce IL-4 production
and histamine release by human basophils. J Allergy Clin Immunol, 2002. 109(5): p. 847-53.
Nilsen, A.M., et al., Reduction of IL-12 p40 production in activated monocytes after exposure to
diesel exhaust particles. Int Arch Allergy Immunol, 2003. 131(3): p. 201-8.
Mamessier, E., et al., Diesel exhaust particles enhance T-cell activation in severe asthmatics.
Allergy, 2006. 61(5): p. 581-8.
Takenaka, H., et al., Enhanced human IgE production results from exposure to the aromatic
hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol,
1995. 95(1 Pt 1): p. 103-15.
Ple, C., et al., Polycyclic aromatic hydrocarbons reciprocally regulate IL-22 and IL-17 cytokines in
peripheral blood mononuclear cells from both healthy and asthmatic subjects. PLoS One, 2015.
10(4): p. e0122372.
Devalia, et al., Differences between Cytokine Release from Bronchial Epithelial Cells of Asthmatic
Patients and Non-Asthmatic Subjects: Effect of Exposure to Diesel Exhaust Particles.
International Archives of Allergy and Immunology, 1999. 118(2-4): p. 437-439.
Fahy, O., et al., Synergistic effect of diesel organic extracts and allergen Der p 1 on the release of
chemokines by peripheral blood mononuclear cells from allergic subjects: involvement of the
map kinase pathway. Am J Respir Cell Mol Biol, 2000. 23(2): p. 247-54.
Fahy, O., et al., Diesel exposure favors Th2 cell recruitment by mononuclear cells and alveolar
macrophages from allergic patients by differentially regulating macrophage-derived chemokine
and IFN-gamma-induced protein-10 production. J Immunol, 2002. 168(11): p. 5912-9.
Chang, Y., et al., Diesel exhaust exposure favors TH2 cell recruitment in nonatopic subjects by
differentially regulating chemokine production. J Allergy Clin Immunol, 2006. 118(2): p. 354-60.
Don Porto Carero, A., et al., Increased HLA-DR expression after exposure of human monocytic
cells to air particulates. Clin Exp Allergy, 2002. 32(2): p. 296-300.
Takizawa, R., et al., Increased expression of HLA-DR and CD86 in nasal epithelial cells in allergic
rhinitics: antigen presentation to T cells and up-regulation by diesel exhaust particles. Clin Exp
Allergy, 2007. 37(3): p. 420-33.
Chan, R.C., et al., Pro-oxidative diesel exhaust particle chemicals inhibit LPS-induced dendritic cell
responses involved in T-helper differentiation. J Allergy Clin Immunol, 2006. 118(2): p. 455-65.
Braun, A., et al., Differential impact of diesel particle composition on pro-allergic dendritic cell
function. Toxicol Sci, 2010. 113(1): p. 85-94.
Ames, B.N., J. McCann, and E. Yamasaki, Methods for detecting carcinogens and mutagens with
the salmonella/mammalian-microsome mutagenicity test. Mutation Research/Environmental
Mutagenesis and Related Subjects, 1975. 31(6): p. 347-363.
Clark, C.R. and C.L. Vigil, Influence of rat lung and liver homogenates on the mutagenicity of
diesel exhaust particulate extracts. Toxicology and Applied Pharmacology, 1980. 56(1): p. 110115.
Clark, C.R., et al., Mutagenicity of diesel exhaust particle extracts: Influence of car type.
Fundamental and Applied Toxicology, 1981. 1(3): p. 260-265.
King, L.C., et al., Evaluation of the release of mutagens from diesel particles in the presence of
physiological fluids. Environ Mutagen, 1981. 3(2): p. 109-21.

210

371.
372.

373.
374.

375.

376.

377.
378.
379.

380.

381.
382.
383.
384.

385.

386.
387.
388.
389.

Barfknecht, T.R., et al., Human cell mutagenicity of polycyclic aromatic hydrocarbon components
of diesel emissions. Dev Toxicol Environ Sci, 1982. 10: p. 277-94.
Bieler, C.A., et al., DNA adduct formation from the mutagenic air pollutant 3-nitrobenzanthrone.
Mutation Research/Genetic Toxicology and Environmental Mutagenesis, 1999. 439(2): p. 307311.
Shi, X.C., et al., Mutagenicity of diesel exhaust particles from an engine with differing exhaust
after treatments. J Toxicol Environ Health A, 2010. 73(19): p. 1314-24.
Arimoto, T., et al., Generation of reactive oxygen species and 8-hydroxy-2'-deoxyguanosine
formation from diesel exhaust particle components in L1210 cells. Jpn J Pharmacol, 1999. 80(1):
p. 49-54.
Don Porto Carero, A., et al., Genotoxic effects of carbon black particles, diesel exhaust particles,
and urban air particulates and their extracts on a human alveolar epithelial cell line (A549) and a
human monocytic cell line (THP-1). Environ Mol Mutagen, 2001. 37(2): p. 155-63.
Jardim, M.J., et al., Disruption of microRNA expression in human airway cells by diesel exhaust
particles is linked to tumorigenesis-associated pathways. Environ Health Perspect, 2009.
117(11): p. 1745-51.
Zhou, F., et al., Effects of diesel exhaust particles on microRNA-21 in human bronchial epithelial
cells and potential carcinogenic mechanisms. Mol Med Rep, 2015. 12(2): p. 2329-35.
Kaira, K., et al., Prognostic significance of L-type amino acid transporter 1 expression in
resectable stage I-III nonsmall cell lung cancer. Br J Cancer, 2008. 98(4): p. 742-748.
Kaira, K., et al., Prognostic significance of l-type amino acid transporter 1 (LAT1) and 4F2 heavy
chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer, 2009. 66(1): p. 120126.
Le Vee, M., et al., Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric
amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in
human bronchial epithelial cells. Toxicol Appl Pharmacol, 2016. 290: p. 74-85.
Shah, P.P., et al., Ubiquilin1 represses migration and epithelial-to-mesenchymal transition of
human non-small cell lung cancer cells. Oncogene, 2015. 34(13): p. 1709-1717.
Yadav, S., et al., MIR155 Regulation of Ubiquilin1 and Ubiquilin2: Implications in Cellular
Protection and Tumorigenesis. Neoplasia, 2017. 19(4): p. 321-332.
Bao, L., et al., Mutagenicity of diesel exhaust particles mediated by cell-particle interaction in
mammalian cells. Toxicology, 2007. 229(1-2): p. 91-100.
Landvik, N.E., et al., Effects of nitrated-polycyclic aromatic hydrocarbons and diesel exhaust
particle extracts on cell signalling related to apoptosis: Possible implications for their mutagenic
and carcinogenic effects. Toxicology, 2007. 231(2): p. 159-174.
Matsunaga, T., et al., Exposure to 9,10-phenanthrenequinone accelerates malignant progression
of lung cancer cells through up-regulation of aldo-keto reductase 1B10. Toxicology and Applied
Pharmacology, 2014. 278(2): p. 180-189.
Thomas, P., et al., Altered human monocyte/macrophage function after exposure to diesel
exhaust particles. Environmental Science and Pollution Research, 1995. 2(2): p. 69-72.
Saito, Y., et al., Effects of diesel exhaust on murine alveolar macrophages and a macrophage cell
line. Exp Lung Res, 2002. 28(3): p. 201-17.
Lundborg, M., et al., Aggregates of ultrafine particles impair phagocytosis of microorganisms by
human alveolar macrophages. Environmental Research, 2006. 100(2): p. 197-204.
Yin, X.J., et al., Suppression of phagocytic and bactericidal functions of rat alveolar macrophages
by the organic component of diesel exhaust particles. Journal of toxicology and environmental
health. Part A, 2007. 70(10): p. 820-8.

211

390.
391.
392.
393.
394.

395.
396.

397.

398.
399.
400.
401.
402.
403.
404.
405.
406.

407.

408.
409.
410.

Sarkar, S., et al., Suppression of the NF-kappaB pathway by diesel exhaust particles impairs
human antimycobacterial immunity. J Immunol, 2012. 188(6): p. 2778-93.
Müller, L., et al., Diesel exhaust particles modify natural killer cell function and cytokine release.
Particle and Fibre Toxicology, 2013. 10: p. 16-16.
Jaspers, I., et al., Diesel exhaust enhances influenza virus infections in respiratory epithelial cells.
Toxicol Sci, 2005. 85(2): p. 990-1002.
Ito, T., et al., Effect of diesel exhaust particles on mRNA expression of viral and bacterial
receptors in rat lung epithelial L2 cells. Toxicology Letters, 2006. 165(1): p. 66-70.
Ciencewicki, J., et al., Diesel exhaust enhances virus- and poly(I:C)-induced Toll-like receptor 3
expression and signaling in respiratory epithelial cells. Am J Physiol Lung Cell Mol Physiol, 2006.
290(6): p. L1154-63.
Nokso-Koivisto, P. and E. Pukkala, Past exposure to asbestos and combustion products and
incidence of cancer among Finnish locomotive drivers. Occup Environ Med, 1994. 51(5): p. 330-4.
Stiegel, M.A., et al., Inflammatory Cytokines and White Blood Cell Counts Response to
Environmental Levels of Diesel Exhaust and Ozone Inhalation Exposures. PLoS One, 2016. 11(4):
p. e0152458.
Mosbach, M., M. Wiener-Schmuck, and A. Seidel, Influence of coexposure of ozone with quartz,
latex, albumin, and LPS on TNF-α and chemotactic factor release by bovine alveolar
macrophages in vitro. Inhalation Toxicology, 1996. 8(6): p. 625-638.
Lacourt, A., et al., Pleural mesothelioma and occupational coexposure to asbestos, mineral wool,
and silica. American Journal of Respiratory and Critical Care Medicine, 2013. 187(9): p. 977-982.
Qu, S.-X., et al., DNA adducts in coal miners: association with exposures to diesel engine
emissions. Biomarkers, 1997. 2(2): p. 95-102.
Hoffmann, B. and K.H. Jockel, Diesel exhaust and coal mine dust: lung cancer risk in occupational
settings. Ann N Y Acad Sci, 2006. 1076: p. 253-65.
Karagianes, M.T., R.F. Palmer, and R.H. Busch, Effects of inhaled diesel emissions and coal dust in
rats. Am Ind Hyg Assoc J, 1981. 42(5): p. 382-91.
Castranova, V., et al., The response of rat alveolar macrophages to chronic inhalation of coal
dust and/or diesel exhaust. Environ Res, 1985. 36(2): p. 405-419.
Lewis, T.R., et al., A chronic inhalation toxicity study of diesel engine emissions and coal dust,
alone and combined. Dev Toxicol Environ Sci, 1986. 13: p. 361-80.
Beckett, W., et al., Adverse Effects of Crystalline Silica Exposure. Am J Respir Crit Care Med,
1997. 155: p. 8.
Yassin, A., F. Yebesi, and R. Tingle, Occupational exposure to crystalline silica dust in the United
States, 1988-2003. Environ Health Perspect, 2005. 113(3): p. 255-60.
Hnizdo, E., Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a
review of epidemiological and pathological evidence. Occup Environ Med, 2003. 60(4): p. 237243.
Madl, A.K., et al., State-of-the-science review of the occupational health hazards of crystalline
silica in abrasive blasting operations and related requirements for respiratory protection. J
Toxicol Environ Health B Crit Rev, 2008. 11(7): p. 548-608.
Maciejewska, A., Health effects of occupational exposure to crystalline silica in the light of
current research results. Med Pr, 2014. 65(6): p. 799-818.
Liao, C.M., et al., Ceramics manufacturing contributes to ambient silica air pollution and burden
of lung disease. Environ Sci Pollut Res Int, 2015. 22(19): p. 15067-79.
Gauderman, W.J., et al., The effect of air pollution on lung development from 10 to 18 years of
age. N Engl J Med, 2004. 351(11): p. 1057-67.

212

411.
412.
413.
414.
415.
416.
417.
418.
419.
420.
421.
422.
423.
424.
425.
426.
427.
428.
429.
430.
431.
432.
433.
434.

Garshick, E., et al., Lung cancer in railroad workers exposed to diesel exhaust. Environ Health
Perspect, 2004. 112(15): p. 1539-43.
McCreanor, J., et al., Respiratory effects of exposure to diesel traffic in persons with asthma. N
Engl J Med, 2007. 357(23): p. 2348-58.
Lucking, A.J., et al., Particle traps prevent adverse vascular and prothrombotic effects of diesel
engine exhaust inhalation in men. Circulation, 2011. 123(16): p. 1721-8.
Beatty, T.K. and J.P. Shimshack, School buses, diesel emissions, and respiratory health. J Health
Econ, 2011. 30(5): p. 987-99.
Kachuri, L., et al., Workplace exposure to diesel and gasoline engine exhausts and the risk of
colorectal cancer in Canadian men. Environ Health, 2016. 15(1): p. 4.
Phibbs, B.P., R.E. Sundin, and R.S. Mitchell, Silicosis in Wyoming bentonite workers. Am Rev
Respir Dis, 1971. 103(1): p. 1-17.
Suratt, P.M., et al., Acute silicosis in tombstone sandblasters. Am Rev Respir Dis, 1977. 115(3): p.
521-9.
Seaton, A. and J.W. Cherrie, Quartz exposures and severe silicosis: a role for the hilar nodes.
Occup Environ Med, 1998. 55(6): p. 383-6.
Friedman, G.K., et al., Notes from the field: silicosis in a countertop fabricator - Texas, 2014.
MMWR Morb Mortal Wkly Rep, 2015. 64(5): p. 129-30.
Halldin, C.N., et al., Debilitating lung disease among surface coal miners with no underground
mining tenure. J Occup Environ Med, 2015. 57(1): p. 62-7.
Nicol, L.M., et al., Six cases of silicosis: implications for health surveillance of stonemasons.
Occup Med (Lond), 2015. 65(3): p. 220-5.
Banks, D.E., et al., Silicosis in silica flour workers. Am Rev Respir Dis, 1981. 124(4): p. 445-50.
Saiyed, H.N., et al., Silicosis in slate pencil workers: I. An environmental and medical study. Am J
Ind Med, 1985. 8(2): p. 127-33.
Landrigan, P.J., et al., Silicosis in a grey iron foundry. The persistence of an ancient disease. Scand
J Work Environ Health, 1986. 12(1): p. 32-9.
Ng, T.P. and S.L. Chan, Lung function in relation to silicosis and silica exposure in granite workers.
Eur Respir J, 1992. 5(8): p. 986-91.
Love, R.G., et al., Respiratory health effects of opencast coalmining: a cross sectional study of
current workers. Occup Environ Med, 1997. 54(6): p. 416-23.
Antao, V.C., et al., High prevalence of silicosis among stone carvers in Brazil. Am J Ind Med, 2004.
45(2): p. 194-201.
Ferreira, A.S., et al., Progressive massive fibrosis in silica-exposed workers. High-resolution
computed tomography findings. J Bras Pneumol, 2006. 32(6): p. 523-8.
Ozmen, C.A., et al., MDCT Findings of Denim-Sandblasting-Induced Silicosis: a cross-sectional
study. Environmental Health, 2010. 9(1): p. 17.
Bakan, N.D., et al., Silicosis in denim sandblasters. Chest, 2011. 140(5): p. 1300-1304.
CDC, Pneumoconiosis and advanced occupational lung disease among surface coal miners--16
states, 2010-2011. MMWR Morb Mortal Wkly Rep, 2012. 61(23): p. 431-4.
Siribaddana, A.D., et al., A study on silicosis among employees of a silica processing factory in the
Central Province of Sri Lanka. Ceylon Med J, 2016. 61(1): p. 6-10.
Davis, J.M., J. Ottery, and A. le Roux, The effect of quartz and other non-coal dusts in
coalworkers' pneumoconiosis. Part II. Lung autopsy study. Inhaled Part, 1975. 4 Pt 2: p. 691-702.
Ahlman, K., A.L. Backman, and T. Partanen, A health survey of granite workers in Finland:
radiographic findings, respiratory function, hearing, electric sensory thresholds of the fingers and
subjective symptoms. Scand J Work Environ Health, 1975. 1(2): p. 109-16.

213

435.
436.
437.
438.
439.
440.
441.
442.
443.
444.
445.
446.

447.
448.
449.
450.
451.

452.

453.

454.
455.
456.

Pang, D., S.C. Fu, and G.C. Yang, Relation between exposure to respirable silica dust and silicosis
in a tungsten mine in China. Br J Ind Med, 1992. 49(1): p. 38-40.
Law, Y.W., et al., Characteristics of workers attending the pneumoconiosis clinic for silicosis
assessment in Hong Kong: retrospective study. Hong Kong Med J, 2001. 7(4): p. 343-9.
Akgun, M., et al., Silicosis Appears Inevitable Among Former Denim Sandblasters. Chest, 2015.
148(3): p. 647-654.
Cohen, R.A., et al., Lung Pathology in U.S. Coal Workers with Rapidly Progressive Pneumoconiosis
Implicates Silica and Silicates. Am J Respir Crit Care Med, 2016. 193(6): p. 673-80.
Craighead, J.E. and N.V. Vallyathan, Cryptic pulmonary lesions in workers occupationally exposed
to dust containing silica. Jama, 1980. 244(17): p. 1939-41.
Leigh, J., et al., Quantitative relation between emphysema and lung mineral content in
coalworkers. Occup Environ Med, 1994. 51(6): p. 400-7.
Dufresne, A., et al., Tentative explanatory variable of lung dust concentration in gold miners
exposed to crystalline silica. J Expo Anal Environ Epidemiol, 1998. 8(3): p. 375-98.
Schenker, M.B., et al., Pneumoconiosis from agricultural dust exposure among young California
farmworkers. Environ Health Perspect, 2009. 117(6): p. 988-94.
Nelson, G. and J. Murray, Silicosis at autopsy in platinum mine workers. Occup Med (Lond),
2013. 63(3): p. 196-202.
Hayes, R.B., et al., Lung cancer in motor exhaust-related occupations. American Journal of
Industrial Medicine, 1989. 16(6): p. 685-695.
Steenland, N.K., D.T. Silverman, and R.W. Hornung, Case-control study of lung cancer and truck
driving in the Teamsters Union. American Journal of Public Health, 1990. 80(6): p. 670-674.
Pfluger, D. and C. Minder, A mortality study of lung cancer among Swiss professional drivers:
Accounting for the smoking related fraction by a multivariate approach. Lung Cancer, 1995.
12(3): p. 267.
Boffetta, P., et al., Occupational Exposure to Diesel Engine Emissions and Risk of Cancer in
Swedish Men and Women. Cancer Causes & Control, 2001. 12(4): p. 365-374.
Laden, F., et al., Historical estimation of diesel exhaust exposure in a cohort study of U.S. railroad
workers and lung cancer. Cancer causes & control : CCC, 2006. 17(7): p. 911-919.
Villeneuve, P.J., et al., Occupational exposure to diesel and gasoline emissions and lung cancer in
Canadian men. Environ Res, 2011. 111(5): p. 727-35.
Koh, D.H., et al., Lung cancer risk in professional drivers in Korea: A population-based
proportionate cancer incidence ratio study. J Occup Health, 2015. 57(4): p. 324-30.
Peters, S., et al., Estimation of quantitative levels of diesel exhaust exposure and the health
impact in the contemporary Australian mining industry. Occupational and Environmental
Medicine, 2017. 74(4): p. 282-289.
Olsson, A.C., et al., Exposure to Diesel Motor Exhaust and Lung Cancer Risk in a Pooled Analysis
from Case-Control Studies in Europe and Canada. American Journal of Respiratory and Critical
Care Medicine, 2011. 183(7): p. 941-948.
Pintos, J., et al., Occupational exposure to diesel engine emissions and risk of lung cancer:
evidence from two case-control studies in Montreal, Canada. Occupational and environmental
medicine, 2012. 69(11): p. 787-92.
Lipsett, M. and S. Campleman, Occupational exposure to diesel exhaust and lung cancer: a metaanalysis. American Journal of Public Health, 1999. 89(7): p. 1009-1017.
Tsoi, C.T. and L.A. Tse, Professional drivers and lung cancer: a systematic review and metaanalysis. Occupational and Environmental Medicine, 2012. 69(11): p. 831-836.
Gustafsson, L., et al., Mortality and cancer incidence among Swedish dock workers--a
retrospective cohort study. Scand J Work Environ Health, 1986. 12(1): p. 22-6.
214

457.
458.

459.
460.
461.

462.
463.
464.

465.
466.
467.
468.

469.
470.
471.

472.

473.
474.
475.

476.
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